id	sid	tid	token	lemma	pos
chd-226	1	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-226	1	2	e1	e1	NOUN
chd-226	1	3	cancer	cancer	NOUN
chd-226	1	4	health	health	NOUN
chd-226	1	5	disparities	disparity	NOUN
chd-226	1	6	research	research	VERB
chd-226	1	7	strong	strong	ADJ
chd-226	1	8	tumor	tumor	NOUN
chd-226	1	9	expression	expression	NOUN
chd-226	1	10	of	of	ADP
chd-226	1	11	aldh1a1	aldh1a1	PROPN
chd-226	1	12	is	be	AUX
chd-226	1	13	associated	associate	VERB
chd-226	1	14	with	with	ADP
chd-226	1	15	black	black	ADJ
chd-226	1	16	race	race	NOUN
chd-226	1	17	,	,	PUNCT
chd-226	1	18	metabolic	metabolic	NOUN
chd-226	1	19	disorders	disorder	NOUN
chd-226	1	20	,	,	PUNCT
chd-226	1	21	and	and	CCONJ
chd-226	1	22	poor	poor	ADJ
chd-226	1	23	breast	breast	NOUN
chd-226	1	24	cancer	cancer	NOUN
chd-226	1	25	outcomes	outcome	NOUN
chd-226	1	26	steficah	steficah	VERB
chd-226	1	27	maosa1,2	maosa1,2	PROPN
chd-226	1	28	,	,	PUNCT
chd-226	1	29	lisa	lisa	PROPN
chd-226	1	30	frerichs1	frerichs1	PROPN
chd-226	1	31	,	,	PUNCT
chd-226	1	32	scott	scott	PROPN
chd-226	1	33	d.	d.	PROPN
chd-226	1	34	siegel	siegel	PROPN
chd-226	1	35	,	,	PUNCT
chd-226	1	36	1zachary	1zachary	NUM
chd-226	1	37	schug3	schug3	NOUN
chd-226	1	38	,	,	PUNCT
chd-226	1	39	jennifer	jennifer	PROPN
chd-226	1	40	sims	sim	NOUN
chd-226	1	41	-	-	PUNCT
chd-226	1	42	mourtada1	mourtada1	NOUN
chd-226	1	43	1cawley	1cawley	NUM
chd-226	1	44	center	center	NOUN
chd-226	1	45	for	for	ADP
chd-226	1	46	translational	translational	ADJ
chd-226	1	47	cancer	cancer	NOUN
chd-226	1	48	research	research	NOUN
chd-226	1	49	,	,	PUNCT
chd-226	1	50	helen	helen	PROPN
chd-226	1	51	f	f	PROPN
chd-226	1	52	graham	graham	PROPN
chd-226	1	53	cancer	cancer	PROPN
chd-226	1	54	center	center	PROPN
chd-226	1	55	and	and	CCONJ
chd-226	1	56	research	research	PROPN
chd-226	1	57	institute	institute	PROPN
chd-226	1	58	,	,	PUNCT
chd-226	1	59	christiana	christiana	PROPN
chd-226	1	60	care	care	PROPN
chd-226	1	61	health	health	PROPN
chd-226	1	62	services	services	PROPN
chd-226	1	63	,	,	PUNCT
chd-226	1	64	inc	inc	PROPN
chd-226	1	65	.	.	PROPN
chd-226	1	66	newark	newark	PROPN
chd-226	1	67	,	,	PUNCT
chd-226	1	68	usa	usa	PROPN
chd-226	1	69	2department	2department	NUM
chd-226	1	70	of	of	ADP
chd-226	1	71	biological	biological	ADJ
chd-226	1	72	sciences	science	NOUN
chd-226	1	73	,	,	PUNCT
chd-226	1	74	the	the	DET
chd-226	1	75	university	university	PROPN
chd-226	1	76	of	of	ADP
chd-226	1	77	delaware	delaware	PROPN
chd-226	1	78	,	,	PUNCT
chd-226	1	79	newark	newark	PROPN
chd-226	1	80	,	,	PUNCT
chd-226	1	81	de	de	PROPN
chd-226	1	82	,	,	PUNCT
chd-226	1	83	usa	usa	PROPN
chd-226	1	84	3the	3the	PROPN
chd-226	1	85	wistar	wistar	PROPN
chd-226	1	86	institute	institute	PROPN
chd-226	1	87	,	,	PUNCT
chd-226	1	88	philadelphia	philadelphia	PROPN
chd-226	1	89	,	,	PUNCT
chd-226	1	90	pennsylvania	pennsylvania	PROPN
chd-226	1	91	,	,	PUNCT
chd-226	1	92	usa	usa	PROPN
chd-226	1	93	*	*	PUNCT
chd-226	1	94	corresponding	correspond	VERB
chd-226	1	95	author	author	NOUN
chd-226	1	96	:	:	PUNCT
chd-226	1	97	jennifer	jennifer	PROPN
chd-226	1	98	sims	sim	NOUN
chd-226	1	99	-	-	PUNCT
chd-226	1	100	mourtada	mourtada	PROPN
chd-226	1	101	,	,	PUNCT
chd-226	1	102	email	email	NOUN
chd-226	1	103	:	:	PUNCT
chd-226	1	104	jsimsmourtada@chrisitanacare.org	jsimsmourtada@chrisitanacare.org	PROPN
chd-226	1	105	abstract	abstract	ADJ
chd-226	1	106	racial	racial	ADJ
chd-226	1	107	differences	difference	NOUN
chd-226	1	108	in	in	ADP
chd-226	1	109	tumor	tumor	NOUN
chd-226	1	110	biology	biology	NOUN
chd-226	1	111	may	may	AUX
chd-226	1	112	explain	explain	VERB
chd-226	1	113	worse	bad	ADJ
chd-226	1	114	breast	breast	NOUN
chd-226	1	115	cancer	cancer	NOUN
chd-226	1	116	outcomes	outcome	NOUN
chd-226	1	117	in	in	ADP
chd-226	1	118	black	black	ADJ
chd-226	1	119	women	woman	NOUN
chd-226	1	120	relative	relative	ADJ
chd-226	1	121	to	to	ADP
chd-226	1	122	white	white	ADJ
chd-226	1	123	women	woman	NOUN
chd-226	1	124	.	.	PUNCT
chd-226	2	1	this	this	DET
chd-226	2	2	study	study	NOUN
chd-226	2	3	provides	provide	VERB
chd-226	2	4	a	a	DET
chd-226	2	5	comparative	comparative	ADJ
chd-226	2	6	racial	racial	ADJ
chd-226	2	7	analysis	analysis	NOUN
chd-226	2	8	in	in	ADP
chd-226	2	9	black	black	ADJ
chd-226	2	10	and	and	CCONJ
chd-226	2	11	white	white	ADJ
chd-226	2	12	women	woman	NOUN
chd-226	2	13	in	in	ADP
chd-226	2	14	terms	term	NOUN
chd-226	2	15	of	of	ADP
chd-226	2	16	aldehyde	aldehyde	NOUN
chd-226	2	17	dehydrogenase1	dehydrogenase1	NOUN
chd-226	2	18	member	member	NOUN
chd-226	2	19	a1	a1	NOUN
chd-226	2	20	(	(	PUNCT
chd-226	2	21	aldh1a1	aldh1a1	ADJ
chd-226	2	22	)	)	PUNCT
chd-226	2	23	expression	expression	NOUN
chd-226	2	24	and	and	CCONJ
chd-226	2	25	its	its	PRON
chd-226	2	26	association	association	NOUN
chd-226	2	27	to	to	ADP
chd-226	2	28	clinicopathological	clinicopathological	ADJ
chd-226	2	29	features	feature	NOUN
chd-226	2	30	.	.	PUNCT
chd-226	3	1	expression	expression	NOUN
chd-226	3	2	of	of	ADP
chd-226	3	3	aldh1a1	aldh1a1	PROPN
chd-226	3	4	in	in	ADP
chd-226	3	5	both	both	PRON
chd-226	3	6	tumor	tumor	NOUN
chd-226	3	7	and	and	CCONJ
chd-226	3	8	stromal	stromal	ADJ
chd-226	3	9	cells	cell	NOUN
chd-226	3	10	was	be	AUX
chd-226	3	11	assessed	assess	VERB
chd-226	3	12	by	by	ADP
chd-226	3	13	immunohistochemistry	immunohistochemistry	NOUN
chd-226	3	14	in	in	ADP
chd-226	3	15	tissue	tissue	NOUN
chd-226	3	16	microarrays	microarray	NOUN
chd-226	3	17	containing	contain	VERB
chd-226	3	18	253	253	NUM
chd-226	3	19	breast	breast	NOUN
chd-226	3	20	tumors	tumor	NOUN
chd-226	3	21	including	include	VERB
chd-226	3	22	161	161	NUM
chd-226	3	23	tumors	tumor	NOUN
chd-226	3	24	from	from	ADP
chd-226	3	25	white	white	ADJ
chd-226	3	26	patients	patient	NOUN
chd-226	3	27	and	and	CCONJ
chd-226	3	28	92	92	NUM
chd-226	3	29	from	from	ADP
chd-226	3	30	black	black	ADJ
chd-226	3	31	patients	patient	NOUN
chd-226	3	32	.	.	PUNCT
chd-226	4	1	relationships	relationship	NOUN
chd-226	4	2	to	to	ADP
chd-226	4	3	clinicopathological	clinicopathological	ADJ
chd-226	4	4	features	feature	NOUN
chd-226	4	5	for	for	ADP
chd-226	4	6	strong	strong	ADJ
chd-226	4	7	and	and	CCONJ
chd-226	4	8	moderate	moderate	ADJ
chd-226	4	9	to	to	PART
chd-226	4	10	low	low	ADJ
chd-226	4	11	aldh1a1	aldh1a1	ADV
chd-226	4	12	staining	stain	VERB
chd-226	4	13	were	be	AUX
chd-226	4	14	determined	determine	VERB
chd-226	4	15	using	use	VERB
chd-226	4	16	pearson	pearson	PROPN
chd-226	4	17	’s	’s	PART
chd-226	4	18	chi	chi	PROPN
chd-226	4	19	square	square	PROPN
chd-226	4	20	and	and	CCONJ
chd-226	4	21	an	an	DET
chd-226	4	22	odds	odd	NOUN
chd-226	4	23	ratio	ratio	NOUN
chd-226	4	24	was	be	AUX
chd-226	4	25	determined	determine	VERB
chd-226	4	26	.	.	PUNCT
chd-226	5	1	survival	survival	NOUN
chd-226	5	2	and	and	CCONJ
chd-226	5	3	recurrence	recurrence	NOUN
chd-226	5	4	were	be	AUX
chd-226	5	5	analyzed	analyze	VERB
chd-226	5	6	using	use	VERB
chd-226	5	7	kaplan	kaplan	PROPN
chd-226	5	8	-	-	PUNCT
chd-226	5	9	meier	meier	PROPN
chd-226	5	10	curves	curve	NOUN
chd-226	5	11	and	and	CCONJ
chd-226	5	12	mantel	mantel	NOUN
chd-226	5	13	log	log	NOUN
chd-226	5	14	-	-	PUNCT
chd-226	5	15	rank	rank	NOUN
chd-226	5	16	tests	test	NOUN
chd-226	5	17	.	.	PUNCT
chd-226	6	1	multivariate	multivariate	NOUN
chd-226	6	2	analysis	analysis	NOUN
chd-226	6	3	was	be	AUX
chd-226	6	4	conducted	conduct	VERB
chd-226	6	5	using	use	VERB
chd-226	6	6	cox	cox	PROPN
chd-226	6	7	-	-	PUNCT
chd-226	6	8	proportional	proportional	ADJ
chd-226	6	9	hazards	hazard	NOUN
chd-226	6	10	tests	test	NOUN
chd-226	6	11	.	.	PUNCT
chd-226	7	1	black	black	ADJ
chd-226	7	2	,	,	PUNCT
chd-226	7	3	obese	obese	ADJ
chd-226	7	4	,	,	PUNCT
chd-226	7	5	and	and	CCONJ
chd-226	7	6	diabetic	diabetic	ADJ
chd-226	7	7	women	woman	NOUN
chd-226	7	8	showed	show	VERB
chd-226	7	9	higher	high	ADJ
chd-226	7	10	staining	staining	ADJ
chd-226	7	11	intensity	intensity	NOUN
chd-226	7	12	in	in	ADP
chd-226	7	13	both	both	PRON
chd-226	7	14	tumor	tumor	NOUN
chd-226	7	15	and	and	CCONJ
chd-226	7	16	stromal	stromal	ADJ
chd-226	7	17	tissue	tissue	NOUN
chd-226	7	18	.	.	PUNCT
chd-226	8	1	strong	strong	ADJ
chd-226	8	2	tumor	tumor	NOUN
chd-226	8	3	staining	stain	VERB
chd-226	8	4	was	be	AUX
chd-226	8	5	associated	associate	VERB
chd-226	8	6	with	with	ADP
chd-226	8	7	black	black	ADJ
chd-226	8	8	race	race	NOUN
chd-226	8	9	,	,	PUNCT
chd-226	8	10	advanced	advanced	ADJ
chd-226	8	11	stage	stage	NOUN
chd-226	8	12	,	,	PUNCT
chd-226	8	13	high	high	ADJ
chd-226	8	14	grade	grade	NOUN
chd-226	8	15	obesity	obesity	NOUN
chd-226	8	16	and	and	CCONJ
chd-226	8	17	diabetes	diabetes	NOUN
chd-226	8	18	.	.	PUNCT
chd-226	9	1	strong	strong	ADJ
chd-226	9	2	stromal	stromal	ADJ
chd-226	9	3	expression	expression	NOUN
chd-226	9	4	was	be	AUX
chd-226	9	5	associated	associate	VERB
chd-226	9	6	with	with	ADP
chd-226	9	7	estrogen	estrogen	NOUN
chd-226	9	8	receptor	receptor	NOUN
chd-226	9	9	positivity	positivity	NOUN
chd-226	9	10	,	,	PUNCT
chd-226	9	11	and	and	CCONJ
chd-226	9	12	prediabetes	prediabete	NOUN
chd-226	9	13	/	/	SYM
chd-226	9	14	diabetes	diabetes	NOUN
chd-226	9	15	.	.	PUNCT
chd-226	10	1	patients	patient	NOUN
chd-226	10	2	with	with	ADP
chd-226	10	3	strong	strong	ADJ
chd-226	10	4	tumor	tumor	NOUN
chd-226	10	5	aldh1a1	aldh1a1	ADV
chd-226	10	6	had	have	VERB
chd-226	10	7	shorter	short	ADJ
chd-226	10	8	recurrence	recurrence	NOUN
chd-226	10	9	free	free	ADJ
chd-226	10	10	and	and	CCONJ
chd-226	10	11	overall	overall	ADJ
chd-226	10	12	survival	survival	NOUN
chd-226	10	13	compared	compare	VERB
chd-226	10	14	to	to	ADP
chd-226	10	15	those	those	PRON
chd-226	10	16	with	with	ADP
chd-226	10	17	moderate	moderate	ADJ
chd-226	10	18	to	to	PART
chd-226	10	19	low	low	ADJ
chd-226	10	20	expression	expression	NOUN
chd-226	10	21	.	.	PUNCT
chd-226	11	1	when	when	SCONJ
chd-226	11	2	stratified	stratify	VERB
chd-226	11	3	by	by	ADP
chd-226	11	4	race	race	NOUN
chd-226	11	5	,	,	PUNCT
chd-226	11	6	black	black	ADJ
chd-226	11	7	women	woman	NOUN
chd-226	11	8	with	with	ADP
chd-226	11	9	strong	strong	ADJ
chd-226	11	10	tumor	tumor	NOUN
chd-226	11	11	aldh1a1	aldh1a1	NOUN
chd-226	11	12	expression	expression	NOUN
chd-226	11	13	had	have	VERB
chd-226	11	14	shorter	short	ADJ
chd-226	11	15	recurrence	recurrence	NOUN
chd-226	11	16	free	free	ADJ
chd-226	11	17	survival	survival	NOUN
chd-226	11	18	compared	compare	VERB
chd-226	11	19	to	to	ADP
chd-226	11	20	white	white	ADJ
chd-226	11	21	women	woman	NOUN
chd-226	11	22	.	.	PUNCT
chd-226	12	1	strong	strong	ADJ
chd-226	12	2	tumor	tumor	NOUN
chd-226	12	3	aldh1a1	aldh1a1	ADP
chd-226	12	4	staining	stain	VERB
chd-226	12	5	was	be	AUX
chd-226	12	6	an	an	DET
chd-226	12	7	independent	independent	ADJ
chd-226	12	8	predictor	predictor	NOUN
chd-226	12	9	of	of	ADP
chd-226	12	10	poor	poor	ADJ
chd-226	12	11	overall	overall	ADJ
chd-226	12	12	survival	survival	NOUN
chd-226	12	13	in	in	ADP
chd-226	12	14	both	both	CCONJ
chd-226	12	15	black	black	ADJ
chd-226	12	16	and	and	CCONJ
chd-226	12	17	white	white	ADJ
chd-226	12	18	women	woman	NOUN
chd-226	12	19	.	.	PUNCT
chd-226	13	1	these	these	DET
chd-226	13	2	findings	finding	NOUN
chd-226	13	3	indicate	indicate	VERB
chd-226	13	4	that	that	SCONJ
chd-226	13	5	aldh1a1	aldh1a1	ADV
chd-226	13	6	expression	expression	NOUN
chd-226	13	7	is	be	AUX
chd-226	13	8	associated	associate	VERB
chd-226	13	9	with	with	ADP
chd-226	13	10	poor	poor	ADJ
chd-226	13	11	outcomes	outcome	NOUN
chd-226	13	12	in	in	ADP
chd-226	13	13	breast	breast	NOUN
chd-226	13	14	cancer	cancer	NOUN
chd-226	13	15	,	,	PUNCT
chd-226	13	16	particularly	particularly	ADV
chd-226	13	17	in	in	ADP
chd-226	13	18	black	black	ADJ
chd-226	13	19	women	woman	NOUN
chd-226	13	20	,	,	PUNCT
chd-226	13	21	and	and	CCONJ
chd-226	13	22	provide	provide	VERB
chd-226	13	23	the	the	DET
chd-226	13	24	first	first	ADJ
chd-226	13	25	link	link	NOUN
chd-226	13	26	between	between	ADP
chd-226	13	27	tumor	tumor	NOUN
chd-226	13	28	aldh1a1	aldh1a1	NOUN
chd-226	13	29	expression	expression	NOUN
chd-226	13	30	,	,	PUNCT
chd-226	13	31	obesity	obesity	NOUN
chd-226	13	32	,	,	PUNCT
chd-226	13	33	and	and	CCONJ
chd-226	13	34	diabetes	diabetes	NOUN
chd-226	13	35	.	.	PUNCT
chd-226	14	1	keywords	keyword	NOUN
chd-226	14	2	:	:	PUNCT
chd-226	14	3	breast	breast	NOUN
chd-226	14	4	cancer	cancer	NOUN
chd-226	14	5	;	;	PUNCT
chd-226	14	6	aldh1a1	aldh1a1	ADV
chd-226	14	7	,	,	PUNCT
chd-226	14	8	black	black	ADJ
chd-226	14	9	women	woman	NOUN
chd-226	14	10	,	,	PUNCT
chd-226	14	11	metabolic	metabolic	NOUN
chd-226	14	12	disorders	disorder	NOUN
chd-226	14	13	,	,	PUNCT
chd-226	14	14	obesity	obesity	NOUN
chd-226	14	15	.	.	PUNCT
chd-226	15	1	citation	citation	NOUN
chd-226	15	2	:	:	PUNCT
chd-226	16	1	maosa	maosa	PROPN
chd-226	16	2	s	s	X
chd-226	16	3	et	et	PROPN
chd-226	16	4	al	al	PROPN
chd-226	16	5	(	(	PUNCT
chd-226	16	6	2023	2023	NUM
chd-226	16	7	)	)	PUNCT
chd-226	16	8	strong	strong	ADJ
chd-226	16	9	tumor	tumor	NOUN
chd-226	16	10	expression	expression	NOUN
chd-226	16	11	of	of	ADP
chd-226	16	12	aldh1a1	aldh1a1	PROPN
chd-226	16	13	is	be	AUX
chd-226	16	14	associated	associate	VERB
chd-226	16	15	with	with	ADP
chd-226	16	16	black	black	ADJ
chd-226	16	17	race	race	NOUN
chd-226	16	18	,	,	PUNCT
chd-226	16	19	metabolic	metabolic	NOUN
chd-226	16	20	disorders	disorder	NOUN
chd-226	16	21	,	,	PUNCT
chd-226	16	22	and	and	CCONJ
chd-226	16	23	poor	poor	ADJ
chd-226	16	24	breast	breast	NOUN
chd-226	16	25	cancer	cancer	NOUN
chd-226	16	26	outcomes	outcome	NOUN
chd-226	16	27	.	.	PUNCT
chd-226	17	1	cancer	cancer	NOUN
chd-226	17	2	health	health	NOUN
chd-226	17	3	disparities	disparity	NOUN
chd-226	17	4	7	7	NUM
chd-226	17	5	:	:	PUNCT
chd-226	17	6	e1	e1	NOUN
chd-226	17	7	-	-	PUNCT
chd-226	17	8	14	14	NUM
chd-226	17	9	,	,	PUNCT
chd-226	17	10	doi:10.9777	doi:10.9777	PROPN
chd-226	17	11	/	/	SYM
chd-226	17	12	chd.2023.1003	chd.2023.1003	X
chd-226	17	13	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-226	17	14	e2	e2	PROPN
chd-226	17	15	cancer	cancer	NOUN
chd-226	17	16	health	health	NOUN
chd-226	17	17	disparities	disparity	NOUN
chd-226	17	18	research	research	NOUN
chd-226	17	19	introduction	introduction	NOUN
chd-226	17	20	breast	breast	NOUN
chd-226	17	21	cancer	cancer	NOUN
chd-226	17	22	accounts	account	VERB
chd-226	17	23	for	for	ADP
chd-226	17	24	a	a	DET
chd-226	17	25	third	third	NOUN
chd-226	17	26	of	of	ADP
chd-226	17	27	all	all	DET
chd-226	17	28	cancers	cancer	NOUN
chd-226	17	29	diagnosed	diagnose	VERB
chd-226	17	30	in	in	ADP
chd-226	17	31	black	black	ADJ
chd-226	17	32	women	woman	NOUN
chd-226	17	33	and	and	CCONJ
chd-226	17	34	is	be	AUX
chd-226	17	35	the	the	DET
chd-226	17	36	leading	lead	VERB
chd-226	17	37	cause	cause	NOUN
chd-226	17	38	of	of	ADP
chd-226	17	39	cancer	cancer	NOUN
chd-226	17	40	death	death	NOUN
chd-226	17	41	in	in	ADP
chd-226	17	42	this	this	DET
chd-226	17	43	population	population	NOUN
chd-226	17	44	(	(	PUNCT
chd-226	17	45	giaquinto	giaquinto	NOUN
chd-226	17	46	et	et	PROPN
chd-226	17	47	al	al	PROPN
chd-226	17	48	.	.	PROPN
chd-226	17	49	,	,	PUNCT
chd-226	17	50	2022	2022	NUM
chd-226	17	51	)	)	PUNCT
chd-226	17	52	.	.	PUNCT
chd-226	18	1	although	although	SCONJ
chd-226	18	2	incidence	incidence	NOUN
chd-226	18	3	rates	rate	NOUN
chd-226	18	4	are	be	AUX
chd-226	18	5	comparable	comparable	ADJ
chd-226	18	6	,	,	PUNCT
chd-226	18	7	black	black	ADJ
chd-226	18	8	women	woman	NOUN
chd-226	18	9	are	be	AUX
chd-226	18	10	41	41	NUM
chd-226	18	11	%	%	NOUN
chd-226	18	12	more	more	ADV
chd-226	18	13	likely	likely	ADJ
chd-226	18	14	to	to	PART
chd-226	18	15	die	die	VERB
chd-226	18	16	of	of	ADP
chd-226	18	17	breast	breast	NOUN
chd-226	18	18	cancer	cancer	NOUN
chd-226	18	19	than	than	ADP
chd-226	18	20	white	white	ADJ
chd-226	18	21	women	woman	NOUN
chd-226	18	22	and	and	CCONJ
chd-226	18	23	are	be	AUX
chd-226	18	24	twice	twice	ADV
chd-226	18	25	as	as	ADV
chd-226	18	26	likely	likely	ADJ
chd-226	18	27	to	to	PART
chd-226	18	28	be	be	AUX
chd-226	18	29	diagnosed	diagnose	VERB
chd-226	18	30	with	with	ADP
chd-226	18	31	aggressive	aggressive	ADJ
chd-226	18	32	breast	breast	NOUN
chd-226	18	33	cancers	cancer	NOUN
chd-226	18	34	such	such	ADJ
chd-226	18	35	as	as	ADP
chd-226	18	36	triple	triple	ADJ
chd-226	18	37	negative	negative	ADJ
chd-226	18	38	or	or	CCONJ
chd-226	18	39	inflammatory	inflammatory	ADJ
chd-226	18	40	breast	breast	NOUN
chd-226	18	41	cancers	cancer	NOUN
chd-226	18	42	(	(	PUNCT
chd-226	18	43	giaquinto	giaquinto	NOUN
chd-226	18	44	et	et	PROPN
chd-226	18	45	al	al	PROPN
chd-226	18	46	.	.	PROPN
chd-226	18	47	,	,	PUNCT
chd-226	18	48	2022	2022	NUM
chd-226	18	49	;	;	PUNCT
chd-226	18	50	stringer	stringer	NOUN
chd-226	18	51	-	-	PUNCT
chd-226	18	52	reasor	reasor	PROPN
chd-226	18	53	et	et	PROPN
chd-226	18	54	al	al	PROPN
chd-226	18	55	.	.	PROPN
chd-226	18	56	,	,	PUNCT
chd-226	18	57	2021	2021	NUM
chd-226	18	58	)	)	PUNCT
chd-226	18	59	.	.	PUNCT
chd-226	19	1	higher	high	ADJ
chd-226	19	2	mortality	mortality	NOUN
chd-226	19	3	rates	rate	NOUN
chd-226	19	4	in	in	ADP
chd-226	19	5	black	black	ADJ
chd-226	19	6	women	woman	NOUN
chd-226	19	7	are	be	AUX
chd-226	19	8	attributable	attributable	ADJ
chd-226	19	9	to	to	ADP
chd-226	19	10	many	many	ADJ
chd-226	19	11	factors	factor	NOUN
chd-226	19	12	including	include	VERB
chd-226	19	13	later	later	ADJ
chd-226	19	14	stage	stage	NOUN
chd-226	19	15	of	of	ADP
chd-226	19	16	diagnosis	diagnosis	NOUN
chd-226	19	17	,	,	PUNCT
chd-226	19	18	limited	limited	ADJ
chd-226	19	19	access	access	NOUN
chd-226	19	20	to	to	ADP
chd-226	19	21	high	high	ADJ
chd-226	19	22	quality	quality	NOUN
chd-226	19	23	care	care	NOUN
chd-226	19	24	,	,	PUNCT
chd-226	19	25	unfavorable	unfavorable	ADJ
chd-226	19	26	tumor	tumor	NOUN
chd-226	19	27	characteristics	characteristic	NOUN
chd-226	19	28	,	,	PUNCT
chd-226	19	29	and	and	CCONJ
chd-226	19	30	increased	increase	VERB
chd-226	19	31	prevalence	prevalence	NOUN
chd-226	19	32	of	of	ADP
chd-226	19	33	obesity	obesity	NOUN
chd-226	19	34	and	and	CCONJ
chd-226	19	35	associated	associated	ADJ
chd-226	19	36	comorbidities	comorbiditie	NOUN
chd-226	19	37	(	(	PUNCT
chd-226	19	38	stringer	stringer	NOUN
chd-226	19	39	-	-	PUNCT
chd-226	19	40	reasor	reasor	NOUN
chd-226	19	41	et	et	PROPN
chd-226	19	42	al	al	PROPN
chd-226	19	43	.	.	PROPN
chd-226	19	44	,	,	PUNCT
chd-226	19	45	2021	2021	NUM
chd-226	19	46	)	)	PUNCT
chd-226	19	47	.	.	PUNCT
chd-226	20	1	studies	study	NOUN
chd-226	20	2	examining	examine	VERB
chd-226	20	3	mortality	mortality	NOUN
chd-226	20	4	rates	rate	NOUN
chd-226	20	5	in	in	ADP
chd-226	20	6	black	black	ADJ
chd-226	20	7	and	and	CCONJ
chd-226	20	8	white	white	ADJ
chd-226	20	9	women	woman	NOUN
chd-226	20	10	diagnosed	diagnose	VERB
chd-226	20	11	with	with	ADP
chd-226	20	12	early	early	ADJ
chd-226	20	13	stage	stage	NOUN
chd-226	20	14	breast	breast	NOUN
chd-226	20	15	cancer	cancer	NOUN
chd-226	20	16	show	show	VERB
chd-226	20	17	that	that	SCONJ
chd-226	20	18	after	after	ADP
chd-226	20	19	controlling	control	VERB
chd-226	20	20	for	for	ADP
chd-226	20	21	non	non	ADJ
chd-226	20	22	-	-	ADJ
chd-226	20	23	biological	biological	ADJ
chd-226	20	24	factors	factor	NOUN
chd-226	20	25	such	such	ADJ
chd-226	20	26	as	as	ADP
chd-226	20	27	socioeconomic	socioeconomic	ADJ
chd-226	20	28	status	status	NOUN
chd-226	20	29	,	,	PUNCT
chd-226	20	30	treatment	treatment	NOUN
chd-226	20	31	factors	factor	NOUN
chd-226	20	32	and	and	CCONJ
chd-226	20	33	tumor	tumor	NOUN
chd-226	20	34	stage	stage	NOUN
chd-226	20	35	at	at	ADP
chd-226	20	36	diagnosis	diagnosis	NOUN
chd-226	20	37	,	,	PUNCT
chd-226	20	38	black	black	ADJ
chd-226	20	39	women	woman	NOUN
chd-226	20	40	still	still	ADV
chd-226	20	41	had	have	VERB
chd-226	20	42	higher	high	ADJ
chd-226	20	43	mortality	mortality	NOUN
chd-226	20	44	rates	rate	NOUN
chd-226	20	45	than	than	ADP
chd-226	20	46	white	white	ADJ
chd-226	20	47	women	woman	NOUN
chd-226	20	48	(	(	PUNCT
chd-226	20	49	dietze	dietze	PROPN
chd-226	20	50	et	et	PROPN
chd-226	20	51	al	al	PROPN
chd-226	20	52	.	.	PROPN
chd-226	20	53	,	,	PUNCT
chd-226	20	54	2015	2015	NUM
chd-226	20	55	;	;	PUNCT
chd-226	20	56	hershman	hershman	NOUN
chd-226	20	57	et	et	PROPN
chd-226	20	58	al	al	PROPN
chd-226	20	59	.	.	PROPN
chd-226	20	60	,	,	PUNCT
chd-226	20	61	2005	2005	NUM
chd-226	20	62	;	;	PUNCT
chd-226	20	63	jatoi	jatoi	PROPN
chd-226	20	64	et	et	PROPN
chd-226	20	65	al	al	PROPN
chd-226	20	66	.	.	PROPN
chd-226	20	67	,	,	PUNCT
chd-226	20	68	2003	2003	NUM
chd-226	20	69	;	;	PUNCT
chd-226	20	70	silber	silber	PROPN
chd-226	20	71	et	et	PROPN
chd-226	20	72	al	al	PROPN
chd-226	20	73	.	.	PROPN
chd-226	20	74	,	,	PUNCT
chd-226	20	75	2013	2013	NUM
chd-226	20	76	)	)	PUNCT
chd-226	20	77	.	.	PUNCT
chd-226	21	1	these	these	DET
chd-226	21	2	findings	finding	NOUN
chd-226	21	3	indicate	indicate	VERB
chd-226	21	4	that	that	SCONJ
chd-226	21	5	racial	racial	ADJ
chd-226	21	6	molecular	molecular	ADJ
chd-226	21	7	and	and	CCONJ
chd-226	21	8	genetic	genetic	ADJ
chd-226	21	9	differences	difference	NOUN
chd-226	21	10	in	in	ADP
chd-226	21	11	tumor	tumor	NOUN
chd-226	21	12	biology	biology	NOUN
chd-226	21	13	may	may	AUX
chd-226	21	14	play	play	VERB
chd-226	21	15	a	a	DET
chd-226	21	16	role	role	NOUN
chd-226	21	17	in	in	ADP
chd-226	21	18	poor	poor	ADJ
chd-226	21	19	survival	survival	NOUN
chd-226	21	20	rates	rate	NOUN
chd-226	21	21	among	among	ADP
chd-226	21	22	black	black	ADJ
chd-226	21	23	women	woman	NOUN
chd-226	21	24	.	.	PUNCT
chd-226	22	1	however	however	ADV
chd-226	22	2	,	,	PUNCT
chd-226	22	3	racial	racial	ADJ
chd-226	22	4	differences	difference	NOUN
chd-226	22	5	in	in	ADP
chd-226	22	6	tumor	tumor	NOUN
chd-226	22	7	biology	biology	NOUN
chd-226	22	8	and	and	CCONJ
chd-226	22	9	their	their	PRON
chd-226	22	10	interaction	interaction	NOUN
chd-226	22	11	with	with	ADP
chd-226	22	12	other	other	ADJ
chd-226	22	13	biological	biological	ADJ
chd-226	22	14	and	and	CCONJ
chd-226	22	15	non	non	ADJ
chd-226	22	16	-	-	ADJ
chd-226	22	17	biological	biological	ADJ
chd-226	22	18	risk	risk	NOUN
chd-226	22	19	factors	factor	NOUN
chd-226	22	20	are	be	AUX
chd-226	22	21	poorly	poorly	ADV
chd-226	22	22	understood	understand	VERB
chd-226	22	23	.	.	PUNCT
chd-226	23	1	aldehyde	aldehyde	NOUN
chd-226	23	2	dehydrogenases	dehydrogenase	NOUN
chd-226	23	3	are	be	AUX
chd-226	23	4	detoxifying	detoxify	VERB
chd-226	23	5	enzymes	enzyme	NOUN
chd-226	23	6	that	that	PRON
chd-226	23	7	play	play	VERB
chd-226	23	8	a	a	DET
chd-226	23	9	critical	critical	ADJ
chd-226	23	10	role	role	NOUN
chd-226	23	11	in	in	ADP
chd-226	23	12	metabolism	metabolism	NOUN
chd-226	23	13	of	of	ADP
chd-226	23	14	intracellular	intracellular	ADJ
chd-226	23	15	aldehydes	aldehyde	NOUN
chd-226	23	16	.	.	PUNCT
chd-226	24	1	in	in	ADP
chd-226	24	2	particular	particular	ADJ
chd-226	24	3	,	,	PUNCT
chd-226	24	4	the	the	DET
chd-226	24	5	aldh1	aldh1	PROPN
chd-226	24	6	family	family	NOUN
chd-226	24	7	has	have	AUX
chd-226	24	8	been	be	AUX
chd-226	24	9	implicated	implicate	VERB
chd-226	24	10	in	in	ADP
chd-226	24	11	the	the	DET
chd-226	24	12	oxidation	oxidation	NOUN
chd-226	24	13	of	of	ADP
chd-226	24	14	retinol	retinol	NOUN
chd-226	24	15	to	to	ADP
chd-226	24	16	retinoic	retinoic	NOUN
chd-226	24	17	acid	acid	PROPN
chd-226	24	18	which	which	PRON
chd-226	24	19	impacts	impact	VERB
chd-226	24	20	differentiation	differentiation	NOUN
chd-226	24	21	state	state	NOUN
chd-226	24	22	,	,	PUNCT
chd-226	24	23	treatment	treatment	NOUN
chd-226	24	24	resistance	resistance	NOUN
chd-226	24	25	,	,	PUNCT
chd-226	24	26	and	and	CCONJ
chd-226	24	27	anti	anti	ADJ
chd-226	24	28	-	-	ADJ
chd-226	24	29	tumor	tumor	ADJ
chd-226	24	30	immune	immune	ADJ
chd-226	24	31	responses(ayub	responses(ayub	NOUN
chd-226	24	32	et	et	PROPN
chd-226	24	33	al	al	PROPN
chd-226	24	34	.	.	PROPN
chd-226	24	35	,	,	PUNCT
chd-226	24	36	2015	2015	NUM
chd-226	24	37	;	;	PUNCT
chd-226	24	38	bazewicz	bazewicz	VERB
chd-226	24	39	et	et	PROPN
chd-226	24	40	al	al	PROPN
chd-226	24	41	.	.	PROPN
chd-226	24	42	,	,	PUNCT
chd-226	24	43	2019	2019	NUM
chd-226	24	44	;	;	PUNCT
chd-226	24	45	ginestier	ginesti	ADJ
chd-226	24	46	et	et	PROPN
chd-226	24	47	al	al	PROPN
chd-226	24	48	.	.	PROPN
chd-226	24	49	,	,	PUNCT
chd-226	24	50	2007	2007	NUM
chd-226	24	51	)	)	PUNCT
chd-226	24	52	.	.	PUNCT
chd-226	25	1	strong	strong	ADJ
chd-226	25	2	aldh1	aldh1	NOUN
chd-226	25	3	expressing	express	VERB
chd-226	25	4	cells	cell	NOUN
chd-226	25	5	are	be	AUX
chd-226	25	6	thought	think	VERB
chd-226	25	7	to	to	PART
chd-226	25	8	be	be	AUX
chd-226	25	9	tumor	tumor	NOUN
chd-226	25	10	initiating	initiate	VERB
chd-226	25	11	cells	cell	NOUN
chd-226	25	12	and	and	CCONJ
chd-226	25	13	are	be	AUX
chd-226	25	14	associated	associate	VERB
chd-226	25	15	with	with	ADP
chd-226	25	16	other	other	ADJ
chd-226	25	17	stem	stem	NOUN
chd-226	25	18	-	-	PUNCT
chd-226	25	19	cell	cell	NOUN
chd-226	25	20	markers	marker	NOUN
chd-226	25	21	and	and	CCONJ
chd-226	25	22	poor	poor	ADJ
chd-226	25	23	outcomes	outcome	NOUN
chd-226	25	24	in	in	ADP
chd-226	25	25	breast	breast	NOUN
chd-226	25	26	cancer	cancer	NOUN
chd-226	25	27	(	(	PUNCT
chd-226	25	28	ginestier	ginestier	NOUN
chd-226	25	29	et	et	PROPN
chd-226	25	30	al	al	PROPN
chd-226	25	31	.	.	PROPN
chd-226	25	32	,	,	PUNCT
chd-226	25	33	2007	2007	NUM
chd-226	25	34	)	)	PUNCT
chd-226	25	35	.	.	PUNCT
chd-226	26	1	in	in	ADP
chd-226	26	2	triple	triple	ADJ
chd-226	26	3	negative	negative	ADJ
chd-226	26	4	breast	breast	NOUN
chd-226	26	5	cancer	cancer	NOUN
chd-226	26	6	,	,	PUNCT
chd-226	26	7	aldh1	aldh1	NOUN
chd-226	26	8	expression	expression	NOUN
chd-226	26	9	was	be	AUX
chd-226	26	10	significantly	significantly	ADV
chd-226	26	11	correlated	correlate	VERB
chd-226	26	12	with	with	ADP
chd-226	26	13	larger	large	ADJ
chd-226	26	14	tumor	tumor	NOUN
chd-226	26	15	size	size	NOUN
chd-226	26	16	,	,	PUNCT
chd-226	26	17	later	later	ADJ
chd-226	26	18	stage	stage	NOUN
chd-226	26	19	and	and	CCONJ
chd-226	26	20	is	be	AUX
chd-226	26	21	an	an	DET
chd-226	26	22	independent	independent	ADJ
chd-226	26	23	prognostic	prognostic	ADJ
chd-226	26	24	factor(ma	factor(ma	PROPN
chd-226	26	25	et	et	PROPN
chd-226	26	26	al	al	PROPN
chd-226	26	27	.	.	PROPN
chd-226	26	28	,	,	PUNCT
chd-226	26	29	2017	2017	NUM
chd-226	26	30	)	)	PUNCT
chd-226	26	31	.	.	PUNCT
chd-226	27	1	strong	strong	ADJ
chd-226	27	2	aldh1	aldh1	NOUN
chd-226	27	3	expression	expression	NOUN
chd-226	27	4	has	have	AUX
chd-226	27	5	been	be	AUX
chd-226	27	6	observed	observe	VERB
chd-226	27	7	in	in	ADP
chd-226	27	8	breast	breast	NOUN
chd-226	27	9	cancers	cancer	NOUN
chd-226	27	10	of	of	ADP
chd-226	27	11	black	black	ADJ
chd-226	27	12	women	woman	NOUN
chd-226	27	13	and	and	CCONJ
chd-226	27	14	is	be	AUX
chd-226	27	15	associated	associate	VERB
chd-226	27	16	with	with	ADP
chd-226	27	17	basal	basal	NOUN
chd-226	27	18	like	like	ADP
chd-226	27	19	features	feature	NOUN
chd-226	27	20	in	in	ADP
chd-226	27	21	this	this	DET
chd-226	27	22	population	population	NOUN
chd-226	27	23	(	(	PUNCT
chd-226	27	24	nalwoga	nalwoga	NOUN
chd-226	27	25	et	et	PROPN
chd-226	27	26	al	al	PROPN
chd-226	27	27	.	.	PROPN
chd-226	27	28	,	,	PUNCT
chd-226	27	29	2010	2010	NUM
chd-226	27	30	)	)	PUNCT
chd-226	27	31	.	.	PUNCT
chd-226	28	1	the	the	DET
chd-226	28	2	aldh1	aldh1	PROPN
chd-226	28	3	family	family	NOUN
chd-226	28	4	is	be	AUX
chd-226	28	5	made	make	VERB
chd-226	28	6	up	up	ADP
chd-226	28	7	of	of	ADP
chd-226	28	8	several	several	ADJ
chd-226	28	9	isoforms	isoform	NOUN
chd-226	28	10	,	,	PUNCT
chd-226	28	11	with	with	ADP
chd-226	28	12	aldh1a1	aldh1a1	ADV
chd-226	28	13	and	and	CCONJ
chd-226	28	14	aldh1a3	aldh1a3	PRON
chd-226	28	15	being	be	AUX
chd-226	28	16	the	the	DET
chd-226	28	17	most	most	ADV
chd-226	28	18	important	important	ADJ
chd-226	28	19	for	for	ADP
chd-226	28	20	breast	breast	NOUN
chd-226	28	21	cancer	cancer	NOUN
chd-226	28	22	progression	progression	NOUN
chd-226	28	23	and	and	CCONJ
chd-226	28	24	resistance	resistance	NOUN
chd-226	28	25	(	(	PUNCT
chd-226	28	26	marcato	marcato	PROPN
chd-226	28	27	et	et	PROPN
chd-226	28	28	al	al	PROPN
chd-226	28	29	.	.	PROPN
chd-226	28	30	,	,	PUNCT
chd-226	28	31	2011b	2011b	NUM
chd-226	28	32	)	)	PUNCT
chd-226	28	33	.	.	PUNCT
chd-226	29	1	although	although	SCONJ
chd-226	29	2	both	both	PRON
chd-226	29	3	are	be	AUX
chd-226	29	4	involved	involve	VERB
chd-226	29	5	in	in	ADP
chd-226	29	6	the	the	DET
chd-226	29	7	biosynthesis	biosynthesis	NOUN
chd-226	29	8	of	of	ADP
chd-226	29	9	retinoic	retinoic	ADJ
chd-226	29	10	acid	acid	NOUN
chd-226	29	11	,	,	PUNCT
chd-226	29	12	aldh1a1	aldh1a1	ADV
chd-226	29	13	has	have	VERB
chd-226	29	14	a	a	DET
chd-226	29	15	broader	broad	ADJ
chd-226	29	16	role	role	NOUN
chd-226	29	17	in	in	ADP
chd-226	29	18	the	the	DET
chd-226	29	19	metabolism	metabolism	NOUN
chd-226	29	20	of	of	ADP
chd-226	29	21	intracellular	intracellular	ADJ
chd-226	29	22	and	and	CCONJ
chd-226	29	23	extracellular	extracellular	ADJ
chd-226	29	24	aldehydes	aldehyde	NOUN
chd-226	29	25	(	(	PUNCT
chd-226	29	26	poturnajova	poturnajova	NOUN
chd-226	29	27	et	et	PROPN
chd-226	29	28	al	al	PROPN
chd-226	29	29	.	.	PROPN
chd-226	29	30	,	,	PUNCT
chd-226	29	31	2021	2021	NUM
chd-226	29	32	)	)	PUNCT
chd-226	29	33	.	.	PUNCT
chd-226	30	1	while	while	SCONJ
chd-226	30	2	our	our	PRON
chd-226	30	3	group	group	NOUN
chd-226	30	4	and	and	CCONJ
chd-226	30	5	others	other	NOUN
chd-226	30	6	have	have	AUX
chd-226	30	7	shown	show	VERB
chd-226	30	8	that	that	SCONJ
chd-226	30	9	aldh1a3	aldh1a3	NOUN
chd-226	30	10	expression	expression	NOUN
chd-226	30	11	correlates	correlate	VERB
chd-226	30	12	with	with	ADP
chd-226	30	13	prognosis	prognosis	NOUN
chd-226	30	14	,	,	PUNCT
chd-226	30	15	the	the	DET
chd-226	30	16	role	role	NOUN
chd-226	30	17	of	of	ADP
chd-226	30	18	aldh1a1	aldh1a1	PROPN
chd-226	30	19	has	have	AUX
chd-226	30	20	been	be	AUX
chd-226	30	21	controversial	controversial	ADJ
chd-226	30	22	and	and	CCONJ
chd-226	30	23	may	may	AUX
chd-226	30	24	be	be	AUX
chd-226	30	25	dependent	dependent	ADJ
chd-226	30	26	on	on	ADP
chd-226	30	27	cutoff	cutoff	NOUN
chd-226	30	28	levels	level	NOUN
chd-226	30	29	used	use	VERB
chd-226	30	30	to	to	PART
chd-226	30	31	score	score	VERB
chd-226	30	32	high	high	ADJ
chd-226	30	33	and	and	CCONJ
chd-226	30	34	low	low	ADJ
chd-226	30	35	(	(	PUNCT
chd-226	30	36	althobiti	althobiti	PROPN
chd-226	30	37	et	et	PROPN
chd-226	30	38	al	al	PROPN
chd-226	30	39	.	.	PROPN
chd-226	30	40	,	,	PUNCT
chd-226	30	41	2020	2020	NUM
chd-226	30	42	;	;	PUNCT
chd-226	30	43	opdenaker	opdenaker	NOUN
chd-226	30	44	et	et	PROPN
chd-226	30	45	al	al	PROPN
chd-226	30	46	.	.	PROPN
chd-226	30	47	,	,	PUNCT
chd-226	30	48	2014	2014	NUM
chd-226	30	49	;	;	PUNCT
chd-226	30	50	sjostrom	sjostrom	NUM
chd-226	30	51	et	et	PROPN
chd-226	30	52	al	al	PROPN
chd-226	30	53	.	.	PROPN
chd-226	30	54	,	,	PUNCT
chd-226	30	55	2015	2015	NUM
chd-226	30	56	)	)	PUNCT
chd-226	30	57	.	.	PUNCT
chd-226	31	1	strong	strong	ADJ
chd-226	31	2	mrna	mrna	PROPN
chd-226	31	3	expression	expression	NOUN
chd-226	31	4	of	of	ADP
chd-226	31	5	aldh1a1	aldh1a1	PROPN
chd-226	31	6	has	have	AUX
chd-226	31	7	been	be	AUX
chd-226	31	8	associated	associate	VERB
chd-226	31	9	with	with	ADP
chd-226	31	10	good	good	ADJ
chd-226	31	11	prognosis	prognosis	NOUN
chd-226	31	12	in	in	ADP
chd-226	31	13	triple	triple	ADJ
chd-226	31	14	negative	negative	ADJ
chd-226	31	15	breast	breast	NOUN
chd-226	31	16	cancer	cancer	NOUN
chd-226	31	17	(	(	PUNCT
chd-226	31	18	liu	liu	PROPN
chd-226	31	19	et	et	PROPN
chd-226	31	20	al	al	PROPN
chd-226	31	21	.	.	PROPN
chd-226	31	22	,	,	PUNCT
chd-226	31	23	2015	2015	NUM
chd-226	31	24	)	)	PUNCT
chd-226	31	25	.	.	PUNCT
chd-226	32	1	however	however	ADV
chd-226	32	2	,	,	PUNCT
chd-226	32	3	at	at	ADP
chd-226	32	4	the	the	DET
chd-226	32	5	protein	protein	NOUN
chd-226	32	6	level	level	NOUN
chd-226	32	7	,	,	PUNCT
chd-226	32	8	strong	strong	ADJ
chd-226	32	9	expression	expression	NOUN
chd-226	32	10	in	in	ADP
chd-226	32	11	tumor	tumor	NOUN
chd-226	32	12	cells	cell	NOUN
chd-226	32	13	was	be	AUX
chd-226	32	14	associated	associate	VERB
chd-226	32	15	with	with	ADP
chd-226	32	16	stage	stage	NOUN
chd-226	32	17	,	,	PUNCT
chd-226	32	18	triple	triple	ADJ
chd-226	32	19	negativity	negativity	NOUN
chd-226	32	20	,	,	PUNCT
chd-226	32	21	and	and	CCONJ
chd-226	32	22	poor	poor	ADJ
chd-226	32	23	response	response	NOUN
chd-226	32	24	to	to	ADP
chd-226	32	25	neoadjuvant	neoadjuvant	ADJ
chd-226	32	26	chemotherapy(khoury	chemotherapy(khoury	PROPN
chd-226	32	27	et	et	PROPN
chd-226	32	28	al	al	PROPN
chd-226	32	29	.	.	PROPN
chd-226	32	30	,	,	PUNCT
chd-226	32	31	2012	2012	NUM
chd-226	32	32	)	)	PUNCT
chd-226	32	33	,	,	PUNCT
chd-226	32	34	as	as	ADV
chd-226	32	35	well	well	ADV
chd-226	32	36	as	as	ADP
chd-226	32	37	worse	bad	ADJ
chd-226	32	38	prognosis	prognosis	NOUN
chd-226	32	39	(	(	PUNCT
chd-226	32	40	sjostrom	sjostrom	NOUN
chd-226	32	41	et	et	PROPN
chd-226	32	42	al	al	PROPN
chd-226	32	43	.	.	PROPN
chd-226	32	44	,	,	PUNCT
chd-226	32	45	2015	2015	NUM
chd-226	32	46	)	)	PUNCT
chd-226	32	47	.	.	PUNCT
chd-226	33	1	a	a	DET
chd-226	33	2	recent	recent	ADJ
chd-226	33	3	study	study	NOUN
chd-226	33	4	examining	examine	VERB
chd-226	33	5	expression	expression	NOUN
chd-226	33	6	of	of	ADP
chd-226	33	7	aldh1a1	aldh1a1	PROPN
chd-226	33	8	in	in	ADP
chd-226	33	9	222	222	NUM
chd-226	33	10	breast	breast	NOUN
chd-226	33	11	cancers	cancer	NOUN
chd-226	33	12	from	from	ADP
chd-226	33	13	ghanian	ghanian	ADJ
chd-226	33	14	women	woman	NOUN
chd-226	33	15	reported	report	VERB
chd-226	33	16	tumor	tumor	NOUN
chd-226	33	17	expression	expression	NOUN
chd-226	33	18	in	in	ADP
chd-226	33	19	90	90	NUM
chd-226	33	20	%	%	NOUN
chd-226	33	21	of	of	ADP
chd-226	33	22	tumors	tumor	NOUN
chd-226	33	23	.	.	PUNCT
chd-226	34	1	although	although	SCONJ
chd-226	34	2	no	no	DET
chd-226	34	3	association	association	NOUN
chd-226	34	4	with	with	ADP
chd-226	34	5	clinicopathologic	clinicopathologic	ADJ
chd-226	34	6	features	feature	NOUN
chd-226	34	7	was	be	AUX
chd-226	34	8	observed	observe	VERB
chd-226	34	9	with	with	ADP
chd-226	34	10	aldh1a1	aldh1a1	PROPN
chd-226	34	11	alone	alone	ADV
chd-226	34	12	,	,	PUNCT
chd-226	34	13	significant	significant	ADJ
chd-226	34	14	associations	association	NOUN
chd-226	34	15	with	with	ADP
chd-226	34	16	tumor	tumor	NOUN
chd-226	34	17	stage	stage	NOUN
chd-226	34	18	and	and	CCONJ
chd-226	34	19	grade	grade	NOUN
chd-226	34	20	were	be	AUX
chd-226	34	21	observed	observe	VERB
chd-226	34	22	in	in	ADP
chd-226	34	23	tumors	tumor	NOUN
chd-226	34	24	with	with	ADP
chd-226	34	25	a	a	DET
chd-226	34	26	large	large	ADJ
chd-226	34	27	stem	stem	NOUN
chd-226	34	28	-	-	PUNCT
chd-226	34	29	like	like	ADJ
chd-226	34	30	population	population	NOUN
chd-226	34	31	indicated	indicate	VERB
chd-226	34	32	by	by	ADP
chd-226	34	33	strong	strong	ADJ
chd-226	34	34	staining	staining	NOUN
chd-226	34	35	of	of	ADP
chd-226	34	36	aldh1a1	aldh1a1	PRON
chd-226	34	37	and	and	CCONJ
chd-226	34	38	cd44	cd44	PROPN
chd-226	34	39	and	and	CCONJ
chd-226	34	40	weak	weak	ADJ
chd-226	34	41	cd24	cd24	PROPN
chd-226	34	42	expression	expression	NOUN
chd-226	34	43	(	(	PUNCT
chd-226	34	44	gyan	gyan	PROPN
chd-226	34	45	et	et	PROPN
chd-226	34	46	al	al	PROPN
chd-226	34	47	.	.	PROPN
chd-226	34	48	,	,	PUNCT
chd-226	34	49	2021	2021	NUM
chd-226	34	50	)	)	PUNCT
chd-226	34	51	.	.	PUNCT
chd-226	35	1	outcome	outcome	NOUN
chd-226	35	2	analysis	analysis	NOUN
chd-226	35	3	was	be	AUX
chd-226	35	4	not	not	PART
chd-226	35	5	performed	perform	VERB
chd-226	35	6	in	in	ADP
chd-226	35	7	this	this	DET
chd-226	35	8	study	study	NOUN
chd-226	35	9	.	.	PUNCT
chd-226	36	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-226	36	2	e3	e3	NOUN
chd-226	36	3	cancer	cancer	NOUN
chd-226	36	4	health	health	NOUN
chd-226	36	5	disparities	disparity	NOUN
chd-226	36	6	research	research	VERB
chd-226	36	7	in	in	ADP
chd-226	36	8	addition	addition	NOUN
chd-226	36	9	to	to	ADP
chd-226	36	10	its	its	PRON
chd-226	36	11	possible	possible	ADJ
chd-226	36	12	role	role	NOUN
chd-226	36	13	in	in	ADP
chd-226	36	14	breast	breast	NOUN
chd-226	36	15	cancer	cancer	NOUN
chd-226	36	16	progression	progression	NOUN
chd-226	36	17	,	,	PUNCT
chd-226	36	18	expression	expression	NOUN
chd-226	36	19	of	of	ADP
chd-226	36	20	aldh1a1	aldh1a1	PROPN
chd-226	36	21	has	have	AUX
chd-226	36	22	been	be	AUX
chd-226	36	23	linked	link	VERB
chd-226	36	24	to	to	ADP
chd-226	36	25	lipogenic	lipogenic	NOUN
chd-226	36	26	adipogenesis	adipogenesis	NOUN
chd-226	36	27	,	,	PUNCT
chd-226	36	28	accumulation	accumulation	NOUN
chd-226	36	29	of	of	ADP
chd-226	36	30	visceral	visceral	ADJ
chd-226	36	31	fat	fat	NOUN
chd-226	36	32	(	(	PUNCT
chd-226	36	33	reichert	reichert	PROPN
chd-226	36	34	et	et	PROPN
chd-226	36	35	al	al	PROPN
chd-226	36	36	.	.	PROPN
chd-226	36	37	,	,	PUNCT
chd-226	36	38	2011	2011	NUM
chd-226	36	39	;	;	PUNCT
chd-226	36	40	yasmeen	yasmeen	PROPN
chd-226	36	41	et	et	PROPN
chd-226	36	42	al	al	PROPN
chd-226	36	43	.	.	PROPN
chd-226	36	44	,	,	PUNCT
chd-226	36	45	2013	2013	NUM
chd-226	36	46	)	)	PUNCT
chd-226	36	47	,	,	PUNCT
chd-226	36	48	and	and	CCONJ
chd-226	36	49	altered	alter	VERB
chd-226	36	50	glucose	glucose	NOUN
chd-226	36	51	tolerance	tolerance	NOUN
chd-226	36	52	(	(	PUNCT
chd-226	36	53	petrosino	petrosino	NOUN
chd-226	36	54	et	et	PROPN
chd-226	36	55	al	al	PROPN
chd-226	36	56	.	.	PROPN
chd-226	36	57	,	,	PUNCT
chd-226	36	58	2014	2014	NUM
chd-226	36	59	)	)	PUNCT
chd-226	36	60	in	in	ADP
chd-226	36	61	aldh1a1	aldh1a1	ADP
chd-226	36	62	knock	knock	VERB
chd-226	36	63	-	-	PUNCT
chd-226	36	64	out	out	ADP
chd-226	36	65	mouse	mouse	NOUN
chd-226	36	66	models	model	NOUN
chd-226	36	67	.	.	PUNCT
chd-226	37	1	additionally	additionally	ADV
chd-226	37	2	,	,	PUNCT
chd-226	37	3	aldh1a1	aldh1a1	ADV
chd-226	37	4	expression	expression	NOUN
chd-226	37	5	in	in	ADP
chd-226	37	6	adipose	adipose	ADJ
chd-226	37	7	tissue	tissue	NOUN
chd-226	37	8	in	in	ADP
chd-226	37	9	both	both	DET
chd-226	37	10	mice	mouse	NOUN
chd-226	37	11	and	and	CCONJ
chd-226	37	12	humans	human	NOUN
chd-226	37	13	is	be	AUX
chd-226	37	14	induced	induce	VERB
chd-226	37	15	by	by	ADP
chd-226	37	16	a	a	DET
chd-226	37	17	high	high	ADJ
chd-226	37	18	-	-	PUNCT
chd-226	37	19	fat	fat	NOUN
chd-226	37	20	diet	diet	NOUN
chd-226	37	21	(	(	PUNCT
chd-226	37	22	landrier	landrier	NOUN
chd-226	37	23	et	et	NOUN
chd-226	37	24	al	al	PROPN
chd-226	37	25	.	.	PROPN
chd-226	37	26	,	,	PUNCT
chd-226	37	27	2017	2017	NUM
chd-226	37	28	)	)	PUNCT
chd-226	37	29	.	.	PUNCT
chd-226	38	1	pharmacological	pharmacological	ADJ
chd-226	38	2	inhibition	inhibition	NOUN
chd-226	38	3	of	of	ADP
chd-226	38	4	aldh1a1	aldh1a1	ADV
chd-226	38	5	suppressed	suppress	VERB
chd-226	38	6	weight	weight	NOUN
chd-226	38	7	gain	gain	NOUN
chd-226	38	8	in	in	ADP
chd-226	38	9	a	a	DET
chd-226	38	10	mouse	mouse	NOUN
chd-226	38	11	model	model	NOUN
chd-226	38	12	of	of	ADP
chd-226	38	13	diet	diet	NOUN
chd-226	38	14	-	-	PUNCT
chd-226	38	15	induced	induce	VERB
chd-226	38	16	obesity	obesity	NOUN
chd-226	38	17	and	and	CCONJ
chd-226	38	18	reduced	reduced	ADJ
chd-226	38	19	genes	gene	NOUN
chd-226	38	20	involved	involve	VERB
chd-226	38	21	in	in	ADP
chd-226	38	22	fatty	fatty	NOUN
chd-226	38	23	acid	acid	NOUN
chd-226	38	24	synthesis	synthesis	NOUN
chd-226	38	25	in	in	ADP
chd-226	38	26	multiple	multiple	ADJ
chd-226	38	27	tissues	tissue	NOUN
chd-226	38	28	(	(	PUNCT
chd-226	38	29	haenisch	haenisch	X
chd-226	38	30	et	et	PROPN
chd-226	38	31	al	al	PROPN
chd-226	38	32	.	.	PROPN
chd-226	38	33	,	,	PUNCT
chd-226	38	34	2018	2018	NUM
chd-226	38	35	)	)	PUNCT
chd-226	38	36	.	.	PUNCT
chd-226	39	1	as	as	SCONJ
chd-226	39	2	obesity	obesity	NOUN
chd-226	39	3	is	be	AUX
chd-226	39	4	strongly	strongly	ADV
chd-226	39	5	associated	associate	VERB
chd-226	39	6	with	with	ADP
chd-226	39	7	breast	breast	NOUN
chd-226	39	8	cancer	cancer	NOUN
chd-226	39	9	risk	risk	NOUN
chd-226	39	10	and	and	CCONJ
chd-226	39	11	outcomes	outcome	NOUN
chd-226	39	12	,	,	PUNCT
chd-226	39	13	particularly	particularly	ADV
chd-226	39	14	in	in	ADP
chd-226	39	15	black	black	ADJ
chd-226	39	16	women	woman	NOUN
chd-226	39	17	(	(	PUNCT
chd-226	39	18	dietze	dietze	PROPN
chd-226	39	19	et	et	PROPN
chd-226	39	20	al	al	PROPN
chd-226	39	21	.	.	PROPN
chd-226	39	22	,	,	PUNCT
chd-226	39	23	2018	2018	NUM
chd-226	39	24	;	;	PUNCT
chd-226	39	25	micaily	micaily	ADV
chd-226	39	26	et	et	PROPN
chd-226	39	27	al	al	PROPN
chd-226	39	28	.	.	PROPN
chd-226	39	29	,	,	PUNCT
chd-226	39	30	2021	2021	NUM
chd-226	39	31	)	)	PUNCT
chd-226	39	32	,	,	PUNCT
chd-226	39	33	we	we	PRON
chd-226	39	34	sought	seek	VERB
chd-226	39	35	to	to	PART
chd-226	39	36	investigate	investigate	VERB
chd-226	39	37	the	the	DET
chd-226	39	38	relationship	relationship	NOUN
chd-226	39	39	between	between	ADP
chd-226	39	40	aldh1a1	aldh1a1	NOUN
chd-226	39	41	expression	expression	NOUN
chd-226	39	42	,	,	PUNCT
chd-226	39	43	metabolic	metabolic	NOUN
chd-226	39	44	disorders	disorder	NOUN
chd-226	39	45	and	and	CCONJ
chd-226	39	46	breast	breast	NOUN
chd-226	39	47	cancer	cancer	NOUN
chd-226	39	48	outcomes	outcome	NOUN
chd-226	39	49	in	in	ADP
chd-226	39	50	black	black	ADJ
chd-226	39	51	women	woman	NOUN
chd-226	39	52	compared	compare	VERB
chd-226	39	53	to	to	ADP
chd-226	39	54	white	white	ADJ
chd-226	39	55	women	woman	NOUN
chd-226	39	56	.	.	PUNCT
chd-226	40	1	methods	method	NOUN
chd-226	40	2	patient	patient	VERB
chd-226	40	3	samples	sample	NOUN
chd-226	40	4	and	and	CCONJ
chd-226	40	5	data	datum	NOUN
chd-226	40	6	paraffin	paraffin	NOUN
chd-226	40	7	embedded	embed	VERB
chd-226	40	8	blocks	block	NOUN
chd-226	40	9	of	of	ADP
chd-226	40	10	breast	breast	NOUN
chd-226	40	11	cancer	cancer	NOUN
chd-226	40	12	tissue	tissue	NOUN
chd-226	40	13	were	be	AUX
chd-226	40	14	obtained	obtain	VERB
chd-226	40	15	from	from	ADP
chd-226	40	16	the	the	DET
chd-226	40	17	biorepository	biorepository	NOUN
chd-226	40	18	at	at	ADP
chd-226	40	19	the	the	DET
chd-226	40	20	helen	helen	PROPN
chd-226	40	21	f.	f.	PROPN
chd-226	40	22	graham	graham	PROPN
chd-226	40	23	cancer	cancer	PROPN
chd-226	40	24	center	center	PROPN
chd-226	40	25	and	and	CCONJ
chd-226	40	26	research	research	PROPN
chd-226	40	27	institute	institute	PROPN
chd-226	40	28	(	(	PUNCT
chd-226	40	29	hfgccri	hfgccri	PROPN
chd-226	40	30	)	)	PUNCT
chd-226	40	31	under	under	ADP
chd-226	40	32	a	a	DET
chd-226	40	33	protocol	protocol	NOUN
chd-226	40	34	approved	approve	VERB
chd-226	40	35	by	by	ADP
chd-226	40	36	the	the	DET
chd-226	40	37	institutional	institutional	ADJ
chd-226	40	38	review	review	PROPN
chd-226	40	39	board	board	NOUN
chd-226	40	40	of	of	ADP
chd-226	40	41	christianacare	christianacare	PROPN
chd-226	40	42	,	,	PUNCT
chd-226	40	43	newark	newark	PROPN
chd-226	40	44	,	,	PUNCT
chd-226	40	45	delaware	delaware	PROPN
chd-226	40	46	.	.	PUNCT
chd-226	41	1	blocks	block	NOUN
chd-226	41	2	were	be	AUX
chd-226	41	3	obtained	obtain	VERB
chd-226	41	4	from	from	ADP
chd-226	41	5	patients	patient	NOUN
chd-226	41	6	undergoing	undergo	VERB
chd-226	41	7	surgical	surgical	ADJ
chd-226	41	8	resection	resection	NOUN
chd-226	41	9	from	from	ADP
chd-226	41	10	years	year	NOUN
chd-226	41	11	2007	2007	NUM
chd-226	41	12	-	-	SYM
chd-226	41	13	2011	2011	NUM
chd-226	41	14	and	and	CCONJ
chd-226	41	15	were	be	AUX
chd-226	41	16	pathologically	pathologically	ADV
chd-226	41	17	confirmed	confirm	VERB
chd-226	41	18	as	as	ADP
chd-226	41	19	invasive	invasive	ADJ
chd-226	41	20	breast	breast	NOUN
chd-226	41	21	cancer	cancer	NOUN
chd-226	41	22	tissue	tissue	NOUN
chd-226	41	23	.	.	PUNCT
chd-226	42	1	paraffin	paraffin	NOUN
chd-226	42	2	tissues	tissue	NOUN
chd-226	42	3	were	be	AUX
chd-226	42	4	constructed	construct	VERB
chd-226	42	5	into	into	ADP
chd-226	42	6	4x5	4x5	NUM
chd-226	42	7	tissue	tissue	NOUN
chd-226	42	8	microarrays	microarray	NOUN
chd-226	42	9	(	(	PUNCT
chd-226	42	10	tma	tma	PROPN
chd-226	42	11	)	)	PUNCT
chd-226	42	12	with	with	ADP
chd-226	42	13	a	a	DET
chd-226	42	14	5	5	NUM
chd-226	42	15	mm	mm	NOUN
chd-226	42	16	core	core	NOUN
chd-226	42	17	size	size	NOUN
chd-226	42	18	and	and	CCONJ
chd-226	42	19	cut	cut	VERB
chd-226	42	20	as	as	ADP
chd-226	42	21	serial	serial	ADJ
chd-226	42	22	sections	section	NOUN
chd-226	42	23	.	.	PUNCT
chd-226	43	1	clinicopathologic	clinicopathologic	ADJ
chd-226	43	2	data	datum	NOUN
chd-226	43	3	was	be	AUX
chd-226	43	4	taken	take	VERB
chd-226	43	5	from	from	ADP
chd-226	43	6	patient	patient	ADJ
chd-226	43	7	charts	chart	NOUN
chd-226	43	8	.	.	PUNCT
chd-226	44	1	patients	patient	NOUN
chd-226	44	2	pathologic	pathologic	ADJ
chd-226	44	3	stage	stage	NOUN
chd-226	44	4	of	of	ADP
chd-226	44	5	iia	iia	NOUN
chd-226	44	6	or	or	CCONJ
chd-226	44	7	stronger	strong	ADJ
chd-226	44	8	were	be	AUX
chd-226	44	9	considered	consider	VERB
chd-226	44	10	to	to	PART
chd-226	44	11	have	have	VERB
chd-226	44	12	advanced	advanced	ADJ
chd-226	44	13	breast	breast	NOUN
chd-226	44	14	cancer	cancer	NOUN
chd-226	44	15	,	,	PUNCT
chd-226	44	16	consistent	consistent	ADJ
chd-226	44	17	with	with	ADP
chd-226	44	18	a	a	DET
chd-226	44	19	recent	recent	ADJ
chd-226	44	20	recommendation	recommendation	NOUN
chd-226	44	21	from	from	ADP
chd-226	44	22	the	the	DET
chd-226	44	23	breast	breast	NOUN
chd-226	44	24	cancer	cancer	NOUN
chd-226	44	25	surveillance	surveillance	NOUN
chd-226	44	26	study	study	NOUN
chd-226	44	27	that	that	PRON
chd-226	44	28	found	find	VERB
chd-226	44	29	that	that	SCONJ
chd-226	44	30	this	this	DET
chd-226	44	31	definition	definition	NOUN
chd-226	44	32	most	most	ADV
chd-226	44	33	accurately	accurately	ADV
chd-226	44	34	predicts	predict	VERB
chd-226	44	35	5	5	NUM
chd-226	44	36	year	year	NOUN
chd-226	44	37	survival	survival	NOUN
chd-226	44	38	(	(	PUNCT
chd-226	44	39	kerlikowske	kerlikowske	PROPN
chd-226	44	40	et	et	PROPN
chd-226	44	41	al	al	PROPN
chd-226	44	42	.	.	PROPN
chd-226	44	43	,	,	PUNCT
chd-226	44	44	2021	2021	NUM
chd-226	44	45	)	)	PUNCT
chd-226	44	46	.	.	PUNCT
chd-226	45	1	obesity	obesity	NOUN
chd-226	45	2	was	be	AUX
chd-226	45	3	determined	determine	VERB
chd-226	45	4	by	by	ADP
chd-226	45	5	bmi	bmi	NOUN
chd-226	45	6	at	at	ADP
chd-226	45	7	diagnosis	diagnosis	NOUN
chd-226	45	8	.	.	PUNCT
chd-226	46	1	patients	patient	NOUN
chd-226	46	2	were	be	AUX
chd-226	46	3	coded	code	VERB
chd-226	46	4	as	as	ADP
chd-226	46	5	obese	obese	ADJ
chd-226	46	6	if	if	SCONJ
chd-226	46	7	their	their	PRON
chd-226	46	8	bmi	bmi	NOUN
chd-226	46	9	was	be	AUX
chd-226	46	10	greater	great	ADJ
chd-226	46	11	than	than	ADP
chd-226	46	12	or	or	CCONJ
chd-226	46	13	equal	equal	ADJ
chd-226	46	14	to	to	ADP
chd-226	46	15	30	30	NUM
chd-226	46	16	.	.	PUNCT
chd-226	47	1	data	datum	NOUN
chd-226	47	2	regarding	regard	VERB
chd-226	47	3	other	other	ADJ
chd-226	47	4	co	co	NOUN
chd-226	47	5	-	-	NOUN
chd-226	47	6	morbidities	morbidity	NOUN
chd-226	47	7	such	such	ADJ
chd-226	47	8	as	as	ADP
chd-226	47	9	blood	blood	NOUN
chd-226	47	10	glucose	glucose	NOUN
chd-226	47	11	levels	level	NOUN
chd-226	47	12	(	(	PUNCT
chd-226	47	13	normal	normal	ADJ
chd-226	47	14	or	or	CCONJ
chd-226	47	15	high	high	ADJ
chd-226	47	16	(	(	PUNCT
chd-226	47	17	prediabetes	prediabete	NOUN
chd-226	47	18	)	)	PUNCT
chd-226	47	19	or	or	CCONJ
chd-226	47	20	a	a	DET
chd-226	47	21	clinical	clinical	ADJ
chd-226	47	22	diagnosis	diagnosis	NOUN
chd-226	47	23	of	of	ADP
chd-226	47	24	diabetes	diabetes	NOUN
chd-226	47	25	mellitus	mellitus	NOUN
chd-226	47	26	at	at	ADP
chd-226	47	27	the	the	DET
chd-226	47	28	time	time	NOUN
chd-226	47	29	breast	breast	NOUN
chd-226	47	30	cancer	cancer	NOUN
chd-226	47	31	occurrence	occurrence	NOUN
chd-226	47	32	was	be	AUX
chd-226	47	33	available	available	ADJ
chd-226	47	34	in	in	ADP
chd-226	47	35	the	the	DET
chd-226	47	36	biorepository	biorepository	ADJ
chd-226	47	37	database	database	NOUN
chd-226	47	38	for	for	ADP
chd-226	47	39	a	a	DET
chd-226	47	40	subset	subset	NOUN
chd-226	47	41	of	of	ADP
chd-226	47	42	patients	patient	NOUN
chd-226	47	43	n=130	n=130	PROPN
chd-226	47	44	.	.	PUNCT
chd-226	48	1	immunohistochemical	immunohistochemical	ADJ
chd-226	48	2	procedure	procedure	NOUN
chd-226	48	3	paraffin	paraffin	NOUN
chd-226	48	4	-	-	PUNCT
chd-226	48	5	embedded	embed	VERB
chd-226	48	6	slides	slide	NOUN
chd-226	48	7	were	be	AUX
chd-226	48	8	deparaffinized	deparaffinize	VERB
chd-226	48	9	and	and	CCONJ
chd-226	48	10	rehydrated	rehydrate	VERB
chd-226	48	11	,	,	PUNCT
chd-226	48	12	and	and	CCONJ
chd-226	48	13	heat	heat	VERB
chd-226	48	14	antigen	antigen	PROPN
chd-226	48	15	epitope	epitope	NOUN
chd-226	48	16	retrieval	retrieval	NOUN
chd-226	48	17	was	be	AUX
chd-226	48	18	performed	perform	VERB
chd-226	48	19	for	for	ADP
chd-226	48	20	16	16	NUM
chd-226	48	21	hours	hour	NOUN
chd-226	48	22	at	at	ADP
chd-226	48	23	60	60	NUM
chd-226	48	24	°	°	NOUN
chd-226	48	25	c	c	NOUN
chd-226	48	26	.	.	PUNCT
chd-226	49	1	slides	slide	NOUN
chd-226	49	2	were	be	AUX
chd-226	49	3	stained	stain	VERB
chd-226	49	4	using	use	VERB
chd-226	49	5	a	a	DET
chd-226	49	6	1:100	1:100	NUM
chd-226	49	7	dilution	dilution	NOUN
chd-226	49	8	of	of	ADP
chd-226	49	9	aldh1a1	aldh1a1	ADJ
chd-226	49	10	antibody	antibody	NOUN
chd-226	49	11	(	(	PUNCT
chd-226	49	12	kiefer	kiefer	NOUN
chd-226	49	13	et	et	PROPN
chd-226	49	14	al	al	PROPN
chd-226	49	15	.	.	PROPN
chd-226	49	16	,	,	PUNCT
chd-226	49	17	2012	2012	NUM
chd-226	49	18	)	)	PUNCT
chd-226	49	19	(	(	PUNCT
chd-226	49	20	abcam	abcam	ADV
chd-226	49	21	,	,	PUNCT
chd-226	49	22	clone	clone	NOUN
chd-226	49	23	ep1933y	ep1933y	NOUN
chd-226	49	24	)	)	PUNCT
chd-226	49	25	using	use	VERB
chd-226	49	26	the	the	DET
chd-226	49	27	mouse	mouse	NOUN
chd-226	49	28	and	and	CCONJ
chd-226	49	29	rabbit	rabbit	NOUN
chd-226	49	30	specific	specific	ADJ
chd-226	49	31	hrp	hrp	PROPN
chd-226	49	32	/	/	SYM
chd-226	49	33	aec	aec	PROPN
chd-226	49	34	(	(	PUNCT
chd-226	49	35	abc	abc	PROPN
chd-226	49	36	)	)	PUNCT
chd-226	49	37	detection	detection	NOUN
chd-226	49	38	ihc	ihc	PROPN
chd-226	49	39	kit	kit	NOUN
chd-226	49	40	(	(	PUNCT
chd-226	49	41	abcam	abcam	PROPN
chd-226	49	42	,	,	PUNCT
chd-226	49	43	ab93705	ab93705	NOUN
chd-226	49	44	)	)	PUNCT
chd-226	49	45	,	,	PUNCT
chd-226	49	46	following	follow	VERB
chd-226	49	47	the	the	DET
chd-226	49	48	manufacturer	manufacturer	NOUN
chd-226	49	49	’s	’s	PART
chd-226	49	50	instructions	instruction	NOUN
chd-226	49	51	.	.	PUNCT
chd-226	50	1	negative	negative	ADJ
chd-226	50	2	control	control	NOUN
chd-226	50	3	slides	slide	NOUN
chd-226	50	4	were	be	AUX
chd-226	50	5	performed	perform	VERB
chd-226	50	6	with	with	ADP
chd-226	50	7	the	the	DET
chd-226	50	8	omission	omission	NOUN
chd-226	50	9	of	of	ADP
chd-226	50	10	antibody	antibody	NOUN
chd-226	50	11	.	.	PUNCT
chd-226	51	1	slides	slide	NOUN
chd-226	51	2	were	be	AUX
chd-226	51	3	counterstained	counterstaine	VERB
chd-226	51	4	with	with	ADP
chd-226	51	5	hematoxylin	hematoxylin	PROPN
chd-226	51	6	.	.	PUNCT
chd-226	52	1	images	image	NOUN
chd-226	52	2	were	be	AUX
chd-226	52	3	captured	capture	VERB
chd-226	52	4	using	use	VERB
chd-226	52	5	a	a	DET
chd-226	52	6	zeiss	zeiss	PROPN
chd-226	52	7	axio	axio	PROPN
chd-226	52	8	microscope	microscope	PROPN
chd-226	52	9	using	use	VERB
chd-226	52	10	a	a	DET
chd-226	52	11	10x	10x	NOUN
chd-226	52	12	objective	objective	NOUN
chd-226	52	13	.	.	PUNCT
chd-226	53	1	segmentation	segmentation	NOUN
chd-226	53	2	of	of	ADP
chd-226	53	3	tumor	tumor	NOUN
chd-226	53	4	and	and	CCONJ
chd-226	53	5	stromal	stromal	ADJ
chd-226	53	6	cells	cell	NOUN
chd-226	53	7	and	and	CCONJ
chd-226	53	8	measurement	measurement	NOUN
chd-226	53	9	of	of	ADP
chd-226	53	10	sum	sum	NOUN
chd-226	53	11	intensity	intensity	NOUN
chd-226	53	12	per	per	ADP
chd-226	53	13	area	area	NOUN
chd-226	53	14	was	be	AUX
chd-226	53	15	performed	perform	VERB
chd-226	53	16	using	use	VERB
chd-226	53	17	zen	zen	PROPN
chd-226	53	18	blue	blue	NOUN
chd-226	53	19	.	.	PUNCT
chd-226	54	1	statistical	statistical	ADJ
chd-226	54	2	analysis	analysis	NOUN
chd-226	54	3	statistical	statistical	ADJ
chd-226	54	4	analysis	analysis	NOUN
chd-226	54	5	was	be	AUX
chd-226	54	6	done	do	VERB
chd-226	54	7	in	in	ADP
chd-226	54	8	graph	graph	NOUN
chd-226	54	9	pad	pad	NOUN
chd-226	54	10	prism	prism	NOUN
chd-226	54	11	8	8	NUM
chd-226	54	12	and	and	CCONJ
chd-226	54	13	ibm27	ibm27	PROPN
chd-226	54	14	spss	spss	NOUN
chd-226	54	15	.	.	PUNCT
chd-226	55	1	comparisons	comparison	NOUN
chd-226	55	2	of	of	ADP
chd-226	55	3	staining	stain	VERB
chd-226	55	4	intensity	intensity	NOUN
chd-226	55	5	were	be	AUX
chd-226	55	6	done	do	VERB
chd-226	55	7	using	use	VERB
chd-226	55	8	student	student	NOUN
chd-226	55	9	’s	’s	PART
chd-226	55	10	t	t	NOUN
chd-226	55	11	tests	test	NOUN
chd-226	55	12	.	.	PUNCT
chd-226	56	1	staining	stain	VERB
chd-226	56	2	intensities	intensity	NOUN
chd-226	56	3	were	be	AUX
chd-226	56	4	divided	divide	VERB
chd-226	56	5	into	into	ADP
chd-226	56	6	quartiles	quartile	NOUN
chd-226	56	7	,	,	PUNCT
chd-226	56	8	with	with	SCONJ
chd-226	56	9	the	the	DET
chd-226	56	10	top	top	ADJ
chd-226	56	11	quartile	quartile	NOUN
chd-226	56	12	considered	consider	VERB
chd-226	56	13	to	to	PART
chd-226	56	14	be	be	AUX
chd-226	56	15	strong	strong	ADJ
chd-226	56	16	aldh1a1	aldh1a1	NOUN
chd-226	56	17	expression	expression	NOUN
chd-226	56	18	.	.	PUNCT
chd-226	57	1	relationships	relationship	NOUN
chd-226	57	2	for	for	ADP
chd-226	57	3	strong	strong	ADJ
chd-226	57	4	and	and	CCONJ
chd-226	57	5	moderate	moderate	ADJ
chd-226	57	6	to	to	PART
chd-226	57	7	low	low	ADJ
chd-226	57	8	expressing	express	VERB
chd-226	57	9	slides	slide	NOUN
chd-226	57	10	were	be	AUX
chd-226	57	11	determined	determine	VERB
chd-226	57	12	using	use	VERB
chd-226	57	13	pearson	pearson	PROPN
chd-226	57	14	’s	’s	PART
chd-226	57	15	chi	chi	PROPN
chd-226	57	16	square	square	PROPN
chd-226	57	17	and	and	CCONJ
chd-226	57	18	an	an	DET
chd-226	57	19	odds	odd	NOUN
chd-226	57	20	ratio	ratio	NOUN
chd-226	57	21	was	be	AUX
chd-226	57	22	determined	determine	VERB
chd-226	57	23	.	.	PUNCT
chd-226	58	1	survival	survival	NOUN
chd-226	58	2	and	and	CCONJ
chd-226	58	3	recurrence	recurrence	NOUN
chd-226	58	4	were	be	AUX
chd-226	58	5	analyzed	analyze	VERB
chd-226	58	6	using	use	VERB
chd-226	58	7	kaplan	kaplan	PROPN
chd-226	58	8	-	-	PUNCT
chd-226	58	9	meier	meier	PROPN
chd-226	58	10	curves	curve	NOUN
chd-226	58	11	and	and	CCONJ
chd-226	58	12	mantel	mantel	NOUN
chd-226	58	13	log	log	NOUN
chd-226	58	14	-	-	PUNCT
chd-226	58	15	rank	rank	NOUN
chd-226	58	16	tests	test	NOUN
chd-226	58	17	.	.	PUNCT
chd-226	59	1	multivariate	multivariate	NOUN
chd-226	59	2	analysis	analysis	NOUN
chd-226	59	3	was	be	AUX
chd-226	59	4	conducted	conduct	VERB
chd-226	59	5	using	use	VERB
chd-226	59	6	cox	cox	PROPN
chd-226	59	7	-	-	PUNCT
chd-226	59	8	proportional	proportional	ADJ
chd-226	59	9	hazards	hazard	NOUN
chd-226	59	10	tests	test	NOUN
chd-226	59	11	.	.	PUNCT
chd-226	60	1	results	result	NOUN
chd-226	60	2	patient	patient	ADJ
chd-226	60	3	characteristics	characteristic	NOUN
chd-226	60	4	this	this	DET
chd-226	60	5	study	study	NOUN
chd-226	60	6	was	be	AUX
chd-226	60	7	comprised	comprise	VERB
chd-226	60	8	of	of	ADP
chd-226	60	9	a	a	DET
chd-226	60	10	cohort	cohort	NOUN
chd-226	60	11	of	of	ADP
chd-226	60	12	253	253	NUM
chd-226	60	13	patients	patient	NOUN
chd-226	60	14	with	with	ADP
chd-226	60	15	invasive	invasive	ADJ
chd-226	60	16	ductal	ductal	ADJ
chd-226	60	17	carcinoma	carcinoma	NOUN
chd-226	60	18	,	,	PUNCT
chd-226	60	19	including	include	VERB
chd-226	60	20	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-226	60	21	e4	e4	PROPN
chd-226	60	22	cancer	cancer	NOUN
chd-226	60	23	health	health	NOUN
chd-226	60	24	disparities	disparity	NOUN
chd-226	60	25	research	research	VERB
chd-226	60	26	161	161	NUM
chd-226	60	27	white	white	ADJ
chd-226	60	28	patients	patient	NOUN
chd-226	60	29	and	and	CCONJ
chd-226	60	30	92	92	NUM
chd-226	60	31	black	black	ADJ
chd-226	60	32	patients	patient	NOUN
chd-226	60	33	.	.	PUNCT
chd-226	61	1	patient	patient	ADJ
chd-226	61	2	demographics	demographic	NOUN
chd-226	61	3	and	and	CCONJ
chd-226	61	4	clinicopathologic	clinicopathologic	ADJ
chd-226	61	5	characteristics	characteristic	NOUN
chd-226	61	6	are	be	AUX
chd-226	61	7	summarized	summarize	VERB
chd-226	61	8	in	in	ADP
chd-226	61	9	table	table	NOUN
chd-226	61	10	1	1	NUM
chd-226	61	11	.	.	PUNCT
chd-226	62	1	her2	her2	PROPN
chd-226	62	2	receptor	receptor	NOUN
chd-226	62	3	status	status	NOUN
chd-226	62	4	was	be	AUX
chd-226	62	5	not	not	PART
chd-226	62	6	known	know	VERB
chd-226	62	7	for	for	ADP
chd-226	62	8	all	all	DET
chd-226	62	9	patients	patient	NOUN
chd-226	62	10	and	and	CCONJ
chd-226	62	11	was	be	AUX
chd-226	62	12	not	not	PART
chd-226	62	13	included	include	VERB
chd-226	62	14	in	in	ADP
chd-226	62	15	this	this	DET
chd-226	62	16	analysis	analysis	NOUN
chd-226	62	17	.	.	PUNCT
chd-226	63	1	black	black	ADJ
chd-226	63	2	patients	patient	NOUN
chd-226	63	3	were	be	AUX
chd-226	63	4	significantly	significantly	ADV
chd-226	63	5	more	more	ADV
chd-226	63	6	likely	likely	ADJ
chd-226	63	7	to	to	PART
chd-226	63	8	have	have	VERB
chd-226	63	9	advanced	advanced	ADJ
chd-226	63	10	stage	stage	NOUN
chd-226	63	11	(	(	PUNCT
chd-226	63	12	p=0.022	p=0.022	NOUN
chd-226	63	13	)	)	PUNCT
chd-226	63	14	and	and	CCONJ
chd-226	63	15	have	have	VERB
chd-226	63	16	a	a	DET
chd-226	63	17	bmi	bmi	NOUN
chd-226	63	18	greater	great	ADJ
chd-226	63	19	than	than	ADP
chd-226	63	20	30	30	NUM
chd-226	63	21	at	at	ADP
chd-226	63	22	diagnosis	diagnosis	NOUN
chd-226	63	23	(	(	PUNCT
chd-226	63	24	p=0.013	p=0.013	NOUN
chd-226	63	25	)	)	PUNCT
chd-226	63	26	.	.	PUNCT
chd-226	64	1	no	no	DET
chd-226	64	2	significant	significant	ADJ
chd-226	64	3	racial	racial	ADJ
chd-226	64	4	differences	difference	NOUN
chd-226	64	5	were	be	AUX
chd-226	64	6	observed	observe	VERB
chd-226	64	7	in	in	ADP
chd-226	64	8	tumor	tumor	NOUN
chd-226	64	9	grade	grade	NOUN
chd-226	64	10	and	and	CCONJ
chd-226	64	11	expression	expression	NOUN
chd-226	64	12	of	of	ADP
chd-226	64	13	hormone	hormone	NOUN
chd-226	64	14	receptors	receptor	NOUN
chd-226	64	15	in	in	ADP
chd-226	64	16	this	this	DET
chd-226	64	17	cohort	cohort	NOUN
chd-226	64	18	.	.	PUNCT
chd-226	65	1	table	table	NOUN
chd-226	65	2	1	1	NUM
chd-226	65	3	.	.	PUNCT
chd-226	65	4	comparison	comparison	NOUN
chd-226	65	5	of	of	ADP
chd-226	65	6	patient	patient	ADJ
chd-226	65	7	characteristics	characteristic	NOUN
chd-226	65	8	between	between	ADP
chd-226	65	9	white	white	ADJ
chd-226	65	10	and	and	CCONJ
chd-226	65	11	black	black	ADJ
chd-226	65	12	patients	patient	NOUN
chd-226	65	13	.	.	PUNCT
chd-226	66	1	patient	patient	ADJ
chd-226	66	2	characteristics	characteristic	NOUN
chd-226	66	3	all	all	DET
chd-226	66	4	white	white	ADJ
chd-226	66	5	black	black	ADJ
chd-226	66	6	p	p	NOUN
chd-226	66	7	value	value	NOUN
chd-226	66	8	number	number	NOUN
chd-226	66	9	%	%	NOUN
chd-226	66	10	number	number	NOUN
chd-226	66	11	%	%	NOUN
chd-226	66	12	number	number	NOUN
chd-226	66	13	%	%	NOUN
chd-226	66	14	samples	sample	VERB
chd-226	66	15	253	253	NUM
chd-226	66	16	100	100	NUM
chd-226	66	17	161	161	NUM
chd-226	66	18	63.6	63.6	NUM
chd-226	66	19	92	92	NUM
chd-226	66	20	36.4	36.4	NUM
chd-226	66	21	stage	stage	NOUN
chd-226	66	22	early	early	ADJ
chd-226	66	23	stage	stage	NOUN
chd-226	66	24	156	156	NUM
chd-226	66	25	61.7	61.7	NUM
chd-226	66	26	108	108	NUM
chd-226	66	27	67.1	67.1	NUM
chd-226	66	28	48	48	NUM
chd-226	66	29	52.2	52.2	NUM
chd-226	66	30	0.022	0.022	NUM
chd-226	66	31	*	*	PUNCT
chd-226	66	32	advanced	advance	VERB
chd-226	66	33	97	97	NUM
chd-226	66	34	38.3	38.3	NUM
chd-226	66	35	53	53	NUM
chd-226	66	36	32.9	32.9	NUM
chd-226	66	37	44	44	NUM
chd-226	66	38	47.8	47.8	NUM
chd-226	66	39	grade	grade	NOUN
chd-226	66	40	low	low	ADJ
chd-226	66	41	-	-	PUNCT
chd-226	66	42	medium	medium	NOUN
chd-226	66	43	74	74	NUM
chd-226	66	44	29.2	29.2	NUM
chd-226	66	45	54	54	NUM
chd-226	66	46	33.5	33.5	NUM
chd-226	66	47	23	23	NUM
chd-226	66	48	25	25	NUM
chd-226	66	49	0.164	0.164	NUM
chd-226	66	50	high	high	ADJ
chd-226	66	51	179	179	NUM
chd-226	66	52	70.8	70.8	NUM
chd-226	66	53	110	110	NUM
chd-226	66	54	68.3	68.3	NUM
chd-226	66	55	69	69	NUM
chd-226	66	56	75	75	NUM
chd-226	66	57	hormone	hormone	NOUN
chd-226	66	58	receptor	receptor	NOUN
chd-226	66	59	expression	expression	NOUN
chd-226	66	60	hr+	hr+	NOUN
chd-226	67	1	75	75	NUM
chd-226	67	2	29.6	29.6	NUM
chd-226	67	3	47	47	NUM
chd-226	67	4	29.2	29.2	NUM
chd-226	67	5	28	28	NUM
chd-226	67	6	30.4	30.4	NUM
chd-226	67	7	0.887	0.887	NUM
chd-226	67	8	hr178	hr178	PROPN
chd-226	67	9	70.4	70.4	NUM
chd-226	67	10	114	114	NUM
chd-226	67	11	70.8	70.8	NUM
chd-226	67	12	64	64	NUM
chd-226	67	13	69.6	69.6	NUM
chd-226	67	14	obesity	obesity	NOUN
chd-226	67	15	non	non	ADJ
chd-226	67	16	-	-	ADJ
chd-226	67	17	obese	obese	ADJ
chd-226	67	18	131	131	NUM
chd-226	67	19	51.8	51.8	NUM
chd-226	67	20	93	93	NUM
chd-226	67	21	57.8	57.8	NUM
chd-226	67	22	38	38	NUM
chd-226	67	23	41.3	41.3	NUM
chd-226	67	24	0.013	0.013	NUM
chd-226	67	25	*	*	PUNCT
chd-226	67	26	obese	obese	ADJ
chd-226	67	27	122	122	NUM
chd-226	67	28	48.2	48.2	NUM
chd-226	67	29	68	68	NUM
chd-226	67	30	42.2	42.2	NUM
chd-226	67	31	54	54	NUM
chd-226	67	32	58.7	58.7	NUM
chd-226	67	33	diabetes	diabete	NOUN
chd-226	67	34	normal	normal	ADJ
chd-226	67	35	blood	blood	NOUN
chd-226	67	36	glucose	glucose	NOUN
chd-226	67	37	99	99	NUM
chd-226	67	38	76.10	76.10	NUM
chd-226	67	39	%	%	NOUN
chd-226	67	40	67	67	NUM
chd-226	67	41	79.8	79.8	NUM
chd-226	67	42	32	32	NUM
chd-226	67	43	69.5	69.5	NUM
chd-226	67	44	0.204	0.204	NUM
chd-226	67	45	pre	pre	NOUN
chd-226	67	46	-	-	NOUN
chd-226	67	47	diabetes	diabetes	ADJ
chd-226	67	48	/	/	SYM
chd-226	67	49	diabetes	diabetes	NOUN
chd-226	67	50	31	31	NUM
chd-226	67	51	23.80	23.80	NUM
chd-226	67	52	%	%	NOUN
chd-226	67	53	17	17	NUM
chd-226	67	54	20.1	20.1	NUM
chd-226	67	55	14	14	NUM
chd-226	67	56	30.4	30.4	NUM
chd-226	67	57	strong	strong	ADJ
chd-226	67	58	tumor	tumor	NOUN
chd-226	67	59	aldh1a1	aldh1a1	ADP
chd-226	67	60	staining	stain	VERB
chd-226	67	61	is	be	AUX
chd-226	67	62	associated	associate	VERB
chd-226	67	63	with	with	ADP
chd-226	67	64	race	race	NOUN
chd-226	67	65	,	,	PUNCT
chd-226	67	66	stage	stage	NOUN
chd-226	67	67	,	,	PUNCT
chd-226	67	68	obesity	obesity	NOUN
chd-226	67	69	,	,	PUNCT
chd-226	67	70	and	and	CCONJ
chd-226	67	71	diabetes	diabetes	NOUN
chd-226	67	72	.	.	PUNCT
chd-226	68	1	tumor	tumor	NOUN
chd-226	68	2	microarrays	microarray	NOUN
chd-226	68	3	were	be	AUX
chd-226	68	4	constructed	construct	VERB
chd-226	68	5	from	from	ADP
chd-226	68	6	paraffin	paraffin	NOUN
chd-226	68	7	embedded	embed	VERB
chd-226	68	8	surgical	surgical	ADJ
chd-226	68	9	sections	section	NOUN
chd-226	68	10	and	and	CCONJ
chd-226	68	11	stained	stain	VERB
chd-226	68	12	with	with	ADP
chd-226	68	13	an	an	DET
chd-226	68	14	anti	anti	ADJ
chd-226	68	15	-	-	ADJ
chd-226	68	16	aldh1a1	aldh1a1	ADJ
chd-226	68	17	specific	specific	ADJ
chd-226	68	18	antibody	antibody	NOUN
chd-226	68	19	.	.	PUNCT
chd-226	69	1	tumor	tumor	NOUN
chd-226	69	2	and	and	CCONJ
chd-226	69	3	stromal	stromal	ADJ
chd-226	69	4	staining	stain	VERB
chd-226	69	5	were	be	AUX
chd-226	69	6	quantified	quantify	VERB
chd-226	69	7	as	as	ADP
chd-226	69	8	sum	sum	NOUN
chd-226	69	9	intensity	intensity	NOUN
chd-226	69	10	per	per	ADP
chd-226	69	11	area	area	NOUN
chd-226	69	12	.	.	PUNCT
chd-226	70	1	figure	figure	NOUN
chd-226	70	2	1	1	NUM
chd-226	70	3	shows	show	VERB
chd-226	70	4	representative	representative	ADJ
chd-226	70	5	samples	sample	NOUN
chd-226	70	6	with	with	ADP
chd-226	70	7	strong	strong	ADJ
chd-226	70	8	and	and	CCONJ
chd-226	70	9	low	low	ADJ
chd-226	70	10	tumor	tumor	NOUN
chd-226	70	11	and	and	CCONJ
chd-226	70	12	stromal	stromal	ADJ
chd-226	70	13	staining	staining	NOUN
chd-226	70	14	.	.	PUNCT
chd-226	71	1	significantly	significantly	ADV
chd-226	71	2	stronger	strong	ADJ
chd-226	71	3	staining	stain	VERB
chd-226	71	4	intensities	intensity	NOUN
chd-226	71	5	were	be	AUX
chd-226	71	6	observed	observe	VERB
chd-226	71	7	in	in	ADP
chd-226	71	8	tumor	tumor	NOUN
chd-226	71	9	tissue	tissue	NOUN
chd-226	71	10	from	from	ADP
chd-226	71	11	black	black	ADJ
chd-226	71	12	women	woman	NOUN
chd-226	71	13	,	,	PUNCT
chd-226	71	14	obese	obese	ADJ
chd-226	71	15	women	woman	NOUN
chd-226	71	16	,	,	PUNCT
chd-226	71	17	and	and	CCONJ
chd-226	71	18	women	woman	NOUN
chd-226	71	19	with	with	ADP
chd-226	71	20	prediabetes/	prediabetes/	NUM
chd-226	71	21	diabetes	diabetes	NOUN
chd-226	71	22	(	(	PUNCT
chd-226	71	23	figure	figure	NOUN
chd-226	71	24	2a	2a	NUM
chd-226	71	25	,	,	PUNCT
chd-226	71	26	2c	2c	NOUN
chd-226	71	27	and	and	CCONJ
chd-226	71	28	2e	2e	NUM
chd-226	71	29	)	)	PUNCT
chd-226	71	30	.	.	PUNCT
chd-226	72	1	similarly	similarly	ADV
chd-226	72	2	,	,	PUNCT
chd-226	72	3	significantly	significantly	ADV
chd-226	72	4	stronger	strong	ADJ
chd-226	72	5	staining	stain	VERB
chd-226	72	6	intensities	intensity	NOUN
chd-226	72	7	of	of	ADP
chd-226	72	8	aldh1a1	aldh1a1	ADV
chd-226	72	9	were	be	AUX
chd-226	72	10	found	find	VERB
chd-226	72	11	in	in	ADP
chd-226	72	12	stroma	stroma	NOUN
chd-226	72	13	of	of	ADP
chd-226	72	14	tumors	tumor	NOUN
chd-226	72	15	from	from	ADP
chd-226	72	16	black	black	ADJ
chd-226	72	17	women	woman	NOUN
chd-226	72	18	and	and	CCONJ
chd-226	72	19	women	woman	NOUN
chd-226	72	20	who	who	PRON
chd-226	72	21	were	be	AUX
chd-226	72	22	obese	obese	ADJ
chd-226	72	23	or	or	CCONJ
chd-226	72	24	had	have	VERB
chd-226	72	25	prediabetes	prediabete	NOUN
chd-226	72	26	or	or	CCONJ
chd-226	72	27	diabetes	diabetes	NOUN
chd-226	72	28	(	(	PUNCT
chd-226	72	29	figure	figure	NOUN
chd-226	72	30	2b	2b	NOUN
chd-226	72	31	,	,	PUNCT
chd-226	72	32	2d	2d	NOUN
chd-226	72	33	and	and	CCONJ
chd-226	72	34	2f	2f	NUM
chd-226	72	35	)	)	PUNCT
chd-226	72	36	.	.	PUNCT
chd-226	73	1	strong	strong	ADJ
chd-226	73	2	tumor	tumor	NOUN
chd-226	73	3	staining	stain	VERB
chd-226	73	4	(	(	PUNCT
chd-226	73	5	specimens	specimen	NOUN
chd-226	73	6	that	that	PRON
chd-226	73	7	were	be	AUX
chd-226	73	8	in	in	ADP
chd-226	73	9	the	the	DET
chd-226	73	10	highest	high	ADJ
chd-226	73	11	quartile	quartile	NOUN
chd-226	73	12	)	)	PUNCT
chd-226	73	13	was	be	AUX
chd-226	73	14	associated	associate	VERB
chd-226	73	15	with	with	ADP
chd-226	73	16	black	black	ADJ
chd-226	73	17	race	race	NOUN
chd-226	73	18	(	(	PUNCT
chd-226	73	19	or	or	CCONJ
chd-226	73	20	1.625	1.625	NUM
chd-226	73	21	,	,	PUNCT
chd-226	73	22	ci	ci	PROPN
chd-226	73	23	1.202	1.202	NUM
chd-226	73	24	-	-	SYM
chd-226	73	25	2.270	2.270	NUM
chd-226	73	26	,	,	PUNCT
chd-226	73	27	p=.004	p=.004	NOUN
chd-226	73	28	)	)	PUNCT
chd-226	73	29	,	,	PUNCT
chd-226	73	30	advanced	advanced	ADJ
chd-226	73	31	stage	stage	NOUN
chd-226	73	32	(	(	PUNCT
chd-226	73	33	or	or	CCONJ
chd-226	73	34	1.454	1.454	NUM
chd-226	73	35	,	,	PUNCT
chd-226	73	36	ci	ci	NOUN
chd-226	73	37	1.062	1.062	NUM
chd-226	73	38	-	-	PUNCT
chd-226	73	39	1.991	1.991	NUM
chd-226	73	40	,	,	PUNCT
chd-226	73	41	p=.037	p=.037	NOUN
chd-226	73	42	)	)	PUNCT
chd-226	73	43	,	,	PUNCT
chd-226	73	44	strong	strong	ADJ
chd-226	73	45	grade	grade	NOUN
chd-226	73	46	(	(	PUNCT
chd-226	73	47	or	or	CCONJ
chd-226	73	48	1.209	1.209	NUM
chd-226	73	49	,	,	PUNCT
chd-226	73	50	ci	ci	PROPN
chd-226	73	51	1.036	1.036	NUM
chd-226	73	52	-	-	PUNCT
chd-226	73	53	1.441	1.441	NUM
chd-226	73	54	,	,	PUNCT
chd-226	73	55	p=.039	p=.039	NOUN
chd-226	73	56	)	)	PUNCT
chd-226	73	57	,	,	PUNCT
chd-226	73	58	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-226	73	59	e5	e5	PROPN
chd-226	73	60	cancer	cancer	NOUN
chd-226	73	61	health	health	NOUN
chd-226	73	62	disparities	disparity	NOUN
chd-226	73	63	research	research	VERB
chd-226	73	64	obesity	obesity	NOUN
chd-226	73	65	(	(	PUNCT
chd-226	73	66	or	or	CCONJ
chd-226	73	67	1.441	1.441	NUM
chd-226	73	68	,	,	PUNCT
chd-226	73	69	ci	ci	PROPN
chd-226	73	70	1.122	1.122	NUM
chd-226	73	71	-	-	SYM
chd-226	73	72	1.825	1.825	NUM
chd-226	73	73	,	,	PUNCT
chd-226	73	74	p=0.009	p=0.009	NOUN
chd-226	73	75	)	)	PUNCT
chd-226	73	76	and	and	CCONJ
chd-226	73	77	diabetes	diabetes	NOUN
chd-226	73	78	(	(	PUNCT
chd-226	73	79	or	or	CCONJ
chd-226	73	80	1.599	1.599	NUM
chd-226	73	81	,	,	PUNCT
chd-226	73	82	ci	ci	NOUN
chd-226	73	83	1.206	1.206	NUM
chd-226	73	84	-	-	SYM
chd-226	73	85	2.119	2.119	NUM
chd-226	73	86	,	,	PUNCT
chd-226	73	87	p=.001	p=.001	NOUN
chd-226	73	88	)	)	PUNCT
chd-226	73	89	.	.	PUNCT
chd-226	74	1	although	although	SCONJ
chd-226	74	2	black	black	ADJ
chd-226	74	3	women	woman	NOUN
chd-226	74	4	in	in	ADP
chd-226	74	5	our	our	PRON
chd-226	74	6	cohort	cohort	NOUN
chd-226	74	7	were	be	AUX
chd-226	74	8	more	more	ADV
chd-226	74	9	likely	likely	ADJ
chd-226	74	10	to	to	PART
chd-226	74	11	be	be	AUX
chd-226	74	12	obese	obese	ADJ
chd-226	74	13	and	and	CCONJ
chd-226	74	14	have	have	VERB
chd-226	74	15	advance	advance	NOUN
chd-226	74	16	cancer	cancer	NOUN
chd-226	74	17	,	,	PUNCT
chd-226	74	18	the	the	DET
chd-226	74	19	association	association	NOUN
chd-226	74	20	with	with	ADP
chd-226	74	21	race	race	NOUN
chd-226	74	22	remained	remain	VERB
chd-226	74	23	even	even	ADV
chd-226	74	24	when	when	SCONJ
chd-226	74	25	controlling	control	VERB
chd-226	74	26	for	for	ADP
chd-226	74	27	stage	stage	NOUN
chd-226	74	28	(	(	PUNCT
chd-226	74	29	chi	chi	PROPN
chd-226	74	30	square	square	PROPN
chd-226	74	31	3.414	3.414	NUM
chd-226	74	32	,	,	PUNCT
chd-226	74	33	p=0.036	p=0.036	NOUN
chd-226	74	34	)	)	PUNCT
chd-226	74	35	and	and	CCONJ
chd-226	74	36	obesity	obesity	NOUN
chd-226	74	37	(	(	PUNCT
chd-226	74	38	chi	chi	PROPN
chd-226	74	39	square	square	PROPN
chd-226	74	40	3.328	3.328	NUM
chd-226	74	41	,	,	PUNCT
chd-226	74	42	p=	p=	NOUN
chd-226	74	43	0.038	0.038	NUM
chd-226	74	44	)	)	PUNCT
chd-226	74	45	.	.	PUNCT
chd-226	75	1	strong	strong	ADJ
chd-226	75	2	stromal	stromal	ADJ
chd-226	75	3	expression	expression	NOUN
chd-226	75	4	was	be	AUX
chd-226	75	5	associated	associate	VERB
chd-226	75	6	with	with	ADP
chd-226	75	7	black	black	ADJ
chd-226	75	8	race	race	NOUN
chd-226	75	9	(	(	PUNCT
chd-226	75	10	or	or	CCONJ
chd-226	75	11	1.216	1.216	NUM
chd-226	75	12	,	,	PUNCT
chd-226	75	13	ci	ci	NOUN
chd-226	75	14	0.843	0.843	NUM
chd-226	75	15	-	-	PUNCT
chd-226	75	16	1.624	1.624	NUM
chd-226	75	17	)	)	PUNCT
chd-226	75	18	,	,	PUNCT
chd-226	75	19	estrogen	estrogen	NOUN
chd-226	75	20	receptor	receptor	NOUN
chd-226	75	21	positivity	positivity	NOUN
chd-226	75	22	(	(	PUNCT
chd-226	75	23	or	or	CCONJ
chd-226	75	24	1.47	1.47	NUM
chd-226	75	25	,	,	PUNCT
chd-226	75	26	ci	ci	NOUN
chd-226	75	27	0.996	0.996	NUM
chd-226	75	28	-	-	SYM
chd-226	75	29	2.190	2.190	NUM
chd-226	75	30	,	,	PUNCT
chd-226	75	31	p=0.004	p=0.004	PROPN
chd-226	75	32	)	)	PUNCT
chd-226	75	33	,	,	PUNCT
chd-226	75	34	obesity	obesity	NOUN
chd-226	75	35	(	(	PUNCT
chd-226	75	36	or	or	CCONJ
chd-226	75	37	1.287	1.287	NUM
chd-226	75	38	,	,	PUNCT
chd-226	75	39	ci	ci	NOUN
chd-226	75	40	1.008	1.008	NUM
chd-226	75	41	-	-	SYM
chd-226	75	42	1.643	1.643	NUM
chd-226	75	43	,	,	PUNCT
chd-226	75	44	p=0.044	p=0.044	NOUN
chd-226	75	45	)	)	PUNCT
chd-226	75	46	,	,	PUNCT
chd-226	75	47	and	and	CCONJ
chd-226	75	48	prediabetes	prediabete	NOUN
chd-226	75	49	/	/	SYM
chd-226	75	50	diabetes	diabetes	NOUN
chd-226	75	51	(	(	PUNCT
chd-226	75	52	or	or	CCONJ
chd-226	75	53	1.290	1.290	NUM
chd-226	75	54	,	,	PUNCT
chd-226	75	55	ci	ci	NOUN
chd-226	75	56	0.970	0.970	NUM
chd-226	75	57	-	-	SYM
chd-226	75	58	1.1716	1.1716	NUM
chd-226	75	59	,	,	PUNCT
chd-226	75	60	p=.038	p=.038	NOUN
chd-226	75	61	)	)	PUNCT
chd-226	75	62	.	.	PUNCT
chd-226	76	1	no	no	DET
chd-226	76	2	associations	association	NOUN
chd-226	76	3	between	between	ADP
chd-226	76	4	race	race	NOUN
chd-226	76	5	,	,	PUNCT
chd-226	76	6	stage	stage	NOUN
chd-226	76	7	and	and	CCONJ
chd-226	76	8	grade	grade	NOUN
chd-226	76	9	were	be	AUX
chd-226	76	10	observed	observe	VERB
chd-226	76	11	with	with	ADP
chd-226	76	12	strong	strong	ADJ
chd-226	76	13	stromal	stromal	ADJ
chd-226	76	14	staining	staining	NOUN
chd-226	76	15	.	.	PUNCT
chd-226	77	1	(	(	PUNCT
chd-226	77	2	table	table	NOUN
chd-226	77	3	2	2	NUM
chd-226	77	4	)	)	PUNCT
chd-226	77	5	.	.	PUNCT
chd-226	78	1	figure	figure	NOUN
chd-226	78	2	1	1	NUM
chd-226	78	3	.	.	PUNCT
chd-226	78	4	immunohistochemical	immunohistochemical	ADJ
chd-226	78	5	analysis	analysis	NOUN
chd-226	78	6	of	of	ADP
chd-226	78	7	aldh1a1	aldh1a1	PROPN
chd-226	78	8	.	.	PUNCT
chd-226	79	1	tumor	tumor	NOUN
chd-226	79	2	sections	section	NOUN
chd-226	79	3	showing	show	VERB
chd-226	79	4	strong	strong	ADJ
chd-226	79	5	(	(	PUNCT
chd-226	79	6	top	top	ADJ
chd-226	79	7	quartile	quartile	NOUN
chd-226	79	8	by	by	ADP
chd-226	79	9	staining	stain	VERB
chd-226	79	10	intensity	intensity	NOUN
chd-226	79	11	/	/	SYM
chd-226	79	12	area	area	NOUN
chd-226	79	13	)	)	PUNCT
chd-226	79	14	and	and	CCONJ
chd-226	79	15	low	low	ADJ
chd-226	79	16	/	/	SYM
chd-226	79	17	moderate	moderate	ADJ
chd-226	79	18	(	(	PUNCT
chd-226	79	19	lower	low	ADJ
chd-226	79	20	quartiles	quartile	NOUN
chd-226	79	21	by	by	ADP
chd-226	79	22	staining	stain	VERB
chd-226	79	23	intensity	intensity	NOUN
chd-226	79	24	/	/	SYM
chd-226	79	25	area	area	NOUN
chd-226	79	26	)	)	PUNCT
chd-226	79	27	tumor	tumor	NOUN
chd-226	79	28	and	and	CCONJ
chd-226	79	29	stromal	stromal	ADJ
chd-226	79	30	expression	expression	NOUN
chd-226	79	31	of	of	ADP
chd-226	79	32	aldh1a1	aldh1a1	PROPN
chd-226	79	33	(	(	PUNCT
chd-226	79	34	red	red	ADJ
chd-226	79	35	stain	stain	NOUN
chd-226	79	36	)	)	PUNCT
chd-226	79	37	.	.	PUNCT
chd-226	80	1	nuclei	nucleus	NOUN
chd-226	80	2	were	be	AUX
chd-226	80	3	counterstained	counterstaine	VERB
chd-226	80	4	with	with	ADP
chd-226	80	5	hematoxylin	hematoxylin	PROPN
chd-226	80	6	(	(	PUNCT
chd-226	80	7	blue	blue	ADJ
chd-226	80	8	)	)	PUNCT
chd-226	80	9	.	.	PUNCT
chd-226	81	1	images	image	NOUN
chd-226	81	2	in	in	ADP
chd-226	81	3	panels	panel	NOUN
chd-226	81	4	were	be	AUX
chd-226	81	5	taken	take	VERB
chd-226	81	6	with	with	ADP
chd-226	81	7	a	a	DET
chd-226	81	8	10x	10x	NOUN
chd-226	81	9	objective	objective	NOUN
chd-226	81	10	.	.	PUNCT
chd-226	82	1	images	image	NOUN
chd-226	82	2	in	in	ADP
chd-226	82	3	inserts	insert	NOUN
chd-226	82	4	were	be	AUX
chd-226	82	5	taken	take	VERB
chd-226	82	6	with	with	ADP
chd-226	82	7	40x	40x	NOUN
chd-226	82	8	objective	objective	NOUN
chd-226	82	9	.	.	PUNCT
chd-226	83	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-226	83	2	e6	e6	VERB
chd-226	83	3	cancer	cancer	NOUN
chd-226	83	4	health	health	NOUN
chd-226	83	5	disparities	disparity	NOUN
chd-226	83	6	research	research	NOUN
chd-226	83	7	figure	figure	NOUN
chd-226	83	8	2	2	NUM
chd-226	83	9	.	.	PUNCT
chd-226	83	10	differential	differential	ADJ
chd-226	83	11	tumor	tumor	NOUN
chd-226	83	12	and	and	CCONJ
chd-226	83	13	stromal	stromal	ADJ
chd-226	83	14	expression	expression	NOUN
chd-226	83	15	of	of	ADP
chd-226	83	16	aldh1a1	aldh1a1	PROPN
chd-226	83	17	.	.	PUNCT
chd-226	84	1	expression	expression	NOUN
chd-226	84	2	of	of	ADP
chd-226	84	3	aldh1a1	aldh1a1	ADJ
chd-226	84	4	expression	expression	NOUN
chd-226	84	5	in	in	ADP
chd-226	84	6	white	white	ADJ
chd-226	84	7	vs	vs	ADP
chd-226	84	8	black	black	ADJ
chd-226	84	9	tumor	tumor	NOUN
chd-226	84	10	(	(	PUNCT
chd-226	84	11	a.	a.	NOUN
chd-226	84	12	)	)	PUNCT
chd-226	84	13	and	and	CCONJ
chd-226	84	14	stroma	stroma	PROPN
chd-226	84	15	(	(	PUNCT
chd-226	84	16	b.	b.	PROPN
chd-226	84	17	)	)	PUNCT
chd-226	84	18	,	,	PUNCT
chd-226	84	19	non	non	ADJ
chd-226	84	20	-	-	ADJ
chd-226	84	21	obese	obese	ADJ
chd-226	84	22	vs	vs	ADP
chd-226	84	23	obese	obese	ADJ
chd-226	84	24	tumor	tumor	NOUN
chd-226	84	25	(	(	PUNCT
chd-226	84	26	c.	c.	NOUN
chd-226	84	27	)	)	PUNCT
chd-226	84	28	and	and	CCONJ
chd-226	84	29	stroma	stroma	NOUN
chd-226	84	30	(	(	PUNCT
chd-226	84	31	d.	d.	PROPN
chd-226	84	32	)	)	PUNCT
chd-226	84	33	,	,	PUNCT
chd-226	84	34	and	and	CCONJ
chd-226	84	35	non	non	ADJ
chd-226	84	36	-	-	ADJ
chd-226	84	37	diabetic	diabetic	ADJ
chd-226	84	38	vs	vs	ADP
chd-226	84	39	prediabetic	prediabetic	ADJ
chd-226	84	40	/	/	SYM
chd-226	84	41	diabetic	diabetic	ADJ
chd-226	84	42	tumors	tumor	NOUN
chd-226	84	43	(	(	PUNCT
chd-226	84	44	e.	e.	PROPN
chd-226	84	45	)	)	PUNCT
chd-226	84	46	and	and	CCONJ
chd-226	84	47	stroma	stroma	PROPN
chd-226	84	48	(	(	PUNCT
chd-226	84	49	f.	f.	PROPN
chd-226	84	50	)	)	PUNCT
chd-226	84	51	data	datum	NOUN
chd-226	84	52	is	be	AUX
chd-226	84	53	reported	report	VERB
chd-226	84	54	as	as	ADP
chd-226	84	55	sum	sum	NOUN
chd-226	84	56	red	red	ADJ
chd-226	84	57	intensity	intensity	NOUN
chd-226	84	58	per	per	ADP
chd-226	84	59	area	area	NOUN
chd-226	84	60	.	.	PUNCT
chd-226	85	1	solid	solid	ADJ
chd-226	85	2	red	red	ADJ
chd-226	85	3	lines	line	NOUN
chd-226	85	4	represent	represent	VERB
chd-226	85	5	quartiles	quartile	NOUN
chd-226	85	6	,	,	PUNCT
chd-226	85	7	dotted	dotted	ADJ
chd-226	85	8	red	red	ADJ
chd-226	85	9	line	line	NOUN
chd-226	85	10	represents	represents	AUX
chd-226	85	11	mean	mean	VERB
chd-226	85	12	.	.	PUNCT
chd-226	86	1	*	*	PUNCT
chd-226	86	2	*	*	PUNCT
chd-226	86	3	*	*	PUNCT
chd-226	86	4	*	*	PUNCT
chd-226	86	5	p<.0001	p<.0001	NOUN
chd-226	86	6	;	;	PUNCT
chd-226	86	7	*	*	PUNCT
chd-226	86	8	*	*	PUNCT
chd-226	86	9	*	*	PUNCT
chd-226	86	10	p<.001	p<.001	NOUN
chd-226	86	11	;	;	PUNCT
chd-226	86	12	*	*	PUNCT
chd-226	86	13	p<.05	p<.05	NOUN
chd-226	86	14	.	.	NOUN
chd-226	86	15	table	table	NOUN
chd-226	86	16	2	2	NUM
chd-226	86	17	.	.	PUNCT
chd-226	87	1	association	association	NOUN
chd-226	87	2	of	of	ADP
chd-226	87	3	aldh1a1	aldh1a1	X
chd-226	87	4	strong	strong	ADJ
chd-226	87	5	tumor	tumor	NOUN
chd-226	87	6	and	and	CCONJ
chd-226	87	7	stromal	stromal	ADJ
chd-226	87	8	expression	expression	NOUN
chd-226	87	9	with	with	ADP
chd-226	87	10	patient	patient	ADJ
chd-226	87	11	and	and	CCONJ
chd-226	87	12	tumor	tumor	NOUN
chd-226	87	13	characteristics	characteristic	NOUN
chd-226	87	14	.	.	PUNCT
chd-226	88	1	strong	strong	ADJ
chd-226	88	2	expression	expression	NOUN
chd-226	88	3	of	of	ADP
chd-226	88	4	aldh1a1	aldh1a1	ADJ
chd-226	88	5	tumor	tumor	NOUN
chd-226	88	6	expression	expression	NOUN
chd-226	88	7	stromal	stromal	ADJ
chd-226	88	8	expression	expression	NOUN
chd-226	88	9	or	or	CCONJ
chd-226	88	10	95	95	NUM
chd-226	88	11	%	%	NOUN
chd-226	88	12	ci	ci	NOUN
chd-226	88	13	p	p	NOUN
chd-226	88	14	value	value	NOUN
chd-226	88	15	or	or	CCONJ
chd-226	88	16	95	95	NUM
chd-226	88	17	%	%	NOUN
chd-226	88	18	ci	ci	NOUN
chd-226	88	19	p	p	NOUN
chd-226	88	20	value	value	NOUN
chd-226	88	21	race	race	NOUN
chd-226	88	22	black	black	ADJ
chd-226	88	23	1.625	1.625	NUM
chd-226	88	24	1.202	1.202	NUM
chd-226	88	25	-	-	SYM
chd-226	88	26	2.270	2.270	NUM
chd-226	88	27	0.004	0.004	NUM
chd-226	88	28	*	*	PUNCT
chd-226	88	29	*	*	PUNCT
chd-226	88	30	black	black	ADJ
chd-226	88	31	1.216	1.216	NUM
chd-226	88	32	0.843	0.843	NUM
chd-226	88	33	-	-	SYM
chd-226	88	34	1.624	1.624	NUM
chd-226	88	35	0.156	0.156	NUM
chd-226	88	36	white	white	ADJ
chd-226	88	37	0.704	0.704	NUM
chd-226	88	38	0.537	0.537	NUM
chd-226	88	39	-	-	SYM
chd-226	88	40	0.923	0.923	NUM
chd-226	88	41	white	white	ADJ
chd-226	88	42	0.973	0.973	NUM
chd-226	88	43	0.702	0.702	NUM
chd-226	88	44	-	-	SYM
chd-226	88	45	1.348	1.348	NUM
chd-226	88	46	stage	stage	NOUN
chd-226	88	47	nonadvanced	nonadvance	VERB
chd-226	88	48	0.762	0.762	NUM
chd-226	88	49	0.584	0.584	NUM
chd-226	88	50	-	-	SYM
chd-226	88	51	0.994	0.994	NUM
chd-226	88	52	0.037	0.037	NUM
chd-226	88	53	*	*	PUNCT
chd-226	88	54	nonadvanced	nonadvance	VERB
chd-226	88	55	1.087	1.087	NUM
chd-226	88	56	0.893	0.893	NUM
chd-226	88	57	-	-	SYM
chd-226	88	58	1.321	1.321	NUM
chd-226	88	59	0.439	0.439	NUM
chd-226	88	60	advanced	advance	VERB
chd-226	88	61	1.454	1.454	NUM
chd-226	88	62	1.062	1.062	NUM
chd-226	88	63	-	-	SYM
chd-226	88	64	1.991	1.991	NUM
chd-226	88	65	advanced	advance	VERB
chd-226	88	66	0.875	0.875	NUM
chd-226	88	67	0.640	0.640	NUM
chd-226	88	68	-	-	SYM
chd-226	88	69	1.197	1.197	NUM
chd-226	88	70	grade	grade	NOUN
chd-226	88	71	low	low	ADJ
chd-226	88	72	-	-	PUNCT
chd-226	88	73	medium	medium	NOUN
chd-226	88	74	0.572	0.572	NUM
chd-226	88	75	0.330	0.330	NUM
chd-226	88	76	-	-	SYM
chd-226	88	77	03990	03990	NUM
chd-226	88	78	0.039	0.039	NUM
chd-226	88	79	*	*	PUNCT
chd-226	88	80	low	low	ADJ
chd-226	88	81	-	-	PUNCT
chd-226	88	82	medium	medium	NOUN
chd-226	88	83	1.222	1.222	NUM
chd-226	88	84	0.829	0.829	NUM
chd-226	88	85	-	-	SYM
chd-226	88	86	1.802	1.802	NUM
chd-226	88	87	0.325	0.325	NUM
chd-226	88	88	high	high	ADJ
chd-226	88	89	1.209	1.209	NUM
chd-226	88	90	1.036	1.036	NUM
chd-226	88	91	-	-	SYM
chd-226	88	92	1.411	1.411	NUM
chd-226	88	93	high	high	ADJ
chd-226	88	94	0.921	0.921	NUM
chd-226	88	95	0.786	0.786	NUM
chd-226	88	96	-	-	SYM
chd-226	88	97	1.079	1.079	NUM
chd-226	88	98	estrogen	estrogen	NOUN
chd-226	88	99	receptor	receptor	NOUN
chd-226	88	100	expression	expression	NOUN
chd-226	88	101	er+	er+	NOUN
chd-226	88	102	0.886	0.886	NUM
chd-226	88	103	0.546	0.546	NUM
chd-226	88	104	-	-	SYM
chd-226	88	105	1.372	1.372	NUM
chd-226	88	106	0.324	0.324	NUM
chd-226	88	107	er+	er+	NOUN
chd-226	88	108	1.472	1.472	NUM
chd-226	88	109	0.996	0.996	NUM
chd-226	88	110	-	-	SYM
chd-226	88	111	2.190	2.190	NUM
chd-226	88	112	.004	.004	NUM
chd-226	88	113	*	*	PUNCT
chd-226	88	114	*	*	PUNCT
chd-226	88	115	er1.06	er1.06	PROPN
chd-226	88	116	0.889	0.889	NUM
chd-226	88	117	-	-	SYM
chd-226	88	118	1.262	1.262	NUM
chd-226	88	119	er0.851	er0.851	NOUN
chd-226	88	120	0.725	0.725	NUM
chd-226	88	121	-	-	SYM
chd-226	88	122	1.970	1.970	NUM
chd-226	88	123	obesity	obesity	NOUN
chd-226	88	124	non	non	ADJ
chd-226	88	125	-	-	ADJ
chd-226	88	126	obese	obese	ADJ
chd-226	88	127	0.669	0.669	NUM
chd-226	88	128	0.471	0.471	NUM
chd-226	88	129	-	-	SYM
chd-226	88	130	0.940	0.940	NUM
chd-226	88	131	0.009	0.009	NUM
chd-226	88	132	*	*	PUNCT
chd-226	88	133	*	*	PUNCT
chd-226	88	134	non	non	ADJ
chd-226	88	135	-	-	ADJ
chd-226	88	136	obese	obese	ADJ
chd-226	88	137	0.764	0.764	NUM
chd-226	88	138	0.591	0.591	NUM
chd-226	88	139	-	-	SYM
chd-226	88	140	0.989	0.989	NUM
chd-226	88	141	.044	.044	NUM
chd-226	88	142	*	*	PUNCT
chd-226	88	143	obese	obese	ADJ
chd-226	88	144	1.441	1.441	NUM
chd-226	88	145	1.122	1.122	NUM
chd-226	88	146	-	-	SYM
chd-226	88	147	1.825	1.825	NUM
chd-226	88	148	obese	obese	ADP
chd-226	88	149	1.287	1.287	NUM
chd-226	88	150	1.008	1.008	NUM
chd-226	88	151	-	-	SYM
chd-226	88	152	1.643	1.643	NUM
chd-226	88	153	prediabetes/	prediabetes/	NUM
chd-226	88	154	diabetes	diabetes	NOUN
chd-226	88	155	normal	normal	ADJ
chd-226	88	156	blood	blood	NOUN
chd-226	88	157	glucose	glucose	NOUN
chd-226	88	158	0.281	0.281	NUM
chd-226	88	159	0.148	0.148	NUM
chd-226	88	160	-	-	SYM
chd-226	88	161	0.534	0.534	NUM
chd-226	88	162	0.001	0.001	NUM
chd-226	88	163	*	*	PUNCT
chd-226	88	164	*	*	PUNCT
chd-226	88	165	normal	normal	ADJ
chd-226	88	166	blood	blood	NOUN
chd-226	88	167	glucose	glucose	NOUN
chd-226	88	168	0.517	0.517	NUM
chd-226	88	169	0.283	0.283	NUM
chd-226	88	170	-	-	SYM
chd-226	88	171	0.944	0.944	NUM
chd-226	88	172	.038	.038	NUM
chd-226	88	173	*	*	PUNCT
chd-226	88	174	pre	pre	ADJ
chd-226	88	175	-	-	ADJ
chd-226	88	176	diabetes/	diabetes/	ADJ
chd-226	88	177	diabetes	diabetes	NOUN
chd-226	88	178	1.599	1.599	NUM
chd-226	88	179	1.206	1.206	NUM
chd-226	88	180	-	-	SYM
chd-226	88	181	2.119	2.119	NUM
chd-226	88	182	pre	pre	ADJ
chd-226	88	183	-	-	ADJ
chd-226	88	184	diabetes/	diabetes/	ADJ
chd-226	88	185	diabetes	diabetes	NOUN
chd-226	88	186	1.29	1.29	NUM
chd-226	88	187	0.970	0.970	NUM
chd-226	88	188	-	-	SYM
chd-226	88	189	1.716	1.716	NUM
chd-226	88	190	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-226	88	191	e7	e7	PROPN
chd-226	88	192	cancer	cancer	NOUN
chd-226	88	193	health	health	NOUN
chd-226	88	194	disparities	disparity	NOUN
chd-226	88	195	research	research	VERB
chd-226	88	196	strong	strong	ADJ
chd-226	88	197	tumor	tumor	NOUN
chd-226	88	198	and	and	CCONJ
chd-226	88	199	stromal	stromal	ADJ
chd-226	88	200	aldh1a1	aldh1a1	PUNCT
chd-226	88	201	staining	stain	VERB
chd-226	88	202	are	be	AUX
chd-226	88	203	associated	associate	VERB
chd-226	88	204	with	with	ADP
chd-226	88	205	poor	poor	ADJ
chd-226	88	206	outcomes	outcome	NOUN
chd-226	88	207	to	to	PART
chd-226	88	208	assess	assess	VERB
chd-226	88	209	the	the	DET
chd-226	88	210	role	role	NOUN
chd-226	88	211	of	of	ADP
chd-226	88	212	strong	strong	ADJ
chd-226	88	213	tumor	tumor	NOUN
chd-226	88	214	and	and	CCONJ
chd-226	88	215	stromal	stromal	ADJ
chd-226	88	216	aldh1a1	aldh1a1	ADV
chd-226	88	217	in	in	ADP
chd-226	88	218	breast	breast	NOUN
chd-226	88	219	cancer	cancer	NOUN
chd-226	88	220	outcomes	outcome	NOUN
chd-226	88	221	,	,	PUNCT
chd-226	88	222	kaplan	kaplan	PROPN
chd-226	88	223	-	-	PUNCT
chd-226	88	224	meyer	meyer	PROPN
chd-226	88	225	analysis	analysis	NOUN
chd-226	88	226	was	be	AUX
chd-226	88	227	conducted	conduct	VERB
chd-226	88	228	.	.	PUNCT
chd-226	89	1	shorter	short	ADJ
chd-226	89	2	recurrence	recurrence	NOUN
chd-226	89	3	free	free	ADJ
chd-226	89	4	survival	survival	NOUN
chd-226	89	5	(	(	PUNCT
chd-226	89	6	rfs	rfs	PROPN
chd-226	89	7	,	,	PUNCT
chd-226	89	8	p<0.001	p<0.001	ADJ
chd-226	89	9	)	)	PUNCT
chd-226	89	10	and	and	CCONJ
chd-226	89	11	overall	overall	ADJ
chd-226	89	12	survival	survival	NOUN
chd-226	89	13	(	(	PUNCT
chd-226	89	14	os	os	NOUN
chd-226	89	15	,	,	PUNCT
chd-226	89	16	p<0.001	p<0.001	PROPN
chd-226	89	17	)	)	PUNCT
chd-226	89	18	were	be	AUX
chd-226	89	19	observed	observe	VERB
chd-226	89	20	in	in	ADP
chd-226	89	21	women	woman	NOUN
chd-226	89	22	whose	whose	DET
chd-226	89	23	tumors	tumor	NOUN
chd-226	89	24	had	have	VERB
chd-226	89	25	strong	strong	ADJ
chd-226	89	26	expression	expression	NOUN
chd-226	89	27	of	of	ADP
chd-226	89	28	aldh	aldh	NOUN
chd-226	89	29	compared	compare	VERB
chd-226	89	30	to	to	ADP
chd-226	89	31	those	those	PRON
chd-226	89	32	with	with	ADP
chd-226	89	33	moderate	moderate	ADJ
chd-226	89	34	to	to	PART
chd-226	89	35	low	low	ADJ
chd-226	89	36	expression	expression	NOUN
chd-226	89	37	(	(	PUNCT
chd-226	89	38	figure	figure	NOUN
chd-226	89	39	3a	3a	NUM
chd-226	89	40	&	&	CCONJ
chd-226	89	41	b	b	PROPN
chd-226	89	42	)	)	PUNCT
chd-226	89	43	.	.	PUNCT
chd-226	90	1	interestingly	interestingly	ADV
chd-226	90	2	,	,	PUNCT
chd-226	90	3	of	of	ADP
chd-226	90	4	those	those	PRON
chd-226	90	5	in	in	ADP
chd-226	90	6	the	the	DET
chd-226	90	7	top	top	ADJ
chd-226	90	8	quartile	quartile	NOUN
chd-226	90	9	,	,	PUNCT
chd-226	90	10	black	black	ADJ
chd-226	90	11	women	woman	NOUN
chd-226	90	12	had	have	VERB
chd-226	90	13	worse	bad	ADJ
chd-226	90	14	rfs	rfs	NOUN
chd-226	90	15	compared	compare	VERB
chd-226	90	16	to	to	ADP
chd-226	90	17	white	white	ADJ
chd-226	90	18	women	woman	NOUN
chd-226	90	19	(	(	PUNCT
chd-226	90	20	p=0.011	p=0.011	X
chd-226	90	21	,	,	PUNCT
chd-226	90	22	figure	figure	NOUN
chd-226	90	23	4a	4a	NOUN
chd-226	90	24	.	.	PUNCT
chd-226	90	25	)	)	PUNCT
chd-226	90	26	.	.	PUNCT
chd-226	91	1	no	no	DET
chd-226	91	2	racial	racial	ADJ
chd-226	91	3	differences	difference	NOUN
chd-226	91	4	were	be	AUX
chd-226	91	5	observed	observe	VERB
chd-226	91	6	in	in	ADP
chd-226	91	7	rfs	rfs	PROPN
chd-226	91	8	between	between	ADP
chd-226	91	9	women	woman	NOUN
chd-226	91	10	with	with	ADP
chd-226	91	11	moderate	moderate	ADJ
chd-226	91	12	to	to	PART
chd-226	91	13	low	low	ADJ
chd-226	91	14	tumor	tumor	NOUN
chd-226	91	15	expression	expression	NOUN
chd-226	91	16	of	of	ADP
chd-226	91	17	aldh1a1	aldh1a1	PROPN
chd-226	91	18	(	(	PUNCT
chd-226	91	19	figure	figure	NOUN
chd-226	91	20	4b	4b	PROPN
chd-226	91	21	.	.	PUNCT
chd-226	91	22	)	)	PUNCT
chd-226	91	23	.	.	PUNCT
chd-226	92	1	race	race	NOUN
chd-226	92	2	had	have	VERB
chd-226	92	3	no	no	DET
chd-226	92	4	effect	effect	NOUN
chd-226	92	5	on	on	ADP
chd-226	92	6	overall	overall	ADJ
chd-226	92	7	survival	survival	NOUN
chd-226	92	8	in	in	ADP
chd-226	92	9	either	either	CCONJ
chd-226	92	10	expression	expression	NOUN
chd-226	92	11	groups	group	NOUN
chd-226	92	12	(	(	PUNCT
chd-226	92	13	figure	figure	NOUN
chd-226	92	14	4c&d	4c&d	NUM
chd-226	92	15	)	)	PUNCT
chd-226	92	16	as	as	SCONJ
chd-226	92	17	shorter	short	ADJ
chd-226	92	18	os	os	NOUN
chd-226	92	19	was	be	AUX
chd-226	92	20	observed	observe	VERB
chd-226	92	21	in	in	ADP
chd-226	92	22	both	both	CCONJ
chd-226	92	23	black	black	ADJ
chd-226	92	24	and	and	CCONJ
chd-226	92	25	white	white	ADJ
chd-226	92	26	women	woman	NOUN
chd-226	92	27	with	with	ADP
chd-226	92	28	strong	strong	ADJ
chd-226	92	29	aldh	aldh	ADJ
chd-226	92	30	expression	expression	NOUN
chd-226	92	31	.	.	PUNCT
chd-226	93	1	figure	figure	NOUN
chd-226	93	2	3	3	NUM
chd-226	93	3	.	.	PUNCT
chd-226	93	4	tumor	tumor	NOUN
chd-226	93	5	aldh1a1	aldh1a1	NOUN
chd-226	93	6	expression	expression	NOUN
chd-226	93	7	is	be	AUX
chd-226	93	8	associated	associate	VERB
chd-226	93	9	with	with	ADP
chd-226	93	10	breast	breast	NOUN
chd-226	93	11	cancer	cancer	NOUN
chd-226	93	12	outcomes	outcome	NOUN
chd-226	93	13	.	.	PUNCT
chd-226	94	1	kaplan	kaplan	PROPN
chd-226	94	2	-	-	PUNCT
chd-226	94	3	meier	meier	PROPN
chd-226	94	4	survival	survival	NOUN
chd-226	94	5	curves	curve	NOUN
chd-226	94	6	showing	show	VERB
chd-226	94	7	shorter	short	ADJ
chd-226	94	8	recurrence	recurrence	NOUN
chd-226	94	9	free	free	ADJ
chd-226	94	10	survival	survival	NOUN
chd-226	94	11	(	(	PUNCT
chd-226	94	12	a.	a.	NOUN
chd-226	94	13	)	)	PUNCT
chd-226	94	14	and	and	CCONJ
chd-226	94	15	overall	overall	ADJ
chd-226	94	16	survival	survival	NOUN
chd-226	94	17	(	(	PUNCT
chd-226	94	18	b.	b.	NOUN
chd-226	94	19	)	)	PUNCT
chd-226	94	20	in	in	ADP
chd-226	94	21	patients	patient	NOUN
chd-226	94	22	with	with	ADP
chd-226	94	23	high	high	ADJ
chd-226	94	24	expression	expression	NOUN
chd-226	94	25	of	of	ADP
chd-226	94	26	aldh1a1	aldh1a1	PROPN
chd-226	94	27	(	(	PUNCT
chd-226	94	28	top	top	ADJ
chd-226	94	29	quartile	quartile	NOUN
chd-226	94	30	)	)	PUNCT
chd-226	94	31	.	.	PUNCT
chd-226	95	1	black	black	ADJ
chd-226	95	2	tick	tick	NOUN
chd-226	95	3	marks	mark	NOUN
chd-226	95	4	represent	represent	VERB
chd-226	95	5	censured	censure	VERB
chd-226	95	6	patients	patient	NOUN
chd-226	95	7	.	.	PUNCT
chd-226	96	1	a	a	DET
chd-226	96	2	sample	sample	NOUN
chd-226	96	3	was	be	AUX
chd-226	96	4	considered	consider	VERB
chd-226	96	5	to	to	PART
chd-226	96	6	have	have	VERB
chd-226	96	7	strong	strong	ADJ
chd-226	96	8	staining	stain	VERB
chd-226	96	9	if	if	SCONJ
chd-226	96	10	its	its	PRON
chd-226	96	11	staining	stain	VERB
chd-226	96	12	index	index	NOUN
chd-226	96	13	was	be	AUX
chd-226	96	14	in	in	ADP
chd-226	96	15	the	the	DET
chd-226	96	16	top	top	ADJ
chd-226	96	17	quartile	quartile	NOUN
chd-226	96	18	.	.	PUNCT
chd-226	97	1	lower	low	ADJ
chd-226	97	2	quartiles	quartile	NOUN
chd-226	97	3	were	be	AUX
chd-226	97	4	considered	consider	VERB
chd-226	97	5	to	to	PART
chd-226	97	6	have	have	VERB
chd-226	97	7	low	low	ADJ
chd-226	97	8	to	to	ADP
chd-226	97	9	moderate	moderate	ADJ
chd-226	97	10	staining	staining	NOUN
chd-226	97	11	.	.	PUNCT
chd-226	98	1	sims	sims	PROPN
chd-226	98	2	mourtada	mourtada	PROPN
chd-226	98	3	,	,	PUNCT
chd-226	98	4	jennifer	jennifer	PROPN
chd-226	98	5	figures	figure	NOUN
chd-226	98	6	are	be	AUX
chd-226	98	7	missing	miss	VERB
chd-226	98	8	title	title	NOUN
chd-226	98	9	rfs	rfs	NOUN
chd-226	98	10	on	on	ADP
chd-226	98	11	the	the	DET
chd-226	98	12	axis	axis	NOUN
chd-226	98	13	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-226	98	14	e8	e8	PROPN
chd-226	98	15	cancer	cancer	NOUN
chd-226	98	16	health	health	NOUN
chd-226	98	17	disparities	disparity	NOUN
chd-226	98	18	research	research	NOUN
chd-226	98	19	figure	figure	NOUN
chd-226	98	20	4	4	NUM
chd-226	98	21	.	.	PUNCT
chd-226	98	22	high	high	ADJ
chd-226	98	23	aldh1a1	aldh1a1	ADV
chd-226	98	24	is	be	AUX
chd-226	98	25	associated	associate	VERB
chd-226	98	26	with	with	ADP
chd-226	98	27	shorter	short	ADJ
chd-226	98	28	rfs	rfs	NOUN
chd-226	98	29	in	in	ADP
chd-226	98	30	black	black	ADJ
chd-226	98	31	women	woman	NOUN
chd-226	98	32	compared	compare	VERB
chd-226	98	33	to	to	ADP
chd-226	98	34	white	white	ADJ
chd-226	98	35	women	woman	NOUN
chd-226	98	36	.	.	PUNCT
chd-226	99	1	(	(	PUNCT
chd-226	99	2	a.	a.	NOUN
chd-226	99	3	)	)	PUNCT
chd-226	99	4	.	.	PUNCT
chd-226	100	1	when	when	SCONJ
chd-226	100	2	stratified	stratify	VERB
chd-226	100	3	by	by	ADP
chd-226	100	4	race	race	NOUN
chd-226	100	5	shorter	short	ADJ
chd-226	100	6	rfs	rfs	NOUN
chd-226	100	7	is	be	AUX
chd-226	100	8	observed	observe	VERB
chd-226	100	9	in	in	ADP
chd-226	100	10	black	black	ADJ
chd-226	100	11	women	woman	NOUN
chd-226	100	12	with	with	ADP
chd-226	100	13	strong	strong	ADJ
chd-226	100	14	tumor	tumor	NOUN
chd-226	100	15	(	(	PUNCT
chd-226	100	16	staining	stain	VERB
chd-226	100	17	intensity	intensity	NOUN
chd-226	100	18	in	in	ADP
chd-226	100	19	top	top	ADJ
chd-226	100	20	quartile	quartile	NOUN
chd-226	100	21	)	)	PUNCT
chd-226	100	22	aldh1a1	aldh1a1	ADV
chd-226	100	23	expression	expression	NOUN
chd-226	100	24	compared	compare	VERB
chd-226	100	25	to	to	ADP
chd-226	100	26	white	white	ADJ
chd-226	100	27	women	woman	NOUN
chd-226	100	28	.	.	PUNCT
chd-226	101	1	(	(	PUNCT
chd-226	101	2	b.	b.	NOUN
chd-226	101	3	)	)	PUNCT
chd-226	101	4	no	no	DET
chd-226	101	5	difference	difference	NOUN
chd-226	101	6	in	in	ADP
chd-226	101	7	rfs	rfs	PROPN
chd-226	101	8	was	be	AUX
chd-226	101	9	observed	observe	VERB
chd-226	101	10	between	between	ADP
chd-226	101	11	black	black	ADJ
chd-226	101	12	and	and	CCONJ
chd-226	101	13	white	white	ADJ
chd-226	101	14	women	woman	NOUN
chd-226	101	15	with	with	ADP
chd-226	101	16	moderate	moderate	ADJ
chd-226	101	17	to	to	PART
chd-226	101	18	low	low	ADJ
chd-226	101	19	tumor	tumor	NOUN
chd-226	101	20	expression	expression	NOUN
chd-226	101	21	of	of	ADP
chd-226	101	22	aldh1a1	aldh1a1	PROPN
chd-226	101	23	(	(	PUNCT
chd-226	101	24	staining	stain	VERB
chd-226	101	25	intensity	intensity	NOUN
chd-226	101	26	in	in	ADP
chd-226	101	27	lower	low	ADJ
chd-226	101	28	3	3	NUM
chd-226	101	29	quartiles	quartile	NOUN
chd-226	101	30	)	)	PUNCT
chd-226	101	31	(	(	PUNCT
chd-226	101	32	c.	c.	NOUN
chd-226	101	33	)	)	PUNCT
chd-226	101	34	no	no	DET
chd-226	101	35	significant	significant	ADJ
chd-226	101	36	racial	racial	ADJ
chd-226	101	37	differences	difference	NOUN
chd-226	101	38	were	be	AUX
chd-226	101	39	observed	observe	VERB
chd-226	101	40	in	in	ADP
chd-226	101	41	os	os	NOUN
chd-226	101	42	in	in	ADP
chd-226	101	43	women	woman	NOUN
chd-226	101	44	with	with	ADP
chd-226	101	45	high	high	ADJ
chd-226	101	46	or	or	CCONJ
chd-226	101	47	(	(	PUNCT
chd-226	101	48	d.	d.	NOUN
chd-226	101	49	)	)	PUNCT
chd-226	101	50	low	low	ADJ
chd-226	101	51	to	to	ADP
chd-226	101	52	moderate	moderate	ADJ
chd-226	101	53	tumor	tumor	NOUN
chd-226	101	54	expression	expression	NOUN
chd-226	101	55	of	of	ADP
chd-226	101	56	aldh1a1	aldh1a1	PROPN
chd-226	101	57	.	.	PUNCT
chd-226	101	58	black	black	ADJ
chd-226	101	59	tick	tick	NOUN
chd-226	101	60	marks	mark	NOUN
chd-226	101	61	represent	represent	VERB
chd-226	101	62	censured	censure	VERB
chd-226	101	63	patients	patient	NOUN
chd-226	101	64	.	.	PUNCT
chd-226	102	1	although	although	SCONJ
chd-226	102	2	a	a	DET
chd-226	102	3	trend	trend	NOUN
chd-226	102	4	of	of	ADP
chd-226	102	5	shorter	short	ADJ
chd-226	102	6	rfs	rfs	NOUN
chd-226	102	7	and	and	CCONJ
chd-226	102	8	os	os	NOUN
chd-226	102	9	was	be	AUX
chd-226	102	10	observed	observe	VERB
chd-226	102	11	in	in	ADP
chd-226	102	12	women	woman	NOUN
chd-226	102	13	with	with	ADP
chd-226	102	14	strong	strong	ADJ
chd-226	102	15	aldh1a1	aldh1a1	ADJ
chd-226	102	16	stromal	stromal	ADJ
chd-226	102	17	expression	expression	NOUN
chd-226	102	18	compared	compare	VERB
chd-226	102	19	to	to	ADP
chd-226	102	20	those	those	PRON
chd-226	102	21	with	with	ADP
chd-226	102	22	moderate	moderate	ADJ
chd-226	102	23	to	to	PART
chd-226	102	24	low	low	ADJ
chd-226	102	25	stromal	stromal	ADJ
chd-226	102	26	expression	expression	NOUN
chd-226	102	27	,	,	PUNCT
chd-226	102	28	this	this	PRON
chd-226	102	29	was	be	AUX
chd-226	102	30	not	not	PART
chd-226	102	31	significant	significant	ADJ
chd-226	102	32	(	(	PUNCT
chd-226	102	33	figure	figure	NOUN
chd-226	102	34	5a.&b	5a.&b	NOUN
chd-226	102	35	.	.	PUNCT
chd-226	102	36	)	)	PUNCT
chd-226	102	37	.	.	PUNCT
chd-226	103	1	no	no	DET
chd-226	103	2	racial	racial	ADJ
chd-226	103	3	differences	difference	NOUN
chd-226	103	4	in	in	ADP
chd-226	103	5	outcomes	outcome	NOUN
chd-226	103	6	were	be	AUX
chd-226	103	7	observed	observe	VERB
chd-226	103	8	between	between	ADP
chd-226	103	9	black	black	ADJ
chd-226	103	10	and	and	CCONJ
chd-226	103	11	white	white	ADJ
chd-226	103	12	women	woman	NOUN
chd-226	103	13	with	with	ADP
chd-226	103	14	strong	strong	ADJ
chd-226	103	15	stromal	stromal	ADJ
chd-226	103	16	aldh1a1	aldh1a1	NOUN
chd-226	103	17	expression	expression	NOUN
chd-226	103	18	(	(	PUNCT
chd-226	103	19	figure	figure	VERB
chd-226	103	20	6a.-d	6a.-d	NUM
chd-226	103	21	.	.	PUNCT
chd-226	103	22	)	)	PUNCT
chd-226	103	23	.	.	PUNCT
chd-226	104	1	multivariate	multivariate	NOUN
chd-226	104	2	analysis	analysis	NOUN
chd-226	104	3	revealed	reveal	VERB
chd-226	104	4	that	that	SCONJ
chd-226	104	5	advanced	advanced	ADJ
chd-226	104	6	stage	stage	NOUN
chd-226	104	7	,	,	PUNCT
chd-226	104	8	hormone	hormone	NOUN
chd-226	104	9	receptor	receptor	NOUN
chd-226	104	10	negativity	negativity	NOUN
chd-226	104	11	,	,	PUNCT
chd-226	104	12	and	and	CCONJ
chd-226	104	13	strong	strong	ADJ
chd-226	104	14	tumor	tumor	NOUN
chd-226	104	15	aldh1a1	aldh1a1	NOUN
chd-226	104	16	expression	expression	NOUN
chd-226	104	17	were	be	AUX
chd-226	104	18	independently	independently	ADV
chd-226	104	19	associated	associate	VERB
chd-226	104	20	with	with	ADP
chd-226	104	21	worse	bad	ADJ
chd-226	104	22	survival	survival	NOUN
chd-226	104	23	outcomes	outcome	NOUN
chd-226	104	24	.	.	PUNCT
chd-226	105	1	(	(	PUNCT
chd-226	105	2	table	table	NOUN
chd-226	105	3	3	3	NUM
chd-226	105	4	)	)	PUNCT
chd-226	105	5	.	.	PUNCT
chd-226	106	1	figure	figure	NOUN
chd-226	106	2	5	5	NUM
chd-226	106	3	.	.	PUNCT
chd-226	106	4	stromal	stromal	ADJ
chd-226	106	5	aldh1a1	aldh1a1	ADJ
chd-226	106	6	expression	expression	NOUN
chd-226	106	7	is	be	AUX
chd-226	106	8	not	not	PART
chd-226	106	9	significantly	significantly	ADV
chd-226	106	10	associated	associate	VERB
chd-226	106	11	with	with	ADP
chd-226	106	12	breast	breast	NOUN
chd-226	106	13	cancer	cancer	NOUN
chd-226	106	14	outcomes	outcome	NOUN
chd-226	106	15	.	.	PUNCT
chd-226	107	1	kaplan	kaplan	PROPN
chd-226	107	2	-	-	PUNCT
chd-226	107	3	meier	meier	PROPN
chd-226	107	4	survival	survival	NOUN
chd-226	107	5	curves	curve	NOUN
chd-226	107	6	showing	show	VERB
chd-226	107	7	shorter	short	ADJ
chd-226	107	8	recurrence	recurrence	NOUN
chd-226	107	9	free	free	ADJ
chd-226	107	10	survival	survival	NOUN
chd-226	107	11	(	(	PUNCT
chd-226	107	12	a.	a.	NOUN
chd-226	107	13	)	)	PUNCT
chd-226	107	14	and	and	CCONJ
chd-226	107	15	overall	overall	ADJ
chd-226	107	16	survival	survival	NOUN
chd-226	107	17	(	(	PUNCT
chd-226	107	18	b.	b.	NOUN
chd-226	107	19	)	)	PUNCT
chd-226	107	20	in	in	ADP
chd-226	107	21	patients	patient	NOUN
chd-226	107	22	with	with	ADP
chd-226	107	23	high	high	ADJ
chd-226	107	24	expression	expression	NOUN
chd-226	107	25	of	of	ADP
chd-226	107	26	aldh1a1	aldh1a1	PROPN
chd-226	107	27	(	(	PUNCT
chd-226	107	28	staining	stain	VERB
chd-226	107	29	intensity	intensity	NOUN
chd-226	107	30	in	in	ADP
chd-226	107	31	top	top	ADJ
chd-226	107	32	quartile	quartile	NOUN
chd-226	107	33	)	)	PUNCT
chd-226	107	34	.	.	PUNCT
chd-226	108	1	black	black	ADJ
chd-226	108	2	tick	tick	NOUN
chd-226	108	3	marks	mark	NOUN
chd-226	108	4	represent	represent	VERB
chd-226	108	5	censured	censure	VERB
chd-226	108	6	patients	patient	NOUN
chd-226	108	7	.	.	PUNCT
chd-226	109	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PUNCT
chd-226	109	2	e9	e9	PROPN
chd-226	109	3	cancer	cancer	NOUN
chd-226	109	4	health	health	NOUN
chd-226	109	5	disparities	disparity	NOUN
chd-226	109	6	research	research	NOUN
chd-226	109	7	figure	figure	NOUN
chd-226	109	8	6	6	NUM
chd-226	109	9	.	.	PUNCT
chd-226	109	10	stromal	stromal	ADJ
chd-226	109	11	expression	expression	NOUN
chd-226	109	12	is	be	AUX
chd-226	109	13	not	not	PART
chd-226	109	14	associated	associate	VERB
chd-226	109	15	with	with	ADP
chd-226	109	16	breast	breast	NOUN
chd-226	109	17	cancer	cancer	NOUN
chd-226	109	18	outcomes	outcome	NOUN
chd-226	109	19	when	when	SCONJ
chd-226	109	20	stratified	stratify	VERB
chd-226	109	21	by	by	ADP
chd-226	109	22	race	race	NOUN
chd-226	109	23	.	.	PUNCT
chd-226	110	1	(	(	PUNCT
chd-226	110	2	a.	a.	NOUN
chd-226	110	3	)	)	PUNCT
chd-226	110	4	.	.	PUNCT
chd-226	111	1	when	when	SCONJ
chd-226	111	2	stratified	stratify	VERB
chd-226	111	3	by	by	ADP
chd-226	111	4	race	race	NOUN
chd-226	111	5	shorter	short	ADJ
chd-226	111	6	rfs	rfs	NOUN
chd-226	111	7	in	in	ADP
chd-226	111	8	black	black	ADJ
chd-226	111	9	women	woman	NOUN
chd-226	111	10	with	with	ADP
chd-226	111	11	high	high	ADJ
chd-226	111	12	stromal	stromal	NOUN
chd-226	111	13	(	(	PUNCT
chd-226	111	14	staining	stain	VERB
chd-226	111	15	intensity	intensity	NOUN
chd-226	111	16	in	in	ADP
chd-226	111	17	top	top	ADJ
chd-226	111	18	quartile	quartile	NOUN
chd-226	111	19	)	)	PUNCT
chd-226	111	20	aldh1a1	aldh1a1	ADV
chd-226	111	21	expression	expression	NOUN
chd-226	111	22	compared	compare	VERB
chd-226	111	23	to	to	ADP
chd-226	111	24	white	white	ADJ
chd-226	111	25	women	woman	NOUN
chd-226	111	26	.	.	PUNCT
chd-226	112	1	(	(	PUNCT
chd-226	112	2	b.	b.	NOUN
chd-226	112	3	)	)	PUNCT
chd-226	112	4	no	no	DET
chd-226	112	5	difference	difference	NOUN
chd-226	112	6	in	in	ADP
chd-226	112	7	rfs	rfs	PROPN
chd-226	112	8	was	be	AUX
chd-226	112	9	observed	observe	VERB
chd-226	112	10	between	between	ADP
chd-226	112	11	black	black	ADJ
chd-226	112	12	and	and	CCONJ
chd-226	112	13	white	white	ADJ
chd-226	112	14	women	woman	NOUN
chd-226	112	15	with	with	ADP
chd-226	112	16	moderate	moderate	ADJ
chd-226	112	17	to	to	PART
chd-226	112	18	low	low	ADJ
chd-226	112	19	stromal	stromal	ADJ
chd-226	112	20	expression	expression	NOUN
chd-226	112	21	of	of	ADP
chd-226	112	22	aldh1a1	aldh1a1	PROPN
chd-226	112	23	(	(	PUNCT
chd-226	112	24	staining	stain	VERB
chd-226	112	25	intensity	intensity	NOUN
chd-226	112	26	in	in	ADP
chd-226	112	27	lower	low	ADJ
chd-226	112	28	3	3	NUM
chd-226	112	29	quartiles	quartile	NOUN
chd-226	112	30	)	)	PUNCT
chd-226	112	31	(	(	PUNCT
chd-226	112	32	c.	c.	NOUN
chd-226	112	33	)	)	PUNCT
chd-226	112	34	no	no	DET
chd-226	112	35	significant	significant	ADJ
chd-226	112	36	racial	racial	ADJ
chd-226	112	37	differences	difference	NOUN
chd-226	112	38	were	be	AUX
chd-226	112	39	observed	observe	VERB
chd-226	112	40	in	in	ADP
chd-226	112	41	os	os	NOUN
chd-226	112	42	in	in	ADP
chd-226	112	43	women	woman	NOUN
chd-226	112	44	with	with	ADP
chd-226	112	45	high	high	ADJ
chd-226	112	46	or	or	CCONJ
chd-226	112	47	(	(	PUNCT
chd-226	112	48	d.	d.	NOUN
chd-226	112	49	)	)	PUNCT
chd-226	112	50	low	low	ADJ
chd-226	112	51	to	to	ADP
chd-226	112	52	moderate	moderate	ADJ
chd-226	112	53	stromal	stromal	ADJ
chd-226	112	54	expression	expression	NOUN
chd-226	112	55	of	of	ADP
chd-226	112	56	aldh1a1	aldh1a1	PROPN
chd-226	112	57	.	.	PUNCT
chd-226	112	58	black	black	ADJ
chd-226	112	59	tick	tick	NOUN
chd-226	112	60	marks	mark	NOUN
chd-226	112	61	represent	represent	VERB
chd-226	112	62	censured	censure	VERB
chd-226	112	63	patients	patient	NOUN
chd-226	112	64	.	.	PUNCT
chd-226	113	1	discussion	discussion	NOUN
chd-226	113	2	considerable	considerable	ADJ
chd-226	113	3	data	datum	NOUN
chd-226	113	4	indicates	indicate	VERB
chd-226	113	5	that	that	SCONJ
chd-226	113	6	tumor	tumor	NOUN
chd-226	113	7	biology	biology	NOUN
chd-226	113	8	may	may	AUX
chd-226	113	9	be	be	AUX
chd-226	113	10	a	a	DET
chd-226	113	11	contributing	contribute	VERB
chd-226	113	12	factor	factor	NOUN
chd-226	113	13	to	to	ADP
chd-226	113	14	racial	racial	ADJ
chd-226	113	15	disparities	disparity	NOUN
chd-226	113	16	in	in	ADP
chd-226	113	17	breast	breast	NOUN
chd-226	113	18	cancer	cancer	NOUN
chd-226	113	19	.	.	PUNCT
chd-226	114	1	previous	previous	ADJ
chd-226	114	2	studies	study	NOUN
chd-226	114	3	have	have	AUX
chd-226	114	4	reported	report	VERB
chd-226	114	5	increased	increase	VERB
chd-226	114	6	expression	expression	NOUN
chd-226	114	7	of	of	ADP
chd-226	114	8	aldh1a1	aldh1a1	PROPN
chd-226	114	9	in	in	ADP
chd-226	114	10	tumors	tumor	NOUN
chd-226	114	11	of	of	ADP
chd-226	114	12	women	woman	NOUN
chd-226	114	13	with	with	ADP
chd-226	114	14	african	african	ADJ
chd-226	114	15	ancestry	ancestry	NOUN
chd-226	114	16	(	(	PUNCT
chd-226	114	17	jiagge	jiagge	NOUN
chd-226	114	18	et	et	PROPN
chd-226	114	19	al	al	PROPN
chd-226	114	20	.	.	PROPN
chd-226	114	21	,	,	PUNCT
chd-226	114	22	2018b	2018b	NUM
chd-226	114	23	)	)	PUNCT
chd-226	114	24	.	.	PUNCT
chd-226	115	1	our	our	PRON
chd-226	115	2	findings	finding	NOUN
chd-226	115	3	confirm	confirm	VERB
chd-226	115	4	that	that	SCONJ
chd-226	115	5	expression	expression	NOUN
chd-226	115	6	of	of	ADP
chd-226	115	7	aldh1a1	aldh1a1	PROPN
chd-226	115	8	is	be	AUX
chd-226	115	9	increased	increase	VERB
chd-226	115	10	in	in	ADP
chd-226	115	11	breast	breast	NOUN
chd-226	115	12	tumor	tumor	NOUN
chd-226	115	13	tissue	tissue	NOUN
chd-226	115	14	from	from	ADP
chd-226	115	15	black	black	ADJ
chd-226	115	16	women	woman	NOUN
chd-226	115	17	compared	compare	VERB
chd-226	115	18	to	to	ADP
chd-226	115	19	those	those	PRON
chd-226	115	20	from	from	ADP
chd-226	115	21	white	white	ADJ
chd-226	115	22	women	woman	NOUN
chd-226	115	23	.	.	PUNCT
chd-226	116	1	strong	strong	ADJ
chd-226	116	2	tumor	tumor	NOUN
chd-226	116	3	expression	expression	NOUN
chd-226	116	4	of	of	ADP
chd-226	116	5	ald1a1	ald1a1	NOUN
chd-226	116	6	was	be	AUX
chd-226	116	7	associated	associate	VERB
chd-226	116	8	with	with	ADP
chd-226	116	9	black	black	ADJ
chd-226	116	10	race	race	NOUN
chd-226	116	11	,	,	PUNCT
chd-226	116	12	high	high	ADJ
chd-226	116	13	grade	grade	NOUN
chd-226	116	14	,	,	PUNCT
chd-226	116	15	advanced	advanced	ADJ
chd-226	116	16	cancer	cancer	NOUN
chd-226	116	17	stage	stage	NOUN
chd-226	116	18	,	,	PUNCT
chd-226	116	19	obesity	obesity	NOUN
chd-226	116	20	,	,	PUNCT
chd-226	116	21	and	and	CCONJ
chd-226	116	22	diabetes	diabetes	NOUN
chd-226	116	23	.	.	PUNCT
chd-226	117	1	in	in	ADP
chd-226	117	2	contrast	contrast	NOUN
chd-226	117	3	to	to	ADP
chd-226	117	4	previous	previous	ADJ
chd-226	117	5	studies	study	NOUN
chd-226	117	6	,	,	PUNCT
chd-226	117	7	we	we	PRON
chd-226	117	8	did	do	AUX
chd-226	117	9	not	not	PART
chd-226	117	10	find	find	VERB
chd-226	117	11	an	an	DET
chd-226	117	12	association	association	NOUN
chd-226	117	13	of	of	ADP
chd-226	117	14	between	between	ADP
chd-226	117	15	strong	strong	ADJ
chd-226	117	16	tumor	tumor	NOUN
chd-226	117	17	aldh1a1	aldh1a1	NOUN
chd-226	117	18	expression	expression	NOUN
chd-226	117	19	and	and	CCONJ
chd-226	117	20	estrogen	estrogen	NOUN
chd-226	117	21	receptor	receptor	NOUN
chd-226	117	22	negativity	negativity	NOUN
chd-226	117	23	.	.	PUNCT
chd-226	118	1	although	although	SCONJ
chd-226	118	2	aldh1a1	aldh1a1	ADP
chd-226	118	3	activity	activity	NOUN
chd-226	118	4	has	have	AUX
chd-226	118	5	been	be	AUX
chd-226	118	6	linked	link	VERB
chd-226	118	7	to	to	ADP
chd-226	118	8	metastatic	metastatic	ADJ
chd-226	118	9	behavior	behavior	NOUN
chd-226	118	10	and	and	CCONJ
chd-226	118	11	treatment	treatment	NOUN
chd-226	118	12	resistance	resistance	NOUN
chd-226	118	13	(	(	PUNCT
chd-226	118	14	croker	croker	NOUN
chd-226	118	15	et	et	PROPN
chd-226	118	16	al	al	PROPN
chd-226	118	17	.	.	PROPN
chd-226	118	18	,	,	PUNCT
chd-226	118	19	2017	2017	NUM
chd-226	118	20	)	)	PUNCT
chd-226	118	21	,	,	PUNCT
chd-226	118	22	the	the	DET
chd-226	118	23	association	association	NOUN
chd-226	118	24	between	between	ADP
chd-226	118	25	tumor	tumor	NOUN
chd-226	118	26	aldh1a1	aldh1a1	NOUN
chd-226	118	27	expression	expression	NOUN
chd-226	118	28	and	and	CCONJ
chd-226	118	29	survival	survival	NOUN
chd-226	118	30	is	be	AUX
chd-226	118	31	controversial	controversial	ADJ
chd-226	118	32	.	.	PUNCT
chd-226	119	1	we	we	PRON
chd-226	119	2	observed	observe	VERB
chd-226	119	3	poor	poor	ADJ
chd-226	119	4	rfs	rfs	NOUN
chd-226	119	5	and	and	CCONJ
chd-226	119	6	os	os	NOUN
chd-226	119	7	in	in	ADP
chd-226	119	8	women	woman	NOUN
chd-226	119	9	with	with	ADP
chd-226	119	10	strong	strong	ADJ
chd-226	119	11	tumor	tumor	NOUN
chd-226	119	12	expression	expression	NOUN
chd-226	119	13	of	of	ADP
chd-226	119	14	aldh1a1	aldh1a1	PROPN
chd-226	119	15	.	.	PUNCT
chd-226	120	1	a	a	DET
chd-226	120	2	multivariate	multivariate	NOUN
chd-226	120	3	analysis	analysis	NOUN
chd-226	120	4	revealed	reveal	VERB
chd-226	120	5	that	that	SCONJ
chd-226	120	6	tumor	tumor	NOUN
chd-226	120	7	,	,	PUNCT
chd-226	120	8	but	but	CCONJ
chd-226	120	9	not	not	PART
chd-226	120	10	stromal	stromal	ADJ
chd-226	120	11	,	,	PUNCT
chd-226	120	12	aldh1a1	aldh1a1	ADV
chd-226	120	13	expression	expression	NOUN
chd-226	120	14	is	be	AUX
chd-226	120	15	an	an	DET
chd-226	120	16	independently	independently	ADV
chd-226	120	17	associated	associate	VERB
chd-226	120	18	with	with	ADP
chd-226	120	19	cancer	cancer	NOUN
chd-226	120	20	outcomes	outcome	NOUN
chd-226	120	21	.	.	PUNCT
chd-226	121	1	analyses	analysis	NOUN
chd-226	121	2	stratified	stratify	VERB
chd-226	121	3	by	by	ADP
chd-226	121	4	race	race	NOUN
chd-226	121	5	revealed	reveal	VERB
chd-226	121	6	worse	bad	ADJ
chd-226	121	7	overall	overall	ADJ
chd-226	121	8	survival	survival	NOUN
chd-226	121	9	in	in	ADP
chd-226	121	10	both	both	CCONJ
chd-226	121	11	black	black	ADJ
chd-226	121	12	and	and	CCONJ
chd-226	121	13	white	white	ADJ
chd-226	121	14	women	woman	NOUN
chd-226	121	15	with	with	ADP
chd-226	121	16	strong	strong	ADJ
chd-226	121	17	tumor	tumor	NOUN
chd-226	121	18	aldh1a1	aldh1a1	ADV
chd-226	121	19	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	VERB
chd-226	121	20	e10	e10	NUM
chd-226	121	21	cancer	cancer	NOUN
chd-226	121	22	health	health	NOUN
chd-226	121	23	disparities	disparity	NOUN
chd-226	121	24	research	research	NOUN
chd-226	121	25	compared	compare	VERB
chd-226	121	26	to	to	ADP
chd-226	121	27	those	those	PRON
chd-226	121	28	with	with	ADP
chd-226	121	29	moderate	moderate	ADJ
chd-226	121	30	to	to	PART
chd-226	121	31	low	low	ADJ
chd-226	121	32	expression	expression	NOUN
chd-226	121	33	.	.	PUNCT
chd-226	122	1	however	however	ADV
chd-226	122	2	,	,	PUNCT
chd-226	122	3	among	among	ADP
chd-226	122	4	women	woman	NOUN
chd-226	122	5	with	with	ADP
chd-226	122	6	strong	strong	ADJ
chd-226	122	7	aldh1a1	aldh1a1	ADJ
chd-226	122	8	staining	stain	VERB
chd-226	122	9	,	,	PUNCT
chd-226	122	10	black	black	ADJ
chd-226	122	11	women	woman	NOUN
chd-226	122	12	had	have	VERB
chd-226	122	13	shorter	short	ADJ
chd-226	122	14	recurrence	recurrence	NOUN
chd-226	122	15	free	free	ADJ
chd-226	122	16	survival	survival	NOUN
chd-226	122	17	compared	compare	VERB
chd-226	122	18	to	to	ADP
chd-226	122	19	white	white	ADJ
chd-226	122	20	women	woman	NOUN
chd-226	122	21	.	.	PUNCT
chd-226	123	1	members	member	NOUN
chd-226	123	2	of	of	ADP
chd-226	123	3	the	the	DET
chd-226	123	4	aldh1	aldh1	PROPN
chd-226	123	5	family	family	NOUN
chd-226	123	6	,	,	PUNCT
chd-226	123	7	including	include	VERB
chd-226	123	8	aldh1a1	aldh1a1	PROPN
chd-226	123	9	.	.	PROPN
chd-226	123	10	have	have	AUX
chd-226	123	11	been	be	AUX
chd-226	123	12	associated	associate	VERB
chd-226	123	13	with	with	ADP
chd-226	123	14	stemness	stemness	NOUN
chd-226	123	15	in	in	ADP
chd-226	123	16	normal	normal	ADJ
chd-226	123	17	and	and	CCONJ
chd-226	123	18	malignant	malignant	ADJ
chd-226	123	19	breast	breast	NOUN
chd-226	123	20	cells	cell	NOUN
chd-226	123	21	(	(	PUNCT
chd-226	123	22	douville	douville	NOUN
chd-226	123	23	et	et	PROPN
chd-226	123	24	al	al	PROPN
chd-226	123	25	.	.	PROPN
chd-226	123	26	,	,	PUNCT
chd-226	123	27	2009	2009	NUM
chd-226	123	28	;	;	PUNCT
chd-226	123	29	ginestier	ginesti	ADJ
chd-226	123	30	et	et	PROPN
chd-226	123	31	al	al	PROPN
chd-226	123	32	.	.	PROPN
chd-226	123	33	,	,	PUNCT
chd-226	123	34	2007	2007	NUM
chd-226	123	35	;	;	PUNCT
chd-226	123	36	ginestier	ginesti	ADJ
chd-226	123	37	et	et	PROPN
chd-226	123	38	al	al	PROPN
chd-226	123	39	.	.	PROPN
chd-226	123	40	,	,	PUNCT
chd-226	123	41	2009	2009	NUM
chd-226	123	42	;	;	PUNCT
chd-226	123	43	honeth	honeth	PROPN
chd-226	123	44	et	et	PROPN
chd-226	123	45	al	al	PROPN
chd-226	123	46	.	.	PROPN
chd-226	123	47	,	,	PUNCT
chd-226	123	48	2014	2014	NUM
chd-226	123	49	;	;	PUNCT
chd-226	123	50	marcato	marcato	PROPN
chd-226	123	51	et	et	PROPN
chd-226	123	52	al	al	PROPN
chd-226	123	53	.	.	PROPN
chd-226	123	54	,	,	PUNCT
chd-226	123	55	2011a	2011a	NUM
chd-226	123	56	;	;	PUNCT
chd-226	123	57	schwartz	schwartz	PROPN
chd-226	123	58	et	et	PROPN
chd-226	123	59	al	al	PROPN
chd-226	123	60	.	.	PROPN
chd-226	123	61	,	,	PUNCT
chd-226	123	62	2013	2013	NUM
chd-226	123	63	)	)	PUNCT
chd-226	123	64	.	.	PUNCT
chd-226	124	1	however	however	ADV
chd-226	124	2	,	,	PUNCT
chd-226	124	3	research	research	NOUN
chd-226	124	4	on	on	ADP
chd-226	124	5	stemness	stemness	NOUN
chd-226	124	6	in	in	ADP
chd-226	124	7	tumors	tumor	NOUN
chd-226	124	8	of	of	ADP
chd-226	124	9	black	black	ADJ
chd-226	124	10	women	woman	NOUN
chd-226	124	11	is	be	AUX
chd-226	124	12	limited	limit	VERB
chd-226	124	13	(	(	PUNCT
chd-226	124	14	jiagge	jiagge	NOUN
chd-226	124	15	et	et	PROPN
chd-226	124	16	al	al	PROPN
chd-226	124	17	.	.	PROPN
chd-226	124	18	,	,	PUNCT
chd-226	124	19	2018a	2018a	NUM
chd-226	124	20	)	)	PUNCT
chd-226	124	21	.	.	PUNCT
chd-226	125	1	one	one	NUM
chd-226	125	2	study	study	NOUN
chd-226	125	3	found	find	VERB
chd-226	125	4	that	that	SCONJ
chd-226	125	5	the	the	DET
chd-226	125	6	overall	overall	ADJ
chd-226	125	7	number	number	NOUN
chd-226	125	8	of	of	ADP
chd-226	125	9	cells	cell	NOUN
chd-226	125	10	expressing	express	VERB
chd-226	125	11	the	the	DET
chd-226	125	12	stem	stem	NOUN
chd-226	125	13	cell	cell	NOUN
chd-226	125	14	markers	marker	NOUN
chd-226	125	15	cd44+/cd24	cd44+/cd24	PART
chd-226	125	16	cells	cell	NOUN
chd-226	125	17	was	be	AUX
chd-226	125	18	elevated	elevate	VERB
chd-226	125	19	in	in	ADP
chd-226	125	20	tumors	tumor	NOUN
chd-226	125	21	from	from	ADP
chd-226	125	22	black	black	ADJ
chd-226	125	23	women	woman	NOUN
chd-226	125	24	(	(	PUNCT
chd-226	125	25	nakshatri	nakshatri	PROPN
chd-226	125	26	et	et	PROPN
chd-226	125	27	al	al	PROPN
chd-226	125	28	.	.	PROPN
chd-226	125	29	,	,	PUNCT
chd-226	125	30	2015	2015	NUM
chd-226	125	31	)	)	PUNCT
chd-226	125	32	.	.	PUNCT
chd-226	126	1	this	this	DET
chd-226	126	2	study	study	NOUN
chd-226	126	3	also	also	ADV
chd-226	126	4	found	find	VERB
chd-226	126	5	that	that	SCONJ
chd-226	126	6	black	black	ADJ
chd-226	126	7	but	but	CCONJ
chd-226	126	8	not	not	PART
chd-226	126	9	white	white	ADJ
chd-226	126	10	tumors	tumor	NOUN
chd-226	126	11	contained	contain	VERB
chd-226	126	12	a	a	DET
chd-226	126	13	distinct	distinct	ADJ
chd-226	126	14	population	population	NOUN
chd-226	126	15	of	of	ADP
chd-226	126	16	cd44+/cd24cells	cd44+/cd24cell	NOUN
chd-226	126	17	that	that	PRON
chd-226	126	18	showed	show	VERB
chd-226	126	19	differential	differential	ADJ
chd-226	126	20	gene	gene	NOUN
chd-226	126	21	expression	expression	NOUN
chd-226	126	22	which	which	PRON
chd-226	126	23	was	be	AUX
chd-226	126	24	like	like	ADP
chd-226	126	25	that	that	PRON
chd-226	126	26	of	of	ADP
chd-226	126	27	mammary	mammary	ADJ
chd-226	126	28	stem	stem	NOUN
chd-226	126	29	cells	cell	NOUN
chd-226	126	30	and	and	CCONJ
chd-226	126	31	included	include	VERB
chd-226	126	32	upregulation	upregulation	NOUN
chd-226	126	33	of	of	ADP
chd-226	126	34	tgfβ	tgfβ	ADJ
chd-226	126	35	/	/	SYM
chd-226	126	36	wnt	wnt	NOUN
chd-226	126	37	and	and	CCONJ
chd-226	126	38	ctnbb1	ctnbb1	PROPN
chd-226	126	39	/	/	SYM
chd-226	126	40	nf	nf	ADJ
chd-226	126	41	-	-	PUNCT
chd-226	126	42	κb	κb	NOUN
chd-226	126	43	pathways	pathway	NOUN
chd-226	126	44	and	and	CCONJ
chd-226	126	45	downregulation	downregulation	NOUN
chd-226	126	46	of	of	ADP
chd-226	126	47	the	the	DET
chd-226	126	48	p53	p53	NOUN
chd-226	126	49	and	and	CCONJ
chd-226	126	50	er	er	INTJ
chd-226	126	51	pathway	pathway	NOUN
chd-226	126	52	.	.	PUNCT
chd-226	127	1	additionally	additionally	ADV
chd-226	127	2	,	,	PUNCT
chd-226	127	3	gyan	gyan	PROPN
chd-226	127	4	et	et	PROPN
chd-226	127	5	al	al	PROPN
chd-226	127	6	found	find	VERB
chd-226	127	7	that	that	SCONJ
chd-226	127	8	expression	expression	NOUN
chd-226	127	9	of	of	ADP
chd-226	127	10	the	the	DET
chd-226	127	11	cd44+cd24population	cd44+cd24population	NOUN
chd-226	127	12	together	together	ADV
chd-226	127	13	with	with	ADP
chd-226	127	14	aldh1a	aldh1a	PROPN
chd-226	127	15	is	be	AUX
chd-226	127	16	associated	associate	VERB
chd-226	127	17	with	with	ADP
chd-226	127	18	aggressive	aggressive	ADJ
chd-226	127	19	tumor	tumor	NOUN
chd-226	127	20	characteristics	characteristic	NOUN
chd-226	127	21	including	include	VERB
chd-226	127	22	high	high	ADJ
chd-226	127	23	tumor	tumor	NOUN
chd-226	127	24	grade	grade	NOUN
chd-226	127	25	and	and	CCONJ
chd-226	127	26	clinical	clinical	ADJ
chd-226	127	27	prognostic	prognostic	ADJ
chd-226	127	28	staging	staging	NOUN
chd-226	127	29	in	in	ADP
chd-226	127	30	black	black	ADJ
chd-226	127	31	women	woman	NOUN
chd-226	127	32	(	(	PUNCT
chd-226	127	33	gyan	gyan	PROPN
chd-226	127	34	et	et	PROPN
chd-226	127	35	al	al	PROPN
chd-226	127	36	.	.	PROPN
chd-226	127	37	,	,	PUNCT
chd-226	127	38	2021	2021	NUM
chd-226	127	39	)	)	PUNCT
chd-226	127	40	.	.	PUNCT
chd-226	128	1	another	another	DET
chd-226	128	2	study	study	NOUN
chd-226	128	3	found	find	VERB
chd-226	128	4	that	that	SCONJ
chd-226	128	5	tumor	tumor	NOUN
chd-226	128	6	cells	cell	NOUN
chd-226	128	7	from	from	ADP
chd-226	128	8	black	black	ADJ
chd-226	128	9	women	woman	NOUN
chd-226	128	10	exhibited	exhibit	VERB
chd-226	128	11	a	a	DET
chd-226	128	12	cancer	cancer	NOUN
chd-226	128	13	stem	stem	NOUN
chd-226	128	14	like	like	ADP
chd-226	128	15	phenotype	phenotype	NOUN
chd-226	128	16	including	include	VERB
chd-226	128	17	increased	increase	VERB
chd-226	128	18	growth	growth	NOUN
chd-226	128	19	and	and	CCONJ
chd-226	128	20	migration	migration	NOUN
chd-226	128	21	compared	compare	VERB
chd-226	128	22	to	to	ADP
chd-226	128	23	tumor	tumor	NOUN
chd-226	128	24	cells	cell	NOUN
chd-226	128	25	from	from	ADP
chd-226	128	26	white	white	ADJ
chd-226	128	27	women	woman	NOUN
chd-226	128	28	(	(	PUNCT
chd-226	128	29	siddharth	siddharth	NOUN
chd-226	128	30	et	et	PROPN
chd-226	128	31	al	al	PROPN
chd-226	128	32	.	.	PROPN
chd-226	128	33	,	,	PUNCT
chd-226	128	34	2021).in	2021).in	PROPN
chd-226	128	35	this	this	DET
chd-226	128	36	study	study	NOUN
chd-226	128	37	,	,	PUNCT
chd-226	128	38	tumor	tumor	NOUN
chd-226	128	39	cells	cell	NOUN
chd-226	128	40	from	from	ADP
chd-226	128	41	black	black	ADJ
chd-226	128	42	women	woman	NOUN
chd-226	128	43	also	also	ADV
chd-226	128	44	showed	show	VERB
chd-226	128	45	different	different	ADJ
chd-226	128	46	gene	gene	NOUN
chd-226	128	47	expression	expression	NOUN
chd-226	128	48	patterns	pattern	NOUN
chd-226	128	49	than	than	ADP
chd-226	128	50	those	those	PRON
chd-226	128	51	from	from	ADP
chd-226	128	52	white	white	ADJ
chd-226	128	53	tumors	tumor	NOUN
chd-226	128	54	,	,	PUNCT
chd-226	128	55	including	include	VERB
chd-226	128	56	elevated	elevated	ADJ
chd-226	128	57	expression	expression	NOUN
chd-226	128	58	of	of	ADP
chd-226	128	59	stemness	stemness	ADJ
chd-226	128	60	genes	gene	NOUN
chd-226	128	61	gli-1	gli-1	PUNCT
chd-226	128	62	and	and	CCONJ
chd-226	128	63	notch1	notch1	NOUN
chd-226	128	64	.	.	PUNCT
chd-226	129	1	stromal	stromal	ADJ
chd-226	129	2	expression	expression	NOUN
chd-226	129	3	of	of	ADP
chd-226	129	4	aldh1a1	aldh1a1	PROPN
chd-226	129	5	has	have	AUX
chd-226	129	6	been	be	AUX
chd-226	129	7	investigated	investigate	VERB
chd-226	129	8	in	in	ADP
chd-226	129	9	only	only	ADV
chd-226	129	10	a	a	DET
chd-226	129	11	few	few	ADJ
chd-226	129	12	studies	study	NOUN
chd-226	129	13	(	(	PUNCT
chd-226	129	14	bednarz	bednarz	NOUN
chd-226	129	15	-	-	PUNCT
chd-226	129	16	knoll	knoll	NOUN
chd-226	129	17	et	et	PROPN
chd-226	129	18	al	al	PROPN
chd-226	129	19	.	.	PROPN
chd-226	129	20	,	,	PUNCT
chd-226	129	21	2015	2015	NUM
chd-226	129	22	;	;	PUNCT
chd-226	129	23	sjostrom	sjostrom	NUM
chd-226	129	24	et	et	PROPN
chd-226	129	25	al	al	PROPN
chd-226	129	26	.	.	PROPN
chd-226	129	27	,	,	PUNCT
chd-226	129	28	2015	2015	NUM
chd-226	129	29	)	)	PUNCT
chd-226	129	30	which	which	PRON
chd-226	129	31	report	report	VERB
chd-226	129	32	that	that	SCONJ
chd-226	129	33	expression	expression	NOUN
chd-226	129	34	of	of	ADP
chd-226	129	35	aldh1a	aldh1a	NOUN
chd-226	129	36	in	in	ADP
chd-226	129	37	tumor	tumor	NOUN
chd-226	129	38	stromal	stromal	NOUN
chd-226	129	39	may	may	AUX
chd-226	129	40	be	be	AUX
chd-226	129	41	associated	associate	VERB
chd-226	129	42	with	with	ADP
chd-226	129	43	improved	improved	ADJ
chd-226	129	44	outcomes	outcome	NOUN
chd-226	129	45	in	in	ADP
chd-226	129	46	breast	breast	NOUN
chd-226	129	47	cancer	cancer	NOUN
chd-226	129	48	.	.	PUNCT
chd-226	130	1	we	we	PRON
chd-226	130	2	found	find	VERB
chd-226	130	3	no	no	DET
chd-226	130	4	association	association	NOUN
chd-226	130	5	between	between	ADP
chd-226	130	6	strong	strong	ADJ
chd-226	130	7	stromal	stromal	ADJ
chd-226	130	8	staining	staining	NOUN
chd-226	130	9	and	and	CCONJ
chd-226	130	10	outcomes	outcome	NOUN
chd-226	130	11	in	in	ADP
chd-226	130	12	our	our	PRON
chd-226	130	13	study	study	NOUN
chd-226	130	14	.	.	PUNCT
chd-226	131	1	however	however	ADV
chd-226	131	2	,	,	PUNCT
chd-226	131	3	we	we	PRON
chd-226	131	4	found	find	VERB
chd-226	131	5	that	that	SCONJ
chd-226	131	6	strong	strong	ADJ
chd-226	131	7	aldh1a1	aldh1a1	ADJ
chd-226	131	8	stromal	stromal	ADJ
chd-226	131	9	expression	expression	NOUN
chd-226	131	10	is	be	AUX
chd-226	131	11	associated	associate	VERB
chd-226	131	12	with	with	ADP
chd-226	131	13	estrogen	estrogen	NOUN
chd-226	131	14	receptor	receptor	NOUN
chd-226	131	15	positivity	positivity	NOUN
chd-226	131	16	,	,	PUNCT
chd-226	131	17	obesity	obesity	NOUN
chd-226	131	18	,	,	PUNCT
chd-226	131	19	and	and	CCONJ
chd-226	131	20	diabetes	diabetes	NOUN
chd-226	131	21	.	.	PUNCT
chd-226	132	1	although	although	SCONJ
chd-226	132	2	no	no	DET
chd-226	132	3	associations	association	NOUN
chd-226	132	4	between	between	ADP
chd-226	132	5	stromal	stromal	ADJ
chd-226	132	6	staining	stain	VERB
chd-226	132	7	and	and	CCONJ
chd-226	132	8	breast	breast	NOUN
chd-226	132	9	cancer	cancer	NOUN
chd-226	132	10	subtypes	subtype	NOUN
chd-226	132	11	have	have	AUX
chd-226	132	12	been	be	AUX
chd-226	132	13	reported	report	VERB
chd-226	132	14	,	,	PUNCT
chd-226	132	15	a	a	DET
chd-226	132	16	positive	positive	ADJ
chd-226	132	17	association	association	NOUN
chd-226	132	18	between	between	ADP
chd-226	132	19	strong	strong	ADJ
chd-226	132	20	stromal	stromal	ADJ
chd-226	132	21	aldh1a1	aldh1a1	NOUN
chd-226	132	22	expression	expression	NOUN
chd-226	132	23	and	and	CCONJ
chd-226	132	24	decreased	decrease	VERB
chd-226	132	25	basal	basal	ADJ
chd-226	132	26	markers	marker	NOUN
chd-226	132	27	in	in	ADP
chd-226	132	28	tumor	tumor	NOUN
chd-226	132	29	cells	cell	NOUN
chd-226	132	30	has	have	AUX
chd-226	132	31	previously	previously	ADV
chd-226	132	32	been	be	AUX
chd-226	132	33	observed	observe	VERB
chd-226	132	34	(	(	PUNCT
chd-226	132	35	bednarz	bednarz	NOUN
chd-226	132	36	-	-	PUNCT
chd-226	132	37	knoll	knoll	NOUN
chd-226	132	38	et	et	PROPN
chd-226	132	39	al	al	PROPN
chd-226	132	40	.	.	PROPN
chd-226	132	41	,	,	PUNCT
chd-226	132	42	2015	2015	NUM
chd-226	132	43	)	)	PUNCT
chd-226	132	44	.	.	PUNCT
chd-226	133	1	further	further	ADJ
chd-226	133	2	investigation	investigation	NOUN
chd-226	133	3	of	of	ADP
chd-226	133	4	the	the	DET
chd-226	133	5	prognostic	prognostic	ADJ
chd-226	133	6	significance	significance	NOUN
chd-226	133	7	of	of	ADP
chd-226	133	8	aldh1a1	aldh1a1	ADJ
chd-226	133	9	stromal	stromal	ADJ
chd-226	133	10	expression	expression	NOUN
chd-226	133	11	by	by	ADP
chd-226	133	12	breast	breast	NOUN
chd-226	133	13	cancer	cancer	NOUN
chd-226	133	14	subtype	subtype	NOUN
chd-226	133	15	is	be	AUX
chd-226	133	16	needed	need	VERB
chd-226	133	17	.	.	PUNCT
chd-226	134	1	metabolic	metabolic	NOUN
chd-226	134	2	disorders	disorder	NOUN
chd-226	134	3	are	be	AUX
chd-226	134	4	associated	associate	VERB
chd-226	134	5	with	with	ADP
chd-226	134	6	breast	breast	NOUN
chd-226	134	7	cancer	cancer	NOUN
chd-226	134	8	risk	risk	NOUN
chd-226	134	9	and	and	CCONJ
chd-226	134	10	outcomes	outcome	NOUN
chd-226	134	11	,	,	PUNCT
chd-226	134	12	particularly	particularly	ADV
chd-226	134	13	in	in	ADP
chd-226	134	14	black	black	ADJ
chd-226	134	15	women(jones	women(jone	NOUN
chd-226	134	16	et	et	PROPN
chd-226	134	17	al	al	PROPN
chd-226	134	18	.	.	PROPN
chd-226	134	19	,	,	PUNCT
chd-226	134	20	2003	2003	NUM
chd-226	134	21	;	;	PUNCT
chd-226	134	22	zhao	zhao	PROPN
chd-226	134	23	et	et	PROPN
chd-226	134	24	al	al	PROPN
chd-226	134	25	.	.	PROPN
chd-226	134	26	,	,	PUNCT
chd-226	134	27	2020	2020	NUM
chd-226	134	28	)	)	PUNCT
chd-226	134	29	.	.	PUNCT
chd-226	135	1	previous	previous	ADJ
chd-226	135	2	studies	study	NOUN
chd-226	135	3	have	have	AUX
chd-226	135	4	shown	show	VERB
chd-226	135	5	that	that	SCONJ
chd-226	135	6	in	in	ADP
chd-226	135	7	addition	addition	NOUN
chd-226	135	8	to	to	ADP
chd-226	135	9	its	its	PRON
chd-226	135	10	role	role	NOUN
chd-226	135	11	in	in	ADP
chd-226	135	12	stemness	stemness	ADV
chd-226	135	13	and	and	CCONJ
chd-226	135	14	oxidative	oxidative	ADJ
chd-226	135	15	stress	stress	NOUN
chd-226	135	16	,	,	PUNCT
chd-226	135	17	aldh1a1	aldh1a1	ADV
chd-226	135	18	plays	play	VERB
chd-226	135	19	a	a	DET
chd-226	135	20	key	key	ADJ
chd-226	135	21	role	role	NOUN
chd-226	135	22	in	in	ADP
chd-226	135	23	glucose	glucose	NOUN
chd-226	135	24	tolerance	tolerance	NOUN
chd-226	135	25	and	and	CCONJ
chd-226	135	26	abdominal	abdominal	ADJ
chd-226	135	27	fat	fat	ADJ
chd-226	135	28	formation	formation	NOUN
chd-226	135	29	(	(	PUNCT
chd-226	135	30	ma	ma	PROPN
chd-226	135	31	et	et	PROPN
chd-226	135	32	al	al	PROPN
chd-226	135	33	.	.	PROPN
chd-226	135	34	,	,	PUNCT
chd-226	135	35	2020	2020	NUM
chd-226	135	36	;	;	PUNCT
chd-226	135	37	petrosino	petrosino	NOUN
chd-226	135	38	et	et	PROPN
chd-226	135	39	al	al	PROPN
chd-226	135	40	.	.	PROPN
chd-226	135	41	,	,	PUNCT
chd-226	135	42	2014	2014	NUM
chd-226	135	43	)	)	PUNCT
chd-226	135	44	.	.	PUNCT
chd-226	136	1	further	far	ADV
chd-226	136	2	,	,	PUNCT
chd-226	136	3	increased	increase	VERB
chd-226	136	4	expression	expression	NOUN
chd-226	136	5	of	of	ADP
chd-226	136	6	aldh1a1	aldh1a1	PROPN
chd-226	136	7	has	have	AUX
chd-226	136	8	been	be	AUX
chd-226	136	9	linked	link	VERB
chd-226	136	10	to	to	ADP
chd-226	136	11	accumulation	accumulation	NOUN
chd-226	136	12	of	of	ADP
chd-226	136	13	visceral	visceral	ADJ
chd-226	136	14	fat	fat	NOUN
chd-226	136	15	in	in	ADP
chd-226	136	16	murine	murine	ADJ
chd-226	136	17	models	model	NOUN
chd-226	136	18	and	and	CCONJ
chd-226	136	19	mediates	mediate	VERB
chd-226	136	20	inflammatory	inflammatory	ADJ
chd-226	136	21	responses	response	NOUN
chd-226	136	22	to	to	ADP
chd-226	136	23	a	a	DET
chd-226	136	24	high	high	ADJ
chd-226	136	25	-	-	PUNCT
chd-226	136	26	fat	fat	NOUN
chd-226	136	27	diet	diet	NOUN
chd-226	136	28	in	in	ADP
chd-226	136	29	females	female	NOUN
chd-226	136	30	(	(	PUNCT
chd-226	136	31	yasmeen	yasmeen	PROPN
chd-226	136	32	et	et	PROPN
chd-226	136	33	al	al	PROPN
chd-226	136	34	.	.	PROPN
chd-226	136	35	,	,	PUNCT
chd-226	136	36	2013	2013	NUM
chd-226	136	37	)	)	PUNCT
chd-226	136	38	.	.	PUNCT
chd-226	137	1	our	our	PRON
chd-226	137	2	findings	finding	NOUN
chd-226	137	3	are	be	AUX
chd-226	137	4	the	the	DET
chd-226	137	5	first	first	ADJ
chd-226	137	6	to	to	PART
chd-226	137	7	show	show	VERB
chd-226	137	8	an	an	DET
chd-226	137	9	association	association	NOUN
chd-226	137	10	between	between	ADP
chd-226	137	11	metabolic	metabolic	NOUN
chd-226	137	12	disorders	disorder	NOUN
chd-226	137	13	and	and	CCONJ
chd-226	137	14	aldh1a1	aldh1a1	ADV
chd-226	137	15	expression	expression	NOUN
chd-226	137	16	in	in	ADP
chd-226	137	17	tumors	tumor	NOUN
chd-226	137	18	.	.	PUNCT
chd-226	138	1	the	the	DET
chd-226	138	2	mechanisms	mechanism	NOUN
chd-226	138	3	driving	drive	VERB
chd-226	138	4	increased	increase	VERB
chd-226	138	5	expression	expression	NOUN
chd-226	138	6	of	of	ADP
chd-226	138	7	aldh1a1	aldh1a1	PROPN
chd-226	138	8	in	in	ADP
chd-226	138	9	tumor	tumor	NOUN
chd-226	138	10	and	and	CCONJ
chd-226	138	11	stroma	stroma	ADJ
chd-226	138	12	cells	cell	NOUN
chd-226	138	13	,	,	PUNCT
chd-226	138	14	particularly	particularly	ADV
chd-226	138	15	in	in	ADP
chd-226	138	16	black	black	ADJ
chd-226	138	17	women	woman	NOUN
chd-226	138	18	,	,	PUNCT
chd-226	138	19	have	have	VERB
chd-226	138	20	yet	yet	ADV
chd-226	138	21	to	to	PART
chd-226	138	22	be	be	AUX
chd-226	138	23	fully	fully	ADV
chd-226	138	24	understood	understand	VERB
chd-226	138	25	.	.	PUNCT
chd-226	139	1	functional	functional	ADJ
chd-226	139	2	polymorphisms	polymorphism	NOUN
chd-226	139	3	in	in	ADP
chd-226	139	4	aldh1a1	aldh1a1	PROPN
chd-226	139	5	have	have	AUX
chd-226	139	6	been	be	AUX
chd-226	139	7	identified	identify	VERB
chd-226	139	8	and	and	CCONJ
chd-226	139	9	studied	study	VERB
chd-226	139	10	in	in	ADP
chd-226	139	11	the	the	DET
chd-226	139	12	context	context	NOUN
chd-226	139	13	of	of	ADP
chd-226	139	14	alcohol	alcohol	NOUN
chd-226	139	15	dependence	dependence	NOUN
chd-226	139	16	(	(	PUNCT
chd-226	139	17	agarwal	agarwal	PROPN
chd-226	139	18	et	et	PROPN
chd-226	139	19	al	al	PROPN
chd-226	139	20	.	.	PROPN
chd-226	139	21	,	,	PUNCT
chd-226	139	22	1981).the	1981).the	DET
chd-226	139	23	frequency	frequency	NOUN
chd-226	139	24	of	of	ADP
chd-226	139	25	these	these	DET
chd-226	139	26	alterations	alteration	NOUN
chd-226	139	27	varies	vary	VERB
chd-226	139	28	across	across	ADP
chd-226	139	29	different	different	ADJ
chd-226	139	30	ethnic	ethnic	ADJ
chd-226	139	31	groups	group	NOUN
chd-226	139	32	and	and	CCONJ
chd-226	139	33	several	several	ADJ
chd-226	139	34	variants	variant	NOUN
chd-226	139	35	have	have	VERB
chd-226	139	36	strong	strong	ADJ
chd-226	139	37	prevalence	prevalence	NOUN
chd-226	139	38	among	among	ADP
chd-226	139	39	black	black	ADJ
chd-226	139	40	individuals	individual	NOUN
chd-226	139	41	(	(	PUNCT
chd-226	139	42	crawford	crawford	PROPN
chd-226	139	43	et	et	PROPN
chd-226	139	44	al	al	PROPN
chd-226	139	45	.	.	PROPN
chd-226	139	46	,	,	PUNCT
chd-226	139	47	2014	2014	NUM
chd-226	139	48	;	;	PUNCT
chd-226	139	49	ji	ji	PROPN
chd-226	139	50	et	et	PROPN
chd-226	139	51	al	al	PROPN
chd-226	139	52	.	.	PROPN
chd-226	139	53	,	,	PUNCT
chd-226	139	54	2019	2019	NUM
chd-226	139	55	;	;	PUNCT
chd-226	139	56	liu	liu	PROPN
chd-226	139	57	et	et	PROPN
chd-226	139	58	al	al	PROPN
chd-226	139	59	.	.	PROPN
chd-226	139	60	,	,	PUNCT
chd-226	139	61	2011	2011	NUM
chd-226	139	62	;	;	PUNCT
chd-226	139	63	spence	spence	NOUN
chd-226	139	64	et	et	PROPN
chd-226	139	65	al	al	PROPN
chd-226	139	66	.	.	PROPN
chd-226	139	67	,	,	PUNCT
chd-226	139	68	2003	2003	NUM
chd-226	139	69	)	)	PUNCT
chd-226	139	70	.	.	PUNCT
chd-226	140	1	a	a	DET
chd-226	140	2	three	three	NUM
chd-226	140	3	base	base	ADJ
chd-226	140	4	-	-	PUNCT
chd-226	140	5	pair	pair	NOUN
chd-226	140	6	insertion	insertion	NOUN
chd-226	140	7	with	with	ADP
chd-226	140	8	prevalence	prevalence	NOUN
chd-226	140	9	exclusively	exclusively	ADV
chd-226	140	10	to	to	ADP
chd-226	140	11	black	black	ADJ
chd-226	140	12	people	people	NOUN
chd-226	140	13	was	be	AUX
chd-226	140	14	shown	show	VERB
chd-226	140	15	to	to	PART
chd-226	140	16	increase	increase	VERB
chd-226	140	17	expression	expression	NOUN
chd-226	140	18	of	of	ADP
chd-226	140	19	aldh1a1	aldh1a1	PROPN
chd-226	140	20	(	(	PUNCT
chd-226	140	21	spence	spence	NOUN
chd-226	140	22	et	et	PROPN
chd-226	140	23	al	al	PROPN
chd-226	140	24	.	.	PROPN
chd-226	140	25	,	,	PUNCT
chd-226	140	26	2003	2003	NUM
chd-226	140	27	)	)	PUNCT
chd-226	140	28	.	.	PUNCT
chd-226	141	1	to	to	ADP
chd-226	141	2	date	date	NOUN
chd-226	141	3	,	,	PUNCT
chd-226	141	4	the	the	DET
chd-226	141	5	role	role	NOUN
chd-226	141	6	of	of	ADP
chd-226	141	7	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PUNCT
chd-226	141	8	e11	e11	ADJ
chd-226	141	9	cancer	cancer	NOUN
chd-226	141	10	health	health	NOUN
chd-226	141	11	disparities	disparity	NOUN
chd-226	141	12	research	research	NOUN
chd-226	141	13	aldh1a1	aldh1a1	PROPN
chd-226	141	14	polymorphisms	polymorphism	NOUN
chd-226	141	15	in	in	ADP
chd-226	141	16	breast	breast	NOUN
chd-226	141	17	cancer	cancer	NOUN
chd-226	141	18	has	have	AUX
chd-226	141	19	not	not	PART
chd-226	141	20	been	be	AUX
chd-226	141	21	well	well	ADV
chd-226	141	22	studied	study	VERB
chd-226	141	23	.	.	PUNCT
chd-226	142	1	additionally	additionally	ADV
chd-226	142	2	,	,	PUNCT
chd-226	142	3	aldh1a1	aldh1a1	ADV
chd-226	142	4	is	be	AUX
chd-226	142	5	regulated	regulate	VERB
chd-226	142	6	by	by	ADP
chd-226	142	7	factors	factor	NOUN
chd-226	142	8	that	that	PRON
chd-226	142	9	are	be	AUX
chd-226	142	10	also	also	ADV
chd-226	142	11	associated	associate	VERB
chd-226	142	12	with	with	ADP
chd-226	142	13	breast	breast	NOUN
chd-226	142	14	cancer	cancer	NOUN
chd-226	142	15	risk	risk	NOUN
chd-226	142	16	including	include	VERB
chd-226	142	17	decreased	decrease	VERB
chd-226	142	18	estrogen	estrogen	NOUN
chd-226	142	19	(	(	PUNCT
chd-226	142	20	petrosino	petrosino	NOUN
chd-226	142	21	,	,	PUNCT
chd-226	142	22	2014	2014	NUM
chd-226	142	23	)	)	PUNCT
chd-226	142	24	,	,	PUNCT
chd-226	142	25	alcohol	alcohol	NOUN
chd-226	142	26	-	-	PUNCT
chd-226	142	27	associated	associate	VERB
chd-226	142	28	inflammation	inflammation	NOUN
chd-226	142	29	(	(	PUNCT
chd-226	142	30	wang	wang	PROPN
chd-226	142	31	et	et	PROPN
chd-226	142	32	al	al	PROPN
chd-226	142	33	.	.	PROPN
chd-226	142	34	,	,	PUNCT
chd-226	142	35	2017	2017	NUM
chd-226	142	36	)	)	PUNCT
chd-226	142	37	and	and	CCONJ
chd-226	142	38	high	high	ADJ
chd-226	142	39	fat	fat	ADJ
chd-226	142	40	diets	diet	NOUN
chd-226	142	41	(	(	PUNCT
chd-226	142	42	he	he	PRON
chd-226	142	43	et	et	PROPN
chd-226	142	44	al	al	PROPN
chd-226	142	45	.	.	PROPN
chd-226	142	46	,	,	PUNCT
chd-226	142	47	2020	2020	NUM
chd-226	142	48	;	;	PUNCT
chd-226	142	49	srinivasan	srinivasan	NOUN
chd-226	142	50	et	et	PROPN
chd-226	142	51	al	al	PROPN
chd-226	142	52	.	.	PROPN
chd-226	142	53	,	,	PUNCT
chd-226	142	54	2019	2019	NUM
chd-226	142	55	)	)	PUNCT
chd-226	142	56	.	.	PUNCT
chd-226	143	1	moreover	moreover	ADV
chd-226	143	2	,	,	PUNCT
chd-226	143	3	we	we	PRON
chd-226	143	4	and	and	CCONJ
chd-226	143	5	other	other	ADJ
chd-226	143	6	groups	group	NOUN
chd-226	143	7	have	have	AUX
chd-226	143	8	shown	show	VERB
chd-226	143	9	that	that	SCONJ
chd-226	143	10	tumor	tumor	NOUN
chd-226	143	11	expression	expression	NOUN
chd-226	143	12	of	of	ADP
chd-226	143	13	aldh1a1	aldh1a1	PROPN
chd-226	143	14	can	can	AUX
chd-226	143	15	be	be	AUX
chd-226	143	16	induced	induce	VERB
chd-226	143	17	by	by	ADP
chd-226	143	18	activation	activation	NOUN
chd-226	143	19	of	of	ADP
chd-226	143	20	the	the	DET
chd-226	143	21	il-6stat3	il-6stat3	PROPN
chd-226	143	22	pathway	pathway	NOUN
chd-226	143	23	(	(	PUNCT
chd-226	143	24	arnold	arnold	PROPN
chd-226	143	25	et	et	PROPN
chd-226	143	26	al	al	PROPN
chd-226	143	27	.	.	PROPN
chd-226	143	28	,	,	PUNCT
chd-226	143	29	2020	2020	NUM
chd-226	143	30	;	;	PUNCT
chd-226	143	31	hellsten	hellsten	PROPN
chd-226	143	32	et	et	PROPN
chd-226	143	33	al	al	PROPN
chd-226	143	34	.	.	PROPN
chd-226	143	35	,	,	PUNCT
chd-226	143	36	2011	2011	NUM
chd-226	143	37	)	)	PUNCT
chd-226	143	38	and	and	CCONJ
chd-226	143	39	may	may	AUX
chd-226	143	40	be	be	AUX
chd-226	143	41	associated	associate	VERB
chd-226	143	42	with	with	ADP
chd-226	143	43	chronic	chronic	ADJ
chd-226	143	44	inflammation	inflammation	NOUN
chd-226	143	45	.	.	PUNCT
chd-226	144	1	our	our	PRON
chd-226	144	2	study	study	NOUN
chd-226	144	3	has	have	VERB
chd-226	144	4	several	several	ADJ
chd-226	144	5	limitations	limitation	NOUN
chd-226	144	6	including	include	VERB
chd-226	144	7	a	a	DET
chd-226	144	8	small	small	ADJ
chd-226	144	9	sample	sample	NOUN
chd-226	144	10	size	size	NOUN
chd-226	144	11	.	.	PUNCT
chd-226	145	1	although	although	SCONJ
chd-226	145	2	our	our	PRON
chd-226	145	3	findings	finding	NOUN
chd-226	145	4	show	show	VERB
chd-226	145	5	that	that	SCONJ
chd-226	145	6	high	high	ADJ
chd-226	145	7	aldh1a1	aldh1a1	NOUN
chd-226	145	8	expression	expression	NOUN
chd-226	145	9	is	be	AUX
chd-226	145	10	correlated	correlate	VERB
chd-226	145	11	with	with	ADP
chd-226	145	12	race	race	NOUN
chd-226	145	13	and	and	CCONJ
chd-226	145	14	metabolic	metabolic	NOUN
chd-226	145	15	disorders	disorder	NOUN
chd-226	145	16	including	include	VERB
chd-226	145	17	obesity	obesity	NOUN
chd-226	145	18	and	and	CCONJ
chd-226	145	19	diabetes	diabetes	NOUN
chd-226	145	20	,	,	PUNCT
chd-226	145	21	these	these	DET
chd-226	145	22	findings	finding	NOUN
chd-226	145	23	need	need	VERB
chd-226	145	24	to	to	PART
chd-226	145	25	be	be	AUX
chd-226	145	26	confirmed	confirm	VERB
chd-226	145	27	in	in	ADP
chd-226	145	28	larger	large	ADJ
chd-226	145	29	studies	study	NOUN
chd-226	145	30	.	.	PUNCT
chd-226	146	1	we	we	PRON
chd-226	146	2	were	be	AUX
chd-226	146	3	able	able	ADJ
chd-226	146	4	to	to	PART
chd-226	146	5	obtain	obtain	VERB
chd-226	146	6	information	information	NOUN
chd-226	146	7	on	on	ADP
chd-226	146	8	diabetes	diabetes	NOUN
chd-226	146	9	and	and	CCONJ
chd-226	146	10	blood	blood	NOUN
chd-226	146	11	glucose	glucose	NOUN
chd-226	146	12	levels	level	NOUN
chd-226	146	13	on	on	ADP
chd-226	146	14	a	a	DET
chd-226	146	15	subset	subset	NOUN
chd-226	146	16	of	of	ADP
chd-226	146	17	patients	patient	NOUN
chd-226	146	18	;	;	PUNCT
chd-226	146	19	however	however	ADV
chd-226	146	20	,	,	PUNCT
chd-226	146	21	this	this	DET
chd-226	146	22	information	information	NOUN
chd-226	146	23	was	be	AUX
chd-226	146	24	missing	miss	VERB
chd-226	146	25	in	in	ADP
chd-226	146	26	our	our	PRON
chd-226	146	27	biorepository	biorepository	ADJ
chd-226	146	28	database	database	NOUN
chd-226	146	29	for	for	ADP
chd-226	146	30	many	many	ADJ
chd-226	146	31	patients	patient	NOUN
chd-226	146	32	and	and	CCONJ
chd-226	146	33	warrants	warrant	NOUN
chd-226	146	34	further	further	ADJ
chd-226	146	35	study	study	NOUN
chd-226	146	36	.	.	PUNCT
chd-226	147	1	due	due	ADP
chd-226	147	2	to	to	ADP
chd-226	147	3	the	the	DET
chd-226	147	4	smaller	small	ADJ
chd-226	147	5	sample	sample	NOUN
chd-226	147	6	size	size	NOUN
chd-226	147	7	,	,	PUNCT
chd-226	147	8	we	we	PRON
chd-226	147	9	were	be	AUX
chd-226	147	10	not	not	PART
chd-226	147	11	able	able	ADJ
chd-226	147	12	to	to	PART
chd-226	147	13	further	far	ADV
chd-226	147	14	stratify	stratify	VERB
chd-226	147	15	patients	patient	NOUN
chd-226	147	16	to	to	PART
chd-226	147	17	compare	compare	VERB
chd-226	147	18	differences	difference	NOUN
chd-226	147	19	among	among	ADP
chd-226	147	20	race	race	NOUN
chd-226	147	21	in	in	ADP
chd-226	147	22	prediabetes	prediabete	NOUN
chd-226	147	23	and	and	CCONJ
chd-226	147	24	diabetes	diabetes	NOUN
chd-226	147	25	groups	group	NOUN
chd-226	147	26	.	.	PUNCT
chd-226	148	1	although	although	SCONJ
chd-226	148	2	our	our	PRON
chd-226	148	3	analysis	analysis	NOUN
chd-226	148	4	included	include	VERB
chd-226	148	5	stratification	stratification	NOUN
chd-226	148	6	by	by	ADP
chd-226	148	7	receptor	receptor	NOUN
chd-226	148	8	subtype	subtype	NOUN
chd-226	148	9	,	,	PUNCT
chd-226	148	10	we	we	PRON
chd-226	148	11	were	be	AUX
chd-226	148	12	not	not	PART
chd-226	148	13	able	able	ADJ
chd-226	148	14	to	to	PART
chd-226	148	15	classify	classify	VERB
chd-226	148	16	patients	patient	NOUN
chd-226	148	17	according	accord	VERB
chd-226	148	18	to	to	ADP
chd-226	148	19	molecular	molecular	ADJ
chd-226	148	20	subtyping	subtyping	NOUN
chd-226	148	21	.	.	PUNCT
chd-226	149	1	racial	racial	ADJ
chd-226	149	2	differences	difference	NOUN
chd-226	149	3	have	have	AUX
chd-226	149	4	been	be	AUX
chd-226	149	5	reported	report	VERB
chd-226	149	6	in	in	ADP
chd-226	149	7	pam50	pam50	PROPN
chd-226	149	8	molecular	molecular	ADJ
chd-226	149	9	subtypes	subtype	NOUN
chd-226	149	10	,	,	PUNCT
chd-226	149	11	with	with	ADP
chd-226	149	12	black	black	ADJ
chd-226	149	13	women	woman	NOUN
chd-226	149	14	having	having	AUX
chd-226	149	15	increased	increase	VERB
chd-226	149	16	luminal	luminal	ADJ
chd-226	149	17	b	b	NOUN
chd-226	149	18	subtypes	subtype	NOUN
chd-226	149	19	(	(	PUNCT
chd-226	149	20	troester	troester	NOUN
chd-226	149	21	et	et	PROPN
chd-226	149	22	al	al	PROPN
chd-226	149	23	.	.	PROPN
chd-226	149	24	,	,	PUNCT
chd-226	149	25	2018	2018	NUM
chd-226	149	26	)	)	PUNCT
chd-226	149	27	.	.	PUNCT
chd-226	150	1	as	as	ADP
chd-226	150	2	aldh1a1	aldh1a1	ADP
chd-226	150	3	expression	expression	NOUN
chd-226	150	4	is	be	AUX
chd-226	150	5	associated	associate	VERB
chd-226	150	6	to	to	ADP
chd-226	150	7	both	both	CCONJ
chd-226	150	8	luminal	luminal	PROPN
chd-226	150	9	b	b	PROPN
chd-226	150	10	and	and	CCONJ
chd-226	150	11	tnbc	tnbc	ADJ
chd-226	150	12	subtypes	subtype	NOUN
chd-226	150	13	(	(	PUNCT
chd-226	150	14	althobiti	althobiti	PROPN
chd-226	150	15	et	et	PROPN
chd-226	150	16	al	al	PROPN
chd-226	150	17	.	.	PROPN
chd-226	150	18	,	,	PUNCT
chd-226	150	19	2020	2020	NUM
chd-226	150	20	)	)	PUNCT
chd-226	150	21	this	this	PRON
chd-226	150	22	could	could	AUX
chd-226	150	23	be	be	AUX
chd-226	150	24	a	a	DET
chd-226	150	25	confounding	confound	VERB
chd-226	150	26	factor	factor	NOUN
chd-226	150	27	.	.	PUNCT
chd-226	151	1	although	although	SCONJ
chd-226	151	2	our	our	PRON
chd-226	151	3	study	study	NOUN
chd-226	151	4	investigated	investigate	VERB
chd-226	151	5	the	the	DET
chd-226	151	6	association	association	NOUN
chd-226	151	7	of	of	ADP
chd-226	151	8	stromal	stromal	ADJ
chd-226	151	9	expression	expression	NOUN
chd-226	151	10	to	to	PART
chd-226	151	11	race	race	NOUN
chd-226	151	12	,	,	PUNCT
chd-226	151	13	comorbidities	comorbiditie	NOUN
chd-226	151	14	and	and	CCONJ
chd-226	151	15	outcomes	outcome	NOUN
chd-226	151	16	,	,	PUNCT
chd-226	151	17	our	our	PRON
chd-226	151	18	study	study	NOUN
chd-226	151	19	focused	focus	VERB
chd-226	151	20	on	on	ADP
chd-226	151	21	staining	stain	VERB
chd-226	151	22	index	index	NOUN
chd-226	151	23	of	of	ADP
chd-226	151	24	the	the	DET
chd-226	151	25	total	total	ADJ
chd-226	151	26	stroma	stroma	NOUN
chd-226	151	27	and	and	CCONJ
chd-226	151	28	did	do	AUX
chd-226	151	29	not	not	PART
chd-226	151	30	determine	determine	VERB
chd-226	151	31	differences	difference	NOUN
chd-226	151	32	by	by	ADP
chd-226	151	33	individual	individual	ADJ
chd-226	151	34	cell	cell	NOUN
chd-226	151	35	type	type	NOUN
chd-226	151	36	.	.	PUNCT
chd-226	152	1	we	we	PRON
chd-226	152	2	did	do	AUX
chd-226	152	3	observe	observe	VERB
chd-226	152	4	strong	strong	ADJ
chd-226	152	5	stromal	stromal	ADJ
chd-226	152	6	staining	stain	VERB
chd-226	152	7	in	in	ADP
chd-226	152	8	multiple	multiple	ADJ
chd-226	152	9	cell	cell	NOUN
chd-226	152	10	types	type	NOUN
chd-226	152	11	,	,	PUNCT
chd-226	152	12	which	which	PRON
chd-226	152	13	warrants	warrant	VERB
chd-226	152	14	further	further	ADJ
chd-226	152	15	investigation	investigation	NOUN
chd-226	152	16	.	.	PUNCT
chd-226	153	1	in	in	ADP
chd-226	153	2	conclusion	conclusion	NOUN
chd-226	153	3	,	,	PUNCT
chd-226	153	4	this	this	DET
chd-226	153	5	study	study	NOUN
chd-226	153	6	shows	show	VERB
chd-226	153	7	that	that	SCONJ
chd-226	153	8	aldha1a1	aldha1a1	X
chd-226	153	9	expression	expression	NOUN
chd-226	153	10	in	in	ADP
chd-226	153	11	breast	breast	NOUN
chd-226	153	12	tumor	tumor	NOUN
chd-226	153	13	and	and	CCONJ
chd-226	153	14	stromal	stromal	ADJ
chd-226	153	15	cells	cell	NOUN
chd-226	153	16	is	be	AUX
chd-226	153	17	associated	associate	VERB
chd-226	153	18	with	with	ADP
chd-226	153	19	black	black	ADJ
chd-226	153	20	race	race	NOUN
chd-226	153	21	,	,	PUNCT
chd-226	153	22	obesity	obesity	NOUN
chd-226	153	23	,	,	PUNCT
chd-226	153	24	and	and	CCONJ
chd-226	153	25	diabetes	diabetes	NOUN
chd-226	153	26	.	.	PUNCT
chd-226	154	1	when	when	SCONJ
chd-226	154	2	stratified	stratify	VERB
chd-226	154	3	by	by	ADP
chd-226	154	4	race	race	NOUN
chd-226	154	5	,	,	PUNCT
chd-226	154	6	black	black	ADJ
chd-226	154	7	women	woman	NOUN
chd-226	154	8	whose	whose	DET
chd-226	154	9	tumors	tumor	NOUN
chd-226	154	10	express	express	VERB
chd-226	154	11	high	high	ADJ
chd-226	154	12	levels	level	NOUN
chd-226	154	13	of	of	ADP
chd-226	154	14	aldh1a1	aldh1a1	X
chd-226	154	15	have	have	VERB
chd-226	154	16	significantly	significantly	ADV
chd-226	154	17	shorter	short	ADJ
chd-226	154	18	recurrence	recurrence	NOUN
chd-226	154	19	times	time	NOUN
chd-226	154	20	than	than	ADP
chd-226	154	21	white	white	ADJ
chd-226	154	22	women	woman	NOUN
chd-226	154	23	with	with	ADP
chd-226	154	24	strong	strong	ADJ
chd-226	154	25	aldh1a1	aldh1a1	ADJ
chd-226	154	26	expression	expression	NOUN
chd-226	154	27	.	.	PUNCT
chd-226	155	1	moreover	moreover	ADV
chd-226	155	2	,	,	PUNCT
chd-226	155	3	aldh1a1	aldh1a1	ADV
chd-226	155	4	expression	expression	NOUN
chd-226	155	5	was	be	AUX
chd-226	155	6	found	find	VERB
chd-226	155	7	to	to	PART
chd-226	155	8	be	be	AUX
chd-226	155	9	an	an	DET
chd-226	155	10	independent	independent	ADJ
chd-226	155	11	driver	driver	NOUN
chd-226	155	12	of	of	ADP
chd-226	155	13	outcomes	outcome	NOUN
chd-226	155	14	.	.	PUNCT
chd-226	156	1	these	these	DET
chd-226	156	2	findings	finding	NOUN
chd-226	156	3	indicate	indicate	VERB
chd-226	156	4	that	that	SCONJ
chd-226	156	5	aldh1a1	aldh1a1	ADV
chd-226	156	6	is	be	AUX
chd-226	156	7	associated	associate	VERB
chd-226	156	8	to	to	ADP
chd-226	156	9	disparities	disparity	NOUN
chd-226	156	10	in	in	ADP
chd-226	156	11	breast	breast	NOUN
chd-226	156	12	cancer	cancer	NOUN
chd-226	156	13	outcomes	outcome	NOUN
chd-226	156	14	and	and	CCONJ
chd-226	156	15	provide	provide	VERB
chd-226	156	16	the	the	DET
chd-226	156	17	first	first	ADJ
chd-226	156	18	link	link	NOUN
chd-226	156	19	between	between	ADP
chd-226	156	20	tumor	tumor	NOUN
chd-226	156	21	aldh1a1	aldh1a1	NOUN
chd-226	156	22	expression	expression	NOUN
chd-226	156	23	,	,	PUNCT
chd-226	156	24	obesity	obesity	NOUN
chd-226	156	25	,	,	PUNCT
chd-226	156	26	and	and	CCONJ
chd-226	156	27	diabetes	diabetes	NOUN
chd-226	156	28	.	.	PUNCT
chd-226	157	1	further	further	ADJ
chd-226	157	2	study	study	NOUN
chd-226	157	3	is	be	AUX
chd-226	157	4	needed	need	VERB
chd-226	157	5	to	to	PART
chd-226	157	6	understand	understand	VERB
chd-226	157	7	the	the	DET
chd-226	157	8	mechanisms	mechanism	NOUN
chd-226	157	9	driving	drive	VERB
chd-226	157	10	high	high	ADJ
chd-226	157	11	aldh1a1	aldh1a1	NOUN
chd-226	157	12	expression	expression	NOUN
chd-226	157	13	in	in	ADP
chd-226	157	14	these	these	DET
chd-226	157	15	cohorts	cohort	NOUN
chd-226	157	16	.	.	PUNCT
chd-226	158	1	financial	financial	ADJ
chd-226	158	2	support	support	NOUN
chd-226	158	3	this	this	DET
chd-226	158	4	work	work	NOUN
chd-226	158	5	was	be	AUX
chd-226	158	6	supported	support	VERB
chd-226	158	7	by	by	ADP
chd-226	158	8	a	a	DET
chd-226	158	9	grant	grant	NOUN
chd-226	158	10	from	from	ADP
chd-226	158	11	the	the	DET
chd-226	158	12	lisa	lisa	PROPN
chd-226	158	13	dean	dean	PROPN
chd-226	158	14	mosely	mosely	PROPN
chd-226	158	15	foundation	foundation	PROPN
chd-226	158	16	,	,	PUNCT
chd-226	158	17	and	and	CCONJ
chd-226	158	18	by	by	ADP
chd-226	158	19	the	the	DET
chd-226	158	20	delaware	delaware	PROPN
chd-226	158	21	inbre	inbre	PROPN
chd-226	158	22	program	program	PROPN
chd-226	158	23	,	,	PUNCT
chd-226	158	24	with	with	ADP
chd-226	158	25	a	a	DET
chd-226	158	26	grant	grant	NOUN
chd-226	158	27	from	from	ADP
chd-226	158	28	the	the	DET
chd-226	158	29	national	national	PROPN
chd-226	158	30	institute	institute	PROPN
chd-226	158	31	of	of	ADP
chd-226	158	32	general	general	PROPN
chd-226	158	33	medical	medical	ADJ
chd-226	158	34	sciences	science	NOUN
chd-226	158	35	–	–	PUNCT
chd-226	158	36	nigms	nigms	NOUN
chd-226	158	37	(	(	PUNCT
chd-226	158	38	p20	p20	NOUN
chd-226	158	39	gm103446	gm103446	NOUN
chd-226	158	40	)	)	PUNCT
chd-226	158	41	from	from	ADP
chd-226	158	42	the	the	DET
chd-226	158	43	national	national	PROPN
chd-226	158	44	institutes	institutes	PROPN
chd-226	158	45	of	of	ADP
chd-226	158	46	health	health	PROPN
chd-226	158	47	and	and	CCONJ
chd-226	158	48	the	the	DET
chd-226	158	49	state	state	NOUN
chd-226	158	50	of	of	ADP
chd-226	158	51	delaware	delaware	PROPN
chd-226	158	52	.	.	PUNCT
chd-226	159	1	acknowledgement	acknowledgement	NOUN
chd-226	159	2	the	the	DET
chd-226	159	3	authors	author	NOUN
chd-226	159	4	have	have	VERB
chd-226	159	5	no	no	DET
chd-226	159	6	acknowledgements	acknowledgement	NOUN
chd-226	159	7	conflicts	conflict	NOUN
chd-226	159	8	of	of	ADP
chd-226	159	9	interest	interest	NOUN
chd-226	159	10	the	the	DET
chd-226	159	11	authors	author	NOUN
chd-226	159	12	report	report	VERB
chd-226	159	13	no	no	DET
chd-226	159	14	conficlts	conficlt	NOUN
chd-226	159	15	of	of	ADP
chd-226	159	16	interest	interest	NOUN
chd-226	159	17	authors	author	NOUN
chd-226	159	18	'	'	PART
chd-226	159	19	contributions	contribution	NOUN
chd-226	159	20	kindly	kindly	ADV
chd-226	159	21	add	add	VERB
chd-226	159	22	.	.	PUNCT
chd-226	160	1	s.m	s.m	PROPN
chd-226	160	2	.	.	PROPN
chd-226	160	3	:	:	PUNCT
chd-226	161	1	experimental	experimental	ADJ
chd-226	161	2	procedures	procedure	NOUN
chd-226	161	3	and	and	CCONJ
chd-226	161	4	contributed	contribute	VERB
chd-226	161	5	to	to	ADP
chd-226	161	6	the	the	DET
chd-226	161	7	writing	writing	NOUN
chd-226	161	8	of	of	ADP
chd-226	161	9	the	the	DET
chd-226	161	10	draft	draft	NOUN
chd-226	161	11	,	,	PUNCT
chd-226	161	12	l.f	l.f	PROPN
chd-226	161	13	.	.	PROPN
chd-226	161	14	:	:	PUNCT
chd-226	161	15	performed	perform	VERB
chd-226	161	16	experimetnal	experimetnal	ADJ
chd-226	161	17	procedures	procedure	NOUN
chd-226	161	18	and	and	CCONJ
chd-226	161	19	manuscript	manuscript	NOUN
chd-226	161	20	reveiw	reveiw	PROPN
chd-226	161	21	.	.	PUNCT
chd-226	161	22	,	,	PUNCT
chd-226	161	23	s.d.s	s.d.s	PROPN
chd-226	161	24	.	.	PUNCT
chd-226	161	25	:	:	PUNCT
chd-226	162	1	conceptualiztion	conceptualiztion	NOUN
chd-226	162	2	,	,	PUNCT
chd-226	162	3	manuscript	manuscript	NOUN
chd-226	162	4	review	review	NOUN
chd-226	162	5	and	and	CCONJ
chd-226	162	6	editing	editing	NOUN
chd-226	162	7	,	,	PUNCT
chd-226	162	8	z.s	z.s	PROPN
chd-226	162	9	.	.	PROPN
chd-226	162	10	conceptualization	conceptualization	NOUN
chd-226	162	11	,	,	PUNCT
chd-226	162	12	manuscript	manuscript	NOUN
chd-226	162	13	review	review	NOUN
chd-226	162	14	and	and	CCONJ
chd-226	162	15	editing	editing	NOUN
chd-226	162	16	,	,	PUNCT
chd-226	162	17	j.s.m	j.s.m	PROPN
chd-226	162	18	.	.	PUNCT
chd-226	162	19	:	:	PUNCT
chd-226	162	20	conceptualization	conceptualization	NOUN
chd-226	162	21	,	,	PUNCT
chd-226	162	22	statistical	statistical	ADJ
chd-226	162	23	analysis	analysis	NOUN
chd-226	162	24	,	,	PUNCT
chd-226	162	25	writing	writing	NOUN
chd-226	162	26	of	of	ADP
chd-226	162	27	the	the	DET
chd-226	162	28	draft	draft	NOUN
chd-226	162	29	and	and	CCONJ
chd-226	162	30	review	review	NOUN
chd-226	162	31	and	and	CCONJ
chd-226	162	32	editing	editing	NOUN
chd-226	162	33	of	of	ADP
chd-226	162	34	manuscript	manuscript	NOUN
chd-226	162	35	.	.	PUNCT
chd-226	163	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-226	163	2	e12	e12	NOUN
chd-226	163	3	cancer	cancer	NOUN
chd-226	163	4	health	health	NOUN
chd-226	163	5	disparities	disparity	NOUN
chd-226	163	6	research	research	NOUN
chd-226	163	7	references	reference	NOUN
chd-226	163	8	agarwal	agarwal	PROPN
chd-226	163	9	,	,	PUNCT
chd-226	163	10	d.p	d.p	PROPN
chd-226	163	11	.	.	PROPN
chd-226	163	12	,	,	PUNCT
chd-226	163	13	harada	harada	PROPN
chd-226	163	14	,	,	PUNCT
chd-226	163	15	s.	s.	PROPN
chd-226	163	16	,	,	PUNCT
chd-226	163	17	and	and	CCONJ
chd-226	163	18	goedde	goedde	PROPN
chd-226	163	19	,	,	PUNCT
chd-226	163	20	h.w	h.w	PROPN
chd-226	163	21	.	.	PUNCT
chd-226	163	22	(	(	PUNCT
chd-226	163	23	1981	1981	NUM
chd-226	163	24	)	)	PUNCT
chd-226	163	25	.	.	PUNCT
chd-226	164	1	racial	racial	ADJ
chd-226	164	2	differences	difference	NOUN
chd-226	164	3	in	in	ADP
chd-226	164	4	biological	biological	ADJ
chd-226	164	5	sensitivity	sensitivity	NOUN
chd-226	164	6	to	to	PART
chd-226	164	7	ethanol	ethanol	VERB
chd-226	164	8	:	:	PUNCT
chd-226	164	9	the	the	DET
chd-226	164	10	role	role	NOUN
chd-226	164	11	of	of	ADP
chd-226	164	12	alcohol	alcohol	NOUN
chd-226	164	13	dehydrogenase	dehydrogenase	NOUN
chd-226	164	14	and	and	CCONJ
chd-226	164	15	aldehyde	aldehyde	NOUN
chd-226	164	16	dehydrogenase	dehydrogenase	NOUN
chd-226	164	17	isozymes	isozyme	NOUN
chd-226	164	18	.	.	PUNCT
chd-226	165	1	alcohol	alcohol	PROPN
chd-226	165	2	clin	clin	PROPN
chd-226	165	3	exp	exp	PROPN
chd-226	165	4	res	re	NOUN
chd-226	165	5	5	5	NUM
chd-226	165	6	,	,	PUNCT
chd-226	165	7	12	12	NUM
chd-226	165	8	-	-	SYM
chd-226	165	9	16	16	NUM
chd-226	165	10	.	.	PUNCT
chd-226	166	1	https://www.ncbi.nlm.nih.gov/pubmed/7013538	https://www.ncbi.nlm.nih.gov/pubmed/7013538	PROPN
chd-226	166	2	.	.	PUNCT
chd-226	167	1	althobiti	althobiti	PROPN
chd-226	167	2	,	,	PUNCT
chd-226	167	3	m.	m.	NOUN
chd-226	167	4	,	,	PUNCT
chd-226	167	5	el	el	PROPN
chd-226	167	6	ansari	ansari	PROPN
chd-226	167	7	,	,	PUNCT
chd-226	167	8	r.	r.	PROPN
chd-226	167	9	,	,	PUNCT
chd-226	167	10	aleskandarany	aleskandarany	PROPN
chd-226	167	11	,	,	PUNCT
chd-226	167	12	m.	m.	NOUN
chd-226	167	13	,	,	PUNCT
chd-226	167	14	joseph	joseph	PROPN
chd-226	167	15	,	,	PUNCT
chd-226	167	16	c.	c.	PROPN
chd-226	167	17	,	,	PUNCT
chd-226	167	18	toss	toss	PROPN
chd-226	167	19	,	,	PUNCT
chd-226	167	20	m.s	m.s	PROPN
chd-226	167	21	.	.	PROPN
chd-226	167	22	,	,	PUNCT
chd-226	167	23	green	green	PROPN
chd-226	167	24	,	,	PUNCT
chd-226	167	25	a.r	a.r	PROPN
chd-226	167	26	.	.	PROPN
chd-226	167	27	,	,	PUNCT
chd-226	167	28	and	and	CCONJ
chd-226	167	29	rakha	rakha	PROPN
chd-226	167	30	,	,	PUNCT
chd-226	167	31	e.a	e.a	PROPN
chd-226	167	32	.	.	PROPN
chd-226	167	33	(	(	PUNCT
chd-226	167	34	2020	2020	NUM
chd-226	167	35	)	)	PUNCT
chd-226	167	36	.	.	PUNCT
chd-226	168	1	the	the	DET
chd-226	168	2	prognostic	prognostic	ADJ
chd-226	168	3	significance	significance	NOUN
chd-226	168	4	of	of	ADP
chd-226	168	5	aldh1a1	aldh1a1	ADJ
chd-226	168	6	expression	expression	NOUN
chd-226	168	7	in	in	ADP
chd-226	168	8	early	early	ADJ
chd-226	168	9	invasive	invasive	ADJ
chd-226	168	10	breast	breast	NOUN
chd-226	168	11	cancer	cancer	NOUN
chd-226	168	12	.	.	PUNCT
chd-226	169	1	histopathology	histopathology	NOUN
chd-226	169	2	77	77	NUM
chd-226	169	3	,	,	PUNCT
chd-226	169	4	437	437	NUM
chd-226	169	5	-	-	SYM
chd-226	169	6	448	448	NUM
chd-226	169	7	.	.	PUNCT
chd-226	170	1	https://www.ncbi.nlm.nih.gov/pubmed/32369651	https://www.ncbi.nlm.nih.gov/pubmed/32369651	X
chd-226	170	2	.	.	PUNCT
chd-226	171	1	arnold	arnold	PROPN
chd-226	171	2	,	,	PUNCT
chd-226	171	3	k.m	k.m	PROPN
chd-226	171	4	.	.	PROPN
chd-226	171	5	,	,	PUNCT
chd-226	171	6	opdenaker	opdenaker	PROPN
chd-226	171	7	,	,	PUNCT
chd-226	171	8	l.m	l.m	PROPN
chd-226	171	9	.	.	PROPN
chd-226	171	10	,	,	PUNCT
chd-226	171	11	flynn	flynn	PROPN
chd-226	171	12	,	,	PUNCT
chd-226	171	13	n.j	n.j	PROPN
chd-226	171	14	.	.	PROPN
chd-226	171	15	,	,	PUNCT
chd-226	171	16	appeah	appeah	PROPN
chd-226	171	17	,	,	PUNCT
chd-226	171	18	d.k	d.k	PROPN
chd-226	171	19	.	.	PROPN
chd-226	171	20	,	,	PUNCT
chd-226	171	21	and	and	CCONJ
chd-226	171	22	sims	sim	NOUN
chd-226	171	23	-	-	PUNCT
chd-226	171	24	mourtada	mourtada	PROPN
chd-226	171	25	,	,	PUNCT
chd-226	171	26	j.	j.	PROPN
chd-226	171	27	(	(	PUNCT
chd-226	171	28	2020	2020	NUM
chd-226	171	29	)	)	PUNCT
chd-226	171	30	.	.	PUNCT
chd-226	172	1	radiation	radiation	NOUN
chd-226	172	2	induces	induce	VERB
chd-226	172	3	an	an	DET
chd-226	172	4	inflammatory	inflammatory	ADJ
chd-226	172	5	response	response	NOUN
chd-226	172	6	that	that	PRON
chd-226	172	7	results	result	VERB
chd-226	172	8	in	in	ADP
chd-226	172	9	stat3	stat3	NOUN
chd-226	172	10	-	-	PUNCT
chd-226	172	11	dependent	dependent	ADJ
chd-226	172	12	changes	change	NOUN
chd-226	172	13	in	in	ADP
chd-226	172	14	cellular	cellular	ADJ
chd-226	172	15	plasticity	plasticity	NOUN
chd-226	172	16	and	and	CCONJ
chd-226	172	17	radioresistance	radioresistance	NOUN
chd-226	172	18	of	of	ADP
chd-226	172	19	breast	breast	NOUN
chd-226	172	20	cancer	cancer	NOUN
chd-226	172	21	stem	stem	NOUN
chd-226	172	22	-	-	PUNCT
chd-226	172	23	like	like	ADJ
chd-226	172	24	cells	cell	NOUN
chd-226	172	25	.	.	PUNCT
chd-226	173	1	int	int	PROPN
chd-226	173	2	j	j	PROPN
chd-226	173	3	radiat	radiat	PROPN
chd-226	173	4	biol	biol	PROPN
chd-226	173	5	96	96	NUM
chd-226	173	6	,	,	PUNCT
chd-226	173	7	434	434	NUM
chd-226	173	8	-	-	SYM
chd-226	173	9	447	447	NUM
chd-226	173	10	.	.	PUNCT
chd-226	174	1	https://www.ncbi.nlm.nih.gov/pubmed/31850822	https://www.ncbi.nlm.nih.gov/pubmed/31850822	NOUN
chd-226	174	2	.	.	PUNCT
chd-226	175	1	ayub	ayub	PROPN
chd-226	175	2	,	,	PUNCT
chd-226	175	3	t.h	t.h	PROPN
chd-226	175	4	.	.	PROPN
chd-226	175	5	,	,	PUNCT
chd-226	175	6	keyver	keyver	NOUN
chd-226	175	7	-	-	PUNCT
chd-226	175	8	paik	paik	NOUN
chd-226	175	9	,	,	PUNCT
chd-226	175	10	m.d	m.d	PROPN
chd-226	175	11	.	.	PROPN
chd-226	175	12	,	,	PUNCT
chd-226	175	13	debald	debald	PROPN
chd-226	175	14	,	,	PUNCT
chd-226	175	15	m.	m.	NOUN
chd-226	175	16	,	,	PUNCT
chd-226	175	17	rostamzadeh	rostamzadeh	PROPN
chd-226	175	18	,	,	PUNCT
chd-226	175	19	b.	b.	PROPN
chd-226	175	20	,	,	PUNCT
chd-226	175	21	thiesler	thiesler	NOUN
chd-226	175	22	,	,	PUNCT
chd-226	175	23	t.	t.	PROPN
chd-226	175	24	,	,	PUNCT
chd-226	175	25	schroder	schroder	PROPN
chd-226	175	26	,	,	PUNCT
chd-226	175	27	l.	l.	PROPN
chd-226	175	28	,	,	PUNCT
chd-226	175	29	barchet	barchet	PROPN
chd-226	175	30	,	,	PUNCT
chd-226	175	31	w.	w.	PROPN
chd-226	175	32	,	,	PUNCT
chd-226	175	33	abramian	abramian	PROPN
chd-226	175	34	,	,	PUNCT
chd-226	175	35	a.	a.	PROPN
chd-226	175	36	,	,	PUNCT
chd-226	175	37	kaiser	kaiser	PROPN
chd-226	175	38	,	,	PUNCT
chd-226	175	39	c.	c.	PROPN
chd-226	175	40	,	,	PUNCT
chd-226	175	41	kristiansen	kristiansen	PROPN
chd-226	175	42	,	,	PUNCT
chd-226	175	43	g.	g.	PROPN
chd-226	175	44	,	,	PUNCT
chd-226	175	45	et	et	PROPN
chd-226	175	46	al	al	PROPN
chd-226	175	47	.	.	PUNCT
chd-226	175	48	(	(	PUNCT
chd-226	175	49	2015	2015	NUM
chd-226	175	50	)	)	PUNCT
chd-226	175	51	.	.	PUNCT
chd-226	176	1	accumulation	accumulation	NOUN
chd-226	176	2	of	of	ADP
chd-226	176	3	aldh1positive	aldh1positive	ADJ
chd-226	176	4	cells	cell	NOUN
chd-226	176	5	after	after	SCONJ
chd-226	176	6	neoadjuvant	neoadjuvant	ADJ
chd-226	176	7	chemotherapy	chemotherapy	NOUN
chd-226	176	8	predicts	predict	VERB
chd-226	176	9	treatment	treatment	NOUN
chd-226	176	10	resistance	resistance	NOUN
chd-226	176	11	and	and	CCONJ
chd-226	176	12	prognosticates	prognosticate	VERB
chd-226	176	13	poor	poor	ADJ
chd-226	176	14	outcome	outcome	NOUN
chd-226	176	15	in	in	ADP
chd-226	176	16	ovarian	ovarian	ADJ
chd-226	176	17	cancer	cancer	NOUN
chd-226	176	18	.	.	PUNCT
chd-226	177	1	oncotarget	oncotarget	NOUN
chd-226	177	2	6	6	NUM
chd-226	177	3	,	,	PUNCT
chd-226	177	4	16437	16437	NUM
chd-226	177	5	-	-	SYM
chd-226	177	6	16448	16448	NUM
chd-226	177	7	.	.	PUNCT
chd-226	178	1	https://www.ncbi.nlm.nih.gov/pubmed/25999351	https://www.ncbi.nlm.nih.gov/pubmed/25999351	PROPN
chd-226	178	2	.	.	PUNCT
chd-226	179	1	bazewicz	bazewicz	PROPN
chd-226	179	2	,	,	PUNCT
chd-226	179	3	c.g	c.g	PROPN
chd-226	179	4	.	.	PROPN
chd-226	179	5	,	,	PUNCT
chd-226	179	6	dinavahi	dinavahi	PROPN
chd-226	179	7	,	,	PUNCT
chd-226	179	8	s.s	s.s	PROPN
chd-226	179	9	.	.	PROPN
chd-226	179	10	,	,	PUNCT
chd-226	179	11	schell	schell	PROPN
chd-226	179	12	,	,	PUNCT
chd-226	179	13	t.d	t.d	PROPN
chd-226	179	14	.	.	PROPN
chd-226	179	15	,	,	PUNCT
chd-226	179	16	and	and	CCONJ
chd-226	179	17	robertson	robertson	PROPN
chd-226	179	18	,	,	PUNCT
chd-226	179	19	g.p	g.p	PROPN
chd-226	179	20	.	.	PROPN
chd-226	179	21	(	(	PUNCT
chd-226	179	22	2019	2019	NUM
chd-226	179	23	)	)	PUNCT
chd-226	179	24	.	.	PUNCT
chd-226	180	1	aldehyde	aldehyde	NOUN
chd-226	180	2	dehydrogenase	dehydrogenase	NOUN
chd-226	180	3	in	in	ADP
chd-226	180	4	regulatory	regulatory	ADJ
chd-226	180	5	t	t	PROPN
chd-226	180	6	-	-	PUNCT
chd-226	180	7	cell	cell	NOUN
chd-226	180	8	development	development	NOUN
chd-226	180	9	,	,	PUNCT
chd-226	180	10	immunity	immunity	NOUN
chd-226	180	11	and	and	CCONJ
chd-226	180	12	cancer	cancer	NOUN
chd-226	180	13	.	.	PUNCT
chd-226	181	1	immunology	immunology	NOUN
chd-226	181	2	156	156	NUM
chd-226	181	3	,	,	PUNCT
chd-226	181	4	4755	4755	NUM
chd-226	181	5	.	.	PUNCT
chd-226	182	1	https://www.ncbi.nlm.nih.gov/pubmed/30387499	https://www.ncbi.nlm.nih.gov/pubmed/30387499	X
chd-226	182	2	.	.	PUNCT
chd-226	182	3	bednarz	bednarz	NOUN
chd-226	182	4	-	-	PUNCT
chd-226	182	5	knoll	knoll	NOUN
chd-226	182	6	,	,	PUNCT
chd-226	182	7	n.	n.	NOUN
chd-226	182	8	,	,	PUNCT
chd-226	182	9	nastaly	nastaly	PROPN
chd-226	182	10	,	,	PUNCT
chd-226	182	11	p.	p.	NOUN
chd-226	182	12	,	,	PUNCT
chd-226	182	13	zaczek	zaczek	NOUN
chd-226	182	14	,	,	PUNCT
chd-226	182	15	a.	a.	NOUN
chd-226	182	16	,	,	PUNCT
chd-226	182	17	stoupiec	stoupiec	PROPN
chd-226	182	18	,	,	PUNCT
chd-226	182	19	m.g	m.g	PROPN
chd-226	182	20	.	.	PROPN
chd-226	182	21	,	,	PUNCT
chd-226	182	22	riethdorf	riethdorf	PROPN
chd-226	182	23	,	,	PUNCT
chd-226	182	24	s.	s.	PROPN
chd-226	182	25	,	,	PUNCT
chd-226	182	26	wikman	wikman	PROPN
chd-226	182	27	,	,	PUNCT
chd-226	182	28	h.	h.	PROPN
chd-226	182	29	,	,	PUNCT
chd-226	182	30	muller	muller	PROPN
chd-226	182	31	,	,	PUNCT
chd-226	182	32	v.	v.	PROPN
chd-226	182	33	,	,	PUNCT
chd-226	182	34	skokowski	skokowski	PROPN
chd-226	182	35	,	,	PUNCT
chd-226	182	36	j.	j.	PROPN
chd-226	182	37	,	,	PUNCT
chd-226	182	38	szade	szade	PROPN
chd-226	182	39	,	,	PUNCT
chd-226	182	40	j.	j.	PROPN
chd-226	182	41	,	,	PUNCT
chd-226	182	42	sejda	sejda	PROPN
chd-226	182	43	,	,	PUNCT
chd-226	182	44	a.	a.	PROPN
chd-226	182	45	,	,	PUNCT
chd-226	182	46	et	et	PROPN
chd-226	182	47	al	al	PROPN
chd-226	182	48	.	.	PUNCT
chd-226	183	1	(	(	PUNCT
chd-226	183	2	2015	2015	NUM
chd-226	183	3	)	)	PUNCT
chd-226	183	4	.	.	PUNCT
chd-226	184	1	stromal	stromal	ADJ
chd-226	184	2	expression	expression	NOUN
chd-226	184	3	of	of	ADP
chd-226	184	4	aldh1	aldh1	NOUN
chd-226	184	5	in	in	ADP
chd-226	184	6	human	human	ADJ
chd-226	184	7	breast	breast	NOUN
chd-226	184	8	carcinomas	carcinoma	NOUN
chd-226	184	9	indicates	indicate	VERB
chd-226	184	10	reduced	reduce	VERB
chd-226	184	11	tumor	tumor	NOUN
chd-226	184	12	progression	progression	NOUN
chd-226	184	13	.	.	PUNCT
chd-226	185	1	oncotarget	oncotarget	NOUN
chd-226	185	2	6	6	NUM
chd-226	185	3	,	,	PUNCT
chd-226	185	4	26789	26789	NUM
chd-226	185	5	-	-	SYM
chd-226	185	6	26803	26803	NUM
chd-226	185	7	.	.	PUNCT
chd-226	186	1	https://www.ncbi.nlm.nih.gov/pubmed/26305673	https://www.ncbi.nlm.nih.gov/pubmed/26305673	PROPN
chd-226	186	2	.	.	PUNCT
chd-226	187	1	crawford	crawford	PROPN
chd-226	187	2	,	,	PUNCT
chd-226	187	3	a.	a.	PROPN
chd-226	187	4	,	,	PUNCT
chd-226	187	5	dalvie	dalvie	NOUN
chd-226	187	6	,	,	PUNCT
chd-226	187	7	s.	s.	PROPN
chd-226	187	8	,	,	PUNCT
chd-226	187	9	lewis	lewis	PROPN
chd-226	187	10	,	,	PUNCT
chd-226	187	11	s.	s.	PROPN
chd-226	187	12	,	,	PUNCT
chd-226	187	13	king	king	PROPN
chd-226	187	14	,	,	PUNCT
chd-226	187	15	a.	a.	NOUN
chd-226	187	16	,	,	PUNCT
chd-226	187	17	liberzon	liberzon	PROPN
chd-226	187	18	,	,	PUNCT
chd-226	187	19	i.	i.	NOUN
chd-226	187	20	,	,	PUNCT
chd-226	187	21	fein	fein	PROPN
chd-226	187	22	,	,	PUNCT
chd-226	187	23	g.	g.	PROPN
chd-226	187	24	,	,	PUNCT
chd-226	187	25	koenen	koenen	PROPN
chd-226	187	26	,	,	PUNCT
chd-226	187	27	k.	k.	PROPN
chd-226	187	28	,	,	PUNCT
chd-226	187	29	ramesar	ramesar	PROPN
chd-226	187	30	,	,	PUNCT
chd-226	187	31	r.	r.	PROPN
chd-226	187	32	,	,	PUNCT
chd-226	187	33	and	and	CCONJ
chd-226	187	34	stein	stein	PROPN
chd-226	187	35	,	,	PUNCT
chd-226	187	36	d.j	d.j	PROPN
chd-226	187	37	.	.	PROPN
chd-226	187	38	(	(	PUNCT
chd-226	187	39	2014	2014	NUM
chd-226	187	40	)	)	PUNCT
chd-226	187	41	.	.	PUNCT
chd-226	188	1	haplotypebased	haplotypebased	ADJ
chd-226	188	2	study	study	NOUN
chd-226	188	3	of	of	ADP
chd-226	188	4	the	the	DET
chd-226	188	5	association	association	NOUN
chd-226	188	6	of	of	ADP
chd-226	188	7	alcohol	alcohol	NOUN
chd-226	188	8	and	and	CCONJ
chd-226	188	9	acetaldehyde	acetaldehyde	NOUN
chd-226	188	10	-	-	PUNCT
chd-226	188	11	metabolising	metabolise	VERB
chd-226	188	12	genes	gene	NOUN
chd-226	188	13	with	with	ADP
chd-226	188	14	alcohol	alcohol	NOUN
chd-226	188	15	dependence	dependence	NOUN
chd-226	188	16	(	(	PUNCT
chd-226	188	17	with	with	ADP
chd-226	188	18	or	or	CCONJ
chd-226	188	19	without	without	ADP
chd-226	188	20	comorbid	comorbid	NOUN
chd-226	188	21	anxiety	anxiety	NOUN
chd-226	188	22	symptoms	symptom	NOUN
chd-226	188	23	)	)	PUNCT
chd-226	188	24	in	in	ADP
chd-226	188	25	a	a	DET
chd-226	188	26	cape	cape	NOUN
chd-226	188	27	mixed	mix	VERB
chd-226	188	28	ancestry	ancestry	NOUN
chd-226	188	29	population	population	NOUN
chd-226	188	30	.	.	PUNCT
chd-226	189	1	metab	metab	ADJ
chd-226	189	2	brain	brain	NOUN
chd-226	189	3	dis	dis	PROPN
chd-226	189	4	29	29	NUM
chd-226	189	5	,	,	PUNCT
chd-226	189	6	333	333	NUM
chd-226	189	7	-	-	SYM
chd-226	189	8	340	340	NUM
chd-226	189	9	.	.	PUNCT
chd-226	190	1	https://www.ncbi.nlm.nih.gov/pubmed/24567230	https://www.ncbi.nlm.nih.gov/pubmed/24567230	NUM
chd-226	190	2	.	.	PUNCT
chd-226	191	1	croker	croker	PROPN
chd-226	191	2	,	,	PUNCT
chd-226	191	3	a.k	a.k	PROPN
chd-226	191	4	.	.	PROPN
chd-226	191	5	,	,	PUNCT
chd-226	191	6	rodriguez	rodriguez	NOUN
chd-226	191	7	-	-	PUNCT
chd-226	191	8	torres	torre	NOUN
chd-226	191	9	,	,	PUNCT
chd-226	191	10	m.	m.	NOUN
chd-226	191	11	,	,	PUNCT
chd-226	191	12	xia	xia	PROPN
chd-226	191	13	,	,	PUNCT
chd-226	191	14	y.	y.	PROPN
chd-226	191	15	,	,	PUNCT
chd-226	191	16	pardhan	pardhan	PROPN
chd-226	191	17	,	,	PUNCT
chd-226	191	18	s.	s.	PROPN
chd-226	191	19	,	,	PUNCT
chd-226	191	20	leong	leong	PROPN
chd-226	191	21	,	,	PUNCT
chd-226	191	22	h.s	h.s	PROPN
chd-226	191	23	.	.	PROPN
chd-226	191	24	,	,	PUNCT
chd-226	191	25	lewis	lewis	PROPN
chd-226	191	26	,	,	PUNCT
chd-226	191	27	j.d	j.d	PROPN
chd-226	191	28	.	.	PROPN
chd-226	191	29	,	,	PUNCT
chd-226	191	30	and	and	CCONJ
chd-226	191	31	allan	allan	PROPN
chd-226	191	32	,	,	PUNCT
chd-226	191	33	a.l	a.l	PROPN
chd-226	191	34	.	.	PROPN
chd-226	191	35	(	(	PUNCT
chd-226	191	36	2017	2017	NUM
chd-226	191	37	)	)	PUNCT
chd-226	191	38	.	.	PUNCT
chd-226	192	1	differential	differential	ADJ
chd-226	192	2	functional	functional	ADJ
chd-226	192	3	roles	role	NOUN
chd-226	192	4	of	of	ADP
chd-226	192	5	aldh1a1	aldh1a1	NOUN
chd-226	192	6	and	and	CCONJ
chd-226	192	7	aldh1a3	aldh1a3	X
chd-226	192	8	in	in	ADP
chd-226	192	9	mediating	mediate	VERB
chd-226	192	10	metastatic	metastatic	ADJ
chd-226	192	11	behavior	behavior	NOUN
chd-226	192	12	and	and	CCONJ
chd-226	192	13	therapy	therapy	NOUN
chd-226	192	14	resistance	resistance	NOUN
chd-226	192	15	of	of	ADP
chd-226	192	16	human	human	ADJ
chd-226	192	17	breast	breast	NOUN
chd-226	192	18	cancer	cancer	NOUN
chd-226	192	19	cells	cell	NOUN
chd-226	192	20	.	.	PUNCT
chd-226	193	1	int	int	PROPN
chd-226	193	2	j	j	PROPN
chd-226	193	3	mol	mol	ADP
chd-226	193	4	sci	sci	PROPN
chd-226	193	5	18	18	NUM
chd-226	193	6	.	.	PUNCT
chd-226	194	1	https://www.ncbi.nlm.nih.gov/pubmed/28937653	https://www.ncbi.nlm.nih.gov/pubmed/28937653	NUM
chd-226	194	2	.	.	PUNCT
chd-226	195	1	dietze	dietze	PROPN
chd-226	195	2	,	,	PUNCT
chd-226	195	3	e.c	e.c	PROPN
chd-226	195	4	.	.	PROPN
chd-226	195	5	,	,	PUNCT
chd-226	195	6	chavez	chavez	PROPN
chd-226	195	7	,	,	PUNCT
chd-226	195	8	t.a	t.a	PROPN
chd-226	195	9	.	.	PROPN
chd-226	195	10	,	,	PUNCT
chd-226	195	11	and	and	CCONJ
chd-226	195	12	seewaldt	seewaldt	ADJ
chd-226	195	13	,	,	PUNCT
chd-226	195	14	v.l	v.l	PROPN
chd-226	195	15	.	.	PROPN
chd-226	195	16	(	(	PUNCT
chd-226	195	17	2018	2018	NUM
chd-226	195	18	)	)	PUNCT
chd-226	195	19	.	.	PUNCT
chd-226	196	1	obesity	obesity	NOUN
chd-226	196	2	and	and	CCONJ
chd-226	196	3	triple	triple	ADJ
chd-226	196	4	-	-	PUNCT
chd-226	196	5	negative	negative	ADJ
chd-226	196	6	breast	breast	NOUN
chd-226	196	7	cancer	cancer	NOUN
chd-226	196	8	:	:	PUNCT
chd-226	196	9	disparities	disparity	NOUN
chd-226	196	10	,	,	PUNCT
chd-226	196	11	controversies	controversy	NOUN
chd-226	196	12	,	,	PUNCT
chd-226	196	13	and	and	CCONJ
chd-226	196	14	biology	biology	NOUN
chd-226	196	15	.	.	PUNCT
chd-226	197	1	am	be	AUX
chd-226	197	2	j	j	PROPN
chd-226	197	3	pathol	pathol	NOUN
chd-226	197	4	188	188	NUM
chd-226	197	5	,	,	PUNCT
chd-226	197	6	280	280	NUM
chd-226	197	7	-	-	SYM
chd-226	197	8	290	290	NUM
chd-226	197	9	.	.	PUNCT
chd-226	198	1	https://www.ncbi.nlm.nih.gov/pubmed/29128565	https://www.ncbi.nlm.nih.gov/pubmed/29128565	PROPN
chd-226	198	2	.	.	PUNCT
chd-226	199	1	dietze	dietze	PROPN
chd-226	199	2	,	,	PUNCT
chd-226	199	3	e.c	e.c	PROPN
chd-226	199	4	.	.	PROPN
chd-226	199	5	,	,	PUNCT
chd-226	199	6	sistrunk	sistrunk	PROPN
chd-226	199	7	,	,	PUNCT
chd-226	199	8	c.	c.	PROPN
chd-226	199	9	,	,	PUNCT
chd-226	199	10	miranda	miranda	NOUN
chd-226	199	11	-	-	PUNCT
chd-226	199	12	carboni	carboni	PROPN
chd-226	199	13	,	,	PUNCT
chd-226	199	14	g.	g.	PROPN
chd-226	199	15	,	,	PUNCT
chd-226	199	16	o'regan	o'regan	PROPN
chd-226	199	17	,	,	PUNCT
chd-226	199	18	r.	r.	PROPN
chd-226	199	19	,	,	PUNCT
chd-226	199	20	and	and	CCONJ
chd-226	199	21	seewaldt	seewaldt	ADJ
chd-226	199	22	,	,	PUNCT
chd-226	199	23	v.l	v.l	PROPN
chd-226	199	24	.	.	PROPN
chd-226	200	1	(	(	PUNCT
chd-226	200	2	2015	2015	NUM
chd-226	200	3	)	)	PUNCT
chd-226	200	4	.	.	PUNCT
chd-226	201	1	triple	triple	ADJ
chd-226	201	2	-	-	PUNCT
chd-226	201	3	negative	negative	ADJ
chd-226	201	4	breast	breast	NOUN
chd-226	201	5	cancer	cancer	NOUN
chd-226	201	6	in	in	ADP
chd-226	201	7	african	african	ADJ
chd-226	201	8	-	-	PUNCT
chd-226	201	9	american	american	ADJ
chd-226	201	10	women	woman	NOUN
chd-226	201	11	:	:	PUNCT
chd-226	202	1	disparities	disparity	NOUN
chd-226	202	2	versus	versus	ADP
chd-226	202	3	biology	biology	NOUN
chd-226	202	4	.	.	PUNCT
chd-226	203	1	nat	nat	PROPN
chd-226	203	2	rev	rev	VERB
chd-226	203	3	cancer	cancer	NOUN
chd-226	203	4	15	15	NUM
chd-226	203	5	,	,	PUNCT
chd-226	203	6	248	248	NUM
chd-226	203	7	-	-	SYM
chd-226	203	8	254	254	NUM
chd-226	203	9	.	.	PUNCT
chd-226	204	1	https://www.ncbi.nlm.nih.gov/pubmed/25673085	https://www.ncbi.nlm.nih.gov/pubmed/25673085	X
chd-226	204	2	.	.	PUNCT
chd-226	204	3	douville	douville	PROPN
chd-226	204	4	,	,	PUNCT
chd-226	204	5	j.	j.	PROPN
chd-226	204	6	,	,	PUNCT
chd-226	204	7	beaulieu	beaulieu	PROPN
chd-226	204	8	,	,	PUNCT
chd-226	204	9	r.	r.	PROPN
chd-226	204	10	,	,	PUNCT
chd-226	204	11	and	and	CCONJ
chd-226	204	12	balicki	balicki	PROPN
chd-226	204	13	,	,	PUNCT
chd-226	204	14	d.	d.	PROPN
chd-226	204	15	(	(	PUNCT
chd-226	204	16	2009	2009	NUM
chd-226	204	17	)	)	PUNCT
chd-226	204	18	.	.	PUNCT
chd-226	205	1	aldh1	aldh1	PROPN
chd-226	206	1	as	as	ADP
chd-226	206	2	a	a	DET
chd-226	206	3	functional	functional	ADJ
chd-226	206	4	marker	marker	NOUN
chd-226	206	5	of	of	ADP
chd-226	206	6	cancer	cancer	NOUN
chd-226	206	7	stem	stem	NOUN
chd-226	206	8	and	and	CCONJ
chd-226	206	9	progenitor	progenitor	NOUN
chd-226	206	10	cells	cell	NOUN
chd-226	206	11	.	.	PUNCT
chd-226	207	1	stem	stem	NOUN
chd-226	207	2	cells	cell	NOUN
chd-226	207	3	dev	dev	PROPN
chd-226	207	4	18	18	NUM
chd-226	207	5	,	,	PUNCT
chd-226	207	6	17	17	NUM
chd-226	207	7	-	-	SYM
chd-226	207	8	25	25	NUM
chd-226	207	9	.	.	PUNCT
chd-226	208	1	https://www.ncbi.nlm.nih.gov/pubmed/18573038	https://www.ncbi.nlm.nih.gov/pubmed/18573038	PROPN
chd-226	208	2	.	.	PUNCT
chd-226	209	1	giaquinto	giaquinto	NOUN
chd-226	209	2	,	,	PUNCT
chd-226	209	3	a.n	a.n	PROPN
chd-226	209	4	.	.	PROPN
chd-226	209	5	,	,	PUNCT
chd-226	209	6	miller	miller	PROPN
chd-226	209	7	,	,	PUNCT
chd-226	209	8	k.d	k.d	PROPN
chd-226	209	9	.	.	PROPN
chd-226	209	10	,	,	PUNCT
chd-226	209	11	tossas	tossas	PROPN
chd-226	209	12	,	,	PUNCT
chd-226	209	13	k.y	k.y	PROPN
chd-226	209	14	.	.	PROPN
chd-226	209	15	,	,	PUNCT
chd-226	209	16	winn	winn	PROPN
chd-226	209	17	,	,	PUNCT
chd-226	209	18	r.a	r.a	PROPN
chd-226	209	19	.	.	PROPN
chd-226	209	20	,	,	PUNCT
chd-226	209	21	jemal	jemal	PROPN
chd-226	209	22	,	,	PUNCT
chd-226	209	23	a.	a.	NOUN
chd-226	209	24	,	,	PUNCT
chd-226	209	25	and	and	CCONJ
chd-226	209	26	siegel	siegel	PROPN
chd-226	209	27	,	,	PUNCT
chd-226	209	28	r.l	r.l	PROPN
chd-226	209	29	.	.	PROPN
chd-226	209	30	(	(	PUNCT
chd-226	209	31	2022	2022	NUM
chd-226	209	32	)	)	PUNCT
chd-226	209	33	.	.	PUNCT
chd-226	210	1	cancer	cancer	NOUN
chd-226	210	2	statistics	statistic	NOUN
chd-226	210	3	for	for	ADP
chd-226	210	4	african	african	ADJ
chd-226	210	5	american	american	PROPN
chd-226	210	6	/	/	SYM
chd-226	210	7	black	black	ADJ
chd-226	210	8	people	people	NOUN
chd-226	210	9	2022	2022	NUM
chd-226	210	10	.	.	PUNCT
chd-226	211	1	ca	can	AUX
chd-226	211	2	cancer	cancer	PROPN
chd-226	211	3	j	j	PROPN
chd-226	211	4	clin	clin	PROPN
chd-226	211	5	72	72	NUM
chd-226	211	6	,	,	PUNCT
chd-226	211	7	202229	202229	NUM
chd-226	211	8	.	.	PUNCT
chd-226	212	1	https://www.ncbi.nlm.nih.gov/pubmed/35143040	https://www.ncbi.nlm.nih.gov/pubmed/35143040	NOUN
chd-226	212	2	.	.	PUNCT
chd-226	213	1	ginestier	ginestier	NOUN
chd-226	213	2	,	,	PUNCT
chd-226	213	3	c.	c.	PROPN
chd-226	213	4	,	,	PUNCT
chd-226	213	5	hur	hur	PROPN
chd-226	213	6	,	,	PUNCT
chd-226	213	7	m.h	m.h	PROPN
chd-226	213	8	.	.	PROPN
chd-226	213	9	,	,	PUNCT
chd-226	213	10	charafe	charafe	NOUN
chd-226	213	11	-	-	PUNCT
chd-226	213	12	jauffret	jauffret	NOUN
chd-226	213	13	,	,	PUNCT
chd-226	213	14	e.	e.	PROPN
chd-226	213	15	,	,	PUNCT
chd-226	213	16	monville	monville	PROPN
chd-226	213	17	,	,	PUNCT
chd-226	213	18	f.	f.	PROPN
chd-226	213	19	,	,	PUNCT
chd-226	213	20	dutcher	dutcher	PROPN
chd-226	213	21	,	,	PUNCT
chd-226	213	22	j.	j.	PROPN
chd-226	213	23	,	,	PUNCT
chd-226	213	24	brown	brown	PROPN
chd-226	213	25	,	,	PUNCT
chd-226	213	26	m.	m.	NOUN
chd-226	213	27	,	,	PUNCT
chd-226	213	28	jacquemier	jacquemier	NOUN
chd-226	213	29	,	,	PUNCT
chd-226	213	30	j.	j.	PROPN
chd-226	213	31	,	,	PUNCT
chd-226	213	32	viens	viens	PROPN
chd-226	213	33	,	,	PUNCT
chd-226	213	34	p.	p.	PROPN
chd-226	213	35	,	,	PUNCT
chd-226	213	36	kleer	kleer	PROPN
chd-226	213	37	,	,	PUNCT
chd-226	213	38	c.g	c.g	PROPN
chd-226	213	39	.	.	PROPN
chd-226	213	40	,	,	PUNCT
chd-226	213	41	liu	liu	PROPN
chd-226	213	42	,	,	PUNCT
chd-226	213	43	s.	s.	PROPN
chd-226	213	44	,	,	PUNCT
chd-226	213	45	et	et	PROPN
chd-226	213	46	al	al	PROPN
chd-226	213	47	.	.	PUNCT
chd-226	213	48	(	(	PUNCT
chd-226	213	49	2007	2007	NUM
chd-226	213	50	)	)	PUNCT
chd-226	213	51	.	.	PUNCT
chd-226	214	1	aldh1	aldh1	PROPN
chd-226	214	2	is	be	AUX
chd-226	214	3	a	a	DET
chd-226	214	4	marker	marker	NOUN
chd-226	214	5	of	of	ADP
chd-226	214	6	normal	normal	ADJ
chd-226	214	7	and	and	CCONJ
chd-226	214	8	malignant	malignant	ADJ
chd-226	214	9	human	human	ADJ
chd-226	214	10	mammary	mammary	ADJ
chd-226	214	11	stem	stem	NOUN
chd-226	214	12	cells	cell	NOUN
chd-226	214	13	and	and	CCONJ
chd-226	214	14	a	a	DET
chd-226	214	15	predictor	predictor	NOUN
chd-226	214	16	of	of	ADP
chd-226	214	17	poor	poor	ADJ
chd-226	214	18	clinical	clinical	ADJ
chd-226	214	19	outcome	outcome	NOUN
chd-226	214	20	.	.	PUNCT
chd-226	215	1	cell	cell	NOUN
chd-226	215	2	stem	stem	NOUN
chd-226	215	3	cell	cell	NOUN
chd-226	215	4	1	1	NUM
chd-226	215	5	,	,	PUNCT
chd-226	215	6	555	555	NUM
chd-226	215	7	-	-	SYM
chd-226	215	8	567	567	NUM
chd-226	215	9	.	.	PUNCT
chd-226	215	10	https://www.ncbi.nlm.nih.gov/pubmed/18371393	https://www.ncbi.nlm.nih.gov/pubmed/18371393	PROPN
chd-226	215	11	.	.	PUNCT
chd-226	216	1	ginestier	ginestier	NOUN
chd-226	216	2	,	,	PUNCT
chd-226	216	3	c.	c.	PROPN
chd-226	216	4	,	,	PUNCT
chd-226	216	5	wicinski	wicinski	PROPN
chd-226	216	6	,	,	PUNCT
chd-226	216	7	j.	j.	PROPN
chd-226	216	8	,	,	PUNCT
chd-226	216	9	cervera	cervera	NOUN
chd-226	216	10	,	,	PUNCT
chd-226	216	11	n.	n.	NOUN
chd-226	216	12	,	,	PUNCT
chd-226	216	13	monville	monville	PROPN
chd-226	216	14	,	,	PUNCT
chd-226	216	15	f.	f.	PROPN
chd-226	216	16	,	,	PUNCT
chd-226	216	17	finetti	finetti	PROPN
chd-226	216	18	,	,	PUNCT
chd-226	216	19	p.	p.	NOUN
chd-226	216	20	,	,	PUNCT
chd-226	216	21	bertucci	bertucci	PROPN
chd-226	216	22	,	,	PUNCT
chd-226	216	23	f.	f.	PROPN
chd-226	216	24	,	,	PUNCT
chd-226	216	25	wicha	wicha	PROPN
chd-226	216	26	,	,	PUNCT
chd-226	216	27	m.s	m.s	PROPN
chd-226	216	28	.	.	PROPN
chd-226	216	29	,	,	PUNCT
chd-226	216	30	birnbaum	birnbaum	PROPN
chd-226	216	31	,	,	PUNCT
chd-226	216	32	d.	d.	PROPN
chd-226	216	33	,	,	PUNCT
chd-226	216	34	and	and	CCONJ
chd-226	216	35	charafejauffret	charafejauffret	ADV
chd-226	216	36	,	,	PUNCT
chd-226	216	37	e.	e.	PROPN
chd-226	216	38	(	(	PUNCT
chd-226	216	39	2009	2009	NUM
chd-226	216	40	)	)	PUNCT
chd-226	216	41	.	.	PUNCT
chd-226	217	1	retinoid	retinoid	PROPN
chd-226	217	2	signaling	signal	VERB
chd-226	217	3	regulates	regulate	VERB
chd-226	217	4	breast	breast	NOUN
chd-226	217	5	cancer	cancer	NOUN
chd-226	217	6	stem	stem	NOUN
chd-226	217	7	cell	cell	NOUN
chd-226	217	8	differentiation	differentiation	NOUN
chd-226	217	9	.	.	PUNCT
chd-226	218	1	cell	cell	NOUN
chd-226	218	2	cycle	cycle	NOUN
chd-226	218	3	8	8	NUM
chd-226	218	4	,	,	PUNCT
chd-226	218	5	3297	3297	NUM
chd-226	218	6	-	-	SYM
chd-226	218	7	3302	3302	NUM
chd-226	218	8	.	.	PUNCT
chd-226	219	1	https://www.ncbi.nlm.nih.gov/pubmed/19806016	https://www.ncbi.nlm.nih.gov/pubmed/19806016	X
chd-226	219	2	.	.	PUNCT
chd-226	220	1	gyan	gyan	PROPN
chd-226	220	2	,	,	PUNCT
chd-226	220	3	e.	e.	PROPN
chd-226	220	4	,	,	PUNCT
chd-226	220	5	green	green	PROPN
chd-226	220	6	,	,	PUNCT
chd-226	220	7	a.	a.	NOUN
chd-226	220	8	,	,	PUNCT
chd-226	220	9	ahenkorah	ahenkorah	PROPN
chd-226	220	10	-	-	PUNCT
chd-226	220	11	fondjo	fondjo	PROPN
chd-226	220	12	,	,	PUNCT
chd-226	220	13	l.	l.	PROPN
chd-226	220	14	,	,	PUNCT
chd-226	220	15	jackson	jackson	PROPN
chd-226	220	16	,	,	PUNCT
chd-226	220	17	a.	a.	PROPN
chd-226	220	18	,	,	PUNCT
chd-226	220	19	toss	toss	PROPN
chd-226	220	20	,	,	PUNCT
chd-226	220	21	m.s	m.s	PROPN
chd-226	220	22	.	.	PROPN
chd-226	220	23	,	,	PUNCT
chd-226	220	24	akakpo	akakpo	PROPN
chd-226	220	25	,	,	PUNCT
chd-226	220	26	p.k	p.k	PROPN
chd-226	220	27	.	.	PROPN
chd-226	220	28	,	,	PUNCT
chd-226	220	29	derkyi	derkyi	PROPN
chd-226	220	30	-	-	PUNCT
chd-226	220	31	kwarteng	kwarteng	PROPN
chd-226	220	32	,	,	PUNCT
chd-226	220	33	l.	l.	PROPN
chd-226	220	34	,	,	PUNCT
chd-226	220	35	rahman	rahman	PROPN
chd-226	220	36	,	,	PUNCT
chd-226	220	37	g.a	g.a	PROPN
chd-226	220	38	.	.	PROPN
chd-226	220	39	,	,	PUNCT
chd-226	220	40	and	and	CCONJ
chd-226	220	41	owiredu	owiredu	PROPN
chd-226	220	42	,	,	PUNCT
chd-226	220	43	w.	w.	NOUN
chd-226	220	44	(	(	PUNCT
chd-226	220	45	2021	2021	NUM
chd-226	220	46	)	)	PUNCT
chd-226	220	47	.	.	PUNCT
chd-226	221	1	the	the	DET
chd-226	221	2	role	role	NOUN
chd-226	221	3	of	of	ADP
chd-226	221	4	aldh1a1	aldh1a1	X
chd-226	221	5	in	in	ADP
chd-226	221	6	contributing	contribute	VERB
chd-226	221	7	to	to	ADP
chd-226	221	8	breast	breast	NOUN
chd-226	221	9	tumour	tumour	NOUN
chd-226	221	10	aggressiveness	aggressiveness	NOUN
chd-226	221	11	:	:	PUNCT
chd-226	221	12	a	a	DET
chd-226	221	13	study	study	NOUN
chd-226	221	14	conducted	conduct	VERB
chd-226	221	15	in	in	ADP
chd-226	221	16	an	an	DET
chd-226	221	17	african	african	ADJ
chd-226	221	18	population	population	NOUN
chd-226	221	19	.	.	PUNCT
chd-226	222	1	ann	ann	PROPN
chd-226	222	2	diagn	diagn	PROPN
chd-226	222	3	pathol	pathol	NOUN
chd-226	222	4	51	51	NUM
chd-226	222	5	,	,	PUNCT
chd-226	222	6	151696	151696	NUM
chd-226	222	7	.	.	PUNCT
chd-226	223	1	https://www.ncbi.nlm.nih.gov/pubmed/33460998	https://www.ncbi.nlm.nih.gov/pubmed/33460998	X
chd-226	223	2	.	.	PUNCT
chd-226	224	1	haenisch	haenisch	PROPN
chd-226	224	2	,	,	PUNCT
chd-226	224	3	m.	m.	NOUN
chd-226	224	4	,	,	PUNCT
chd-226	224	5	treuting	treuting	NOUN
chd-226	224	6	,	,	PUNCT
chd-226	224	7	p.m.	p.m.	NOUN
chd-226	224	8	,	,	PUNCT
chd-226	224	9	brabb	brabb	ADJ
chd-226	224	10	,	,	PUNCT
chd-226	224	11	t.	t.	PROPN
chd-226	224	12	,	,	PUNCT
chd-226	224	13	goldstein	goldstein	PROPN
chd-226	224	14	,	,	PUNCT
chd-226	224	15	a.s	a.s	PROPN
chd-226	224	16	.	.	PROPN
chd-226	224	17	,	,	PUNCT
chd-226	224	18	berkseth	berkseth	PROPN
chd-226	224	19	,	,	PUNCT
chd-226	224	20	k.	k.	PROPN
chd-226	224	21	,	,	PUNCT
chd-226	224	22	amory	amory	PROPN
chd-226	224	23	,	,	PUNCT
chd-226	224	24	j.k	j.k	PROPN
chd-226	224	25	.	.	PROPN
chd-226	224	26	,	,	PUNCT
chd-226	224	27	and	and	CCONJ
chd-226	224	28	paik	paik	NOUN
chd-226	224	29	,	,	PUNCT
chd-226	224	30	j.	j.	PROPN
chd-226	224	31	(	(	PUNCT
chd-226	224	32	2018	2018	NUM
chd-226	224	33	)	)	PUNCT
chd-226	224	34	.	.	PUNCT
chd-226	225	1	pharmacological	pharmacological	ADJ
chd-226	225	2	inhibition	inhibition	NOUN
chd-226	225	3	of	of	ADP
chd-226	225	4	aldh1a	aldh1a	ADJ
chd-226	225	5	enzymes	enzyme	NOUN
chd-226	225	6	suppresses	suppress	VERB
chd-226	225	7	weight	weight	NOUN
chd-226	225	8	gain	gain	NOUN
chd-226	225	9	in	in	ADP
chd-226	225	10	a	a	DET
chd-226	225	11	mouse	mouse	NOUN
chd-226	225	12	model	model	NOUN
chd-226	225	13	of	of	ADP
chd-226	225	14	diet	diet	NOUN
chd-226	225	15	-	-	PUNCT
chd-226	225	16	induced	induce	VERB
chd-226	225	17	obesity	obesity	NOUN
chd-226	225	18	.	.	PUNCT
chd-226	226	1	obes	obe	NOUN
chd-226	226	2	res	re	VERB
chd-226	226	3	clin	clin	PROPN
chd-226	226	4	pract	pract	PROPN
chd-226	226	5	12	12	NUM
chd-226	226	6	,	,	PUNCT
chd-226	226	7	93	93	NUM
chd-226	226	8	-	-	SYM
chd-226	226	9	101	101	NUM
chd-226	226	10	.	.	PUNCT
chd-226	227	1	https://www.ncbi.nlm.nih.gov/pubmed/28919001	https://www.ncbi.nlm.nih.gov/pubmed/28919001	NUM
chd-226	227	2	.	.	PUNCT
chd-226	228	1	he	he	PRON
chd-226	228	2	,	,	PUNCT
chd-226	228	3	y.	y.	PROPN
chd-226	228	4	,	,	PUNCT
chd-226	228	5	yang	yang	PROPN
chd-226	228	6	,	,	PUNCT
chd-226	228	7	t.	t.	PROPN
chd-226	228	8	,	,	PUNCT
chd-226	228	9	du	du	PROPN
chd-226	228	10	,	,	PUNCT
chd-226	228	11	y.	y.	PROPN
chd-226	228	12	,	,	PUNCT
chd-226	228	13	qin	qin	PROPN
chd-226	228	14	,	,	PUNCT
chd-226	228	15	l.	l.	PROPN
chd-226	228	16	,	,	PUNCT
chd-226	228	17	ma	ma	PROPN
chd-226	228	18	,	,	PUNCT
chd-226	228	19	f.	f.	PROPN
chd-226	228	20	,	,	PUNCT
chd-226	228	21	wu	wu	PROPN
chd-226	228	22	,	,	PUNCT
chd-226	228	23	z.	z.	PROPN
chd-226	228	24	,	,	PUNCT
chd-226	228	25	ling	ling	PROPN
chd-226	228	26	,	,	PUNCT
chd-226	228	27	h.	h.	PROPN
chd-226	228	28	,	,	PUNCT
chd-226	228	29	yang	yang	PROPN
chd-226	228	30	,	,	PUNCT
chd-226	228	31	l.	l.	PROPN
chd-226	228	32	,	,	PUNCT
chd-226	228	33	wang	wang	PROPN
chd-226	228	34	,	,	PUNCT
chd-226	228	35	z.	z.	PROPN
chd-226	228	36	,	,	PUNCT
chd-226	228	37	zhou	zhou	PROPN
chd-226	228	38	,	,	PUNCT
chd-226	228	39	q.	q.	PROPN
chd-226	228	40	,	,	PUNCT
chd-226	228	41	et	et	PROPN
chd-226	228	42	al	al	PROPN
chd-226	228	43	.	.	PROPN
chd-226	228	44	(	(	PUNCT
chd-226	228	45	2020	2020	NUM
chd-226	228	46	)	)	PUNCT
chd-226	228	47	.	.	PUNCT
chd-226	229	1	high	high	ADJ
chd-226	229	2	fat	fat	ADJ
chd-226	229	3	diet	diet	PROPN
chd-226	229	4	significantly	significantly	ADV
chd-226	229	5	changed	change	VERB
chd-226	229	6	the	the	DET
chd-226	229	7	global	global	ADJ
chd-226	229	8	gene	gene	NOUN
chd-226	229	9	expression	expression	NOUN
chd-226	229	10	profile	profile	NOUN
chd-226	229	11	involved	involve	VERB
chd-226	229	12	in	in	ADP
chd-226	229	13	hepatic	hepatic	ADJ
chd-226	229	14	drug	drug	NOUN
chd-226	229	15	metabolism	metabolism	NOUN
chd-226	229	16	and	and	CCONJ
chd-226	229	17	pharmacokinetic	pharmacokinetic	ADJ
chd-226	229	18	system	system	NOUN
chd-226	229	19	in	in	ADP
chd-226	229	20	mice	mouse	NOUN
chd-226	229	21	.	.	PUNCT
chd-226	230	1	nutr	nutr	PROPN
chd-226	230	2	metab	metab	PROPN
chd-226	230	3	(	(	PUNCT
chd-226	230	4	lond	lond	PROPN
chd-226	230	5	)	)	PUNCT
chd-226	230	6	17	17	NUM
chd-226	230	7	,	,	PUNCT
chd-226	230	8	37	37	NUM
chd-226	230	9	.	.	PUNCT
chd-226	231	1	https://www.ncbi.nlm.nih.gov/pubmed/32489392	https://www.ncbi.nlm.nih.gov/pubmed/32489392	NOUN
chd-226	231	2	.	.	NOUN
chd-226	231	3	hellsten	hellsten	PROPN
chd-226	231	4	,	,	PUNCT
chd-226	231	5	r.	r.	PROPN
chd-226	231	6	,	,	PUNCT
chd-226	231	7	johansson	johansson	PROPN
chd-226	231	8	,	,	PUNCT
chd-226	231	9	m.	m.	NOUN
chd-226	231	10	,	,	PUNCT
chd-226	231	11	dahlman	dahlman	PROPN
chd-226	231	12	,	,	PUNCT
chd-226	231	13	a.	a.	NOUN
chd-226	231	14	,	,	PUNCT
chd-226	231	15	sterner	stern	ADJ
chd-226	231	16	,	,	PUNCT
chd-226	231	17	o.	o.	INTJ
chd-226	231	18	,	,	PUNCT
chd-226	231	19	and	and	CCONJ
chd-226	231	20	bjartell	bjartell	VERB
chd-226	231	21	,	,	PUNCT
chd-226	231	22	a.	a.	NOUN
chd-226	231	23	(	(	PUNCT
chd-226	231	24	2011	2011	NUM
chd-226	231	25	)	)	PUNCT
chd-226	231	26	.	.	PUNCT
chd-226	232	1	galiellalactone	galiellalactone	NOUN
chd-226	232	2	inhibits	inhibit	VERB
chd-226	232	3	stem	stem	NOUN
chd-226	232	4	cell	cell	NOUN
chd-226	232	5	-	-	PUNCT
chd-226	232	6	like	like	ADJ
chd-226	232	7	aldh	aldh	ADJ
chd-226	232	8	-	-	PUNCT
chd-226	232	9	positive	positive	ADJ
chd-226	232	10	prostate	prostate	NOUN
chd-226	232	11	cancer	cancer	NOUN
chd-226	232	12	cells	cell	NOUN
chd-226	232	13	.	.	PUNCT
chd-226	233	1	plos	plos	PROPN
chd-226	233	2	one	one	NUM
chd-226	233	3	6	6	NUM
chd-226	233	4	,	,	PUNCT
chd-226	233	5	e22118	e22118	NUM
chd-226	233	6	.	.	PUNCT
chd-226	234	1	https://www.ncbi.nlm.nih.gov/pubmed/21779382	https://www.ncbi.nlm.nih.gov/pubmed/21779382	PROPN
chd-226	234	2	.	.	PUNCT
chd-226	234	3	hershman	hershman	PROPN
chd-226	234	4	,	,	PUNCT
chd-226	234	5	d.	d.	PROPN
chd-226	234	6	,	,	PUNCT
chd-226	234	7	mcbride	mcbride	PROPN
chd-226	234	8	,	,	PUNCT
chd-226	234	9	r.	r.	PROPN
chd-226	234	10	,	,	PUNCT
chd-226	234	11	jacobson	jacobson	PROPN
chd-226	234	12	,	,	PUNCT
chd-226	234	13	j.s	j.s	PROPN
chd-226	234	14	.	.	PROPN
chd-226	234	15	,	,	PUNCT
chd-226	234	16	lamerato	lamerato	PROPN
chd-226	234	17	,	,	PUNCT
chd-226	234	18	l.	l.	PROPN
chd-226	234	19	,	,	PUNCT
chd-226	234	20	roberts	roberts	PROPN
chd-226	234	21	,	,	PUNCT
chd-226	234	22	k.	k.	PROPN
chd-226	234	23	,	,	PUNCT
chd-226	234	24	grann	grann	PROPN
chd-226	234	25	,	,	PUNCT
chd-226	234	26	v.r	v.r	PROPN
chd-226	234	27	.	.	PROPN
chd-226	234	28	,	,	PUNCT
chd-226	234	29	and	and	CCONJ
chd-226	234	30	neugut	neugut	NOUN
chd-226	234	31	,	,	PUNCT
chd-226	234	32	a.i	a.i	PROPN
chd-226	234	33	.	.	PROPN
chd-226	234	34	(	(	PUNCT
chd-226	234	35	2005	2005	NUM
chd-226	234	36	)	)	PUNCT
chd-226	234	37	.	.	PUNCT
chd-226	235	1	racial	racial	ADJ
chd-226	235	2	disparities	disparity	NOUN
chd-226	235	3	in	in	ADP
chd-226	235	4	treatment	treatment	NOUN
chd-226	235	5	and	and	CCONJ
chd-226	235	6	survival	survival	NOUN
chd-226	235	7	among	among	ADP
chd-226	235	8	women	woman	NOUN
chd-226	235	9	with	with	ADP
chd-226	235	10	https://www.ncbi.nlm.nih.gov/pubmed/7013538	https://www.ncbi.nlm.nih.gov/pubmed/7013538	NUM
chd-226	235	11	https://www.ncbi.nlm.nih.gov/pubmed/32369651	https://www.ncbi.nlm.nih.gov/pubmed/32369651	NUM
chd-226	235	12	https://www.ncbi.nlm.nih.gov/pubmed/31850822	https://www.ncbi.nlm.nih.gov/pubmed/31850822	NUM
chd-226	235	13	https://www.ncbi.nlm.nih.gov/pubmed/25999351	https://www.ncbi.nlm.nih.gov/pubmed/25999351	NOUN
chd-226	236	1	https://www.ncbi.nlm.nih.gov/pubmed/30387499	https://www.ncbi.nlm.nih.gov/pubmed/30387499	NOUN
chd-226	237	1	https://www.ncbi.nlm.nih.gov/pubmed/26305673	https://www.ncbi.nlm.nih.gov/pubmed/26305673	NUM
chd-226	237	2	https://www.ncbi.nlm.nih.gov/pubmed/24567230	https://www.ncbi.nlm.nih.gov/pubmed/24567230	NUM
chd-226	237	3	https://www.ncbi.nlm.nih.gov/pubmed/28937653	https://www.ncbi.nlm.nih.gov/pubmed/28937653	NUM
chd-226	237	4	https://www.ncbi.nlm.nih.gov/pubmed/29128565	https://www.ncbi.nlm.nih.gov/pubmed/29128565	PROPN
chd-226	237	5	https://www.ncbi.nlm.nih.gov/pubmed/25673085	https://www.ncbi.nlm.nih.gov/pubmed/25673085	NUM
chd-226	237	6	https://www.ncbi.nlm.nih.gov/pubmed/18573038	https://www.ncbi.nlm.nih.gov/pubmed/18573038	NUM
chd-226	237	7	https://www.ncbi.nlm.nih.gov/pubmed/35143040	https://www.ncbi.nlm.nih.gov/pubmed/35143040	PUNCT
chd-226	237	8	https://www.ncbi.nlm.nih.gov/pubmed/18371393	https://www.ncbi.nlm.nih.gov/pubmed/18371393	PROPN
chd-226	237	9	https://www.ncbi.nlm.nih.gov/pubmed/19806016	https://www.ncbi.nlm.nih.gov/pubmed/19806016	NUM
chd-226	237	10	https://www.ncbi.nlm.nih.gov/pubmed/33460998	https://www.ncbi.nlm.nih.gov/pubmed/33460998	PRON
chd-226	237	11	https://www.ncbi.nlm.nih.gov/pubmed/28919001	https://www.ncbi.nlm.nih.gov/pubmed/28919001	NUM
chd-226	237	12	https://www.ncbi.nlm.nih.gov/pubmed/32489392	https://www.ncbi.nlm.nih.gov/pubmed/32489392	NUM
chd-226	237	13	https://www.ncbi.nlm.nih.gov/pubmed/21779382	https://www.ncbi.nlm.nih.gov/pubmed/21779382	NUM
chd-226	237	14	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-226	237	15	e13	e13	NOUN
chd-226	237	16	cancer	cancer	NOUN
chd-226	237	17	health	health	NOUN
chd-226	237	18	disparities	disparity	NOUN
chd-226	237	19	research	research	VERB
chd-226	237	20	early	early	ADJ
chd-226	237	21	-	-	PUNCT
chd-226	237	22	stage	stage	NOUN
chd-226	237	23	breast	breast	NOUN
chd-226	237	24	cancer	cancer	NOUN
chd-226	237	25	.	.	PUNCT
chd-226	238	1	j	j	PROPN
chd-226	238	2	clin	clin	PROPN
chd-226	238	3	oncol	oncol	PROPN
chd-226	238	4	23	23	NUM
chd-226	238	5	,	,	PUNCT
chd-226	238	6	6639	6639	NUM
chd-226	238	7	-	-	SYM
chd-226	238	8	6646	6646	NUM
chd-226	238	9	.	.	PUNCT
chd-226	239	1	https://www.ncbi.nlm.nih.gov/pubmed/16170171	https://www.ncbi.nlm.nih.gov/pubmed/16170171	X
chd-226	239	2	.	.	PUNCT
chd-226	240	1	honeth	honeth	PROPN
chd-226	240	2	,	,	PUNCT
chd-226	240	3	g.	g.	PROPN
chd-226	240	4	,	,	PUNCT
chd-226	240	5	lombardi	lombardi	PROPN
chd-226	240	6	,	,	PUNCT
chd-226	240	7	s.	s.	PROPN
chd-226	240	8	,	,	PUNCT
chd-226	240	9	ginestier	ginestier	NOUN
chd-226	240	10	,	,	PUNCT
chd-226	240	11	c.	c.	PROPN
chd-226	240	12	,	,	PUNCT
chd-226	240	13	hur	hur	PROPN
chd-226	240	14	,	,	PUNCT
chd-226	240	15	m.	m.	NOUN
chd-226	240	16	,	,	PUNCT
chd-226	240	17	marlow	marlow	PROPN
chd-226	240	18	,	,	PUNCT
chd-226	240	19	r.	r.	PROPN
chd-226	240	20	,	,	PUNCT
chd-226	240	21	buchupalli	buchupalli	PROPN
chd-226	240	22	,	,	PUNCT
chd-226	240	23	b.	b.	PROPN
chd-226	240	24	,	,	PUNCT
chd-226	240	25	shinomiya	shinomiya	PROPN
chd-226	240	26	,	,	PUNCT
chd-226	240	27	i.	i.	NOUN
chd-226	240	28	,	,	PUNCT
chd-226	240	29	gazinska	gazinska	NOUN
chd-226	240	30	,	,	PUNCT
chd-226	240	31	p.	p.	PROPN
chd-226	240	32	,	,	PUNCT
chd-226	240	33	bombelli	bombelli	PROPN
chd-226	240	34	,	,	PUNCT
chd-226	240	35	s.	s.	PROPN
chd-226	240	36	,	,	PUNCT
chd-226	240	37	ramalingam	ramalingam	NOUN
chd-226	240	38	,	,	PUNCT
chd-226	240	39	v.	v.	PROPN
chd-226	240	40	,	,	PUNCT
chd-226	240	41	et	et	PROPN
chd-226	240	42	al	al	PROPN
chd-226	240	43	.	.	PUNCT
chd-226	240	44	(	(	PUNCT
chd-226	240	45	2014	2014	NUM
chd-226	240	46	)	)	PUNCT
chd-226	240	47	.	.	PUNCT
chd-226	241	1	aldehyde	aldehyde	NOUN
chd-226	241	2	dehydrogenase	dehydrogenase	NOUN
chd-226	241	3	and	and	CCONJ
chd-226	241	4	estrogen	estrogen	NOUN
chd-226	241	5	receptor	receptor	NOUN
chd-226	241	6	define	define	VERB
chd-226	241	7	a	a	DET
chd-226	241	8	hierarchy	hierarchy	NOUN
chd-226	241	9	of	of	ADP
chd-226	241	10	cellular	cellular	ADJ
chd-226	241	11	differentiation	differentiation	NOUN
chd-226	241	12	in	in	ADP
chd-226	241	13	the	the	DET
chd-226	241	14	normal	normal	ADJ
chd-226	241	15	human	human	ADJ
chd-226	241	16	mammary	mammary	ADJ
chd-226	241	17	epithelium	epithelium	NOUN
chd-226	241	18	.	.	PUNCT
chd-226	242	1	breast	breast	NOUN
chd-226	242	2	cancer	cancer	NOUN
chd-226	242	3	res	re	NOUN
chd-226	242	4	16	16	NUM
chd-226	242	5	,	,	PUNCT
chd-226	242	6	r52	r52	PROPN
chd-226	242	7	.	.	PUNCT
chd-226	243	1	https://www.ncbi.nlm.nih.gov/pubmed/24887554	https://www.ncbi.nlm.nih.gov/pubmed/24887554	X
chd-226	243	2	.	.	PUNCT
chd-226	244	1	jatoi	jatoi	PROPN
chd-226	244	2	,	,	PUNCT
chd-226	244	3	i.	i.	PROPN
chd-226	244	4	,	,	PUNCT
chd-226	244	5	becher	becher	PROPN
chd-226	244	6	,	,	PUNCT
chd-226	244	7	h.	h.	PROPN
chd-226	244	8	,	,	PUNCT
chd-226	244	9	and	and	CCONJ
chd-226	244	10	leake	leake	PROPN
chd-226	244	11	,	,	PUNCT
chd-226	244	12	c.r	c.r	PROPN
chd-226	244	13	.	.	PROPN
chd-226	244	14	(	(	PUNCT
chd-226	244	15	2003	2003	NUM
chd-226	244	16	)	)	PUNCT
chd-226	244	17	.	.	PUNCT
chd-226	245	1	widening	widen	VERB
chd-226	245	2	disparity	disparity	NOUN
chd-226	245	3	in	in	ADP
chd-226	245	4	survival	survival	NOUN
chd-226	245	5	between	between	ADP
chd-226	245	6	white	white	ADJ
chd-226	245	7	and	and	CCONJ
chd-226	245	8	african	african	ADJ
chd-226	245	9	-	-	PUNCT
chd-226	245	10	american	american	ADJ
chd-226	245	11	patients	patient	NOUN
chd-226	245	12	with	with	ADP
chd-226	245	13	breast	breast	NOUN
chd-226	245	14	carcinoma	carcinoma	NOUN
chd-226	245	15	treated	treat	VERB
chd-226	245	16	in	in	ADP
chd-226	245	17	the	the	DET
chd-226	245	18	u.	u.	PROPN
chd-226	245	19	s.	s.	PROPN
chd-226	245	20	department	department	PROPN
chd-226	245	21	of	of	ADP
chd-226	245	22	defense	defense	PROPN
chd-226	245	23	healthcare	healthcare	PROPN
chd-226	245	24	system	system	NOUN
chd-226	245	25	.	.	PUNCT
chd-226	246	1	cancer	cancer	NOUN
chd-226	246	2	98	98	NUM
chd-226	246	3	,	,	PUNCT
chd-226	246	4	894	894	NUM
chd-226	246	5	-	-	SYM
chd-226	246	6	899	899	NUM
chd-226	246	7	.	.	PUNCT
chd-226	247	1	https://www.ncbi.nlm.nih.gov/pubmed/12942554	https://www.ncbi.nlm.nih.gov/pubmed/12942554	X
chd-226	247	2	.	.	PUNCT
chd-226	248	1	ji	ji	PROPN
chd-226	248	2	,	,	PUNCT
chd-226	248	3	z.	z.	PROPN
chd-226	248	4	,	,	PUNCT
chd-226	248	5	he	he	PRON
chd-226	248	6	,	,	PUNCT
chd-226	248	7	l.	l.	PROPN
chd-226	248	8	,	,	PUNCT
chd-226	248	9	regev	regev	PROPN
chd-226	248	10	,	,	PUNCT
chd-226	248	11	a.	a.	NOUN
chd-226	248	12	,	,	PUNCT
chd-226	248	13	and	and	CCONJ
chd-226	248	14	struhl	struhl	VERB
chd-226	248	15	,	,	PUNCT
chd-226	248	16	k.	k.	PROPN
chd-226	248	17	(	(	PUNCT
chd-226	248	18	2019	2019	NUM
chd-226	248	19	)	)	PUNCT
chd-226	248	20	.	.	PUNCT
chd-226	249	1	inflammatory	inflammatory	ADJ
chd-226	249	2	regulatory	regulatory	ADJ
chd-226	249	3	network	network	NOUN
chd-226	249	4	mediated	mediate	VERB
chd-226	249	5	by	by	ADP
chd-226	249	6	the	the	DET
chd-226	249	7	joint	joint	ADJ
chd-226	249	8	action	action	NOUN
chd-226	249	9	of	of	ADP
chd-226	249	10	nf	nf	NOUN
chd-226	249	11	-	-	PUNCT
chd-226	249	12	kb	kb	PROPN
chd-226	249	13	,	,	PUNCT
chd-226	249	14	stat3	stat3	NOUN
chd-226	249	15	,	,	PUNCT
chd-226	249	16	and	and	CCONJ
chd-226	249	17	ap-1	ap-1	ADP
chd-226	249	18	factors	factor	NOUN
chd-226	249	19	is	be	AUX
chd-226	249	20	involved	involve	VERB
chd-226	249	21	in	in	ADP
chd-226	249	22	many	many	ADJ
chd-226	249	23	human	human	ADJ
chd-226	249	24	cancers	cancer	NOUN
chd-226	249	25	.	.	PUNCT
chd-226	250	1	proc	proc	PROPN
chd-226	250	2	natl	natl	PROPN
chd-226	250	3	acad	acad	PROPN
chd-226	250	4	sci	sci	PROPN
chd-226	250	5	u	u	PROPN
chd-226	250	6	s	s	PROPN
chd-226	250	7	a	a	DET
chd-226	250	8	116	116	NUM
chd-226	250	9	,	,	PUNCT
chd-226	250	10	9453	9453	NUM
chd-226	250	11	-	-	SYM
chd-226	250	12	9462	9462	NUM
chd-226	250	13	.	.	PUNCT
chd-226	251	1	https://www.ncbi.nlm.nih.gov/pubmed/30910960	https://www.ncbi.nlm.nih.gov/pubmed/30910960	X
chd-226	251	2	.	.	PUNCT
chd-226	251	3	jiagge	jiagge	PROPN
chd-226	251	4	,	,	PUNCT
chd-226	251	5	e.	e.	PROPN
chd-226	251	6	,	,	PUNCT
chd-226	251	7	chitale	chitale	PROPN
chd-226	251	8	,	,	PUNCT
chd-226	251	9	d.	d.	PROPN
chd-226	251	10	,	,	PUNCT
chd-226	251	11	and	and	CCONJ
chd-226	251	12	newman	newman	PROPN
chd-226	251	13	,	,	PUNCT
chd-226	251	14	l.a	l.a	PROPN
chd-226	251	15	.	.	PROPN
chd-226	251	16	(	(	PUNCT
chd-226	251	17	2018a	2018a	NUM
chd-226	251	18	)	)	PUNCT
chd-226	251	19	.	.	PUNCT
chd-226	252	1	triplenegative	triplenegative	VERB
chd-226	252	2	breast	breast	NOUN
chd-226	252	3	cancer	cancer	NOUN
chd-226	252	4	,	,	PUNCT
chd-226	252	5	stem	stem	NOUN
chd-226	252	6	cells	cell	NOUN
chd-226	252	7	,	,	PUNCT
chd-226	252	8	and	and	CCONJ
chd-226	252	9	african	african	ADJ
chd-226	252	10	ancestry	ancestry	NOUN
chd-226	252	11	.	.	PUNCT
chd-226	253	1	am	be	AUX
chd-226	253	2	j	j	PROPN
chd-226	253	3	pathol	pathol	NOUN
chd-226	253	4	188	188	NUM
chd-226	253	5	,	,	PUNCT
chd-226	253	6	271	271	NUM
chd-226	253	7	-	-	SYM
chd-226	253	8	279	279	NUM
chd-226	253	9	.	.	PUNCT
chd-226	254	1	https://www.ncbi.nlm.nih.gov/pubmed/29137951	https://www.ncbi.nlm.nih.gov/pubmed/29137951	X
chd-226	254	2	.	.	PUNCT
chd-226	255	1	jiagge	jiagge	PROPN
chd-226	255	2	,	,	PUNCT
chd-226	255	3	e.	e.	PROPN
chd-226	255	4	,	,	PUNCT
chd-226	255	5	jibril	jibril	PROPN
chd-226	255	6	,	,	PUNCT
chd-226	255	7	a.s	a.s	PROPN
chd-226	255	8	.	.	PROPN
chd-226	255	9	,	,	PUNCT
chd-226	255	10	davis	davis	PROPN
chd-226	255	11	,	,	PUNCT
chd-226	255	12	m.	m.	NOUN
chd-226	255	13	,	,	PUNCT
chd-226	255	14	murga	murga	PROPN
chd-226	255	15	-	-	PUNCT
chd-226	255	16	zamalloa	zamalloa	PROPN
chd-226	255	17	,	,	PUNCT
chd-226	255	18	c.	c.	PROPN
chd-226	255	19	,	,	PUNCT
chd-226	255	20	kleer	kleer	PROPN
chd-226	255	21	,	,	PUNCT
chd-226	255	22	c.g	c.g	PROPN
chd-226	255	23	.	.	PROPN
chd-226	255	24	,	,	PUNCT
chd-226	255	25	gyan	gyan	PROPN
chd-226	255	26	,	,	PUNCT
chd-226	255	27	k.	k.	PROPN
chd-226	255	28	,	,	PUNCT
chd-226	255	29	divine	divine	ADJ
chd-226	255	30	,	,	PUNCT
chd-226	255	31	g.	g.	PROPN
chd-226	255	32	,	,	PUNCT
chd-226	255	33	hoenerhoff	hoenerhoff	NOUN
chd-226	255	34	,	,	PUNCT
chd-226	255	35	m.	m.	NOUN
chd-226	255	36	,	,	PUNCT
chd-226	255	37	bensenhave	bensenhave	PROPN
chd-226	255	38	,	,	PUNCT
chd-226	255	39	j.	j.	PROPN
chd-226	255	40	,	,	PUNCT
chd-226	255	41	awuah	awuah	NOUN
chd-226	255	42	,	,	PUNCT
chd-226	255	43	b.	b.	PROPN
chd-226	255	44	,	,	PUNCT
chd-226	255	45	et	et	PROPN
chd-226	255	46	al	al	PROPN
chd-226	255	47	.	.	PROPN
chd-226	255	48	(	(	PUNCT
chd-226	255	49	2018b	2018b	NUM
chd-226	255	50	)	)	PUNCT
chd-226	255	51	.	.	PUNCT
chd-226	256	1	androgen	androgen	NOUN
chd-226	256	2	receptor	receptor	NOUN
chd-226	256	3	and	and	CCONJ
chd-226	256	4	aldh1	aldh1	NOUN
chd-226	256	5	expression	expression	NOUN
chd-226	256	6	among	among	ADP
chd-226	256	7	internationally	internationally	ADV
chd-226	256	8	diverse	diverse	ADJ
chd-226	256	9	patient	patient	ADJ
chd-226	256	10	populations	population	NOUN
chd-226	256	11	.	.	PUNCT
chd-226	257	1	j	j	PROPN
chd-226	257	2	glob	glob	PROPN
chd-226	257	3	oncol	oncol	ADJ
chd-226	257	4	4	4	NUM
chd-226	257	5	,	,	PUNCT
chd-226	257	6	1	1	NUM
chd-226	257	7	-	-	SYM
chd-226	257	8	8	8	NUM
chd-226	257	9	.	.	PUNCT
chd-226	258	1	https://www.ncbi.nlm.nih.gov/pubmed/30307804	https://www.ncbi.nlm.nih.gov/pubmed/30307804	PROPN
chd-226	258	2	.	.	PUNCT
chd-226	259	1	jones	jones	PROPN
chd-226	259	2	,	,	PUNCT
chd-226	259	3	l.a	l.a	PROPN
chd-226	259	4	.	.	PROPN
chd-226	259	5	,	,	PUNCT
chd-226	259	6	brawley	brawley	PROPN
chd-226	259	7	,	,	PUNCT
chd-226	259	8	o.	o.	PROPN
chd-226	259	9	,	,	PUNCT
chd-226	259	10	johnson	johnson	PROPN
chd-226	259	11	-	-	PUNCT
chd-226	259	12	thompson	thompson	PROPN
chd-226	259	13	,	,	PUNCT
chd-226	259	14	m.	m.	NOUN
chd-226	259	15	,	,	PUNCT
chd-226	259	16	lythcott	lythcott	PROPN
chd-226	259	17	,	,	PUNCT
chd-226	259	18	n.	n.	NOUN
chd-226	259	19	,	,	PUNCT
chd-226	259	20	and	and	CCONJ
chd-226	259	21	newman	newman	PROPN
chd-226	259	22	,	,	PUNCT
chd-226	259	23	l.	l.	PROPN
chd-226	259	24	(	(	PUNCT
chd-226	259	25	2003	2003	NUM
chd-226	259	26	)	)	PUNCT
chd-226	259	27	.	.	PUNCT
chd-226	260	1	overview	overview	NOUN
chd-226	260	2	of	of	ADP
chd-226	260	3	the	the	DET
chd-226	260	4	summit	summit	NOUN
chd-226	260	5	meeting	meeting	NOUN
chd-226	260	6	evaluating	evaluate	VERB
chd-226	260	7	research	research	NOUN
chd-226	260	8	in	in	ADP
chd-226	260	9	african	african	ADJ
chd-226	260	10	-	-	PUNCT
chd-226	260	11	american	american	ADJ
chd-226	260	12	women	woman	NOUN
chd-226	260	13	.	.	PUNCT
chd-226	261	1	cancer	cancer	NOUN
chd-226	261	2	97	97	NUM
chd-226	261	3	,	,	PUNCT
chd-226	261	4	207	207	NUM
chd-226	261	5	-	-	SYM
chd-226	261	6	210	210	NUM
chd-226	261	7	.	.	PUNCT
chd-226	262	1	https://www.ncbi.nlm.nih.gov/pubmed/	https://www.ncbi.nlm.nih.gov/pubmed/	PROPN
chd-226	262	2	12491483	12491483	NUM
chd-226	262	3	.	.	PUNCT
chd-226	263	1	kerlikowske	kerlikowske	PROPN
chd-226	263	2	,	,	PUNCT
chd-226	263	3	k.	k.	PROPN
chd-226	263	4	,	,	PUNCT
chd-226	263	5	bissell	bissell	PROPN
chd-226	263	6	,	,	PUNCT
chd-226	263	7	m.c.s	m.c.s	PROPN
chd-226	263	8	.	.	PROPN
chd-226	263	9	,	,	PUNCT
chd-226	263	10	sprague	sprague	PROPN
chd-226	263	11	,	,	PUNCT
chd-226	263	12	b.l	b.l	PROPN
chd-226	263	13	.	.	PROPN
chd-226	263	14	,	,	PUNCT
chd-226	263	15	buist	buist	NOUN
chd-226	263	16	,	,	PUNCT
chd-226	263	17	d.s.m	d.s.m	PROPN
chd-226	263	18	.	.	PROPN
chd-226	263	19	,	,	PUNCT
chd-226	263	20	henderson	henderson	PROPN
chd-226	263	21	,	,	PUNCT
chd-226	263	22	l.m	l.m	PROPN
chd-226	263	23	.	.	PROPN
chd-226	263	24	,	,	PUNCT
chd-226	263	25	lee	lee	PROPN
chd-226	263	26	,	,	PUNCT
chd-226	263	27	j.m	j.m	PROPN
chd-226	263	28	.	.	PROPN
chd-226	263	29	,	,	PUNCT
chd-226	263	30	and	and	CCONJ
chd-226	263	31	miglioretti	miglioretti	PROPN
chd-226	263	32	,	,	PUNCT
chd-226	263	33	d.l	d.l	PROPN
chd-226	263	34	.	.	PROPN
chd-226	263	35	(	(	PUNCT
chd-226	263	36	2021	2021	NUM
chd-226	263	37	)	)	PUNCT
chd-226	263	38	.	.	PUNCT
chd-226	264	1	advanced	advanced	ADJ
chd-226	264	2	breast	breast	NOUN
chd-226	264	3	cancer	cancer	NOUN
chd-226	264	4	definitions	definition	NOUN
chd-226	264	5	by	by	ADP
chd-226	264	6	staging	stage	VERB
chd-226	264	7	system	system	NOUN
chd-226	264	8	examined	examine	VERB
chd-226	264	9	in	in	ADP
chd-226	264	10	the	the	DET
chd-226	264	11	breast	breast	NOUN
chd-226	264	12	cancer	cancer	NOUN
chd-226	264	13	surveillance	surveillance	NOUN
chd-226	264	14	consortium	consortium	NOUN
chd-226	264	15	.	.	PUNCT
chd-226	265	1	j	j	PROPN
chd-226	265	2	natl	natl	PROPN
chd-226	265	3	cancer	cancer	PROPN
chd-226	265	4	inst	inst	PROPN
chd-226	265	5	113	113	NUM
chd-226	265	6	,	,	PUNCT
chd-226	265	7	909	909	NUM
chd-226	265	8	-	-	SYM
chd-226	265	9	916	916	NUM
chd-226	265	10	.	.	PUNCT
chd-226	266	1	https://www.ncbi.nlm	https://www.ncbi.nlm	X
chd-226	266	2	.	.	PUNCT
chd-226	267	1	nih.gov/pubmed/33169794	nih.gov/pubmed/33169794	PROPN
chd-226	267	2	.	.	PUNCT
chd-226	268	1	khoury	khoury	PROPN
chd-226	268	2	,	,	PUNCT
chd-226	268	3	t.	t.	PROPN
chd-226	268	4	,	,	PUNCT
chd-226	268	5	ademuyiwa	ademuyiwa	PROPN
chd-226	268	6	,	,	PUNCT
chd-226	268	7	f.o	f.o	PROPN
chd-226	268	8	.	.	PROPN
chd-226	268	9	,	,	PUNCT
chd-226	268	10	chandrasekhar	chandrasekhar	PROPN
chd-226	268	11	,	,	PUNCT
chd-226	268	12	r.	r.	PROPN
chd-226	268	13	,	,	PUNCT
chd-226	268	14	jabbour	jabbour	NOUN
chd-226	268	15	,	,	PUNCT
chd-226	268	16	m.	m.	NOUN
chd-226	268	17	,	,	PUNCT
chd-226	268	18	deleo	deleo	PROPN
chd-226	268	19	,	,	PUNCT
chd-226	268	20	a.	a.	NOUN
chd-226	268	21	,	,	PUNCT
chd-226	268	22	ferrone	ferrone	NOUN
chd-226	268	23	,	,	PUNCT
chd-226	268	24	s.	s.	PROPN
chd-226	268	25	,	,	PUNCT
chd-226	268	26	wang	wang	PROPN
chd-226	268	27	,	,	PUNCT
chd-226	268	28	y.	y.	PROPN
chd-226	268	29	,	,	PUNCT
chd-226	268	30	and	and	CCONJ
chd-226	268	31	wang	wang	PROPN
chd-226	268	32	,	,	PUNCT
chd-226	268	33	x.	x.	NOUN
chd-226	268	34	(	(	PUNCT
chd-226	268	35	2012	2012	NUM
chd-226	268	36	)	)	PUNCT
chd-226	268	37	.	.	PUNCT
chd-226	269	1	aldehyde	aldehyde	NOUN
chd-226	269	2	dehydrogenase	dehydrogenase	NOUN
chd-226	269	3	1a1	1a1	NUM
chd-226	269	4	expression	expression	NOUN
chd-226	269	5	in	in	ADP
chd-226	269	6	breast	breast	NOUN
chd-226	269	7	cancer	cancer	NOUN
chd-226	269	8	is	be	AUX
chd-226	269	9	associated	associate	VERB
chd-226	269	10	with	with	ADP
chd-226	269	11	stage	stage	NOUN
chd-226	269	12	,	,	PUNCT
chd-226	269	13	triple	triple	ADJ
chd-226	269	14	negativity	negativity	NOUN
chd-226	269	15	,	,	PUNCT
chd-226	269	16	and	and	CCONJ
chd-226	269	17	outcome	outcome	VERB
chd-226	269	18	to	to	ADP
chd-226	269	19	neoadjuvant	neoadjuvant	ADJ
chd-226	269	20	chemotherapy	chemotherapy	NOUN
chd-226	269	21	.	.	PUNCT
chd-226	270	1	mod	mod	PROPN
chd-226	270	2	pathol	pathol	PROPN
chd-226	270	3	25	25	NUM
chd-226	270	4	,	,	PUNCT
chd-226	270	5	388	388	NUM
chd-226	270	6	-	-	SYM
chd-226	270	7	397	397	NUM
chd-226	270	8	.	.	PUNCT
chd-226	271	1	https://www.ncbi.nlm.nih.gov/pubmed/22080062	https://www.ncbi.nlm.nih.gov/pubmed/22080062	PRON
chd-226	271	2	.	.	PUNCT
chd-226	272	1	kiefer	kiefer	PROPN
chd-226	272	2	,	,	PUNCT
chd-226	272	3	f.w	f.w	PROPN
chd-226	272	4	.	.	PROPN
chd-226	272	5	,	,	PUNCT
chd-226	272	6	vernochet	vernochet	NOUN
chd-226	272	7	,	,	PUNCT
chd-226	272	8	c.	c.	PROPN
chd-226	272	9	,	,	PUNCT
chd-226	272	10	o'brien	o'brien	PROPN
chd-226	272	11	,	,	PUNCT
chd-226	272	12	p.	p.	NOUN
chd-226	272	13	,	,	PUNCT
chd-226	272	14	spoerl	spoerl	PROPN
chd-226	272	15	,	,	PUNCT
chd-226	272	16	s.	s.	PROPN
chd-226	272	17	,	,	PUNCT
chd-226	272	18	brown	brown	PROPN
chd-226	272	19	,	,	PUNCT
chd-226	272	20	j.d	j.d	PROPN
chd-226	272	21	.	.	PROPN
chd-226	272	22	,	,	PUNCT
chd-226	272	23	nallamshetty	nallamshetty	PROPN
chd-226	272	24	,	,	PUNCT
chd-226	272	25	s.	s.	PROPN
chd-226	272	26	,	,	PUNCT
chd-226	272	27	zeyda	zeyda	PROPN
chd-226	272	28	,	,	PUNCT
chd-226	272	29	m.	m.	NOUN
chd-226	272	30	,	,	PUNCT
chd-226	272	31	stulnig	stulnig	PROPN
chd-226	272	32	,	,	PUNCT
chd-226	272	33	t.m	t.m	PROPN
chd-226	272	34	.	.	PROPN
chd-226	272	35	,	,	PUNCT
chd-226	272	36	cohen	cohen	PROPN
chd-226	272	37	,	,	PUNCT
chd-226	272	38	d.e	d.e	PROPN
chd-226	272	39	.	.	PROPN
chd-226	272	40	,	,	PUNCT
chd-226	272	41	kahn	kahn	PROPN
chd-226	272	42	,	,	PUNCT
chd-226	272	43	c.r	c.r	PROPN
chd-226	272	44	.	.	PROPN
chd-226	272	45	,	,	PUNCT
chd-226	272	46	and	and	CCONJ
chd-226	272	47	plutzky	plutzky	ADJ
chd-226	272	48	,	,	PUNCT
chd-226	272	49	j.	j.	PROPN
chd-226	272	50	(	(	PUNCT
chd-226	272	51	2012	2012	NUM
chd-226	272	52	)	)	PUNCT
chd-226	272	53	.	.	PUNCT
chd-226	273	1	retinaldehyde	retinaldehyde	NOUN
chd-226	273	2	dehydrogenase	dehydrogenase	NOUN
chd-226	273	3	1	1	NUM
chd-226	273	4	regulates	regulate	VERB
chd-226	273	5	a	a	DET
chd-226	273	6	thermogenic	thermogenic	ADJ
chd-226	273	7	program	program	NOUN
chd-226	273	8	in	in	ADP
chd-226	273	9	white	white	ADJ
chd-226	273	10	adipose	adipose	ADJ
chd-226	273	11	tissue	tissue	NOUN
chd-226	273	12	.	.	PUNCT
chd-226	274	1	nat	nat	PROPN
chd-226	274	2	med	me	VERB
chd-226	274	3	18	18	NUM
chd-226	274	4	,	,	PUNCT
chd-226	274	5	918	918	NUM
chd-226	274	6	-	-	SYM
chd-226	274	7	925	925	NUM
chd-226	274	8	.	.	PUNCT
chd-226	275	1	https://www.ncbi.nlm.nih.gov/pubmed/22561685	https://www.ncbi.nlm.nih.gov/pubmed/22561685	NUM
chd-226	275	2	.	.	PUNCT
chd-226	276	1	landrier	landrier	PROPN
chd-226	276	2	,	,	PUNCT
chd-226	276	3	j.f	j.f	PROPN
chd-226	276	4	.	.	PROPN
chd-226	276	5	,	,	PUNCT
chd-226	276	6	kasiri	kasiri	PROPN
chd-226	276	7	,	,	PUNCT
chd-226	276	8	e.	e.	PROPN
chd-226	276	9	,	,	PUNCT
chd-226	276	10	karkeni	karkeni	PROPN
chd-226	276	11	,	,	PUNCT
chd-226	276	12	e.	e.	PROPN
chd-226	276	13	,	,	PUNCT
chd-226	276	14	mihaly	mihaly	PROPN
chd-226	276	15	,	,	PUNCT
chd-226	276	16	j.	j.	PROPN
chd-226	276	17	,	,	PUNCT
chd-226	276	18	beke	beke	PROPN
chd-226	276	19	,	,	PUNCT
chd-226	276	20	g.	g.	PROPN
chd-226	276	21	,	,	PUNCT
chd-226	276	22	weiss	weiss	PROPN
chd-226	276	23	,	,	PUNCT
chd-226	276	24	k.	k.	PROPN
chd-226	276	25	,	,	PUNCT
chd-226	276	26	lucas	lucas	PROPN
chd-226	276	27	,	,	PUNCT
chd-226	276	28	r.	r.	PROPN
chd-226	276	29	,	,	PUNCT
chd-226	276	30	aydemir	aydemir	PROPN
chd-226	276	31	,	,	PUNCT
chd-226	276	32	g.	g.	PROPN
chd-226	276	33	,	,	PUNCT
chd-226	276	34	salles	salles	PROPN
chd-226	276	35	,	,	PUNCT
chd-226	276	36	j.	j.	PROPN
chd-226	276	37	,	,	PUNCT
chd-226	276	38	walrand	walrand	PROPN
chd-226	276	39	,	,	PUNCT
chd-226	276	40	s.	s.	PROPN
chd-226	276	41	,	,	PUNCT
chd-226	276	42	et	et	PROPN
chd-226	276	43	al	al	PROPN
chd-226	276	44	.	.	PUNCT
chd-226	277	1	(	(	PUNCT
chd-226	277	2	2017	2017	NUM
chd-226	277	3	)	)	PUNCT
chd-226	277	4	.	.	PUNCT
chd-226	278	1	reduced	reduce	VERB
chd-226	278	2	adiponectin	adiponectin	NOUN
chd-226	278	3	expression	expression	NOUN
chd-226	278	4	after	after	ADP
chd-226	278	5	high	high	ADJ
chd-226	278	6	-	-	PUNCT
chd-226	278	7	fat	fat	NOUN
chd-226	278	8	diet	diet	NOUN
chd-226	278	9	is	be	AUX
chd-226	278	10	associated	associate	VERB
chd-226	278	11	with	with	ADP
chd-226	278	12	selective	selective	ADJ
chd-226	278	13	up	up	NOUN
chd-226	278	14	-	-	PUNCT
chd-226	278	15	regulation	regulation	NOUN
chd-226	278	16	of	of	ADP
chd-226	278	17	aldh1a1	aldh1a1	ADV
chd-226	278	18	and	and	CCONJ
chd-226	278	19	further	further	ADJ
chd-226	278	20	retinoic	retinoic	ADJ
chd-226	278	21	acid	acid	NOUN
chd-226	278	22	receptor	receptor	NOUN
chd-226	278	23	signaling	signal	VERB
chd-226	278	24	in	in	ADP
chd-226	278	25	adipose	adipose	ADJ
chd-226	278	26	tissue	tissue	NOUN
chd-226	278	27	.	.	PUNCT
chd-226	279	1	faseb	faseb	PROPN
chd-226	279	2	j	j	PROPN
chd-226	279	3	31	31	NUM
chd-226	279	4	,	,	PUNCT
chd-226	279	5	203	203	NUM
chd-226	279	6	-	-	SYM
chd-226	279	7	211	211	NUM
chd-226	279	8	.	.	PUNCT
chd-226	280	1	https://www.ncbi.nlm.nih.gov/pubmed/27729412	https://www.ncbi.nlm.nih.gov/pubmed/27729412	NUM
chd-226	280	2	.	.	PUNCT
chd-226	281	1	liu	liu	PROPN
chd-226	281	2	,	,	PUNCT
chd-226	281	3	j.	j.	PROPN
chd-226	281	4	,	,	PUNCT
chd-226	281	5	zhou	zhou	PROPN
chd-226	281	6	,	,	PUNCT
chd-226	281	7	z.	z.	PROPN
chd-226	281	8	,	,	PUNCT
chd-226	281	9	hodgkinson	hodgkinson	PROPN
chd-226	281	10	,	,	PUNCT
chd-226	281	11	c.a	c.a	PROPN
chd-226	281	12	.	.	PROPN
chd-226	281	13	,	,	PUNCT
chd-226	281	14	yuan	yuan	PROPN
chd-226	281	15	,	,	PUNCT
chd-226	281	16	q.	q.	PROPN
chd-226	281	17	,	,	PUNCT
chd-226	281	18	shen	shen	PROPN
chd-226	281	19	,	,	PUNCT
chd-226	281	20	p.h	p.h	PROPN
chd-226	281	21	.	.	PROPN
chd-226	281	22	,	,	PUNCT
chd-226	281	23	mulligan	mulligan	PROPN
chd-226	281	24	,	,	PUNCT
chd-226	281	25	c.j	c.j	PROPN
chd-226	281	26	.	.	PROPN
chd-226	281	27	,	,	PUNCT
chd-226	281	28	wang	wang	PROPN
chd-226	281	29	,	,	PUNCT
chd-226	281	30	a.	a.	NOUN
chd-226	281	31	,	,	PUNCT
chd-226	281	32	gray	gray	ADJ
chd-226	281	33	,	,	PUNCT
chd-226	281	34	r.r	r.r	PROPN
chd-226	281	35	.	.	PROPN
chd-226	281	36	,	,	PUNCT
chd-226	281	37	roy	roy	PROPN
chd-226	281	38	,	,	PUNCT
chd-226	281	39	a.	a.	PROPN
chd-226	281	40	,	,	PUNCT
chd-226	281	41	virkkunen	virkkunen	PROPN
chd-226	281	42	,	,	PUNCT
chd-226	281	43	m.	m.	NOUN
chd-226	281	44	,	,	PUNCT
chd-226	281	45	et	et	PROPN
chd-226	281	46	al	al	PROPN
chd-226	281	47	.	.	PUNCT
chd-226	281	48	(	(	PUNCT
chd-226	281	49	2011	2011	NUM
chd-226	281	50	)	)	PUNCT
chd-226	281	51	.	.	PUNCT
chd-226	282	1	haplotype	haplotype	NOUN
chd-226	282	2	-	-	PUNCT
chd-226	282	3	based	base	VERB
chd-226	282	4	study	study	NOUN
chd-226	282	5	of	of	ADP
chd-226	282	6	the	the	DET
chd-226	282	7	association	association	NOUN
chd-226	282	8	of	of	ADP
chd-226	282	9	alcohol	alcohol	NOUN
chd-226	282	10	-	-	PUNCT
chd-226	282	11	metabolizing	metabolize	VERB
chd-226	282	12	genes	gene	NOUN
chd-226	282	13	with	with	ADP
chd-226	282	14	alcohol	alcohol	NOUN
chd-226	282	15	dependence	dependence	NOUN
chd-226	282	16	in	in	ADP
chd-226	282	17	four	four	NUM
chd-226	282	18	independent	independent	ADJ
chd-226	282	19	populations	population	NOUN
chd-226	282	20	.	.	PUNCT
chd-226	283	1	alcohol	alcohol	PROPN
chd-226	283	2	clin	clin	PROPN
chd-226	283	3	exp	exp	PROPN
chd-226	283	4	res	re	NOUN
chd-226	283	5	35	35	NUM
chd-226	283	6	,	,	PUNCT
chd-226	283	7	304	304	NUM
chd-226	283	8	-	-	SYM
chd-226	283	9	316	316	NUM
chd-226	283	10	.	.	PUNCT
chd-226	283	11	https://www.ncbi.nlm.nih.gov/pubmed/21083667	https://www.ncbi.nlm.nih.gov/pubmed/21083667	NOUN
chd-226	283	12	.	.	PUNCT
chd-226	284	1	liu	liu	PROPN
chd-226	284	2	,	,	PUNCT
chd-226	284	3	y.	y.	PROPN
chd-226	284	4	,	,	PUNCT
chd-226	284	5	baglia	baglia	PROPN
chd-226	284	6	,	,	PUNCT
chd-226	284	7	m.	m.	NOUN
chd-226	284	8	,	,	PUNCT
chd-226	284	9	zheng	zheng	PROPN
chd-226	284	10	,	,	PUNCT
chd-226	284	11	y.	y.	PROPN
chd-226	284	12	,	,	PUNCT
chd-226	284	13	blot	blot	PROPN
chd-226	284	14	,	,	PUNCT
chd-226	284	15	w.	w.	PROPN
chd-226	284	16	,	,	PUNCT
chd-226	284	17	bao	bao	PROPN
chd-226	284	18	,	,	PUNCT
chd-226	284	19	p.p	p.p	PROPN
chd-226	284	20	.	.	PROPN
chd-226	284	21	,	,	PUNCT
chd-226	284	22	cai	cai	PROPN
chd-226	284	23	,	,	PUNCT
chd-226	284	24	h.	h.	PROPN
chd-226	284	25	,	,	PUNCT
chd-226	284	26	nechuta	nechuta	PROPN
chd-226	284	27	,	,	PUNCT
chd-226	284	28	s.	s.	PROPN
chd-226	284	29	,	,	PUNCT
chd-226	284	30	zheng	zheng	PROPN
chd-226	284	31	,	,	PUNCT
chd-226	284	32	w.	w.	PROPN
chd-226	284	33	,	,	PUNCT
chd-226	284	34	cai	cai	PROPN
chd-226	284	35	,	,	PUNCT
chd-226	284	36	q.	q.	PROPN
chd-226	284	37	,	,	PUNCT
chd-226	284	38	and	and	CCONJ
chd-226	284	39	shu	shu	PROPN
chd-226	284	40	,	,	PUNCT
chd-226	284	41	x.o	x.o	PROPN
chd-226	284	42	.	.	PROPN
chd-226	284	43	(	(	PUNCT
chd-226	284	44	2015	2015	NUM
chd-226	284	45	)	)	PUNCT
chd-226	284	46	.	.	PUNCT
chd-226	285	1	aldh1a1	aldh1a1	PROPN
chd-226	285	2	mrna	mrna	PROPN
chd-226	285	3	expression	expression	NOUN
chd-226	285	4	in	in	ADP
chd-226	285	5	association	association	NOUN
chd-226	285	6	with	with	ADP
chd-226	285	7	prognosis	prognosis	NOUN
chd-226	285	8	of	of	ADP
chd-226	285	9	triplenegative	triplenegative	ADJ
chd-226	285	10	breast	breast	NOUN
chd-226	285	11	cancer	cancer	NOUN
chd-226	285	12	.	.	PUNCT
chd-226	286	1	oncotarget	oncotarget	NOUN
chd-226	286	2	6	6	NUM
chd-226	286	3	,	,	PUNCT
chd-226	286	4	41360	41360	NUM
chd-226	286	5	-	-	SYM
chd-226	286	6	41369	41369	NUM
chd-226	286	7	.	.	PUNCT
chd-226	287	1	https://www.ncbi.nlm.nih.gov/pubmed/26462023	https://www.ncbi.nlm.nih.gov/pubmed/26462023	NUM
chd-226	287	2	.	.	PUNCT
chd-226	288	1	ma	ma	PROPN
chd-226	288	2	,	,	PUNCT
chd-226	288	3	f.	f.	PROPN
chd-226	288	4	,	,	PUNCT
chd-226	288	5	li	li	PROPN
chd-226	288	6	,	,	PUNCT
chd-226	288	7	h.	h.	PROPN
chd-226	288	8	,	,	PUNCT
chd-226	288	9	li	li	PROPN
chd-226	288	10	,	,	PUNCT
chd-226	288	11	y.	y.	PROPN
chd-226	288	12	,	,	PUNCT
chd-226	288	13	ding	ding	NOUN
chd-226	288	14	,	,	PUNCT
chd-226	288	15	x.	x.	PROPN
chd-226	288	16	,	,	PUNCT
chd-226	288	17	wang	wang	PROPN
chd-226	288	18	,	,	PUNCT
chd-226	288	19	h.	h.	PROPN
chd-226	288	20	,	,	PUNCT
chd-226	288	21	fan	fan	PROPN
chd-226	288	22	,	,	PUNCT
chd-226	288	23	y.	y.	PROPN
chd-226	288	24	,	,	PUNCT
chd-226	288	25	lin	lin	PROPN
chd-226	288	26	,	,	PUNCT
chd-226	288	27	c.	c.	PROPN
chd-226	288	28	,	,	PUNCT
chd-226	288	29	qian	qian	PROPN
chd-226	288	30	,	,	PUNCT
chd-226	288	31	h.	h.	PROPN
chd-226	288	32	,	,	PUNCT
chd-226	288	33	and	and	CCONJ
chd-226	288	34	xu	xu	PROPN
chd-226	288	35	,	,	PUNCT
chd-226	288	36	b.	b.	PROPN
chd-226	288	37	(	(	PUNCT
chd-226	288	38	2017	2017	NUM
chd-226	288	39	)	)	PUNCT
chd-226	288	40	.	.	PUNCT
chd-226	289	1	aldehyde	aldehyde	NOUN
chd-226	289	2	dehydrogenase	dehydrogenase	NOUN
chd-226	289	3	1	1	NUM
chd-226	289	4	(	(	PUNCT
chd-226	289	5	aldh1	aldh1	NOUN
chd-226	289	6	)	)	PUNCT
chd-226	289	7	expression	expression	NOUN
chd-226	289	8	is	be	AUX
chd-226	289	9	an	an	DET
chd-226	289	10	independent	independent	ADJ
chd-226	289	11	prognostic	prognostic	ADJ
chd-226	289	12	factor	factor	NOUN
chd-226	289	13	in	in	ADP
chd-226	289	14	triple	triple	ADJ
chd-226	289	15	negative	negative	ADJ
chd-226	289	16	breast	breast	NOUN
chd-226	289	17	cancer	cancer	NOUN
chd-226	289	18	(	(	PUNCT
chd-226	289	19	tnbc	tnbc	ADJ
chd-226	289	20	)	)	PUNCT
chd-226	289	21	.	.	PUNCT
chd-226	290	1	medicine	medicine	NOUN
chd-226	290	2	(	(	PUNCT
chd-226	290	3	baltimore	baltimore	PROPN
chd-226	290	4	)	)	PUNCT
chd-226	290	5	96	96	NUM
chd-226	290	6	,	,	PUNCT
chd-226	290	7	e6561	e6561	PROPN
chd-226	290	8	.	.	PUNCT
chd-226	291	1	https://www.ncbi.nlm.nih.gov/pubmed/28383433	https://www.ncbi.nlm.nih.gov/pubmed/28383433	X
chd-226	291	2	.	.	PUNCT
chd-226	292	1	ma	ma	PROPN
chd-226	292	2	,	,	PUNCT
chd-226	292	3	z.	z.	PROPN
chd-226	292	4	,	,	PUNCT
chd-226	292	5	jiang	jiang	PROPN
chd-226	292	6	,	,	PUNCT
chd-226	292	7	l.	l.	PROPN
chd-226	292	8	,	,	PUNCT
chd-226	292	9	li	li	PROPN
chd-226	292	10	,	,	PUNCT
chd-226	292	11	g.	g.	PROPN
chd-226	292	12	,	,	PUNCT
chd-226	292	13	liang	liang	PROPN
chd-226	292	14	,	,	PUNCT
chd-226	292	15	d.	d.	PROPN
chd-226	292	16	,	,	PUNCT
chd-226	292	17	li	li	PROPN
chd-226	292	18	,	,	PUNCT
chd-226	292	19	l.	l.	PROPN
chd-226	292	20	,	,	PUNCT
chd-226	292	21	liu	liu	PROPN
chd-226	292	22	,	,	PUNCT
chd-226	292	23	l.	l.	PROPN
chd-226	292	24	,	,	PUNCT
chd-226	292	25	and	and	CCONJ
chd-226	292	26	jiang	jiang	PROPN
chd-226	292	27	,	,	PUNCT
chd-226	292	28	c.	c.	PROPN
chd-226	292	29	(	(	PUNCT
chd-226	292	30	2020	2020	NUM
chd-226	292	31	)	)	PUNCT
chd-226	292	32	.	.	PUNCT
chd-226	293	1	design	design	NOUN
chd-226	293	2	,	,	PUNCT
chd-226	293	3	synthesis	synthesis	NOUN
chd-226	293	4	of	of	ADP
chd-226	293	5	1,3	1,3	NUM
chd-226	293	6	-	-	PUNCT
chd-226	293	7	dimethylpyrimidine-2,4diones	dimethylpyrimidine-2,4dione	NOUN
chd-226	293	8	as	as	ADV
chd-226	293	9	potent	potent	ADJ
chd-226	293	10	and	and	CCONJ
chd-226	293	11	selective	selective	ADJ
chd-226	293	12	aldehyde	aldehyde	NOUN
chd-226	293	13	dehydrogenase	dehydrogenase	NOUN
chd-226	293	14	1a1	1a1	NUM
chd-226	293	15	(	(	PUNCT
chd-226	293	16	aldh1a1	aldh1a1	NOUN
chd-226	293	17	)	)	PUNCT
chd-226	293	18	inhibitors	inhibitor	NOUN
chd-226	293	19	with	with	ADP
chd-226	293	20	glucose	glucose	NOUN
chd-226	293	21	consumption	consumption	NOUN
chd-226	293	22	improving	improve	VERB
chd-226	293	23	activity	activity	NOUN
chd-226	293	24	.	.	PUNCT
chd-226	294	1	bioorg	bioorg	PROPN
chd-226	294	2	chem	chem	NOUN
chd-226	294	3	101	101	NUM
chd-226	294	4	,	,	PUNCT
chd-226	294	5	103971	103971	NUM
chd-226	294	6	.	.	PUNCT
chd-226	295	1	https://www.ncbi.nlm.nih.gov/pubmed/32480173	https://www.ncbi.nlm.nih.gov/pubmed/32480173	X
chd-226	295	2	.	.	PUNCT
chd-226	296	1	marcato	marcato	PROPN
chd-226	296	2	,	,	PUNCT
chd-226	296	3	p.	p.	PROPN
chd-226	296	4	,	,	PUNCT
chd-226	296	5	dean	dean	PROPN
chd-226	296	6	,	,	PUNCT
chd-226	296	7	c.a	c.a	PROPN
chd-226	296	8	.	.	PROPN
chd-226	296	9	,	,	PUNCT
chd-226	296	10	giacomantonio	giacomantonio	PROPN
chd-226	296	11	,	,	PUNCT
chd-226	296	12	c.a	c.a	PROPN
chd-226	296	13	.	.	PROPN
chd-226	296	14	,	,	PUNCT
chd-226	296	15	and	and	CCONJ
chd-226	296	16	lee	lee	PROPN
chd-226	296	17	,	,	PUNCT
chd-226	296	18	p.w	p.w	PROPN
chd-226	296	19	.	.	PUNCT
chd-226	296	20	(	(	PUNCT
chd-226	296	21	2011a	2011a	NUM
chd-226	296	22	)	)	PUNCT
chd-226	296	23	.	.	PUNCT
chd-226	297	1	aldehyde	aldehyde	NOUN
chd-226	297	2	dehydrogenase	dehydrogenase	NOUN
chd-226	297	3	:	:	PUNCT
chd-226	297	4	its	its	PRON
chd-226	297	5	role	role	NOUN
chd-226	297	6	as	as	ADP
chd-226	297	7	a	a	DET
chd-226	297	8	cancer	cancer	NOUN
chd-226	297	9	stem	stem	NOUN
chd-226	297	10	cell	cell	NOUN
chd-226	297	11	marker	marker	NOUN
chd-226	297	12	comes	come	VERB
chd-226	297	13	down	down	ADP
chd-226	297	14	to	to	ADP
chd-226	297	15	the	the	DET
chd-226	297	16	specific	specific	ADJ
chd-226	297	17	isoform	isoform	NOUN
chd-226	297	18	.	.	PUNCT
chd-226	298	1	cell	cell	NOUN
chd-226	298	2	cycle	cycle	NOUN
chd-226	298	3	10	10	NUM
chd-226	298	4	,	,	PUNCT
chd-226	298	5	1378	1378	NUM
chd-226	298	6	-	-	SYM
chd-226	298	7	1384	1384	NUM
chd-226	298	8	.	.	PUNCT
chd-226	299	1	https://www.ncbi.nlm.nih.gov/	https://www.ncbi.nlm.nih.gov/	PROPN
chd-226	299	2	pubmed/21552008	pubmed/21552008	PROPN
chd-226	299	3	.	.	PUNCT
chd-226	300	1	marcato	marcato	PROPN
chd-226	300	2	,	,	PUNCT
chd-226	300	3	p.	p.	PROPN
chd-226	300	4	,	,	PUNCT
chd-226	300	5	dean	dean	PROPN
chd-226	300	6	,	,	PUNCT
chd-226	300	7	c.a	c.a	PROPN
chd-226	300	8	.	.	PROPN
chd-226	300	9	,	,	PUNCT
chd-226	300	10	pan	pan	PROPN
chd-226	300	11	,	,	PUNCT
chd-226	300	12	d.	d.	PROPN
chd-226	300	13	,	,	PUNCT
chd-226	300	14	araslanova	araslanova	PROPN
chd-226	300	15	,	,	PUNCT
chd-226	300	16	r.	r.	PROPN
chd-226	300	17	,	,	PUNCT
chd-226	300	18	gillis	gillis	PROPN
chd-226	300	19	,	,	PUNCT
chd-226	300	20	m.	m.	NOUN
chd-226	300	21	,	,	PUNCT
chd-226	300	22	joshi	joshi	PROPN
chd-226	300	23	,	,	PUNCT
chd-226	300	24	m.	m.	NOUN
chd-226	300	25	,	,	PUNCT
chd-226	300	26	helyer	helyer	PROPN
chd-226	300	27	,	,	PUNCT
chd-226	300	28	l.	l.	PROPN
chd-226	300	29	,	,	PUNCT
chd-226	300	30	pan	pan	PROPN
chd-226	300	31	,	,	PUNCT
chd-226	300	32	l.	l.	PROPN
chd-226	300	33	,	,	PUNCT
chd-226	300	34	leidal	leidal	PROPN
chd-226	300	35	,	,	PUNCT
chd-226	300	36	a.	a.	NOUN
chd-226	300	37	,	,	PUNCT
chd-226	300	38	gujar	gujar	PROPN
chd-226	300	39	,	,	PUNCT
chd-226	300	40	s.	s.	PROPN
chd-226	300	41	,	,	PUNCT
chd-226	300	42	et	et	PROPN
chd-226	300	43	al	al	PROPN
chd-226	300	44	.	.	PUNCT
chd-226	300	45	(	(	PUNCT
chd-226	300	46	2011b	2011b	NUM
chd-226	300	47	)	)	PUNCT
chd-226	300	48	.	.	PUNCT
chd-226	301	1	aldehyde	aldehyde	NOUN
chd-226	301	2	dehydrogenase	dehydrogenase	NOUN
chd-226	301	3	activity	activity	NOUN
chd-226	301	4	of	of	ADP
chd-226	301	5	breast	breast	NOUN
chd-226	301	6	cancer	cancer	NOUN
chd-226	301	7	stem	stem	NOUN
chd-226	301	8	cells	cell	NOUN
chd-226	301	9	is	be	AUX
chd-226	301	10	primarily	primarily	ADV
chd-226	301	11	due	due	ADJ
chd-226	301	12	to	to	ADP
chd-226	301	13	isoform	isoform	VERB
chd-226	301	14	aldh1a3	aldh1a3	NOUN
chd-226	301	15	and	and	CCONJ
chd-226	301	16	its	its	PRON
chd-226	301	17	expression	expression	NOUN
chd-226	301	18	is	be	AUX
chd-226	301	19	predictive	predictive	ADJ
chd-226	301	20	of	of	ADP
chd-226	301	21	metastasis	metastasis	NOUN
chd-226	301	22	.	.	PUNCT
chd-226	302	1	stem	stem	NOUN
chd-226	302	2	cells	cell	NOUN
chd-226	302	3	29	29	NUM
chd-226	302	4	,	,	PUNCT
chd-226	302	5	3245	3245	NUM
chd-226	302	6	.	.	PUNCT
chd-226	303	1	https://www.ncbi.nlm.nih.gov/pubmed/	https://www.ncbi.nlm.nih.gov/pubmed/	PRON
chd-226	303	2	21280157	21280157	NUM
chd-226	303	3	.	.	PUNCT
chd-226	304	1	micaily	micaily	ADV
chd-226	304	2	,	,	PUNCT
chd-226	304	3	i.	i.	PROPN
chd-226	304	4	,	,	PUNCT
chd-226	304	5	hackbart	hackbart	NOUN
chd-226	304	6	,	,	PUNCT
chd-226	304	7	h.	h.	PROPN
chd-226	304	8	,	,	PUNCT
chd-226	304	9	butryn	butryn	PROPN
chd-226	304	10	,	,	PUNCT
chd-226	304	11	m.	m.	NOUN
chd-226	304	12	,	,	PUNCT
chd-226	304	13	and	and	CCONJ
chd-226	304	14	abu	abu	PROPN
chd-226	304	15	-	-	PUNCT
chd-226	304	16	khalaf	khalaf	PROPN
chd-226	304	17	,	,	PUNCT
chd-226	304	18	m.m	m.m	PROPN
chd-226	304	19	.	.	PROPN
chd-226	304	20	(	(	PUNCT
chd-226	304	21	2021	2021	NUM
chd-226	304	22	)	)	PUNCT
chd-226	304	23	.	.	PUNCT
chd-226	305	1	obesity	obesity	NOUN
chd-226	305	2	in	in	ADP
chd-226	305	3	early	early	ADJ
chd-226	305	4	onset	onset	NOUN
chd-226	305	5	breast	breast	NOUN
chd-226	305	6	cancer	cancer	NOUN
chd-226	305	7	in	in	ADP
chd-226	305	8	african	african	ADJ
chd-226	305	9	american	american	ADJ
chd-226	305	10	patients	patient	NOUN
chd-226	305	11	.	.	PUNCT
chd-226	306	1	breast	breast	NOUN
chd-226	306	2	j	j	PROPN
chd-226	306	3	27	27	NUM
chd-226	306	4	,	,	PUNCT
chd-226	306	5	603	603	NUM
chd-226	306	6	-	-	SYM
chd-226	306	7	607	607	NUM
chd-226	306	8	.	.	PUNCT
chd-226	307	1	https://www.ncbi.nlm.nih.gov/pubmed/34117672	https://www.ncbi.nlm.nih.gov/pubmed/34117672	X
chd-226	307	2	.	.	PUNCT
chd-226	307	3	nakshatri	nakshatri	PROPN
chd-226	307	4	,	,	PUNCT
chd-226	307	5	h.	h.	PROPN
chd-226	307	6	,	,	PUNCT
chd-226	307	7	anjanappa	anjanappa	ADJ
chd-226	307	8	,	,	PUNCT
chd-226	307	9	m.	m.	NOUN
chd-226	307	10	,	,	PUNCT
chd-226	307	11	and	and	CCONJ
chd-226	307	12	bhat	bhat	PROPN
chd-226	307	13	-	-	PUNCT
chd-226	307	14	nakshatri	nakshatri	ADJ
chd-226	307	15	,	,	PUNCT
chd-226	307	16	p.	p.	NOUN
chd-226	307	17	(	(	PUNCT
chd-226	307	18	2015	2015	NUM
chd-226	307	19	)	)	PUNCT
chd-226	307	20	.	.	PUNCT
chd-226	308	1	ethnicity	ethnicity	NOUN
chd-226	308	2	-	-	PUNCT
chd-226	308	3	dependent	dependent	ADJ
chd-226	308	4	and	and	CCONJ
chd-226	308	5	-independent	-independent	ADJ
chd-226	308	6	heterogeneity	heterogeneity	NOUN
chd-226	308	7	in	in	ADP
chd-226	308	8	healthy	healthy	ADJ
chd-226	308	9	normal	normal	ADJ
chd-226	308	10	breast	breast	NOUN
chd-226	308	11	hierarchy	hierarchy	NOUN
chd-226	308	12	impacts	impact	VERB
chd-226	308	13	tumor	tumor	NOUN
chd-226	308	14	characterization	characterization	NOUN
chd-226	308	15	.	.	PUNCT
chd-226	309	1	sci	sci	PROPN
chd-226	309	2	rep	rep	PROPN
chd-226	309	3	5	5	NUM
chd-226	309	4	,	,	PUNCT
chd-226	309	5	13526	13526	NUM
chd-226	309	6	.	.	PUNCT
chd-226	310	1	https://www.ncbi.nlm.nih.gov/pubmed/26311223	https://www.ncbi.nlm.nih.gov/pubmed/26311223	PROPN
chd-226	310	2	.	.	PUNCT
chd-226	311	1	https://www.ncbi.nlm.nih.gov/pubmed/16170171	https://www.ncbi.nlm.nih.gov/pubmed/16170171	NUM
chd-226	312	1	https://www.ncbi.nlm.nih.gov/pubmed/24887554	https://www.ncbi.nlm.nih.gov/pubmed/24887554	INTJ
chd-226	313	1	https://www.ncbi.nlm.nih.gov/pubmed/12942554	https://www.ncbi.nlm.nih.gov/pubmed/12942554	INTJ
chd-226	313	2	https://www.ncbi.nlm.nih.gov/pubmed/30910960	https://www.ncbi.nlm.nih.gov/pubmed/30910960	X
chd-226	313	3	https://www.ncbi.nlm.nih.gov/pubmed/29137951	https://www.ncbi.nlm.nih.gov/pubmed/29137951	X
chd-226	313	4	https://www.ncbi.nlm.nih.gov/pubmed/30307804	https://www.ncbi.nlm.nih.gov/pubmed/30307804	NOUN
chd-226	313	5	https://www.ncbi.nlm.nih.gov/pubmed/12491483	https://www.ncbi.nlm.nih.gov/pubmed/12491483	NUM
chd-226	313	6	https://www.ncbi.nlm.nih.gov/pubmed/12491483	https://www.ncbi.nlm.nih.gov/pubmed/12491483	NUM
chd-226	313	7	https://www.ncbi.nlm.nih.gov/pubmed/33169794	https://www.ncbi.nlm.nih.gov/pubmed/33169794	NUM
chd-226	313	8	https://www.ncbi.nlm.nih.gov/pubmed/33169794	https://www.ncbi.nlm.nih.gov/pubmed/33169794	PRON
chd-226	313	9	https://www.ncbi.nlm.nih.gov/pubmed/22080062	https://www.ncbi.nlm.nih.gov/pubmed/22080062	NUM
chd-226	313	10	https://www.ncbi.nlm.nih.gov/pubmed/22561685	https://www.ncbi.nlm.nih.gov/pubmed/22561685	NUM
chd-226	313	11	https://www.ncbi.nlm.nih.gov/pubmed/27729412	https://www.ncbi.nlm.nih.gov/pubmed/27729412	NUM
chd-226	313	12	https://www.ncbi.nlm.nih.gov/pubmed/21083667	https://www.ncbi.nlm.nih.gov/pubmed/21083667	NUM
chd-226	313	13	https://www.ncbi.nlm.nih.gov/pubmed/26462023	https://www.ncbi.nlm.nih.gov/pubmed/26462023	NUM
chd-226	313	14	https://www.ncbi.nlm.nih.gov/pubmed/28383433	https://www.ncbi.nlm.nih.gov/pubmed/28383433	NOUN
chd-226	313	15	https://www.ncbi.nlm.nih.gov/pubmed/32480173	https://www.ncbi.nlm.nih.gov/pubmed/32480173	NOUN
chd-226	313	16	https://www.ncbi.nlm.nih.gov/pubmed/21552008	https://www.ncbi.nlm.nih.gov/pubmed/21552008	NOUN
chd-226	313	17	https://www.ncbi.nlm.nih.gov/pubmed/21552008	https://www.ncbi.nlm.nih.gov/pubmed/21552008	NOUN
chd-226	313	18	https://www.ncbi.nlm.nih.gov/pubmed/21280157	https://www.ncbi.nlm.nih.gov/pubmed/21280157	NOUN
chd-226	313	19	https://www.ncbi.nlm.nih.gov/pubmed/21280157	https://www.ncbi.nlm.nih.gov/pubmed/21280157	X
chd-226	313	20	https://www.ncbi.nlm.nih.gov/pubmed/34117672	https://www.ncbi.nlm.nih.gov/pubmed/34117672	PROPN
chd-226	313	21	https://www.ncbi.nlm.nih.gov/pubmed/26311223	https://www.ncbi.nlm.nih.gov/pubmed/26311223	PROPN
chd-226	313	22	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-226	313	23	e14	e14	NOUN
chd-226	313	24	cancer	cancer	NOUN
chd-226	313	25	health	health	NOUN
chd-226	313	26	disparities	disparity	NOUN
chd-226	313	27	research	research	NOUN
chd-226	313	28	nalwoga	nalwoga	PROPN
chd-226	313	29	,	,	PUNCT
chd-226	313	30	h.	h.	PROPN
chd-226	313	31	,	,	PUNCT
chd-226	313	32	arnes	arne	NOUN
chd-226	313	33	,	,	PUNCT
chd-226	313	34	j.b	j.b	PROPN
chd-226	313	35	.	.	PROPN
chd-226	313	36	,	,	PUNCT
chd-226	313	37	wabinga	wabinga	PROPN
chd-226	313	38	,	,	PUNCT
chd-226	313	39	h.	h.	PROPN
chd-226	313	40	,	,	PUNCT
chd-226	313	41	and	and	CCONJ
chd-226	313	42	akslen	akslen	PROPN
chd-226	313	43	,	,	PUNCT
chd-226	313	44	l.a	l.a	PROPN
chd-226	313	45	.	.	PROPN
chd-226	313	46	(	(	PUNCT
chd-226	313	47	2010	2010	NUM
chd-226	313	48	)	)	PUNCT
chd-226	313	49	.	.	PUNCT
chd-226	314	1	expression	expression	NOUN
chd-226	314	2	of	of	ADP
chd-226	314	3	aldehyde	aldehyde	NOUN
chd-226	314	4	dehydrogenase	dehydrogenase	NOUN
chd-226	314	5	1	1	NUM
chd-226	314	6	(	(	PUNCT
chd-226	314	7	aldh1	aldh1	NOUN
chd-226	314	8	)	)	PUNCT
chd-226	314	9	is	be	AUX
chd-226	314	10	associated	associate	VERB
chd-226	314	11	with	with	ADP
chd-226	314	12	basal	basal	NOUN
chd-226	314	13	-	-	PUNCT
chd-226	314	14	like	like	ADJ
chd-226	314	15	markers	marker	NOUN
chd-226	314	16	and	and	CCONJ
chd-226	314	17	features	feature	NOUN
chd-226	314	18	of	of	ADP
chd-226	314	19	aggressive	aggressive	ADJ
chd-226	314	20	tumours	tumour	NOUN
chd-226	314	21	in	in	ADP
chd-226	314	22	african	african	ADJ
chd-226	314	23	breast	breast	NOUN
chd-226	314	24	cancer	cancer	NOUN
chd-226	314	25	.	.	PUNCT
chd-226	315	1	br	br	PROPN
chd-226	315	2	j	j	PROPN
chd-226	315	3	cancer	cancer	NOUN
chd-226	315	4	102	102	NUM
chd-226	315	5	,	,	PUNCT
chd-226	315	6	369	369	NUM
chd-226	315	7	-	-	SYM
chd-226	315	8	375	375	NUM
chd-226	315	9	.	.	PUNCT
chd-226	316	1	https://www.ncbi.nlm.nih.gov/pubmed/20010944	https://www.ncbi.nlm.nih.gov/pubmed/20010944	X
chd-226	316	2	.	.	PUNCT
chd-226	317	1	opdenaker	opdenaker	PROPN
chd-226	317	2	,	,	PUNCT
chd-226	317	3	l.m	l.m	PROPN
chd-226	317	4	.	.	PROPN
chd-226	317	5	,	,	PUNCT
chd-226	317	6	arnold	arnold	PROPN
chd-226	317	7	,	,	PUNCT
chd-226	317	8	k.m	k.m	PROPN
chd-226	317	9	.	.	PROPN
chd-226	317	10	,	,	PUNCT
chd-226	317	11	pohlig	pohlig	PROPN
chd-226	317	12	,	,	PUNCT
chd-226	317	13	r.t	r.t	PROPN
chd-226	317	14	.	.	PROPN
chd-226	317	15	,	,	PUNCT
chd-226	317	16	padmanabhan	padmanabhan	PROPN
chd-226	317	17	,	,	PUNCT
chd-226	317	18	j.s	j.s	PROPN
chd-226	317	19	.	.	PROPN
chd-226	317	20	,	,	PUNCT
chd-226	317	21	flynn	flynn	PROPN
chd-226	317	22	,	,	PUNCT
chd-226	317	23	d.c	d.c	PROPN
chd-226	317	24	.	.	PROPN
chd-226	317	25	,	,	PUNCT
chd-226	317	26	and	and	CCONJ
chd-226	317	27	sims	sim	NOUN
chd-226	317	28	-	-	PUNCT
chd-226	317	29	mourtada	mourtada	PROPN
chd-226	317	30	,	,	PUNCT
chd-226	317	31	j.	j.	PROPN
chd-226	317	32	(	(	PUNCT
chd-226	317	33	2014	2014	NUM
chd-226	317	34	)	)	PUNCT
chd-226	317	35	.	.	PUNCT
chd-226	318	1	immunohistochemical	immunohistochemical	ADJ
chd-226	318	2	analysis	analysis	NOUN
chd-226	318	3	of	of	ADP
chd-226	318	4	aldehyde	aldehyde	NOUN
chd-226	318	5	dehydrogenase	dehydrogenase	NOUN
chd-226	318	6	isoforms	isoform	NOUN
chd-226	318	7	and	and	CCONJ
chd-226	318	8	their	their	PRON
chd-226	318	9	association	association	NOUN
chd-226	318	10	with	with	ADP
chd-226	318	11	estrogen	estrogen	NOUN
chd-226	318	12	-	-	PUNCT
chd-226	318	13	receptor	receptor	NOUN
chd-226	318	14	status	status	NOUN
chd-226	318	15	and	and	CCONJ
chd-226	318	16	disease	disease	NOUN
chd-226	318	17	progression	progression	NOUN
chd-226	318	18	in	in	ADP
chd-226	318	19	breast	breast	NOUN
chd-226	318	20	cancer	cancer	NOUN
chd-226	318	21	.	.	PUNCT
chd-226	319	1	breast	breast	NOUN
chd-226	319	2	cancer	cancer	NOUN
chd-226	319	3	(	(	PUNCT
chd-226	319	4	dove	dove	VERB
chd-226	319	5	med	med	ADJ
chd-226	319	6	press	press	NOUN
chd-226	319	7	)	)	PUNCT
chd-226	319	8	6	6	NUM
chd-226	319	9	,	,	PUNCT
chd-226	319	10	205	205	NUM
chd-226	319	11	-	-	SYM
chd-226	319	12	209	209	NUM
chd-226	319	13	.	.	PUNCT
chd-226	320	1	https://www.ncbi.nlm.nih.gov/pubmed/25540596	https://www.ncbi.nlm.nih.gov/pubmed/25540596	X
chd-226	320	2	.	.	PUNCT
chd-226	321	1	petrosino	petrosino	NOUN
chd-226	321	2	,	,	PUNCT
chd-226	321	3	j.m	j.m	PROPN
chd-226	321	4	.	.	PROPN
chd-226	321	5	,	,	PUNCT
chd-226	321	6	disilvestro	disilvestro	PROPN
chd-226	321	7	,	,	PUNCT
chd-226	321	8	d.	d.	PROPN
chd-226	321	9	,	,	PUNCT
chd-226	321	10	and	and	CCONJ
chd-226	321	11	ziouzenkova	ziouzenkova	NUM
chd-226	321	12	,	,	PUNCT
chd-226	321	13	o.	o.	PROPN
chd-226	321	14	(	(	PUNCT
chd-226	321	15	2014	2014	NUM
chd-226	321	16	)	)	PUNCT
chd-226	321	17	.	.	PUNCT
chd-226	322	1	aldehyde	aldehyde	NOUN
chd-226	322	2	dehydrogenase	dehydrogenase	NOUN
chd-226	322	3	1a1	1a1	NUM
chd-226	322	4	:	:	PUNCT
chd-226	322	5	friend	friend	NOUN
chd-226	322	6	or	or	CCONJ
chd-226	322	7	foe	foe	NOUN
chd-226	322	8	to	to	ADP
chd-226	322	9	female	female	ADJ
chd-226	322	10	metabolism	metabolism	NOUN
chd-226	322	11	?	?	PUNCT
chd-226	323	1	nutrients	nutrient	NOUN
chd-226	323	2	6	6	NUM
chd-226	323	3	,	,	PUNCT
chd-226	323	4	950	950	NUM
chd-226	323	5	-	-	SYM
chd-226	323	6	973	973	NUM
chd-226	323	7	.	.	PUNCT
chd-226	324	1	https://www.ncbi.nlm.nih.gov/pubmed/24594504	https://www.ncbi.nlm.nih.gov/pubmed/24594504	NUM
chd-226	324	2	.	.	PUNCT
chd-226	325	1	poturnajova	poturnajova	ADJ
chd-226	325	2	,	,	PUNCT
chd-226	325	3	m.	m.	NOUN
chd-226	325	4	,	,	PUNCT
chd-226	325	5	kozovska	kozovska	PROPN
chd-226	325	6	,	,	PUNCT
chd-226	325	7	z.	z.	PROPN
chd-226	325	8	,	,	PUNCT
chd-226	325	9	and	and	CCONJ
chd-226	325	10	matuskova	matuskova	NOUN
chd-226	325	11	,	,	PUNCT
chd-226	325	12	m.	m.	NOUN
chd-226	325	13	(	(	PUNCT
chd-226	325	14	2021	2021	NUM
chd-226	325	15	)	)	PUNCT
chd-226	325	16	.	.	PUNCT
chd-226	326	1	aldehyde	aldehyde	NOUN
chd-226	326	2	dehydrogenase	dehydrogenase	NOUN
chd-226	326	3	1a1	1a1	NUM
chd-226	326	4	and	and	CCONJ
chd-226	326	5	1a3	1a3	NUM
chd-226	326	6	isoforms	isoform	NOUN
chd-226	326	7	mechanism	mechanism	NOUN
chd-226	326	8	of	of	ADP
chd-226	326	9	activation	activation	NOUN
chd-226	326	10	and	and	CCONJ
chd-226	326	11	regulation	regulation	NOUN
chd-226	326	12	in	in	ADP
chd-226	326	13	cancer	cancer	NOUN
chd-226	326	14	.	.	PUNCT
chd-226	327	1	cell	cell	NOUN
chd-226	327	2	signal	signal	VERB
chd-226	327	3	87	87	NUM
chd-226	327	4	,	,	PUNCT
chd-226	327	5	110120	110120	NUM
chd-226	327	6	.	.	PUNCT
chd-226	328	1	https://www.ncbi.nlm.nih.gov/pubmed/34428540	https://www.ncbi.nlm.nih.gov/pubmed/34428540	X
chd-226	328	2	.	.	PUNCT
chd-226	329	1	reichert	reichert	PROPN
chd-226	329	2	,	,	PUNCT
chd-226	329	3	b.	b.	PROPN
chd-226	329	4	,	,	PUNCT
chd-226	329	5	yasmeen	yasmeen	PROPN
chd-226	329	6	,	,	PUNCT
chd-226	329	7	r.	r.	PROPN
chd-226	329	8	,	,	PUNCT
chd-226	329	9	jeyakumar	jeyakumar	PROPN
chd-226	329	10	,	,	PUNCT
chd-226	329	11	s.m	s.m	PROPN
chd-226	329	12	.	.	PROPN
chd-226	329	13	,	,	PUNCT
chd-226	329	14	yang	yang	PROPN
chd-226	329	15	,	,	PUNCT
chd-226	329	16	f.	f.	PROPN
chd-226	329	17	,	,	PUNCT
chd-226	329	18	thomou	thomou	ADV
chd-226	329	19	,	,	PUNCT
chd-226	329	20	t.	t.	PROPN
chd-226	329	21	,	,	PUNCT
chd-226	329	22	alder	alder	NOUN
chd-226	329	23	,	,	PUNCT
chd-226	329	24	h.	h.	PROPN
chd-226	329	25	,	,	PUNCT
chd-226	329	26	duester	duester	PROPN
chd-226	329	27	,	,	PUNCT
chd-226	329	28	g.	g.	PROPN
chd-226	329	29	,	,	PUNCT
chd-226	329	30	maiseyeu	maiseyeu	PROPN
chd-226	329	31	,	,	PUNCT
chd-226	329	32	a.	a.	PROPN
chd-226	329	33	,	,	PUNCT
chd-226	329	34	mihai	mihai	PROPN
chd-226	329	35	,	,	PUNCT
chd-226	329	36	g.	g.	PROPN
chd-226	329	37	,	,	PUNCT
chd-226	329	38	harrison	harrison	PROPN
chd-226	329	39	,	,	PUNCT
chd-226	329	40	e.h	e.h	PROPN
chd-226	329	41	.	.	PROPN
chd-226	329	42	,	,	PUNCT
chd-226	329	43	et	et	PROPN
chd-226	329	44	al	al	PROPN
chd-226	329	45	.	.	PUNCT
chd-226	329	46	(	(	PUNCT
chd-226	329	47	2011	2011	NUM
chd-226	329	48	)	)	PUNCT
chd-226	329	49	.	.	PUNCT
chd-226	330	1	concerted	concerted	ADJ
chd-226	330	2	action	action	NOUN
chd-226	330	3	of	of	ADP
chd-226	330	4	aldehyde	aldehyde	NOUN
chd-226	330	5	dehydrogenases	dehydrogenase	VERB
chd-226	330	6	influences	influence	VERB
chd-226	330	7	depot	depot	NOUN
chd-226	330	8	-	-	PUNCT
chd-226	330	9	specific	specific	ADJ
chd-226	330	10	fat	fat	ADJ
chd-226	330	11	formation	formation	NOUN
chd-226	330	12	.	.	PUNCT
chd-226	331	1	mol	mol	ADP
chd-226	331	2	endocrinol	endocrinol	NOUN
chd-226	331	3	25	25	NUM
chd-226	331	4	,	,	PUNCT
chd-226	331	5	799	799	NUM
chd-226	331	6	-	-	SYM
chd-226	331	7	809	809	NUM
chd-226	331	8	.	.	PUNCT
chd-226	331	9	https://www.ncbi.nlm	https://www.ncbi.nlm	X
chd-226	331	10	.	.	PUNCT
chd-226	332	1	nih.gov/pubmed/21436255	nih.gov/pubmed/21436255	PROPN
chd-226	332	2	.	.	PROPN
chd-226	332	3	schwartz	schwartz	PROPN
chd-226	332	4	,	,	PUNCT
chd-226	332	5	t.	t.	PROPN
chd-226	332	6	,	,	PUNCT
chd-226	332	7	stark	stark	PROPN
chd-226	332	8	,	,	PUNCT
chd-226	332	9	a.	a.	NOUN
chd-226	332	10	,	,	PUNCT
chd-226	332	11	pang	pang	NOUN
chd-226	332	12	,	,	PUNCT
chd-226	332	13	j.	j.	PROPN
chd-226	332	14	,	,	PUNCT
chd-226	332	15	awuah	awuah	PROPN
chd-226	332	16	,	,	PUNCT
chd-226	332	17	b.	b.	PROPN
chd-226	332	18	,	,	PUNCT
chd-226	332	19	kleer	kleer	PROPN
chd-226	332	20	,	,	PUNCT
chd-226	332	21	c.g	c.g	PROPN
chd-226	332	22	.	.	PROPN
chd-226	332	23	,	,	PUNCT
chd-226	332	24	quayson	quayson	PROPN
chd-226	332	25	,	,	PUNCT
chd-226	332	26	s.	s.	PROPN
chd-226	332	27	,	,	PUNCT
chd-226	332	28	kingman	kingman	PROPN
chd-226	332	29	,	,	PUNCT
chd-226	332	30	s.	s.	PROPN
chd-226	332	31	,	,	PUNCT
chd-226	332	32	aitpillah	aitpillah	PROPN
chd-226	332	33	,	,	PUNCT
chd-226	332	34	f.	f.	PROPN
chd-226	332	35	,	,	PUNCT
chd-226	332	36	abantanga	abantanga	PROPN
chd-226	332	37	,	,	PUNCT
chd-226	332	38	f.	f.	PROPN
chd-226	332	39	,	,	PUNCT
chd-226	332	40	jiagge	jiagge	PROPN
chd-226	332	41	,	,	PUNCT
chd-226	332	42	e.	e.	PROPN
chd-226	332	43	,	,	PUNCT
chd-226	332	44	et	et	PROPN
chd-226	332	45	al	al	PROPN
chd-226	332	46	.	.	PROPN
chd-226	333	1	(	(	PUNCT
chd-226	333	2	2013	2013	NUM
chd-226	333	3	)	)	PUNCT
chd-226	333	4	.	.	PUNCT
chd-226	334	1	expression	expression	NOUN
chd-226	334	2	of	of	ADP
chd-226	334	3	aldehyde	aldehyde	NOUN
chd-226	334	4	dehydrogenase	dehydrogenase	NOUN
chd-226	334	5	1	1	NUM
chd-226	334	6	as	as	ADP
chd-226	334	7	a	a	DET
chd-226	334	8	marker	marker	NOUN
chd-226	334	9	of	of	ADP
chd-226	334	10	mammary	mammary	ADJ
chd-226	334	11	stem	stem	NOUN
chd-226	334	12	cells	cell	NOUN
chd-226	334	13	in	in	ADP
chd-226	334	14	benign	benign	ADJ
chd-226	334	15	and	and	CCONJ
chd-226	334	16	malignant	malignant	ADJ
chd-226	334	17	breast	breast	NOUN
chd-226	334	18	lesions	lesion	NOUN
chd-226	334	19	of	of	ADP
chd-226	334	20	ghanaian	ghanaian	ADJ
chd-226	334	21	women	woman	NOUN
chd-226	334	22	.	.	PUNCT
chd-226	335	1	cancer	cancer	NOUN
chd-226	335	2	119	119	NUM
chd-226	335	3	,	,	PUNCT
chd-226	335	4	488	488	NUM
chd-226	335	5	-	-	SYM
chd-226	335	6	494	494	NUM
chd-226	335	7	.	.	PUNCT
chd-226	335	8	https://www.ncbi.nlm.nih	https://www.ncbi.nlm.nih	PROPN
chd-226	335	9	.gov	.gov	ADJ
chd-226	335	10	/	/	SYM
chd-226	335	11	pubmed/22930220	pubmed/22930220	PROPN
chd-226	335	12	.	.	PUNCT
chd-226	336	1	siddharth	siddharth	PROPN
chd-226	336	2	,	,	PUNCT
chd-226	336	3	s.	s.	PROPN
chd-226	336	4	,	,	PUNCT
chd-226	336	5	parida	parida	PROPN
chd-226	336	6	,	,	PUNCT
chd-226	336	7	s.	s.	PROPN
chd-226	336	8	,	,	PUNCT
chd-226	336	9	muniraj	muniraj	PROPN
chd-226	336	10	,	,	PUNCT
chd-226	336	11	n.	n.	PROPN
chd-226	336	12	,	,	PUNCT
chd-226	336	13	hercules	hercules	PROPN
chd-226	336	14	,	,	PUNCT
chd-226	336	15	s.	s.	PROPN
chd-226	336	16	,	,	PUNCT
chd-226	336	17	lim	lim	PROPN
chd-226	336	18	,	,	PUNCT
chd-226	336	19	d.	d.	PROPN
chd-226	336	20	,	,	PUNCT
chd-226	336	21	nagalingam	nagalingam	PROPN
chd-226	336	22	,	,	PUNCT
chd-226	336	23	a.	a.	PROPN
chd-226	336	24	,	,	PUNCT
chd-226	336	25	wang	wang	PROPN
chd-226	336	26	,	,	PUNCT
chd-226	336	27	c.	c.	PROPN
chd-226	336	28	,	,	PUNCT
chd-226	336	29	gyorffy	gyorffy	PROPN
chd-226	336	30	,	,	PUNCT
chd-226	336	31	b.	b.	PROPN
chd-226	336	32	,	,	PUNCT
chd-226	336	33	daniel	daniel	PROPN
chd-226	336	34	,	,	PUNCT
chd-226	336	35	j.m	j.m	PROPN
chd-226	336	36	.	.	PROPN
chd-226	336	37	,	,	PUNCT
chd-226	336	38	and	and	CCONJ
chd-226	336	39	sharma	sharma	PROPN
chd-226	336	40	,	,	PUNCT
chd-226	336	41	d.	d.	PROPN
chd-226	336	42	(	(	PUNCT
chd-226	336	43	2021	2021	NUM
chd-226	336	44	)	)	PUNCT
chd-226	336	45	.	.	PUNCT
chd-226	337	1	concomitant	concomitant	ADJ
chd-226	337	2	activation	activation	NOUN
chd-226	337	3	of	of	ADP
chd-226	337	4	gli1	gli1	NOUN
chd-226	337	5	and	and	CCONJ
chd-226	337	6	notch1	notch1	NOUN
chd-226	337	7	contributes	contribute	VERB
chd-226	337	8	to	to	ADP
chd-226	337	9	racial	racial	ADJ
chd-226	337	10	disparity	disparity	NOUN
chd-226	337	11	of	of	ADP
chd-226	337	12	human	human	ADJ
chd-226	337	13	triple	triple	ADJ
chd-226	337	14	negative	negative	ADJ
chd-226	337	15	breast	breast	NOUN
chd-226	337	16	cancer	cancer	NOUN
chd-226	337	17	progression	progression	NOUN
chd-226	337	18	.	.	PUNCT
chd-226	338	1	elife	elife	NOUN
chd-226	338	2	10	10	NUM
chd-226	338	3	.	.	PUNCT
chd-226	339	1	https://www.ncbi.nlm.nih.gov/pubmed/34889737	https://www.ncbi.nlm.nih.gov/pubmed/34889737	PROPN
chd-226	339	2	.	.	PUNCT
chd-226	339	3	silber	silber	PROPN
chd-226	339	4	,	,	PUNCT
chd-226	339	5	j.h	j.h	PROPN
chd-226	339	6	.	.	PROPN
chd-226	339	7	,	,	PUNCT
chd-226	339	8	rosenbaum	rosenbaum	PROPN
chd-226	339	9	,	,	PUNCT
chd-226	339	10	p.r	p.r	PROPN
chd-226	339	11	.	.	PROPN
chd-226	339	12	,	,	PUNCT
chd-226	339	13	clark	clark	PROPN
chd-226	339	14	,	,	PUNCT
chd-226	339	15	a.s	a.s	PROPN
chd-226	339	16	.	.	PROPN
chd-226	339	17	,	,	PUNCT
chd-226	339	18	giantonio	giantonio	PROPN
chd-226	339	19	,	,	PUNCT
chd-226	339	20	b.j	b.j	PROPN
chd-226	339	21	.	.	PROPN
chd-226	339	22	,	,	PUNCT
chd-226	339	23	ross	ross	PROPN
chd-226	339	24	,	,	PUNCT
chd-226	339	25	r.n	r.n	PROPN
chd-226	339	26	.	.	PROPN
chd-226	339	27	,	,	PUNCT
chd-226	339	28	teng	teng	PROPN
chd-226	339	29	,	,	PUNCT
chd-226	339	30	y.	y.	PROPN
chd-226	339	31	,	,	PUNCT
chd-226	339	32	wang	wang	PROPN
chd-226	339	33	,	,	PUNCT
chd-226	339	34	m.	m.	NOUN
chd-226	339	35	,	,	PUNCT
chd-226	339	36	niknam	niknam	PROPN
chd-226	339	37	,	,	PUNCT
chd-226	339	38	b.a	b.a	PROPN
chd-226	339	39	.	.	PROPN
chd-226	339	40	,	,	PUNCT
chd-226	339	41	ludwig	ludwig	PROPN
chd-226	339	42	,	,	PUNCT
chd-226	339	43	j.m	j.m	PROPN
chd-226	339	44	.	.	PROPN
chd-226	339	45	,	,	PUNCT
chd-226	339	46	wang	wang	PROPN
chd-226	339	47	,	,	PUNCT
chd-226	339	48	w.	w.	PROPN
chd-226	339	49	,	,	PUNCT
chd-226	339	50	et	et	PROPN
chd-226	339	51	al	al	PROPN
chd-226	339	52	.	.	PROPN
chd-226	339	53	(	(	PUNCT
chd-226	339	54	2013	2013	NUM
chd-226	339	55	)	)	PUNCT
chd-226	339	56	.	.	PUNCT
chd-226	340	1	characteristics	characteristic	NOUN
chd-226	340	2	associated	associate	VERB
chd-226	340	3	with	with	ADP
chd-226	340	4	differences	difference	NOUN
chd-226	340	5	in	in	ADP
chd-226	340	6	survival	survival	NOUN
chd-226	340	7	among	among	ADP
chd-226	340	8	black	black	ADJ
chd-226	340	9	and	and	CCONJ
chd-226	340	10	white	white	ADJ
chd-226	340	11	women	woman	NOUN
chd-226	340	12	with	with	ADP
chd-226	340	13	breast	breast	NOUN
chd-226	340	14	cancer	cancer	NOUN
chd-226	340	15	.	.	PUNCT
chd-226	341	1	jama	jama	PROPN
chd-226	341	2	310	310	NUM
chd-226	341	3	,	,	PUNCT
chd-226	341	4	389	389	NUM
chd-226	341	5	-	-	SYM
chd-226	341	6	397	397	NUM
chd-226	341	7	.	.	PUNCT
chd-226	342	1	https://www.ncbi.nlm.nih.gov/pubmed/23917289	https://www.ncbi.nlm.nih.gov/pubmed/23917289	PROPN
chd-226	342	2	.	.	PUNCT
chd-226	342	3	sjostrom	sjostrom	PROPN
chd-226	342	4	,	,	PUNCT
chd-226	342	5	m.	m.	NOUN
chd-226	342	6	,	,	PUNCT
chd-226	342	7	hartman	hartman	PROPN
chd-226	342	8	,	,	PUNCT
chd-226	342	9	l.	l.	PROPN
chd-226	342	10	,	,	PUNCT
chd-226	342	11	honeth	honeth	PROPN
chd-226	342	12	,	,	PUNCT
chd-226	342	13	g.	g.	PROPN
chd-226	342	14	,	,	PUNCT
chd-226	342	15	grabau	grabau	PROPN
chd-226	342	16	,	,	PUNCT
chd-226	342	17	d.	d.	PROPN
chd-226	342	18	,	,	PUNCT
chd-226	342	19	malmstrom	malmstrom	NOUN
chd-226	342	20	,	,	PUNCT
chd-226	342	21	p.	p.	NOUN
chd-226	342	22	,	,	PUNCT
chd-226	342	23	hegardt	hegardt	PROPN
chd-226	342	24	,	,	PUNCT
chd-226	342	25	c.	c.	PROPN
chd-226	342	26	,	,	PUNCT
chd-226	342	27	ferno	ferno	PROPN
chd-226	342	28	,	,	PUNCT
chd-226	342	29	m.	m.	NOUN
chd-226	342	30	,	,	PUNCT
chd-226	342	31	and	and	CCONJ
chd-226	342	32	nimeus	nimeus	PROPN
chd-226	342	33	,	,	PUNCT
chd-226	342	34	e.	e.	PROPN
chd-226	342	35	(	(	PUNCT
chd-226	342	36	2015	2015	NUM
chd-226	342	37	)	)	PUNCT
chd-226	342	38	.	.	PUNCT
chd-226	343	1	stem	stem	NOUN
chd-226	343	2	cell	cell	NOUN
chd-226	343	3	biomarker	biomarker	NOUN
chd-226	343	4	aldh1a1	aldh1a1	ADV
chd-226	343	5	in	in	ADP
chd-226	343	6	breast	breast	NOUN
chd-226	343	7	cancer	cancer	NOUN
chd-226	343	8	shows	show	VERB
chd-226	343	9	an	an	DET
chd-226	343	10	association	association	NOUN
chd-226	343	11	with	with	ADP
chd-226	343	12	prognosis	prognosis	NOUN
chd-226	343	13	and	and	CCONJ
chd-226	343	14	clinicopathological	clinicopathological	ADJ
chd-226	343	15	variables	variable	NOUN
chd-226	343	16	that	that	PRON
chd-226	343	17	is	be	AUX
chd-226	343	18	highly	highly	ADV
chd-226	343	19	cut	cut	VERB
chd-226	343	20	-	-	PUNCT
chd-226	343	21	off	off	ADP
chd-226	343	22	dependent	dependent	ADJ
chd-226	343	23	.	.	PUNCT
chd-226	344	1	j	j	PROPN
chd-226	344	2	clin	clin	PROPN
chd-226	344	3	pathol	pathol	VERB
chd-226	344	4	68	68	NUM
chd-226	344	5	,	,	PUNCT
chd-226	344	6	1012	1012	NUM
chd-226	344	7	-	-	SYM
chd-226	344	8	1019	1019	NUM
chd-226	344	9	.	.	PUNCT
chd-226	345	1	https://www.ncbi.nlm.nih.gov/pubmed/	https://www.ncbi.nlm.nih.gov/pubmed/	PROPN
chd-226	345	2	26175266	26175266	NUM
chd-226	345	3	.	.	PUNCT
chd-226	346	1	spence	spence	PROPN
chd-226	346	2	,	,	PUNCT
chd-226	346	3	j.p	j.p	PROPN
chd-226	346	4	.	.	PROPN
chd-226	346	5	,	,	PUNCT
chd-226	346	6	liang	liang	PROPN
chd-226	346	7	,	,	PUNCT
chd-226	346	8	t.	t.	PROPN
chd-226	346	9	,	,	PUNCT
chd-226	346	10	eriksson	eriksson	PROPN
chd-226	346	11	,	,	PUNCT
chd-226	346	12	c.j	c.j	PROPN
chd-226	346	13	.	.	PROPN
chd-226	346	14	,	,	PUNCT
chd-226	346	15	taylor	taylor	PROPN
chd-226	346	16	,	,	PUNCT
chd-226	346	17	r.e	r.e	PROPN
chd-226	346	18	.	.	PROPN
chd-226	346	19	,	,	PUNCT
chd-226	346	20	wall	wall	PROPN
chd-226	346	21	,	,	PUNCT
chd-226	346	22	t.l	t.l	PROPN
chd-226	346	23	.	.	PROPN
chd-226	346	24	,	,	PUNCT
chd-226	346	25	ehlers	ehlers	PROPN
chd-226	346	26	,	,	PUNCT
chd-226	346	27	c.l	c.l	PROPN
chd-226	346	28	.	.	PROPN
chd-226	346	29	,	,	PUNCT
chd-226	346	30	and	and	CCONJ
chd-226	346	31	carr	carr	PROPN
chd-226	346	32	,	,	PUNCT
chd-226	346	33	l.g	l.g	PROPN
chd-226	346	34	.	.	PROPN
chd-226	346	35	(	(	PUNCT
chd-226	346	36	2003	2003	NUM
chd-226	346	37	)	)	PUNCT
chd-226	346	38	.	.	PUNCT
chd-226	347	1	evaluation	evaluation	NOUN
chd-226	347	2	of	of	ADP
chd-226	347	3	aldehyde	aldehyde	NOUN
chd-226	347	4	dehydrogenase	dehydrogenase	NOUN
chd-226	347	5	1	1	NUM
chd-226	347	6	promoter	promoter	NOUN
chd-226	347	7	polymorphisms	polymorphism	NOUN
chd-226	347	8	identified	identify	VERB
chd-226	347	9	in	in	ADP
chd-226	347	10	human	human	ADJ
chd-226	347	11	populations	population	NOUN
chd-226	347	12	.	.	PUNCT
chd-226	348	1	alcohol	alcohol	PROPN
chd-226	348	2	clin	clin	PROPN
chd-226	348	3	exp	exp	PROPN
chd-226	348	4	res	re	NOUN
chd-226	348	5	27	27	NUM
chd-226	348	6	,	,	PUNCT
chd-226	348	7	1389	1389	NUM
chd-226	348	8	-	-	SYM
chd-226	348	9	1394	1394	NUM
chd-226	348	10	.	.	PUNCT
chd-226	349	1	https://www.ncbi.nlm.nih.gov/pubmed/14506398	https://www.ncbi.nlm.nih.gov/pubmed/14506398	X
chd-226	349	2	.	.	PUNCT
chd-226	350	1	srinivasan	srinivasan	NOUN
chd-226	350	2	,	,	PUNCT
chd-226	350	3	s.	s.	PROPN
chd-226	350	4	,	,	PUNCT
chd-226	350	5	dubey	dubey	PROPN
chd-226	350	6	,	,	PUNCT
chd-226	350	7	k.k	k.k	PROPN
chd-226	350	8	.	.	PROPN
chd-226	350	9	,	,	PUNCT
chd-226	350	10	and	and	CCONJ
chd-226	350	11	singhal	singhal	PROPN
chd-226	350	12	,	,	PUNCT
chd-226	350	13	r.s	r.s	PROPN
chd-226	350	14	.	.	PROPN
chd-226	350	15	(	(	PUNCT
chd-226	350	16	2019	2019	NUM
chd-226	350	17	)	)	PUNCT
chd-226	350	18	.	.	PUNCT
chd-226	351	1	influence	influence	NOUN
chd-226	351	2	of	of	ADP
chd-226	351	3	food	food	NOUN
chd-226	351	4	commodities	commodity	NOUN
chd-226	351	5	on	on	ADP
chd-226	351	6	hangover	hangover	NOUN
chd-226	351	7	based	base	VERB
chd-226	351	8	on	on	ADP
chd-226	351	9	alcohol	alcohol	NOUN
chd-226	351	10	dehydrogenase	dehydrogenase	NOUN
chd-226	351	11	and	and	CCONJ
chd-226	351	12	aldehyde	aldehyde	NOUN
chd-226	351	13	dehydrogenase	dehydrogenase	NOUN
chd-226	351	14	activities	activity	NOUN
chd-226	351	15	.	.	PUNCT
chd-226	352	1	curr	curr	PROPN
chd-226	352	2	res	res	PROPN
chd-226	352	3	food	food	NOUN
chd-226	352	4	sci	sci	PROPN
chd-226	352	5	1	1	NUM
chd-226	352	6	,	,	PUNCT
chd-226	352	7	8	8	NUM
chd-226	352	8	-	-	SYM
chd-226	352	9	16	16	NUM
chd-226	352	10	.	.	PUNCT
chd-226	353	1	https://www.ncbi.nlm.nih.gov/pubmed/32914100	https://www.ncbi.nlm.nih.gov/pubmed/32914100	X
chd-226	353	2	.	.	PUNCT
chd-226	353	3	stringer	stringer	NOUN
chd-226	353	4	-	-	PUNCT
chd-226	353	5	reasor	reasor	PROPN
chd-226	353	6	,	,	PUNCT
chd-226	353	7	e.m	e.m	PROPN
chd-226	353	8	.	.	PROPN
chd-226	353	9	,	,	PUNCT
chd-226	353	10	elkhanany	elkhanany	NOUN
chd-226	353	11	,	,	PUNCT
chd-226	353	12	a.	a.	NOUN
chd-226	353	13	,	,	PUNCT
chd-226	353	14	khoury	khoury	PROPN
chd-226	353	15	,	,	PUNCT
chd-226	353	16	k.	k.	PROPN
chd-226	353	17	,	,	PUNCT
chd-226	353	18	simon	simon	PROPN
chd-226	353	19	,	,	PUNCT
chd-226	353	20	m.a	m.a	PROPN
chd-226	353	21	.	.	PROPN
chd-226	353	22	,	,	PUNCT
chd-226	353	23	and	and	CCONJ
chd-226	353	24	newman	newman	PROPN
chd-226	353	25	,	,	PUNCT
chd-226	353	26	l.a	l.a	PROPN
chd-226	353	27	.	.	PROPN
chd-226	353	28	(	(	PUNCT
chd-226	353	29	2021	2021	NUM
chd-226	353	30	)	)	PUNCT
chd-226	353	31	.	.	PUNCT
chd-226	354	1	disparities	disparity	NOUN
chd-226	354	2	in	in	ADP
chd-226	354	3	breast	breast	NOUN
chd-226	354	4	cancer	cancer	NOUN
chd-226	354	5	associated	associate	VERB
chd-226	354	6	with	with	ADP
chd-226	354	7	african	african	ADJ
chd-226	354	8	american	american	ADJ
chd-226	354	9	identity	identity	NOUN
chd-226	354	10	.	.	PUNCT
chd-226	355	1	am	be	AUX
chd-226	355	2	soc	soc	PROPN
chd-226	355	3	clin	clin	PROPN
chd-226	355	4	oncol	oncol	PROPN
chd-226	355	5	educ	educ	VERB
chd-226	355	6	book	book	NOUN
chd-226	355	7	41	41	NUM
chd-226	355	8	,	,	PUNCT
chd-226	355	9	e29	e29	PROPN
chd-226	355	10	-	-	PUNCT
chd-226	355	11	e46	e46	NOUN
chd-226	355	12	.	.	PUNCT
chd-226	356	1	https://www.ncbi.nlm.nih.gov/pubmed/34161138	https://www.ncbi.nlm.nih.gov/pubmed/34161138	PROPN
chd-226	356	2	.	.	PUNCT
chd-226	357	1	troester	troester	PROPN
chd-226	357	2	,	,	PUNCT
chd-226	357	3	m.a	m.a	PROPN
chd-226	357	4	.	.	PROPN
chd-226	357	5	,	,	PUNCT
chd-226	357	6	sun	sun	PROPN
chd-226	357	7	,	,	PUNCT
chd-226	357	8	x.	x.	NOUN
chd-226	357	9	,	,	PUNCT
chd-226	357	10	allott	allott	PROPN
chd-226	357	11	,	,	PUNCT
chd-226	357	12	e.h	e.h	PROPN
chd-226	357	13	.	.	PROPN
chd-226	357	14	,	,	PUNCT
chd-226	357	15	geradts	geradts	PROPN
chd-226	357	16	,	,	PUNCT
chd-226	357	17	j.	j.	PROPN
chd-226	357	18	,	,	PUNCT
chd-226	357	19	cohen	cohen	PROPN
chd-226	357	20	,	,	PUNCT
chd-226	357	21	s.m	s.m	PROPN
chd-226	357	22	.	.	PROPN
chd-226	357	23	,	,	PUNCT
chd-226	357	24	tse	tse	PROPN
chd-226	357	25	,	,	PUNCT
chd-226	357	26	c.k	c.k	PROPN
chd-226	357	27	.	.	PROPN
chd-226	357	28	,	,	PUNCT
chd-226	357	29	kirk	kirk	PROPN
chd-226	357	30	,	,	PUNCT
chd-226	357	31	e.l	e.l	PROPN
chd-226	357	32	.	.	PROPN
chd-226	357	33	,	,	PUNCT
chd-226	357	34	thorne	thorne	PROPN
chd-226	357	35	,	,	PUNCT
chd-226	357	36	l.b	l.b	PROPN
chd-226	357	37	.	.	PROPN
chd-226	357	38	,	,	PUNCT
chd-226	357	39	mathews	mathews	PROPN
chd-226	357	40	,	,	PUNCT
chd-226	357	41	m.	m.	NOUN
chd-226	357	42	,	,	PUNCT
chd-226	357	43	li	li	PROPN
chd-226	357	44	,	,	PUNCT
chd-226	357	45	y.	y.	PROPN
chd-226	357	46	,	,	PUNCT
chd-226	357	47	et	et	PROPN
chd-226	357	48	al	al	PROPN
chd-226	357	49	.	.	PUNCT
chd-226	358	1	(	(	PUNCT
chd-226	358	2	2018	2018	NUM
chd-226	358	3	)	)	PUNCT
chd-226	358	4	.	.	PUNCT
chd-226	359	1	racial	racial	ADJ
chd-226	359	2	differences	difference	NOUN
chd-226	359	3	in	in	ADP
chd-226	359	4	pam50	pam50	PROPN
chd-226	359	5	subtypes	subtype	NOUN
chd-226	359	6	in	in	ADP
chd-226	359	7	the	the	DET
chd-226	359	8	carolina	carolina	PROPN
chd-226	359	9	breast	breast	PROPN
chd-226	359	10	cancer	cancer	NOUN
chd-226	359	11	study	study	NOUN
chd-226	359	12	.	.	PUNCT
chd-226	360	1	j	j	PROPN
chd-226	360	2	natl	natl	PROPN
chd-226	360	3	cancer	cancer	PROPN
chd-226	360	4	inst	inst	PROPN
chd-226	360	5	110	110	NUM
chd-226	360	6	.	.	PUNCT
chd-226	361	1	https://www.ncbi.nlm.nih.gov/pubmed/28859290	https://www.ncbi.nlm.nih.gov/pubmed/28859290	X
chd-226	361	2	.	.	PUNCT
chd-226	362	1	wang	wang	PROPN
chd-226	362	2	,	,	PUNCT
chd-226	362	3	b.	b.	PROPN
chd-226	362	4	,	,	PUNCT
chd-226	362	5	wang	wang	PROPN
chd-226	362	6	,	,	PUNCT
chd-226	362	7	z.	z.	PROPN
chd-226	362	8	,	,	PUNCT
chd-226	362	9	de	de	PROPN
chd-226	362	10	avila	avila	PROPN
chd-226	362	11	,	,	PUNCT
chd-226	362	12	j.m	j.m	PROPN
chd-226	362	13	.	.	PROPN
chd-226	362	14	,	,	PUNCT
chd-226	362	15	zhu	zhu	PROPN
chd-226	362	16	,	,	PUNCT
chd-226	362	17	m.j	m.j	PROPN
chd-226	362	18	.	.	PROPN
chd-226	362	19	,	,	PUNCT
chd-226	362	20	zhang	zhang	PROPN
chd-226	362	21	,	,	PUNCT
chd-226	362	22	f.	f.	PROPN
chd-226	362	23	,	,	PUNCT
chd-226	362	24	gomez	gomez	PROPN
chd-226	362	25	,	,	PUNCT
chd-226	362	26	n.a	n.a	PROPN
chd-226	362	27	.	.	PROPN
chd-226	362	28	,	,	PUNCT
chd-226	362	29	zhao	zhao	PROPN
chd-226	362	30	,	,	PUNCT
chd-226	362	31	l.	l.	PROPN
chd-226	362	32	,	,	PUNCT
chd-226	362	33	tian	tian	PROPN
chd-226	362	34	,	,	PUNCT
chd-226	362	35	q.	q.	PROPN
chd-226	362	36	,	,	PUNCT
chd-226	362	37	zhao	zhao	PROPN
chd-226	362	38	,	,	PUNCT
chd-226	362	39	j.	j.	PROPN
chd-226	362	40	,	,	PUNCT
chd-226	362	41	maricelli	maricelli	PROPN
chd-226	362	42	,	,	PUNCT
chd-226	362	43	j.	j.	PROPN
chd-226	362	44	,	,	PUNCT
chd-226	362	45	et	et	PROPN
chd-226	362	46	al	al	PROPN
chd-226	362	47	.	.	PUNCT
chd-226	362	48	(	(	PUNCT
chd-226	362	49	2017	2017	NUM
chd-226	362	50	)	)	PUNCT
chd-226	362	51	.	.	PUNCT
chd-226	363	1	moderate	moderate	ADJ
chd-226	363	2	alcohol	alcohol	PROPN
chd-226	363	3	intake	intake	NOUN
chd-226	363	4	induces	induce	VERB
chd-226	363	5	thermogenic	thermogenic	ADJ
chd-226	363	6	brown	brown	ADJ
chd-226	363	7	/	/	SYM
chd-226	363	8	beige	beige	ADJ
chd-226	363	9	adipocyte	adipocyte	NOUN
chd-226	363	10	formation	formation	NOUN
chd-226	363	11	via	via	ADP
chd-226	363	12	elevating	elevate	VERB
chd-226	363	13	retinoic	retinoic	ADJ
chd-226	363	14	acid	acid	PROPN
chd-226	363	15	signaling	signaling	NOUN
chd-226	363	16	.	.	PUNCT
chd-226	364	1	faseb	faseb	PROPN
chd-226	364	2	j	j	PROPN
chd-226	364	3	31	31	NUM
chd-226	364	4	,	,	PUNCT
chd-226	364	5	4612	4612	NUM
chd-226	364	6	-	-	SYM
chd-226	364	7	4622	4622	NUM
chd-226	364	8	.	.	PUNCT
chd-226	365	1	https://www.ncbi.nlm.nih.gov/pubmed/28679528	https://www.ncbi.nlm.nih.gov/pubmed/28679528	X
chd-226	365	2	.	.	PUNCT
chd-226	366	1	yasmeen	yasmeen	PROPN
chd-226	366	2	,	,	PUNCT
chd-226	366	3	r.	r.	PROPN
chd-226	366	4	,	,	PUNCT
chd-226	366	5	reichert	reichert	PROPN
chd-226	366	6	,	,	PUNCT
chd-226	366	7	b.	b.	PROPN
chd-226	366	8	,	,	PUNCT
chd-226	366	9	deiuliis	deiuliis	PROPN
chd-226	366	10	,	,	PUNCT
chd-226	366	11	j.	j.	PROPN
chd-226	366	12	,	,	PUNCT
chd-226	366	13	yang	yang	PROPN
chd-226	366	14	,	,	PUNCT
chd-226	366	15	f.	f.	PROPN
chd-226	366	16	,	,	PUNCT
chd-226	366	17	lynch	lynch	PROPN
chd-226	366	18	,	,	PUNCT
chd-226	366	19	a.	a.	PROPN
chd-226	366	20	,	,	PUNCT
chd-226	366	21	meyers	meyers	PROPN
chd-226	366	22	,	,	PUNCT
chd-226	366	23	j.	j.	PROPN
chd-226	366	24	,	,	PUNCT
chd-226	366	25	sharlach	sharlach	NOUN
chd-226	366	26	,	,	PUNCT
chd-226	366	27	m.	m.	NOUN
chd-226	366	28	,	,	PUNCT
chd-226	366	29	shin	shin	PROPN
chd-226	366	30	,	,	PUNCT
chd-226	366	31	s.	s.	PROPN
chd-226	366	32	,	,	PUNCT
chd-226	366	33	volz	volz	PROPN
chd-226	366	34	,	,	PUNCT
chd-226	366	35	k.s	k.s	PROPN
chd-226	366	36	.	.	PROPN
chd-226	366	37	,	,	PUNCT
chd-226	366	38	green	green	PROPN
chd-226	366	39	,	,	PUNCT
chd-226	366	40	k.b	k.b	PROPN
chd-226	366	41	.	.	PROPN
chd-226	366	42	,	,	PUNCT
chd-226	366	43	et	et	PROPN
chd-226	366	44	al	al	PROPN
chd-226	366	45	.	.	PROPN
chd-226	367	1	(	(	PUNCT
chd-226	367	2	2013	2013	NUM
chd-226	367	3	)	)	PUNCT
chd-226	367	4	.	.	PUNCT
chd-226	368	1	autocrine	autocrine	NOUN
chd-226	368	2	function	function	NOUN
chd-226	368	3	of	of	ADP
chd-226	368	4	aldehyde	aldehyde	NOUN
chd-226	368	5	dehydrogenase	dehydrogenase	NOUN
chd-226	368	6	1	1	NUM
chd-226	368	7	as	as	ADP
chd-226	368	8	a	a	DET
chd-226	368	9	determinant	determinant	NOUN
chd-226	368	10	of	of	ADP
chd-226	368	11	dietand	dietand	NOUN
chd-226	368	12	sex	sex	NOUN
chd-226	368	13	-	-	PUNCT
chd-226	368	14	specific	specific	ADJ
chd-226	368	15	differences	difference	NOUN
chd-226	368	16	in	in	ADP
chd-226	368	17	visceral	visceral	ADJ
chd-226	368	18	adiposity	adiposity	NOUN
chd-226	368	19	.	.	PUNCT
chd-226	369	1	diabetes	diabetes	NOUN
chd-226	369	2	62	62	NUM
chd-226	369	3	,	,	PUNCT
chd-226	369	4	124	124	NUM
chd-226	369	5	-	-	SYM
chd-226	369	6	136	136	NUM
chd-226	369	7	.	.	PUNCT
chd-226	370	1	https://www.ncbi.nlm.nih.gov/pubmed/22933113	https://www.ncbi.nlm.nih.gov/pubmed/22933113	NUM
chd-226	370	2	.	.	PUNCT
chd-226	371	1	zhao	zhao	PROPN
chd-226	371	2	,	,	PUNCT
chd-226	371	3	p.	p.	PROPN
chd-226	371	4	,	,	PUNCT
chd-226	371	5	xia	xia	PROPN
chd-226	371	6	,	,	PUNCT
chd-226	371	7	n.	n.	PROPN
chd-226	371	8	,	,	PUNCT
chd-226	371	9	zhang	zhang	PROPN
chd-226	371	10	,	,	PUNCT
chd-226	371	11	h.	h.	PROPN
chd-226	371	12	,	,	PUNCT
chd-226	371	13	and	and	CCONJ
chd-226	371	14	deng	deng	PROPN
chd-226	371	15	,	,	PUNCT
chd-226	371	16	t.	t.	PROPN
chd-226	371	17	(	(	PUNCT
chd-226	371	18	2020	2020	NUM
chd-226	371	19	)	)	PUNCT
chd-226	371	20	.	.	PUNCT
chd-226	372	1	the	the	DET
chd-226	372	2	metabolic	metabolic	NOUN
chd-226	372	3	syndrome	syndrome	NOUN
chd-226	372	4	is	be	AUX
chd-226	372	5	a	a	DET
chd-226	372	6	risk	risk	NOUN
chd-226	372	7	factor	factor	NOUN
chd-226	372	8	for	for	ADP
chd-226	372	9	breast	breast	NOUN
chd-226	372	10	cancer	cancer	NOUN
chd-226	372	11	:	:	PUNCT
chd-226	372	12	a	a	DET
chd-226	372	13	systematic	systematic	ADJ
chd-226	372	14	review	review	NOUN
chd-226	372	15	and	and	CCONJ
chd-226	372	16	meta	meta	ADJ
chd-226	372	17	-	-	PUNCT
chd-226	372	18	analysis	analysis	NOUN
chd-226	372	19	.	.	PUNCT
chd-226	373	1	obes	obe	NOUN
chd-226	373	2	facts	fact	VERB
chd-226	373	3	13	13	NUM
chd-226	373	4	,	,	PUNCT
chd-226	373	5	384	384	NUM
chd-226	373	6	-	-	SYM
chd-226	373	7	396	396	NUM
chd-226	373	8	.	.	PUNCT
chd-226	374	1	https://www.ncbi.nlm.nih.gov/pubmed/	https://www.ncbi.nlm.nih.gov/pubmed/	PROPN
chd-226	374	2	32698183	32698183	NUM
chd-226	374	3	.	.	PUNCT
chd-226	375	1	https://www.ncbi.nlm.nih.gov/pubmed/20010944	https://www.ncbi.nlm.nih.gov/pubmed/20010944	X
chd-226	376	1	https://www.ncbi.nlm.nih.gov/pubmed/25540596	https://www.ncbi.nlm.nih.gov/pubmed/25540596	NUM
chd-226	376	2	https://www.ncbi.nlm.nih.gov/pubmed/24594504	https://www.ncbi.nlm.nih.gov/pubmed/24594504	NUM
chd-226	376	3	https://www.ncbi.nlm.nih.gov/pubmed/34428540	https://www.ncbi.nlm.nih.gov/pubmed/34428540	NUM
chd-226	376	4	https://www.ncbi.nlm.nih.gov/pubmed/21436255	https://www.ncbi.nlm.nih.gov/pubmed/21436255	NUM
chd-226	376	5	https://www.ncbi.nlm.nih.gov/pubmed/21436255	https://www.ncbi.nlm.nih.gov/pubmed/21436255	NUM
chd-226	376	6	https://www.ncbi.nlm.nih.gov/pubmed/22930220	https://www.ncbi.nlm.nih.gov/pubmed/22930220	NUM
chd-226	376	7	https://www.ncbi.nlm.nih.gov/pubmed/22930220	https://www.ncbi.nlm.nih.gov/pubmed/22930220	NUM
chd-226	376	8	https://www.ncbi.nlm.nih.gov/pubmed/34889737	https://www.ncbi.nlm.nih.gov/pubmed/34889737	NUM
chd-226	376	9	https://www.ncbi.nlm.nih.gov/pubmed/23917289	https://www.ncbi.nlm.nih.gov/pubmed/23917289	NUM
chd-226	376	10	https://www.ncbi.nlm.nih.gov/pubmed/26175266	https://www.ncbi.nlm.nih.gov/pubmed/26175266	X
chd-226	376	11	https://www.ncbi.nlm.nih.gov/pubmed/26175266	https://www.ncbi.nlm.nih.gov/pubmed/26175266	X
chd-226	376	12	https://www.ncbi.nlm.nih.gov/pubmed/14506398	https://www.ncbi.nlm.nih.gov/pubmed/14506398	X
chd-226	376	13	https://www.ncbi.nlm.nih.gov/pubmed/32914100	https://www.ncbi.nlm.nih.gov/pubmed/32914100	NUM
chd-226	376	14	https://www.ncbi.nlm.nih.gov/pubmed/34161138	https://www.ncbi.nlm.nih.gov/pubmed/34161138	NOUN
chd-226	376	15	https://www.ncbi.nlm.nih.gov/pubmed/28859290	https://www.ncbi.nlm.nih.gov/pubmed/28859290	X
chd-226	377	1	https://www.ncbi.nlm.nih.gov/pubmed/28679528	https://www.ncbi.nlm.nih.gov/pubmed/28679528	NUM
chd-226	377	2	https://www.ncbi.nlm.nih.gov/pubmed/22933113	https://www.ncbi.nlm.nih.gov/pubmed/22933113	NUM
chd-226	377	3	https://www.ncbi.nlm.nih.gov/pubmed/32698183	https://www.ncbi.nlm.nih.gov/pubmed/32698183	NUM
chd-226	377	4	https://www.ncbi.nlm.nih.gov/pubmed/32698183	https://www.ncbi.nlm.nih.gov/pubmed/32698183	NUM
chd-226	377	5	introduction	introduction	NOUN
chd-226	377	6	methods	method	NOUN
chd-226	377	7	patient	patient	VERB
chd-226	377	8	samples	sample	NOUN
chd-226	377	9	and	and	CCONJ
chd-226	377	10	data	datum	NOUN
chd-226	377	11	immunohistochemical	immunohistochemical	ADJ
chd-226	377	12	procedure	procedure	NOUN
chd-226	377	13	statistical	statistical	ADJ
chd-226	377	14	analysis	analysis	NOUN
chd-226	377	15	results	result	VERB
chd-226	377	16	patient	patient	ADJ
chd-226	377	17	characteristics	characteristic	NOUN
chd-226	377	18	strong	strong	ADJ
chd-226	377	19	tumor	tumor	NOUN
chd-226	377	20	aldh1a1	aldh1a1	PUNCT
chd-226	377	21	staining	stain	VERB
chd-226	377	22	is	be	AUX
chd-226	377	23	associated	associate	VERB
chd-226	377	24	with	with	ADP
chd-226	377	25	race	race	NOUN
chd-226	377	26	,	,	PUNCT
chd-226	377	27	stage	stage	NOUN
chd-226	377	28	,	,	PUNCT
chd-226	377	29	obesity	obesity	NOUN
chd-226	377	30	,	,	PUNCT
chd-226	377	31	and	and	CCONJ
chd-226	377	32	diabetes	diabetes	NOUN
chd-226	377	33	.	.	PUNCT
chd-226	378	1	strong	strong	ADJ
chd-226	378	2	tumor	tumor	NOUN
chd-226	378	3	and	and	CCONJ
chd-226	378	4	stromal	stromal	ADJ
chd-226	378	5	aldh1a1	aldh1a1	PUNCT
chd-226	378	6	staining	stain	VERB
chd-226	378	7	are	be	AUX
chd-226	378	8	associated	associate	VERB
chd-226	378	9	with	with	ADP
chd-226	378	10	poor	poor	ADJ
chd-226	378	11	outcomes	outcome	NOUN
chd-226	378	12	discussion	discussion	NOUN
chd-226	378	13	financial	financial	ADJ
chd-226	378	14	support	support	NOUN
chd-226	378	15	acknowledgement	acknowledgement	NOUN
chd-226	378	16	conflicts	conflict	NOUN
chd-226	378	17	of	of	ADP
chd-226	378	18	interest	interest	NOUN
chd-226	378	19	authors	author	NOUN
chd-226	378	20	'	'	PART
chd-226	378	21	contributions	contribution	NOUN